data_1dwm_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1dwm _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.458 ' HA2' ' ND2' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 25.5 ttmt -56.11 142.81 35.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.705 0.288 . . . . 0.0 110.68 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -100.77 -11.34 19.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -155.47 140.2 17.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . 17.1 m-90 -121.2 68.58 18.75 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.434 ' O ' HG21 ' A' ' 14' ' ' VAL . 67.3 Cg_exo -49.74 -36.18 41.07 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.183 1.922 . . . . 0.0 112.177 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -64.12 -8.33 11.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.276 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 17.9 mt -83.71 -20.1 34.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 11' ' ' PRO . 44.1 t -56.57 114.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.823 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -8.1 31.5 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.35 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -99.25 157.9 16.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.312 . . . . 0.0 110.716 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -56.99 139.43 52.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -51.58 -29.16 23.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.512 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.22 -46.69 40.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 tpt -65.25 -33.87 77.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.032 0.444 . . . . 0.0 109.829 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.367 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.71 -42.72 57.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.15 -46.13 91.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.429 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -57.03 -40.47 76.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.0 -54.98 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.315 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -64.76 -26.05 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.609 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -83.46 -56.22 3.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 111.186 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -63.05 -30.52 71.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.073 0.463 . . . . 0.0 110.322 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.5 ' O ' HG21 ' A' ' 32' ' ' VAL . 50.2 t-20 -127.84 85.04 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.783 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -8.17 3.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.233 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -95.04 2.42 55.25 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.698 HG11 ' O ' ' A' ' 49' ' ' CYS . 30.6 m -129.09 167.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 128.44 36.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.673 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.73 144.07 31.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.233 0.54 . . . . 0.0 112.139 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.463 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 20.3 mt -120.19 143.46 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.159 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 58.3 t -97.49 130.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -157.72 151.88 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.97 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -87.31 161.06 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 112.405 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.517 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 5.8 tt0 -54.12 119.29 4.89 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.228 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.02 56.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.685 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t -64.24 131.9 48.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.06 0.457 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.86 81.85 0.11 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.656 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.524 ' HB3' ' CZ2' ' A' ' 53' ' ' TRP . 13.5 mmt -113.94 164.24 14.05 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.886 0.374 . . . . 0.0 111.453 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.2 164.02 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.23 -25.73 7.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.323 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -52.04 171.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 33.4 t80 -97.96 128.4 44.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -143.87 111.2 5.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.501 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.698 ' O ' HG11 ' A' ' 32' ' ' VAL . 18.4 m -60.25 -35.96 76.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 16.2 p-10 -78.81 -3.48 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.442 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.453 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 40.8 ttp180 -123.04 129.99 52.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.194 0.521 . . . . 0.0 111.784 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.16 119.79 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.358 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.524 ' CZ2' ' HB3' ' A' ' 43' ' ' MET . 2.7 m95 -78.9 130.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 55.1 t -113.16 84.38 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.01 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.5 mp -79.87 118.4 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.62 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 29.8 m -122.93 165.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.236 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.17 -172.62 3.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -23.36 61.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.379 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -90.65 2.93 55.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 25.09 64.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.166 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.0 t -100.22 132.88 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 108.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.528 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.6 p -93.06 -33.8 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.155 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 22.9 t -102.2 157.15 17.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 3.1 t -69.58 123.39 88.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 10' ' ' TRP . 91.5 Cg_endo -81.99 101.77 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.313 2.009 . . . . 0.0 110.576 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.7 p-80 -132.26 145.98 51.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.08 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 68' ' ' ILE . 1.1 mt -39.34 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.674 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.78 -179.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-O 120.944 0.191 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 26.2 ttmt -59.62 154.11 18.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.816 0.341 . . . . 0.0 111.31 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -115.92 -5.55 12.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.32 124.61 6.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.0 m-90 -111.4 74.93 1.2 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.869 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.49 -35.67 95.34 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.986 1.791 . . . . 0.0 111.604 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -65.0 -9.89 25.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.861 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.548 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 26.8 mt -82.81 -19.8 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.719 0.295 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -55.47 111.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.6 -9.76 23.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.118 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 6.0 mmtt -95.43 157.84 15.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.297 . . . . 0.0 110.733 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 p -59.51 138.5 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.763 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.25 -31.63 8.92 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.084 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.38 63.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.985 0.421 . . . . 0.0 110.268 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -33.1 75.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.871 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.67 -59.5 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.73 73.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.559 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.22 -46.63 89.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -57.83 -43.75 85.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.452 HG11 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -63.68 -52.05 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -63.82 -29.14 70.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.519 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -78.66 -57.11 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.836 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.4 -35.22 80.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.438 . . . . 0.0 110.454 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -123.16 78.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -3.15 0.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.609 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.64 -5.05 49.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 12.8 m -139.72 168.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -133.58 146.79 51.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.684 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.06 138.72 44.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 3.1 mp -105.09 120.55 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.623 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.5 p -80.43 129.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.46 152.35 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -89.67 155.1 19.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 111.946 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 117.11 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.054 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.98 -1.97 30.09 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 39.7 t -70.11 -172.54 0.56 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.313 . . . . 0.0 110.738 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -88.87 104.82 17.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 100.95 6.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.459 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -58.68 147.55 32.45 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.875 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -80.43 -26.42 38.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.25 161.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.414 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 42.7 t80 -103.81 137.32 41.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -152.49 112.85 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' O ' HG12 ' A' ' 68' ' ' ILE . 50.3 m -58.45 -37.84 76.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 21.7 p-10 -79.36 -2.82 43.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.48 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -120.63 111.47 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.609 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.9 t -113.15 117.64 55.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -78.71 128.79 33.91 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 7.2 t -116.52 98.93 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.87 122.4 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.5 m -126.66 168.35 19.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.423 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.75 -170.93 2.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -18.83 61.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.77 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.56 -1.8 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.14 24.19 38.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.3 t -96.04 131.92 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 16' ' ' LYS . 43.9 t -70.92 112.82 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 111.378 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -97.14 -33.07 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 6.8 t -97.86 149.94 21.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.218 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.92 108.36 2.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.541 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 10' ' ' TRP . 17.2 Cg_exo -62.19 106.14 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.211 1.941 . . . . 0.0 111.594 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.13 146.68 51.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.418 0.628 . . . . 0.0 111.768 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -47.51 109.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.668 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.52 -179.455 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 3.6 ttmt -69.67 148.7 48.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.592 0.234 . . . . 0.0 110.546 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -110.34 -0.16 17.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.48 125.55 3.83 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.52 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 21.6 m-90 -113.39 67.46 1.23 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.767 0.317 . . . . 0.0 111.151 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.62 -33.67 59.84 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.386 2.058 . . . . 0.0 111.907 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -64.68 -9.2 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.696 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.6 mt -84.18 -18.87 35.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.844 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.84 113.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.746 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 -12.89 43.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.175 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.07 162.31 16.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 110.646 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 p -63.97 137.53 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.497 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.58 -29.74 32.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -70.1 -54.24 13.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.85 95.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . . . -60.06 -51.42 69.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.495 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.2 75.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.373 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.65 88.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.498 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -59.64 -45.73 91.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.531 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.7 -50.92 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -31.95 73.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 111.419 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -79.4 -56.51 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.181 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.17 -29.31 70.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -126.7 79.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -65.14 -2.88 3.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -92.9 -9.78 38.92 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.603 0.24 . . . . 0.0 111.287 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 49' ' ' CYS . 3.0 m -140.3 169.55 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.932 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.566 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -133.88 151.06 51.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.162 0.506 . . . . 0.0 111.129 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.82 137.91 51.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.86 129.07 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.514 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 65.5 t -80.16 128.39 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.04 0.447 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.61 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -150.67 143.36 24.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.518 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 157.2 17.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.95 120.46 2.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.96 55.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.738 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 14.8 t -70.49 -179.7 2.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 110.857 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.64 101.54 14.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.29 104.85 8.16 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.014 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.35 151.44 9.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -27.59 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -46.58 134.99 9.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.44 132.16 35.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.555 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.0 mtm180 -146.9 111.82 5.38 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.602 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.409 ' O ' HG12 ' A' ' 68' ' ' ILE . 97.3 m -60.63 -34.11 73.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 19.8 p-10 -79.54 -0.32 32.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.66 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 47.9 ttp180 -126.43 129.49 48.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.433 . . . . 0.0 111.471 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 68' ' ' ILE . 52.7 t -128.32 116.26 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.15 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 37' ' ' LEU . 3.9 m95 -78.76 133.89 37.08 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 29.3 t -115.25 96.38 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.49 ' HA ' HD11 ' A' ' 37' ' ' LEU . 4.0 mp -84.47 121.28 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.172 0.51 . . . . 0.0 111.57 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 27.0 m -125.87 162.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.013 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -85.84 -179.7 6.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.92 -20.98 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.53 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.21 -24.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.295 . . . . 0.0 111.227 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.33 21.14 7.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.18 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.6 t -98.28 139.49 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.6 111.78 7.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.816 0.341 . . . . 0.0 110.756 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -91.19 -31.3 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 48.3 t -107.59 150.13 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -64.82 102.14 0.31 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.38 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.9 Cg_endo -58.86 97.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.114 1.876 . . . . 0.0 111.596 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -123.68 157.47 33.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.551 . . . . 0.0 111.347 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.505 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -51.09 114.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.535 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.813 -179.518 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.47 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 26.4 ttmt -33.23 143.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.634 0.254 . . . . 0.0 111.49 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HA ' HD13 ' A' ' 68' ' ' ILE . 5.0 p30 -112.23 -0.54 15.47 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.46 4.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 28.2 m-90 -108.79 74.81 0.59 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.94 0.4 . . . . 0.0 111.453 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 -33.25 93.79 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.208 1.939 . . . . 0.0 111.401 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pm0 -63.7 -14.13 49.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 22.2 mt -81.07 -20.63 41.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.645 0.259 . . . . 0.0 110.565 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.41 117.34 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.614 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.76 -14.6 53.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.14 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.17 174.78 8.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.622 0.248 . . . . 0.0 110.516 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 p -75.99 144.01 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.98 -31.62 40.22 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.084 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.4 -52.87 22.77 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.708 0.289 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -29.97 70.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 109.999 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 -60.55 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.449 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.1 68.67 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.58 84.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -43.12 90.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -65.61 -51.41 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.37 -28.51 69.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.57 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -81.86 -54.75 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 110.899 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.71 -34.95 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.281 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -124.63 80.0 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.656 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -5.46 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -93.53 2.52 56.39 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -137.06 170.61 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 0.0 111.663 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.428 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -137.23 126.65 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.321 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.74 135.98 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.686 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.428 HG12 ' CE1' ' A' ' 33' ' ' HIS . 34.8 mt -107.38 120.73 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.738 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.6 p -79.79 128.74 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 111.438 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.9 144.72 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.534 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.24 159.31 16.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.584 . . . . 0.0 111.915 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.67 122.05 3.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.46 29.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.594 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 15.4 t -68.09 -178.09 0.96 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 110.71 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.9 102.7 15.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.518 ' HE3' HD11 ' A' ' 55' ' ' ILE . 2.7 ptp -124.51 100.15 6.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -60.09 148.92 34.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.053 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -82.31 -24.56 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.023 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -45.95 159.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -100.82 131.98 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.064 0.459 . . . . 0.0 111.422 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.04 108.17 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 48.8 t -60.56 -36.75 79.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.576 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.64 3.46 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -129.19 128.06 42.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.025 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.64 119.09 50.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.017 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -78.7 130.52 35.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 31.1 t -113.83 95.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.934 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.518 HD11 ' HE3' ' A' ' 43' ' ' MET . 5.6 mm -79.99 119.9 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.675 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.6 m -124.94 164.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.254 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -89.72 -171.76 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -18.18 62.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.496 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -96.21 -1.57 47.97 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.502 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.9 t -99.49 137.33 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.33 109.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.937 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -93.76 -28.04 16.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -106.57 157.7 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 111.141 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.622 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 5.0 t -72.19 111.02 9.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.438 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 7.8 Cg_exo -67.57 103.55 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.664 1.576 . . . . 0.0 110.517 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.622 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.9 p-80 -131.7 145.2 51.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -40.82 111.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.28 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.425 ' OXT' ' CG2' ' A' ' 69' ' ' THR . 16.3 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.051 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 CA-C-O 121.062 0.257 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.6 tttt -68.24 149.86 48.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.303 . . . . 0.0 110.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -110.98 -8.33 14.48 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.58 123.81 3.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.865 0.364 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 21.7 m-90 -109.52 74.36 0.68 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.11 -37.53 96.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.495 2.13 . . . . 0.0 112.174 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.54 -6.88 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.166 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.8 mt -85.37 -21.2 28.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.744 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.72 113.05 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-O 120.777 0.322 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.17 -10.53 26.82 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.133 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 157.89 15.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.933 0.396 . . . . 0.0 110.928 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 p -56.66 141.66 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.41 -29.38 38.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -72.46 -45.19 60.68 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.514 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -39.07 91.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.56 -58.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.027 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.71 -38.81 61.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -63.26 -46.21 87.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.244 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' HD12 ' A' ' 13' ' ' LEU . 13.1 m -59.97 -42.31 93.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.762 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.57 -51.59 61.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.6 -28.5 68.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.749 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 6.0 mpp_? -82.77 -52.32 6.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -67.32 -31.58 71.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 0.0 110.371 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -126.07 76.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 1.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.196 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -95.45 -13.99 24.12 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.348 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 5.1 m -134.05 168.37 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.422 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.39 140.36 51.37 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.159 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.01 134.77 47.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.373 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.422 HG12 ' CE1' ' A' ' 33' ' ' HIS . 31.5 mt -102.15 116.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.926 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.5 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 41.8 t -83.73 118.95 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.998 0.428 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.2 pp -143.66 156.67 44.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.118 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -90.76 160.49 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.222 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 115.7 1.73 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.844 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.76 -6.53 20.2 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.361 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 44.8 t -64.93 178.95 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 88.06 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.445 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.5 ptm -111.42 104.88 13.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 110.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.9 p -67.47 153.72 43.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.069 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -24.94 40.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.508 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.29 139.88 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.467 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.405 ' CE1' HG23 ' A' ' 68' ' ' ILE . 48.2 t80 -85.76 128.34 34.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HD3' ' NH1' ' A' ' 51' ' ' ARG . 69.3 mtp180 -145.73 112.68 6.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.511 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.431 ' O ' HG12 ' A' ' 68' ' ' ILE . 33.0 m -59.11 -38.71 80.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 19.3 p-10 -78.36 -0.17 27.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' NH1' ' HD3' ' A' ' 48' ' ' ARG . 39.3 ttp180 -128.62 106.37 8.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.17 0.509 . . . . 0.0 111.826 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 68' ' ' ILE . 43.2 t -105.92 120.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.404 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 3.0 m95 -78.39 132.68 37.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.672 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 54.6 t -123.4 87.73 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.955 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -79.95 124.1 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.71 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 15.9 m -121.36 162.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -91.97 -170.61 2.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.548 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 15.4 t70 -54.76 -22.7 14.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 22.41 12.18 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.0 56.34 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.626 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.9 t -93.81 138.31 20.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.431 HG23 HG11 ' A' ' 54' ' ' VAL . 43.7 t -76.31 112.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.143 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -93.34 -33.81 13.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.133 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.52 151.56 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.687 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.06 104.53 0.64 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.49 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 20.5 Cg_endo -60.32 99.84 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.744 1.629 . . . . 0.0 111.309 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -130.09 150.21 51.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.501 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -46.33 112.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.734 -179.458 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.202 0 CA-C-O 120.843 0.135 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.3 ttmm -65.64 151.04 47.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -110.8 -14.92 13.92 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -148.99 130.9 15.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.598 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 29.3 m-90 -116.71 67.35 3.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.457 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.81 -34.41 91.19 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.211 1.941 . . . . 0.0 111.84 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.85 -10.44 20.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.636 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 20.1 mt -81.76 -23.2 36.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.32 118.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.09 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.86 44.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.608 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.67 -175.4 3.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.514 0.197 . . . . 0.0 110.558 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 p -83.68 142.51 30.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.723 0.297 . . . . 0.0 110.834 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.65 -32.15 38.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.866 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -47.8 67.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.256 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 tpt -64.11 -34.35 77.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 62' ' ' VAL . . . -63.42 -61.0 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.372 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.94 -40.14 66.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.61 96.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -61.39 -42.35 98.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.798 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 21' ' ' ALA . 45.8 t -63.18 -49.04 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.92 -31.42 70.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.489 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mtp85 -77.48 -50.74 12.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.17 -37.54 72.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -119.44 78.18 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.974 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -0.07 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.834 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -94.86 -9.8 33.24 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.637 0.256 . . . . 0.0 111.328 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 49' ' ' CYS . 4.0 m -138.97 168.0 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.176 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.43 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 1.5 p80 -128.23 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.351 0.596 . . . . 0.0 111.942 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . . . -109.83 131.17 55.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.0 mt -103.16 127.16 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.642 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 44.8 t -83.85 121.18 36.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 111.323 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.552 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -146.69 155.71 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.737 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' CE ' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -90.09 162.22 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.256 0.551 . . . . 0.0 112.061 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 55' ' ' ILE . 1.4 mm-40 -52.73 125.24 16.12 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.206 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.83 -2.91 62.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.867 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t -57.44 134.64 56.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.54 81.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.565 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 28.6 mmt -124.73 130.2 51.95 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.845 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -56.68 152.94 11.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -23.38 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.74 152.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.466 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.498 ' CE2' HG23 ' A' ' 68' ' ' ILE . 51.1 t80 -93.36 133.07 36.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.116 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -149.35 110.67 4.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.429 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -59.67 -35.86 75.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -78.6 0.85 24.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 44.8 ttp180 -129.63 129.92 44.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.391 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.419 HG23 HG12 ' A' ' 25' ' ' VAL . 41.1 t -126.79 118.04 49.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.973 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.565 ' CE2' ' HB3' ' A' ' 43' ' ' MET . 1.7 m95 -78.7 132.88 37.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 110.229 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.2 t -114.86 83.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.6 mt -79.85 121.99 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.538 0.685 . . . . 0.0 111.466 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.5 m -125.95 165.34 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.291 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -84.19 -175.55 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.447 ' HA ' ' CE ' ' A' ' 38' ' ' LYS . 2.9 t70 -59.58 -18.87 44.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.436 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -89.54 -19.9 24.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.86 20.24 13.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.958 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.5 t -95.68 132.93 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 21' ' ' ALA . 40.3 t -69.29 111.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.937 0.399 . . . . 0.0 110.38 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 p -90.91 -29.55 17.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.136 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 12.9 m -104.89 148.4 26.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.72 106.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.615 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.598 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 35.8 Cg_exo -56.92 98.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.748 1.632 . . . . 0.0 111.538 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -125.24 166.45 16.46 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.342 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.498 HG23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -64.39 107.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.135 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.511 -178.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.5 ttmt -59.59 145.36 44.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.697 0.284 . . . . 0.0 110.566 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.24 -15.32 16.67 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.72 132.36 11.36 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.139 -0.35 . . . . 0.0 110.52 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.638 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 28.0 m-90 -113.52 74.88 2.33 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.264 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.06 -40.98 81.52 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.209 1.939 . . . . 0.0 112.417 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -62.82 -6.8 4.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.455 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.514 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 mt -83.36 -20.88 33.45 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.12 116.0 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.701 0.286 . . . . 0.0 110.791 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.41 38.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.407 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 62' ' ' VAL . 1.9 tppm? -93.56 161.26 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.507 0.194 . . . . 0.0 110.705 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -62.7 141.84 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.34 -29.35 46.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.427 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.87 -49.74 35.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.371 . . . . 0.0 110.69 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.8 tpt -63.7 -40.97 98.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -60.02 -54.58 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.991 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -52.18 -44.6 64.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.573 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.66 95.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -59.8 -43.08 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 21' ' ' ALA . 44.3 t -66.72 -52.31 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 8.0 mt-10 -67.11 -24.02 65.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.319 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -84.98 -56.14 3.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.683 0.278 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.49 -31.9 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.143 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.453 ' OD1' HG12 ' A' ' 32' ' ' VAL . 53.2 t-20 -125.05 80.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.713 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -4.79 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -98.72 6.14 47.15 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.629 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.453 HG12 ' OD1' ' A' ' 29' ' ' ASN . 5.8 m -138.4 165.95 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.32 . . . . 0.0 111.358 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.44 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -128.63 132.84 48.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.346 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.09 127.44 44.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.44 HG13 ' CE1' ' A' ' 33' ' ' HIS . 2.5 mp -104.53 108.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 11.2 p -78.86 121.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.592 0.71 . . . . 0.0 110.874 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -146.72 155.34 42.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.296 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 56' ' ' VAL . 9.2 mtmt -89.55 165.76 14.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.305 0.574 . . . . 0.0 112.264 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 122.17 6.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.518 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.97 4.89 62.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.88 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.7 t -65.73 -173.93 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.89 87.06 6.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.2 ptm -121.13 105.87 11.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.059 0.457 . . . . 0.0 110.481 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -63.52 150.9 42.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.009 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -79.65 -23.5 42.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -45.52 155.0 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.847 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 37.5 t80 -99.41 136.18 39.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.005 0.431 . . . . 0.0 111.385 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -153.0 110.11 3.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.386 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.509 ' O ' HG12 ' A' ' 68' ' ' ILE . 23.5 m -58.37 -38.82 78.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.892 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.436 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 18.6 p-10 -79.25 5.55 12.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.33 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 35' ' ' ILE . 42.0 ttp180 -127.25 131.48 50.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.982 0.42 . . . . 0.0 111.206 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.23 117.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -78.77 140.34 38.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 64.5 t -128.05 87.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mt -79.62 128.92 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.152 0.501 . . . . 0.0 111.645 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.2 m -126.92 164.21 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -84.72 -171.49 3.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.029 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 -9.2 12.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.941 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -5.67 20.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.63 20.17 38.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.365 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.5 t -97.35 132.36 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 16' ' ' LYS . 60.0 t -66.43 110.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.781 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -87.87 -35.73 17.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.1 m -105.65 156.56 18.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 111.377 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 3.8 t -66.82 128.18 93.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.437 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.638 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 15.6 Cg_endo -86.34 96.34 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.431 2.087 . . . . 0.0 110.766 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -128.54 153.15 47.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.19 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.7 OUTLIER -44.11 103.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.159 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.504 -179.328 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.602 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 1.7 ttmp? -88.42 154.9 20.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.284 . . . . 0.0 110.763 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -114.57 -2.05 13.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.61 130.51 7.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.118 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.602 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.2 m-90 -119.49 74.16 16.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.55 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.7 -39.3 91.93 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.219 1.946 . . . . 0.0 111.986 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -62.01 -9.68 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.193 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 42.4 mt -83.97 -23.67 30.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.797 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -58.26 111.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -7.63 29.44 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.177 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 166.01 11.48 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.532 0.206 . . . . 0.0 110.621 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -63.62 142.7 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.31 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.12 42.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.844 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -68.97 -42.18 76.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -65.68 -35.22 80.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.906 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -60.1 3.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.043 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 -50.17 40.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.11 86.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.417 ' CB ' HD23 ' A' ' 13' ' ' LEU . 94.6 m -60.11 -43.4 95.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.767 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.86 -51.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.23 -29.07 69.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -81.5 -57.19 3.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.53 -30.83 71.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.412 ' CG ' HG21 ' A' ' 32' ' ' VAL . 46.7 t-20 -127.11 78.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.276 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -64.62 1.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.965 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -98.36 -5.35 32.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.573 0.225 . . . . 0.0 111.482 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 17.9 m -148.69 166.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.422 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -129.47 152.91 48.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 111.361 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 147.93 35.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.34 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 114.35 46.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.791 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 57.5 t -83.25 111.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 111.345 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -135.27 154.72 51.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.535 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -85.54 157.2 20.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 0.0 111.527 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 113.61 1.18 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.718 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.79 -9.4 11.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.162 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -66.01 -174.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 97.67 11.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.119 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -124.83 103.69 8.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.56 160.09 23.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.27 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -87.84 -23.36 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.51 140.39 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.059 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 68' ' ' ILE . 42.6 t80 -84.06 131.03 34.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.181 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -146.48 110.92 5.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.468 ' O ' HG12 ' A' ' 68' ' ' ILE . 98.3 m -59.05 -38.22 78.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.287 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.549 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 11.6 p-10 -78.8 -6.14 55.22 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.395 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -119.21 105.96 11.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.989 0.424 . . . . 0.0 111.694 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 68' ' ' ILE . 62.0 t -106.65 119.26 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CZ2' ' HA ' ' A' ' 43' ' ' MET . 1.3 m95 -78.37 136.8 37.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 -178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 49.0 t -127.64 84.0 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.051 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.2 mt -79.67 121.52 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.071 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.0 m -119.91 161.3 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.999 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -80.0 -171.48 2.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.272 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -20.47 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.612 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.73 -7.36 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.43 23.86 27.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.936 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.7 t -96.57 134.21 35.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.77 104.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.017 0.437 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -88.04 -34.74 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.17 157.27 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.922 0.392 . . . . 0.0 111.502 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.84 106.24 1.88 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.639 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 64' ' ' SER . 36.2 Cg_exo -58.06 103.39 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.688 1.592 . . . . 0.0 110.84 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.78 143.63 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.332 0.587 . . . . 0.0 111.474 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.489 HG23 ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -41.81 107.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.685 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.083 -179.119 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.721 -0.152 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.549 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.1 ttmm -49.54 146.04 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 111.205 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -103.46 -16.72 15.49 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 7' ' ' LYS . . . -146.96 149.99 34.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.549 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 m-90 -134.56 67.64 71.71 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.229 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.91 -33.08 87.77 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.101 1.867 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.24 -12.48 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.666 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 21.4 mt -82.21 -20.3 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.91 111.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.15 -2.99 29.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.64 177.09 4.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -72.29 135.58 46.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.563 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.23 -30.51 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.038 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -70.94 -47.25 60.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.876 0.37 . . . . 0.0 110.399 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.4 tpt -63.18 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.783 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.577 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.01 -39.59 59.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.36 90.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.7 m -60.0 -42.54 94.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.403 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 19.0 t -64.41 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.01 -29.68 70.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.334 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -76.44 -54.35 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.37 -40.71 85.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.776 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -115.44 80.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -64.96 -5.52 6.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.796 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 -0.66 56.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.548 0.213 . . . . 0.0 111.262 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 4.3 m -139.09 171.78 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -136.46 137.81 40.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.83 133.2 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.761 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 HG12 ' CE1' ' A' ' 33' ' ' HIS . 45.1 mt -102.14 119.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.439 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 63.1 t -87.12 115.83 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.286 0.565 . . . . 0.0 111.275 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.82 156.14 47.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.899 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 151.64 21.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.278 0.561 . . . . 0.0 111.781 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.37 113.93 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.183 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.1 23.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -72.76 -164.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.98 99.1 12.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.91 96.9 5.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 111.422 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.48 155.96 39.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.428 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -87.15 -24.97 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.274 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.84 141.06 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -88.53 125.67 34.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.29 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.5 mtm180 -145.33 111.03 5.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.236 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.504 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 73.9 m -60.49 -32.78 71.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.637 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -78.94 -4.56 50.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.408 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 54.9 ttp180 -120.73 124.26 44.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.435 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -123.54 119.39 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.398 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CZ3' ' CD2' ' A' ' 37' ' ' LEU . 1.1 m95 -78.71 131.35 36.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.841 0.353 . . . . 0.0 111.177 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 5.5 t -122.88 91.95 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -85.72 125.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.685 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.8 m -125.16 164.79 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.492 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -89.94 -177.17 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.91 -20.76 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.316 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -88.49 -22.2 23.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.162 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.1 22.26 9.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.206 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 36.8 t -98.19 144.67 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.28 110.85 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.648 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -91.53 -33.68 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -101.96 148.46 25.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.64 108.47 2.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.214 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.3 Cg_exo -62.73 117.55 4.44 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.138 1.892 . . . . 0.0 111.471 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -151.8 143.89 23.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.98 0.419 . . . . 0.0 110.792 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.42 HD12 HG12 ' A' ' 32' ' ' VAL . 1.6 mt -40.3 122.69 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.048 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' THR . . . . . 0.412 HG23 ' OXT' ' A' ' 69' ' ' THR . 2.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.189 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 32.2 ttmt -59.0 154.12 16.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.727 0.299 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.497 ' HA ' HD13 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -108.1 -20.4 13.17 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -147.71 127.04 13.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.531 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 22.7 m-90 -108.65 74.14 0.53 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.851 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.35 -37.06 92.68 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.047 1.831 . . . . 0.0 111.819 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -63.34 -9.59 12.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.865 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 13.4 mt -80.88 -24.38 38.34 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.515 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.68 112.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -6.99 24.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.407 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -102.69 160.38 14.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.287 . . . . 0.0 110.497 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.0 p -56.81 135.81 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.923 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.45 -30.61 4.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.171 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -44.77 64.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.827 0.346 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -32.46 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.032 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -60.09 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.545 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.28 -39.73 67.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.755 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -64.12 -44.92 90.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.637 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.405 ' HB ' HD12 ' A' ' 13' ' ' LEU . 89.1 m -59.27 -41.0 87.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.11 -57.58 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.107 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.17 -24.17 67.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 19.8 ttm-85 -80.77 -58.18 3.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.351 . . . . 0.0 110.819 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.05 -37.17 86.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.105 0.479 . . . . 0.0 110.377 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -121.16 78.22 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -0.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.22 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.29 -11.64 32.01 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.349 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 14.0 m -122.67 171.0 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 133.38 45.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 135.11 47.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.574 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.7 mt -104.03 122.81 57.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.567 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.0 t -91.3 123.02 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -150.6 158.6 44.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.478 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -89.0 159.76 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.098 0.475 . . . . 0.0 111.499 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.77 122.31 5.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.323 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.78 -8.82 43.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.933 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 32.8 t -68.69 -166.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.354 . . . . 0.0 111.123 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' CH2' ' A' ' 53' ' ' TRP . . . -71.14 93.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.514 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 1.5 ttp -121.18 99.12 6.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.48 151.52 20.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.356 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -79.82 -26.72 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.05 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.99 142.38 2.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -88.05 129.5 35.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.716 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.3 mtp180 -144.72 108.6 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.236 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -56.12 -43.21 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.282 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -79.48 3.57 18.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 40.4 ttp180 -126.65 115.71 19.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.42 122.47 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.249 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.514 ' CD1' ' HG2' ' A' ' 43' ' ' MET . 1.2 m95 -78.69 125.54 29.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.212 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.32 85.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mp -83.27 127.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.154 0.502 . . . . 0.0 111.73 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.8 m -124.9 163.72 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.242 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -83.55 -178.75 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.54 -22.0 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.855 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -24.43 21.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.335 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.78 22.23 7.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.318 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.0 t -99.02 140.47 18.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.43 HG12 ' HG3' ' A' ' 66' ' ' PRO . 43.4 t -70.71 112.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.098 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.9 p -94.66 -32.8 13.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.176 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.5 t -103.79 151.74 22.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.499 . . . . 0.0 111.543 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 4.5 t -64.47 114.85 15.83 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.142 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 5.3 Cg_exo -75.41 88.18 1.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.904 1.736 . . . . 0.0 111.451 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 18.0 p-80 -121.8 144.04 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.118 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -38.28 116.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.069 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.768 -179.068 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.122 0 CA-C-O 120.956 0.198 . . . . 0.0 113.391 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.601 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 2.8 ttmp? -55.64 149.78 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -103.73 -16.67 15.38 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -154.39 138.15 16.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.601 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 19.9 m-90 -120.49 71.06 17.8 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.84 0.352 . . . . 0.0 111.276 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.78 -37.81 92.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.328 2.019 . . . . 0.0 112.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -62.19 -9.15 6.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.156 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 17.1 mt -81.13 -24.21 37.8 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.769 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.93 110.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.845 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.25 15.76 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.404 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -103.91 179.39 4.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.632 0.253 . . . . 0.0 110.625 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -76.04 143.23 41.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.664 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.71 -33.57 12.91 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.009 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.08 -36.92 66.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.987 0.422 . . . . 0.0 110.161 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -39.65 84.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.791 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -65.66 -58.85 4.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.504 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.66 -41.97 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.45 94.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 13' ' ' LEU . 39.9 m -61.3 -41.09 96.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 21' ' ' ALA . 46.9 t -66.64 -54.96 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 33' ' ' HIS . 9.0 mt-10 -65.6 -23.88 66.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -83.61 -53.01 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.824 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.67 -36.95 81.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.661 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.406 ' CG ' HG21 ' A' ' 32' ' ' VAL . 45.9 t-20 -118.73 79.48 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.702 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -2.65 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.093 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.03 -13.9 28.05 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.695 0.283 . . . . 0.0 111.47 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 49' ' ' CYS . 4.8 m -140.67 164.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.986 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.521 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -132.79 163.51 28.89 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.911 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.11 140.94 48.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.063 0.459 . . . . 0.0 111.935 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.58 111.59 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.39 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.3 p -81.33 125.68 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 0.0 111.819 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 41' ' ' SER . 0.5 OUTLIER -155.88 160.1 39.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.195 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HG3' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -89.69 155.04 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 111.627 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -47.91 115.95 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.396 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.78 -7.5 21.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.621 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.564 ' HB3' HD12 ' A' ' 37' ' ' LEU . 32.4 t -70.46 -162.38 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.91 96.88 5.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.0 110.743 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.561 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 10.1 tmm? -119.42 96.14 5.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.91 154.76 24.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.251 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -84.53 -27.93 27.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.67 130.78 5.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -80.71 134.56 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.072 0.463 . . . . 0.0 111.8 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 10.4 mtp180 -152.61 109.83 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.533 ' O ' HG13 ' A' ' 32' ' ' VAL . 6.7 m -61.33 -30.36 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.09 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.521 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 17.7 p-10 -79.06 -8.25 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.637 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 39.6 ttp180 -122.26 119.2 30.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.042 0.449 . . . . 0.0 111.699 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.93 122.2 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 43' ' ' MET . 1.0 OUTLIER -78.58 129.46 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.5 t -120.56 92.79 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 7.3 mm -85.15 129.67 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.257 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.4 m -129.09 164.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -86.0 -168.95 2.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.78 -18.7 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.64 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.02 4.69 51.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.31 24.76 65.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.222 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 23.3 t -97.54 131.47 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.37 106.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.7 p -93.52 -29.46 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.03 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -103.94 151.14 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.511 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 8.0 t -66.27 118.91 57.76 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.341 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -81.73 99.57 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.171 1.914 . . . . 0.0 111.351 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 7.8 p-80 -133.21 147.23 52.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -36.63 116.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.678 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.571 -179.872 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.435 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 5.9 tttp -59.99 156.08 15.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.921 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -113.77 -16.36 12.29 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.34 12.15 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.562 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 28.1 m-90 -108.0 73.95 0.46 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.881 0.372 . . . . 0.0 111.553 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.9 -35.11 94.71 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.281 1.987 . . . . 0.0 111.528 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -64.34 -12.52 43.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.47 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 23.4 mt -82.01 -22.41 36.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.421 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.23 114.99 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 110.619 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.52 -13.11 33.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.245 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -92.72 160.08 15.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.708 0.29 . . . . 0.0 110.59 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -60.73 140.79 57.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.77 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.87 -32.08 8.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.153 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -71.37 -45.26 63.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -38.83 92.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.881 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.402 ' CA ' HD12 ' A' ' 13' ' ' LEU . . . -63.26 -58.95 5.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.465 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -52.19 -39.22 59.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.66 -45.46 90.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.713 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 m -60.29 -41.21 92.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.4 t -67.32 -51.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.432 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.03 -26.99 67.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.678 0.275 . . . . 0.0 111.155 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -81.02 -56.33 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.39 -36.46 84.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.58 79.59 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -61.17 -5.62 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.231 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -88.69 -1.59 58.15 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.242 -0.286 . . . . 0.0 111.734 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -140.71 170.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.469 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.456 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -135.89 140.89 44.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 22' ' ' ALA . . . -104.83 141.07 37.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.634 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.456 HG13 ' CE1' ' A' ' 33' ' ' HIS . 3.9 mt -114.83 123.09 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.639 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.48 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.7 t -79.82 123.49 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.602 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -141.49 149.6 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.789 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 155.5 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 0.0 111.55 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HG3' HG21 ' A' ' 55' ' ' ILE . 15.3 mt-10 -48.83 115.87 1.42 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.153 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 1.57 37.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.526 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 t -65.77 178.93 0.94 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.993 0.425 . . . . 0.0 110.599 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.07 92.73 9.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.626 ' HE2' HG12 ' A' ' 55' ' ' ILE . 2.0 ptp -112.82 105.08 13.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.979 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.66 152.07 9.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.749 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.63 -27.04 27.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.089 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.2 142.42 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.99 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 68' ' ' ILE . 77.3 t80 -86.9 134.21 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -148.46 113.88 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -58.87 -41.07 86.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -79.43 2.73 20.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -125.56 113.49 17.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.976 0.417 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.15 119.34 61.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.933 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.602 ' CE3' ' CD2' ' A' ' 37' ' ' LEU . 2.3 m95 -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 37.8 t -120.42 87.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.032 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.626 HG12 ' HE2' ' A' ' 43' ' ' MET . 4.3 mt -79.92 122.63 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.335 0.588 . . . . 0.0 111.836 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.0 m -122.44 163.77 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.254 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -88.99 -168.27 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.21 -17.63 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -97.8 9.85 41.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.29 22.54 77.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.311 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 44.5 t -97.98 137.61 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.542 HG12 ' HG3' ' A' ' 66' ' ' PRO . 58.2 t -75.58 116.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.2 p -95.37 -28.57 14.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 17.7 m -102.72 148.83 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.304 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -64.18 106.84 1.05 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.37 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 24.0 Cg_exo -59.42 99.04 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 121.952 1.768 . . . . 0.0 111.744 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.19 156.74 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.293 0.568 . . . . 0.0 111.025 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.2 114.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.634 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.895 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.166 0 N-CA-C 112.584 -0.207 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 7.1 ttmt -57.26 143.27 40.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -99.22 -26.36 14.21 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.64 22.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.843 0.354 . . . . 0.0 110.082 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.657 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 30.1 m-90 -110.86 73.11 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.255 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.89 -35.57 93.3 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.363 2.042 . . . . 0.0 111.676 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -63.01 -11.84 21.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.519 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 35.9 mt -83.69 -22.69 31.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.761 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.72 114.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.98 -11.16 29.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.373 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 161.05 13.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.288 . . . . 0.0 110.71 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -58.72 142.24 50.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.402 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -50.87 -31.89 25.22 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.187 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -47.13 63.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -34.49 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.118 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.432 ' CB ' HG22 ' A' ' 62' ' ' VAL . . . -65.27 -60.27 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.768 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.55 -42.23 61.68 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.156 0.503 . . . . 0.0 110.095 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -58.59 -48.11 82.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.288 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 m -59.84 -41.56 91.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.816 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.72 -57.09 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.78 0.324 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.47 -22.58 67.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.721 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.71 -55.5 3.95 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.116 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.44 -33.14 75.26 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.443 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -127.41 76.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.309 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -2.64 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.096 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.64 -1.45 57.87 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 13.3 m -141.39 169.38 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.79 142.6 49.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.385 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.4 136.91 46.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 111.966 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.3 mt -101.93 108.99 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.647 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.5 t -79.85 120.95 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.185 0.517 . . . . 0.0 110.659 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.76 159.29 44.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -89.96 161.93 15.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.262 0.553 . . . . 0.0 111.815 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.19 123.49 6.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.527 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.8 -7.35 55.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.985 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 47.9 t -66.44 -167.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 94.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.096 0.474 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.504 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -123.04 91.98 3.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.385 0.612 . . . . 0.0 111.533 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -81.5 151.98 27.54 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -79.81 -25.0 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.48 159.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -104.54 132.97 50.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.0 111.596 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.411 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 28.0 mtp85 -147.28 110.9 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.838 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.1 t -56.35 -47.5 78.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.198 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -79.22 3.53 17.57 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.818 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.1 ttp180 -122.22 110.29 15.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.9 t -111.91 121.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.504 ' CD1' ' HG2' ' A' ' 43' ' ' MET . 1.3 m95 -78.21 128.9 34.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.31 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.3 t -121.88 80.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.838 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.1 mt -80.08 127.63 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.237 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.9 m -124.09 159.96 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -84.82 -171.39 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.54 -20.63 48.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -95.98 12.76 29.26 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.58 23.9 72.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.967 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.6 t -96.89 137.58 24.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 66' ' ' PRO . 44.3 t -75.84 114.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.089 0.471 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -94.55 -34.6 12.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.981 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -94.42 142.26 27.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.87 103.59 0.4 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.321 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.657 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 31.6 Cg_exo -54.47 95.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.603 1.535 . . . . 0.0 111.385 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.4 ' CD2' ' O ' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -128.13 143.25 51.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.119 0.485 . . . . 0.0 110.934 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER -44.23 109.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.663 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.703 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.36 -0.296 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.599 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.9 ttmt -77.93 151.11 33.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.614 0.245 . . . . 0.0 110.598 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -109.88 -13.07 14.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.9 128.89 11.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.891 0.376 . . . . 0.0 110.056 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.599 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 31.0 m-90 -114.82 70.06 2.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 -34.11 98.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.164 1.91 . . . . 0.0 111.617 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.48 -12.93 35.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.414 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.7 mt -81.67 -22.64 37.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.708 0.289 . . . . 0.0 110.506 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 65' ' ' VAL . 46.9 t -56.95 113.46 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -10.99 29.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.321 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 171.74 8.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.643 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 p -68.4 142.53 55.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.912 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.28 -31.67 35.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.035 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -71.08 -46.22 62.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.309 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.14 -35.46 78.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.812 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -63.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.219 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.57 -35.9 32.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.694 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.11 -46.28 78.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.271 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' HB ' HD12 ' A' ' 13' ' ' LEU . 35.0 m -59.88 -41.37 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 17.2 t -66.44 -50.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.73 0.3 . . . . 0.0 111.329 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.44 -31.7 72.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.506 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.25 -51.04 10.0 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.813 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.19 -37.81 81.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -119.55 80.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -5.86 2.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -96.45 6.53 48.55 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -144.71 169.21 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.338 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.509 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -131.78 138.14 48.45 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.096 0.474 . . . . 0.0 110.852 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.16 131.98 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 mp -107.04 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.577 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 47.8 t -80.37 119.59 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 111.257 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -147.79 153.21 38.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.254 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 157.12 19.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 111.786 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -50.86 118.1 2.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -7.11 31.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -61.43 -178.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.82 92.79 9.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.126 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.23 121.04 31.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.241 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.01 156.56 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -24.79 24.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -48.41 141.51 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CE2' HG23 ' A' ' 68' ' ' ILE . 28.9 t80 -83.26 133.77 34.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 11.2 mtm180 -146.12 114.32 6.63 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.794 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -60.07 -37.83 81.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.509 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -79.79 1.51 26.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.468 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 41.4 ttp180 -126.77 129.63 48.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.966 0.412 . . . . 0.0 111.429 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 68' ' ' ILE . 44.8 t -128.7 112.77 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -78.43 133.73 37.45 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 109.995 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.4 t -119.11 90.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.799 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.533 ' HB ' ' OG ' ' A' ' 64' ' ' SER . 1.8 mp -79.68 119.57 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.4 m -116.51 161.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.4 -174.09 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.41 -22.07 52.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.593 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -17.14 29.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.23 22.42 13.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.928 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.3 t -99.6 143.97 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.75 115.84 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 0.0 111.023 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 p -95.7 -31.99 12.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 1.8 p -105.56 159.03 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 14' ' ' VAL . 18.3 t -68.07 104.56 0.71 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.825 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.555 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 32.3 Cg_exo -59.05 100.3 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.867 1.711 . . . . 0.0 111.233 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.03 152.56 49.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.262 0.553 . . . . 0.0 111.099 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER -47.71 109.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.644 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.656 -179.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 120.925 0.181 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.6 ttmm -50.85 147.46 4.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.658 0.266 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -111.19 -1.53 16.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.02 132.37 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.512 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.9 m-90 -119.45 72.13 13.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.885 0.374 . . . . 0.0 111.534 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.34 -35.71 98.88 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.166 1.91 . . . . 0.0 111.694 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.93 -10.42 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 16.7 mt -80.35 -22.85 40.98 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.338 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -58.67 112.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.23 22.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -102.88 -174.64 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.623 0.249 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 p -83.03 140.32 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.63 -29.88 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.14 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.66 -47.9 51.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -62.2 1.53 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -35.93 63.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.037 0.446 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.5 -45.35 79.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.403 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.3 m -59.41 -40.61 87.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.424 HG11 ' CH2' ' A' ' 10' ' ' TRP . 13.7 t -66.39 -56.2 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.73 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.608 0.242 . . . . 0.0 111.331 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 30.2 ttp180 -80.75 -57.39 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.775 0.321 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.14 -33.13 75.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.444 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.424 ' OD1' HG11 ' A' ' 32' ' ' VAL . 44.7 t-20 -125.62 79.71 1.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -0.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.309 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -100.37 0.18 39.45 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.607 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 29' ' ' ASN . 10.1 m -129.27 167.98 23.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.47 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.419 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -131.59 124.63 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.41 137.91 38.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.419 HG12 ' CE1' ' A' ' 33' ' ' HIS . 27.7 mt -110.12 119.25 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 68.1 t -83.29 116.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.566 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.559 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -135.31 154.21 51.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.374 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.53 19.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.231 0.539 . . . . 0.0 111.779 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -45.76 117.89 1.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.476 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 1.09 41.34 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.863 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 34.4 t -67.61 -167.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 101.08 13.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.94 99.8 6.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 111.638 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -74.47 155.7 37.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.071 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.045 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.18 141.52 1.76 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -90.02 133.97 34.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 111.813 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -152.64 111.98 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.273 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 68' ' ' ILE . 73.8 m -58.86 -37.11 75.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.582 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -79.77 -1.42 38.62 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -122.99 108.67 13.19 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.984 0.421 . . . . 0.0 111.57 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.88 120.04 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.828 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CE3' HD23 ' A' ' 37' ' ' LEU . 2.5 m95 -78.63 125.24 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.429 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.2 88.13 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 23.0 mt -80.1 125.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.267 0.556 . . . . 0.0 111.827 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.4 m -124.56 164.6 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.461 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -84.57 -177.11 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -54.6 -25.44 26.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.787 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -88.38 -22.66 23.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.618 0.246 . . . . 0.0 111.358 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.08 22.67 7.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.232 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 58.3 t -96.14 135.41 30.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.18 112.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.911 0.386 . . . . 0.0 110.811 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.5 p -97.1 -30.33 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -100.85 147.64 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.136 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.7 103.46 0.43 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.578 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 64' ' ' SER . 39.8 Cg_endo -64.76 108.54 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.116 1.877 . . . . 0.0 111.543 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -137.95 148.7 45.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.173 0.511 . . . . 0.0 111.346 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER -44.28 113.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.61 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.808 -179.224 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-O 121.066 0.259 . . . . 0.0 112.92 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.2 ttmm -67.52 157.47 34.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.674 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -115.37 -9.92 12.09 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -152.69 129.13 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.621 0.248 . . . . 0.0 110.607 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.586 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 26.7 m-90 -115.48 72.85 3.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.767 0.318 . . . . 0.0 111.479 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -34.53 94.21 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.166 1.91 . . . . 0.0 111.506 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -64.5 -12.05 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.684 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 17.6 mt -81.94 -20.36 38.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.44 114.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.702 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.43 -9.92 33.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.286 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' O ' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -95.6 157.1 16.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.751 0.31 . . . . 0.0 110.502 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 p -59.37 141.28 54.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.51 -30.27 19.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.32 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.02 -53.15 15.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -37.11 82.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.359 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 62' ' ' VAL . . . -63.14 -56.68 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.414 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.31 -36.64 63.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.336 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.19 88.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.316 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.0 m -59.72 -44.11 93.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.644 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.09 -51.99 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 33' ' ' HIS . 2.5 mt-10 -64.53 -30.06 71.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.668 0.27 . . . . 0.0 111.449 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -79.5 -55.2 5.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -64.54 -34.59 78.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -124.77 80.02 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -65.16 -5.71 7.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.559 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -89.85 -2.05 58.12 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 68' ' ' ILE . 4.5 m -137.52 171.23 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.487 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -134.2 136.03 43.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.352 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.65 125.45 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.611 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 33' ' ' HIS . 3.1 mp -94.22 143.12 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.782 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 72.6 t -99.63 114.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.646 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -142.19 144.91 33.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.986 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 153.31 24.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.337 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 107.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 -10.19 6.05 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -67.58 160.21 28.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.362 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.72 7.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.468 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.462 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -120.55 139.45 52.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.83 0.347 . . . . 0.0 111.008 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.26 161.07 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -96.78 -24.15 16.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -41.88 163.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.333 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -102.23 130.59 48.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -145.96 113.22 6.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.56 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 43.0 m -58.45 -39.83 80.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.618 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.443 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 23.7 p-10 -79.52 2.68 21.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -124.92 119.14 27.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.954 0.407 . . . . 0.0 110.983 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.02 116.39 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CE2' ' HB3' ' A' ' 43' ' ' MET . 1.0 OUTLIER -78.82 124.29 28.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 110.73 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 42.2 t -106.07 87.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.1 mp -80.15 114.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.8 m -119.26 165.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.507 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -85.34 -173.48 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.71 -21.69 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -89.63 -13.0 38.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.535 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.83 24.91 16.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.083 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 22.0 t -101.16 134.9 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 21' ' ' ALA . 91.1 t -68.27 107.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 110.539 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.7 p -90.05 -32.85 16.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.863 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -104.01 152.99 21.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.89 106.47 1.01 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.441 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.586 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 17.3 Cg_exo -60.81 90.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.825 1.683 . . . . 0.0 111.394 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -121.0 146.82 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 111.468 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.619 HD13 HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -45.77 117.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.673 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.666 -0.174 . . . . 0.0 112.666 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.484 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.1 ttmt -67.85 145.59 54.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.705 0.288 . . . . 0.0 110.521 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -105.5 -5.81 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.81 128.31 4.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.689 0.281 . . . . 0.0 110.367 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.522 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 25.3 m-90 -112.62 69.89 1.09 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.44 -37.33 94.93 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.011 1.807 . . . . 0.0 111.938 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -65.05 -5.99 7.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 28.4 mt -84.44 -18.95 34.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.661 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.64 113.56 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.571 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.16 19.86 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.386 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.49 156.36 17.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.583 0.23 . . . . 0.0 110.661 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 p -56.8 145.73 28.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 111.43 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -53.76 -32.35 47.45 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.204 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.82 -47.14 66.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -44.13 97.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.271 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -60.25 -52.64 64.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.19 65.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.39 93.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.32 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.7 m -61.77 -43.46 98.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.596 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 21' ' ' ALA . 44.5 t -66.9 -48.45 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.192 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.21 -31.05 71.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.395 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -81.62 -53.39 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.022 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -65.17 -33.22 75.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.66 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -127.99 81.28 2.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -63.3 -8.39 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -87.16 -1.32 57.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.605 0.241 . . . . 0.0 111.587 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 3.9 m -140.07 173.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.493 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -134.06 136.5 44.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.5 125.76 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.116 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.455 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 15.4 mt -98.28 111.29 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.571 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.611 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.7 p -79.67 125.29 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.565 0.698 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -156.96 148.86 22.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.023 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.75 158.14 17.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 111.807 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.17 123.69 4.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.201 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.41 -11.98 33.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 42.4 t -68.27 -166.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.881 0.372 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 100.0 12.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.191 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.21 96.58 4.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.265 0.555 . . . . 0.0 111.328 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.49 150.17 48.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.227 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.31 -25.06 31.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.31 141.13 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -84.78 132.25 34.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.266 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.05 109.38 4.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 55.5 m -59.61 -34.15 72.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.712 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.493 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 9.9 p-10 -79.12 -3.31 44.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.785 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -123.66 135.13 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.13 117.25 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.585 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' HD13 ' A' ' 35' ' ' ILE . 1.8 m95 -78.67 131.37 36.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.094 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 33.8 t -116.0 89.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.014 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mm -79.72 121.33 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.358 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 28.6 m -122.31 163.8 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.206 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -84.09 -177.33 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.347 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.8 -22.1 22.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.602 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -90.73 -21.88 21.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.552 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 22.04 7.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.266 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.1 t -101.27 134.23 42.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.539 HG12 ' HG3' ' A' ' 66' ' ' PRO . 61.3 t -65.33 114.85 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.419 . . . . 0.0 111.081 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -96.9 -33.11 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.1 m -105.03 158.57 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 111.36 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 3.7 t -65.88 117.01 37.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.394 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HG3' HG12 ' A' ' 62' ' ' VAL . 2.4 Cg_endo -79.28 93.53 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.552 2.168 . . . . 0.0 110.673 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 12.6 p-80 -125.8 151.41 46.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.088 0.47 . . . . 0.0 111.218 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -40.75 110.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.897 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.655 -179.014 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 31.4 ttmt -66.42 150.5 48.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.35 -19.03 13.71 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -149.66 127.5 11.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 0.0 110.081 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.647 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 27.5 m-90 -110.34 68.93 0.54 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.388 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.63 -36.56 97.1 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.999 1.799 . . . . 0.0 111.513 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -64.51 -9.36 18.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.922 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.2 mt -79.95 -21.2 44.07 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.442 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.25 117.85 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.48 -14.21 27.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -95.8 158.72 15.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.666 0.27 . . . . 0.0 110.679 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.6 p -57.98 143.59 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.116 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.29 -31.48 20.11 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.255 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -45.92 60.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.712 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -39.01 92.47 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.97 -60.76 3.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.384 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -51.25 -44.09 61.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.431 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.97 -45.79 93.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.299 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -56.86 -43.18 80.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.91 -54.08 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.332 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt-10 -63.61 -27.08 68.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.421 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.64 -56.48 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.695 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -61.72 -35.74 78.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 110.025 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -126.02 75.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.64 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -62.58 0.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.464 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -93.56 -5.0 49.93 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.252 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 49' ' ' CYS . 4.2 m -140.51 166.45 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.94 145.48 50.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.415 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.26 137.38 46.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 mt -106.29 113.7 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.505 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -78.88 120.26 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.389 0.614 . . . . 0.0 111.072 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -145.12 154.91 42.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.99 -179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 156.75 17.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.315 0.579 . . . . 0.0 112.014 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.61 110.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.06 -3.79 12.81 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.362 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 30.9 t -67.62 -176.01 0.58 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 110.585 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -90.52 101.36 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ptp -127.83 103.77 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 p -63.66 152.54 38.72 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -24.32 36.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.293 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -44.5 147.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 68' ' ' ILE . 72.2 t80 -93.46 135.16 34.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.435 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.4 mtm180 -147.97 112.02 5.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.559 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.5 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -59.42 -36.59 76.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -79.75 0.2 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 44.8 ttp180 -127.91 124.88 38.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 111.444 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.84 118.32 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.108 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -78.47 133.31 37.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 25.5 t -120.43 90.63 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -81.25 123.78 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.474 0.654 . . . . 0.0 112.184 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.6 m -124.92 165.95 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.01 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -86.73 -172.68 4.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.681 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -21.28 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.501 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.67 -8.68 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.89 25.08 23.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 24.1 t -100.51 135.11 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.14 114.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 111.434 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -98.74 -31.01 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 1.2 t -99.73 154.05 18.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.0 t -68.52 106.89 1.55 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.748 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.647 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 12.8 Cg_exo -65.69 89.29 0.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.868 1.712 . . . . 0.0 111.012 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -123.76 145.67 48.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.839 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -41.17 114.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.074 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.803 -179.435 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.502 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 ttmm -69.65 154.36 42.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.584 0.23 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' HB ' ' A' ' 68' ' ' ILE . 1.8 t-20 -111.46 -6.41 14.45 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.92 126.7 4.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.315 -0.241 . . . . 0.0 110.362 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.516 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 20.0 m-90 -112.52 73.48 1.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.66 -33.47 96.73 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.441 2.094 . . . . 0.0 111.854 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.5 -13.08 37.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 21.1 mt -81.33 -22.99 38.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.6 113.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -9.48 20.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.416 ' CD ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -105.95 177.26 4.91 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -66.47 144.75 56.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 0.0 111.338 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.32 -28.22 66.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.423 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -72.7 -53.48 11.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 110.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -30.92 70.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.412 ' CA ' ' HD2' ' A' ' 16' ' ' LYS . . . -65.85 -61.72 1.9 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.283 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.13 -38.17 50.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 110.129 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.2 94.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.412 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.41 ' HB ' HD12 ' A' ' 13' ' ' LEU . 11.4 m -58.49 -43.88 89.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.28 -60.66 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.074 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -59.01 -23.56 62.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 0.0 111.321 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -81.39 -61.04 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.32 . . . . 0.0 111.023 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.11 -31.79 73.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.558 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' HG21 ' A' ' 32' ' ' VAL . 52.8 t-20 -127.41 80.86 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.726 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.64 -8.08 5.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.02 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.32 -2.68 58.54 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 49' ' ' CYS . 11.6 m -129.45 168.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 0.0 111.552 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.52 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -133.65 135.14 43.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.328 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' VAL . . . -108.1 123.42 48.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.424 . . . . 0.0 111.741 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 33' ' ' HIS . 3.8 mp -97.87 115.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.468 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.467 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 53.4 t -79.72 113.05 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.324 0.583 . . . . 0.0 110.989 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -134.55 150.16 50.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.962 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -90.02 156.77 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.081 0.467 . . . . 0.0 111.766 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.73 123.88 3.98 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.458 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.1 -3.7 55.39 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.913 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 12.0 t -67.62 -179.32 1.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.955 0.407 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -86.02 101.68 13.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -129.73 100.05 5.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.098 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 p -59.37 147.31 36.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.099 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.91 -25.06 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.159 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.81 160.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -104.0 131.11 51.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.423 . . . . 0.0 111.61 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -145.22 109.36 4.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.308 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.539 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.3 m -60.01 -33.32 71.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.536 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -79.51 -2.97 44.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.626 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -121.11 142.76 49.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 111.478 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 68' ' ' ILE . 94.2 t -138.68 114.28 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.819 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.555 ' CE3' HD23 ' A' ' 37' ' ' LEU . 2.3 m95 -78.69 131.55 36.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.706 0.288 . . . . 0.0 110.484 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 11.3 t -119.21 88.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.101 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mt -79.84 122.15 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.8 m -121.26 164.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.433 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -87.91 -174.64 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -58.11 -23.48 55.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.55 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -86.04 -20.44 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 111.162 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.67 22.66 10.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.165 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 19.2 t -98.78 144.7 11.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . 0.405 HG12 ' HD3' ' A' ' 66' ' ' PRO . 48.0 t -75.58 112.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.993 0.425 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 p -94.04 -31.45 14.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.518 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -103.48 154.01 19.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.564 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 5.7 t -66.12 101.36 0.28 Allowed Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.736 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 64' ' ' SER . 19.1 Cg_endo -57.75 92.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.618 1.545 . . . . 0.0 110.827 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 16.1 p-80 -122.67 153.76 38.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.483 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -48.53 115.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.792 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.941 -179.422 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.249 0 CA-C-O 121.042 0.245 . . . . 0.0 113.061 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 33.3 ttmt -66.73 146.83 54.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.795 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -107.03 -4.2 19.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.32 134.51 7.31 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.528 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 21.6 m-90 -119.73 68.15 11.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.29 -37.35 49.7 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.283 1.989 . . . . 0.0 112.348 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.92 -13.48 25.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.968 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 24.8 mt -80.51 -23.42 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.67 0.272 . . . . 0.0 110.663 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.71 112.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.798 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -12.01 29.96 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.231 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.23 157.11 16.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.786 0.327 . . . . 0.0 110.875 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -56.82 141.33 44.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.38 -31.59 20.98 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.319 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.35 -45.54 59.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -42.08 99.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.043 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -62.56 -56.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.711 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.51 64.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.65 -45.23 93.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.5 m -58.27 -42.1 85.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.883 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 21' ' ' ALA . 21.8 t -67.35 -58.05 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.337 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.15 -24.89 66.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.46 0.171 . . . . 0.0 111.446 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 17.8 ttp180 -83.9 -58.72 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.833 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.98 -29.55 70.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.999 0.428 . . . . 0.0 110.269 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' HG21 ' A' ' 32' ' ' VAL . 50.0 t-20 -131.0 85.07 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -8.57 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.25 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.76 -10.03 52.21 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 49' ' ' CYS . 13.7 m -115.06 175.5 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 112.062 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CE1' ' CG1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -143.48 125.36 15.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.549 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 129.63 44.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.12 0.485 . . . . 0.0 112.007 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CG1' ' CE1' ' A' ' 33' ' ' HIS . 27.0 mt -106.82 119.64 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.452 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -79.45 132.45 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.369 0.604 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -157.03 150.94 24.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.17 153.87 20.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.165 0.507 . . . . 0.0 111.585 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -49.06 115.48 1.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.31 -1.85 25.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -69.71 -177.22 1.2 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.839 0.352 . . . . 0.0 110.655 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.52 104.86 17.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' MET . . . . . 0.428 ' HB2' ' HE1' ' A' ' 43' ' ' MET . 0.5 OUTLIER -124.14 106.52 10.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.305 -178.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -56.47 147.76 21.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.079 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 mmpp? -84.54 -26.13 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.954 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.93 138.24 5.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -84.81 130.34 34.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 3.9 mtp85 -144.71 112.25 6.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' CYS . . . . . 0.591 ' O ' HG13 ' A' ' 32' ' ' VAL . 90.9 m -63.95 -13.67 47.79 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.752 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 48' ' ' ARG . 18.8 p-10 -97.88 -4.7 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.646 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -122.35 143.31 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 111.35 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 68' ' ' ILE . 59.6 t -139.36 118.47 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.645 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TRP . . . . . 0.452 ' CE3' HD23 ' A' ' 37' ' ' LEU . 4.9 m95 -78.42 135.2 37.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.253 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 43.1 t -120.13 89.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.053 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 mt -81.98 126.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.016 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.8 m -123.47 165.27 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.798 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -88.13 -172.72 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.964 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.62 -21.98 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -95.48 -8.85 34.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.78 21.97 24.72 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.537 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 t -96.38 140.66 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.65 112.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.804 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.1 p -94.45 -32.41 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.567 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 9.0 t -100.82 146.41 27.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.73 101.44 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.509 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.1 Cg_endo -57.91 99.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.034 1.823 . . . . 0.0 111.647 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -127.98 152.83 47.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.115 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.515 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -49.72 116.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.453 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.979 -179.353 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.051 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.7 t -75.65 94.88 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtp-105 -152.67 70.91 0.91 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.748 1.219 . . . . 0.0 110.953 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -151.12 88.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.3 m -88.37 148.28 42.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.802 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.72 160.84 47.88 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.133 1.889 . . . . 0.0 112.162 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.458 ' HA2' ' ND2' ' A' ' 29' ' ' ASN . . . 74.43 158.46 6.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.443 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 25.5 ttmt -56.11 142.81 35.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.705 0.288 . . . . 0.0 110.68 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -100.77 -11.34 19.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -155.47 140.2 17.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB2' ' HG2' ' A' ' 66' ' ' PRO . 17.1 m-90 -121.2 68.58 18.75 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.434 ' O ' HG21 ' A' ' 14' ' ' VAL . 67.3 Cg_exo -49.74 -36.18 41.07 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.183 1.922 . . . . 0.0 112.177 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -64.12 -8.33 11.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.276 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.473 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 17.9 mt -83.71 -20.1 34.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG21 ' O ' ' A' ' 11' ' ' PRO . 44.1 t -56.57 114.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.823 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -8.1 31.5 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.35 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 3.2 mmtt -99.25 157.9 16.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.312 . . . . 0.0 110.716 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -56.99 139.43 52.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -51.58 -29.16 23.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.512 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.22 -46.69 40.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 7.0 tpt -65.25 -33.87 77.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.032 0.444 . . . . 0.0 109.829 179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.4 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.367 179.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.71 -42.72 57.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.15 -46.13 91.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.429 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -57.03 -40.47 76.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 45.3 t -66.0 -54.98 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.315 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -64.76 -26.05 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.609 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.541 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -83.46 -56.22 3.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 111.186 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -63.05 -30.52 71.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.073 0.463 . . . . 0.0 110.322 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.5 ' O ' HG21 ' A' ' 32' ' ' VAL . 50.2 t-20 -127.84 85.04 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.783 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -8.17 3.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.233 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -95.04 2.42 55.25 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.698 HG11 ' O ' ' A' ' 49' ' ' CYS . 30.6 m -129.09 167.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 128.44 36.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.673 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.73 144.07 31.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.233 0.54 . . . . 0.0 112.139 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.463 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 20.3 mt -120.19 143.46 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.159 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.44 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 58.3 t -97.49 130.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.577 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -157.72 151.88 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.97 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -87.31 161.06 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 112.405 -178.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.517 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 5.8 tt0 -54.12 119.29 4.89 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.228 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.02 56.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.685 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 3.1 t -64.24 131.9 48.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.06 0.457 . . . . 0.0 110.908 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.86 81.85 0.11 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.656 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.524 ' HB3' ' CZ2' ' A' ' 53' ' ' TRP . 13.5 mmt -113.94 164.24 14.05 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.886 0.374 . . . . 0.0 111.453 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.2 164.02 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.23 -25.73 7.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.323 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -52.04 171.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 33.4 t80 -97.96 128.4 44.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -143.87 111.2 5.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.501 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.698 ' O ' HG11 ' A' ' 32' ' ' VAL . 18.4 m -60.25 -35.96 76.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 16.2 p-10 -78.81 -3.48 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.442 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.453 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 40.8 ttp180 -123.04 129.99 52.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.194 0.521 . . . . 0.0 111.784 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 84.6 t -133.16 119.79 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.358 178.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.524 ' CZ2' ' HB3' ' A' ' 43' ' ' MET . 2.7 m95 -78.9 130.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 55.1 t -113.16 84.38 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.01 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.577 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.5 mp -79.87 118.4 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.62 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.59 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 29.8 m -122.93 165.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.236 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.17 -172.62 3.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -23.36 61.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.379 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -90.65 2.93 55.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 25.09 64.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.166 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.59 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.0 t -100.22 132.88 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.2 t -68.1 108.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.528 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.6 p -93.06 -33.8 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.155 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.446 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 22.9 t -102.2 157.15 17.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.542 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 3.1 t -69.58 123.39 88.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.478 ' HG2' ' HB2' ' A' ' 10' ' ' TRP . 91.5 Cg_endo -81.99 101.77 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.313 2.009 . . . . 0.0 110.576 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.7 p-80 -132.26 145.98 51.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.08 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.462 ' O ' HG23 ' A' ' 68' ' ' ILE . 1.1 mt -39.34 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.674 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.78 -179.077 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.3 p -74.11 82.37 1.78 Allowed 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.53 60.01 1.21 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.303 1.041 . . . . 0.0 110.927 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -151.35 89.23 1.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.335 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.69 136.77 83.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 164.69 34.47 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.06 1.84 . . . . 0.0 112.541 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.34 163.89 10.36 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.735 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 26.2 ttmt -59.62 154.11 18.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.816 0.341 . . . . 0.0 111.31 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -115.92 -5.55 12.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -155.32 124.61 6.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.548 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.0 m-90 -111.4 74.93 1.2 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.869 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -59.49 -35.67 95.34 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.986 1.791 . . . . 0.0 111.604 179.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -65.0 -9.89 25.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.861 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.548 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 26.8 mt -82.81 -19.8 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.719 0.295 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 45.2 t -55.47 111.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.6 -9.76 23.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.118 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' ' CG2' ' A' ' 62' ' ' VAL . 6.0 mmtt -95.43 157.84 15.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.297 . . . . 0.0 110.733 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 p -59.51 138.5 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.763 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.25 -31.63 8.92 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.084 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.38 63.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.985 0.421 . . . . 0.0 110.268 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -33.1 75.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.871 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.67 -59.5 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.49 -41.73 73.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.559 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.431 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.22 -46.63 89.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 88.0 m -57.83 -43.75 85.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.452 HG11 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -63.68 -52.05 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -63.82 -29.14 70.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.519 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -78.66 -57.11 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.836 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.4 -35.22 80.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.438 . . . . 0.0 110.454 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.3 t-20 -123.16 78.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -3.15 0.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.609 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.64 -5.05 49.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.479 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 12.8 m -139.72 168.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -133.58 146.79 51.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.684 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -109.06 138.72 44.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.504 -179.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 ' CD1' ' N ' ' A' ' 35' ' ' ILE . 3.1 mp -105.09 120.55 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.623 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.442 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.5 p -80.43 129.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -156.46 152.35 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.19 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.462 ' HG3' HG22 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -89.67 155.1 19.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 111.946 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 117.11 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.054 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.98 -1.97 30.09 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 39.7 t -70.11 -172.54 0.56 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.313 . . . . 0.0 110.738 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -88.87 104.82 17.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 100.95 6.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.459 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -58.68 147.55 32.45 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.875 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -80.43 -26.42 38.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.25 161.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.414 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 42.7 t80 -103.81 137.32 41.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -152.49 112.85 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' O ' HG12 ' A' ' 68' ' ' ILE . 50.3 m -58.45 -37.84 76.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 21.7 p-10 -79.36 -2.82 43.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.48 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -120.63 111.47 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.609 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 78.9 t -113.15 117.64 55.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 1.9 m95 -78.71 128.79 33.91 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.442 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 7.2 t -116.52 98.93 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 9.0 mm -83.87 122.4 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 -179.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.5 m -126.66 168.35 19.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.423 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.75 -170.93 2.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -18.83 61.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.77 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.56 -1.8 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.14 24.19 38.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.3 t -96.04 131.92 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.405 ' CG2' ' O ' ' A' ' 16' ' ' LYS . 43.9 t -70.92 112.82 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 111.378 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -97.14 -33.07 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 6.8 t -97.86 149.94 21.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.218 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 21.3 t -66.92 108.36 2.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.541 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' O ' ' A' ' 10' ' ' TRP . 17.2 Cg_exo -62.19 106.14 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.211 1.941 . . . . 0.0 111.594 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.13 146.68 51.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.418 0.628 . . . . 0.0 111.768 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.534 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.3 OUTLIER -47.51 109.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.668 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 11.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.52 -179.455 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.043 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.345 69.7 p 64.62 -93.37 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 58.87 80.11 0.2 Allowed 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.928 2.491 . . . . 0.0 111.233 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.42 98.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.76 151.53 40.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 111.203 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.49 153.0 30.56 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.313 2.008 . . . . 0.0 112.542 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 172.12 10.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.662 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 3.6 ttmt -69.67 148.7 48.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.592 0.234 . . . . 0.0 110.546 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -110.34 -0.16 17.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.48 125.55 3.83 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.52 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 21.6 m-90 -113.39 67.46 1.23 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.767 0.317 . . . . 0.0 111.151 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.62 -33.67 59.84 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.386 2.058 . . . . 0.0 111.907 179.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -64.68 -9.2 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.696 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.6 mt -84.18 -18.87 35.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.844 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.6 t -56.84 113.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.746 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 -12.89 43.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.175 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.07 162.31 16.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 110.646 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 p -63.97 137.53 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.497 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.58 -29.74 32.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.364 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -70.1 -54.24 13.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.85 95.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HA ' ' CD2' ' A' ' 13' ' ' LEU . . . -60.06 -51.42 69.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.495 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.2 75.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.373 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.65 88.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.498 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -59.64 -45.73 91.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.531 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 40.3 t -64.7 -50.92 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -31.95 73.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 111.419 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -79.4 -56.51 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.181 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.17 -29.31 70.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.7 t-20 -126.7 79.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -65.14 -2.88 3.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -92.9 -9.78 38.92 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.603 0.24 . . . . 0.0 111.287 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.402 HG12 ' O ' ' A' ' 49' ' ' CYS . 3.0 m -140.3 169.55 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.932 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.566 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -133.88 151.06 51.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.162 0.506 . . . . 0.0 111.129 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.82 137.91 51.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.9 mp -104.86 129.07 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.514 179.441 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 65.5 t -80.16 128.39 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.04 0.447 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.61 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -150.67 143.36 24.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.518 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 157.2 17.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.95 120.46 2.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.96 55.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.738 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 14.8 t -70.49 -179.7 2.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 110.857 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.64 101.54 14.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.29 104.85 8.16 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.014 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.35 151.44 9.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -27.59 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -46.58 134.99 9.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -80.44 132.16 35.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.555 -179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.41 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.0 mtm180 -146.9 111.82 5.38 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.602 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.409 ' O ' HG12 ' A' ' 68' ' ' ILE . 97.3 m -60.63 -34.11 73.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.566 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 19.8 p-10 -79.54 -0.32 32.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.66 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.41 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 47.9 ttp180 -126.43 129.49 48.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.433 . . . . 0.0 111.471 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG21 ' HA ' ' A' ' 68' ' ' ILE . 52.7 t -128.32 116.26 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.15 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.61 ' CE3' ' CD2' ' A' ' 37' ' ' LEU . 3.9 m95 -78.76 133.89 37.08 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.478 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 29.3 t -115.25 96.38 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.49 ' HA ' HD11 ' A' ' 37' ' ' LEU . 4.0 mp -84.47 121.28 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.172 0.51 . . . . 0.0 111.57 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 27.0 m -125.87 162.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.013 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -85.84 -179.7 6.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.92 -20.98 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.53 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.21 -24.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.295 . . . . 0.0 111.227 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.33 21.14 7.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.18 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.6 t -98.28 139.49 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.9 t -72.6 111.78 7.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.816 0.341 . . . . 0.0 110.756 -179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -91.19 -31.3 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 48.3 t -107.59 150.13 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.4 t -64.82 102.14 0.31 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.38 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.9 Cg_endo -58.86 97.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.114 1.876 . . . . 0.0 111.596 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.404 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -123.68 157.47 33.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.551 . . . . 0.0 111.347 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.505 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -51.09 114.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.535 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 2.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.813 -179.518 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.4 m -60.03 145.45 46.34 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.96 72.62 0.72 Allowed 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.918 -1.114 . . . . 0.0 110.747 -160.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.52 74.36 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.11 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 2.5 m -111.12 128.22 25.68 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.519 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -69.56 63.46 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.981 1.788 . . . . 0.0 111.595 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . 142.26 148.5 5.0 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.298 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 26.4 ttmt -33.23 143.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.634 0.254 . . . . 0.0 111.49 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HA ' HD13 ' A' ' 68' ' ' ILE . 5.0 p30 -112.23 -0.54 15.47 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.12 121.46 4.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.478 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 28.2 m-90 -108.79 74.81 0.59 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.94 0.4 . . . . 0.0 111.453 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -60.59 -33.25 93.79 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.208 1.939 . . . . 0.0 111.401 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pm0 -63.7 -14.13 49.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.478 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 22.2 mt -81.07 -20.63 41.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.645 0.259 . . . . 0.0 110.565 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.41 117.34 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.614 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.76 -14.6 53.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.14 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.17 174.78 8.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.622 0.248 . . . . 0.0 110.516 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 p -75.99 144.01 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.98 -31.62 40.22 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.084 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.4 -52.87 22.77 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.708 0.289 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -29.97 70.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 109.999 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.73 -60.55 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.449 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.1 68.67 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.01 -44.58 84.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -58.85 -43.12 90.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.46 HG11 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -65.61 -51.41 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.37 -28.51 69.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.57 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -81.86 -54.75 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 110.899 -179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.71 -34.95 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.281 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.9 t-20 -124.63 80.0 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.656 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -5.46 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -93.53 2.52 56.39 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -137.06 170.61 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 0.0 111.663 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.428 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -137.23 126.65 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.321 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.74 135.98 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.686 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.428 HG12 ' CE1' ' A' ' 33' ' ' HIS . 34.8 mt -107.38 120.73 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.738 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.583 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.6 p -79.79 128.74 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 111.438 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.9 144.72 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.534 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.416 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.24 159.31 16.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.584 . . . . 0.0 111.915 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.67 122.05 3.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.46 29.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.594 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 15.4 t -68.09 -178.09 0.96 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 110.71 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.9 102.7 15.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.518 ' HE3' HD11 ' A' ' 55' ' ' ILE . 2.7 ptp -124.51 100.15 6.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -60.09 148.92 34.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.053 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -82.31 -24.56 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.023 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -45.95 159.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -100.82 131.98 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.064 0.459 . . . . 0.0 111.422 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.04 108.17 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 48.8 t -60.56 -36.75 79.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.576 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.64 3.46 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -129.19 128.06 42.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.025 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.0 t -127.64 119.09 50.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.017 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 2.4 m95 -78.7 130.52 35.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.182 -179.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 31.1 t -113.83 95.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.934 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.518 HD11 ' HE3' ' A' ' 43' ' ' MET . 5.6 mm -79.99 119.9 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.675 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.639 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.6 m -124.94 164.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.254 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -89.72 -171.76 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -18.18 62.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.496 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -96.21 -1.57 47.97 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.502 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.639 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.9 t -99.49 137.33 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.4 t -72.33 109.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.937 -179.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -93.76 -28.04 16.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.2 t -106.57 157.7 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 111.141 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.622 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 5.0 t -72.19 111.02 9.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.438 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 7.8 Cg_exo -67.57 103.55 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.664 1.576 . . . . 0.0 110.517 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.622 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.9 p-80 -131.7 145.2 51.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.427 HD13 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -40.82 111.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.28 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.425 ' OXT' ' CG2' ' A' ' 69' ' ' THR . 16.3 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.051 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.356 82.8 p 71.66 -88.33 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 124.898 1.279 . . . . 0.0 114.024 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -103.22 52.5 0.78 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.07 1.348 . . . . 0.0 110.416 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.6 mtt-85 -153.68 84.24 1.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.263 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 m -129.76 144.12 51.74 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.27 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.94 -178.31 4.06 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.137 1.891 . . . . 0.0 112.439 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.62 169.82 7.2 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.154 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.6 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.6 tttt -68.24 149.86 48.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.303 . . . . 0.0 110.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -110.98 -8.33 14.48 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.58 123.81 3.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.865 0.364 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.6 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 21.7 m-90 -109.52 74.36 0.68 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -56.11 -37.53 96.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.495 2.13 . . . . 0.0 112.174 179.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.54 -6.88 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.166 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.476 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.8 mt -85.37 -21.2 28.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.744 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.9 t -56.72 113.05 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-O 120.777 0.322 . . . . 0.0 110.775 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.17 -10.53 26.82 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.133 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.08 157.89 15.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.933 0.396 . . . . 0.0 110.928 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 p -56.66 141.66 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.41 -29.38 38.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -72.46 -45.19 60.68 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.514 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -39.07 91.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.75 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.56 -58.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.027 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.71 -38.81 61.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.483 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -63.26 -46.21 87.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.244 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.471 ' HB ' HD12 ' A' ' 13' ' ' LEU . 13.1 m -59.97 -42.31 93.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.762 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.4 t -65.57 -51.59 61.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.6 -28.5 68.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.749 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 6.0 mpp_? -82.77 -52.32 6.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -67.32 -31.58 71.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 0.0 110.371 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -126.07 76.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.601 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 1.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.196 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -95.45 -13.99 24.12 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.348 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.469 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 5.1 m -134.05 168.37 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.422 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.39 140.36 51.37 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.159 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.01 134.77 47.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.373 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.422 HG12 ' CE1' ' A' ' 33' ' ' HIS . 31.5 mt -102.15 116.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.926 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.5 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 41.8 t -83.73 118.95 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.998 0.428 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 2.2 pp -143.66 156.67 44.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.118 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.548 ' HE3' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -90.76 160.49 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.222 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 115.7 1.73 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.844 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.76 -6.53 20.2 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.361 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.41 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 44.8 t -64.93 178.95 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 88.06 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.445 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.5 ptm -111.42 104.88 13.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 110.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.9 p -67.47 153.72 43.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.069 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -24.94 40.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.508 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.29 139.88 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.467 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.405 ' CE1' HG23 ' A' ' 68' ' ' ILE . 48.2 t80 -85.76 128.34 34.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HD3' ' NH1' ' A' ' 51' ' ' ARG . 69.3 mtp180 -145.73 112.68 6.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.511 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.431 ' O ' HG12 ' A' ' 68' ' ' ILE . 33.0 m -59.11 -38.71 80.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.469 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 19.3 p-10 -78.36 -0.17 27.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' NH1' ' HD3' ' A' ' 48' ' ' ARG . 39.3 ttp180 -128.62 106.37 8.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.17 0.509 . . . . 0.0 111.826 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 68' ' ' ILE . 43.2 t -105.92 120.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.404 ' HA ' ' CE3' ' A' ' 53' ' ' TRP . 3.0 m95 -78.39 132.68 37.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.672 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.5 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 54.6 t -123.4 87.73 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.955 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.511 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -79.95 124.1 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.71 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.705 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 15.9 m -121.36 162.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -91.97 -170.61 2.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.548 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 15.4 t70 -54.76 -22.7 14.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 22.41 12.18 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.0 56.34 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.626 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.705 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.9 t -93.81 138.31 20.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.431 HG23 HG11 ' A' ' 54' ' ' VAL . 43.7 t -76.31 112.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.143 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -93.34 -33.81 13.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.133 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.44 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.52 151.56 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.687 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.0 t -67.06 104.53 0.64 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.49 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 20.5 Cg_endo -60.32 99.84 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.744 1.629 . . . . 0.0 111.309 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -130.09 150.21 51.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.501 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -46.33 112.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.734 -179.458 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.058 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.4 49.2 m 87.08 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -154.94 73.77 0.89 Allowed 'General case' 0 C--N 1.357 0.919 0 CA-C-N 121.637 2.017 . . . . 0.0 111.042 -161.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 82.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.682 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 18.1 p -85.79 143.68 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.96 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_exo -63.23 -176.83 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.35 2.033 . . . . 0.0 112.703 -179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.85 168.81 0.21 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.026 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.522 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.3 ttmm -65.64 151.04 47.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -110.8 -14.92 13.92 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -148.99 130.9 15.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.598 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 29.3 m-90 -116.71 67.35 3.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.457 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.81 -34.41 91.19 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.211 1.941 . . . . 0.0 111.84 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.85 -10.44 20.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.636 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.492 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 20.1 mt -81.76 -23.2 36.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.6 t -55.32 118.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.09 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.86 44.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.608 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.67 -175.4 3.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.514 0.197 . . . . 0.0 110.558 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 p -83.68 142.51 30.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.723 0.297 . . . . 0.0 110.834 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.65 -32.15 38.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.866 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -47.8 67.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.256 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 tpt -64.11 -34.35 77.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 62' ' ' VAL . . . -63.42 -61.0 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.372 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.94 -40.14 66.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -62.02 -44.61 96.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 179.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -61.39 -42.35 98.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.798 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.429 HG22 ' O ' ' A' ' 21' ' ' ALA . 45.8 t -63.18 -49.04 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.92 -31.42 70.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.489 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 7.4 mtp85 -77.48 -50.74 12.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.17 -37.54 72.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.6 t-20 -119.44 78.18 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.974 179.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -0.07 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.834 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -94.86 -9.8 33.24 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.637 0.256 . . . . 0.0 111.328 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.419 HG13 ' O ' ' A' ' 49' ' ' CYS . 4.0 m -138.97 168.0 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.176 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.43 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 1.5 p80 -128.23 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.351 0.596 . . . . 0.0 111.942 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . . . -109.83 131.17 55.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 20.0 mt -103.16 127.16 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.642 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 44.8 t -83.85 121.18 36.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 111.323 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.552 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -146.69 155.71 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.737 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' CE ' ' HA ' ' A' ' 58' ' ' ASP . 0.0 OUTLIER -90.09 162.22 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.256 0.551 . . . . 0.0 112.061 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG2' HG23 ' A' ' 55' ' ' ILE . 1.4 mm-40 -52.73 125.24 16.12 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.206 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.83 -2.91 62.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.867 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 2.9 t -57.44 134.64 56.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.54 81.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.565 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 28.6 mmt -124.73 130.2 51.95 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.845 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -56.68 152.94 11.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -23.38 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.74 152.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.466 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.498 ' CE2' HG23 ' A' ' 68' ' ' ILE . 51.1 t80 -93.36 133.07 36.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.116 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -149.35 110.67 4.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.429 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -59.67 -35.86 75.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.43 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -78.6 0.85 24.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 44.8 ttp180 -129.63 129.92 44.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.391 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.419 HG23 HG12 ' A' ' 25' ' ' VAL . 41.1 t -126.79 118.04 49.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.973 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.565 ' CE2' ' HB3' ' A' ' 43' ' ' MET . 1.7 m95 -78.7 132.88 37.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 110.229 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.642 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.2 t -114.86 83.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.534 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.6 mt -79.85 121.99 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.538 0.685 . . . . 0.0 111.466 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.5 m -125.95 165.34 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.291 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -84.19 -175.55 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.447 ' HA ' ' CE ' ' A' ' 38' ' ' LYS . 2.9 t70 -59.58 -18.87 44.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.436 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -89.54 -19.9 24.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.86 20.24 13.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.958 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.593 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.5 t -95.68 132.93 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 21' ' ' ALA . 40.3 t -69.29 111.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.937 0.399 . . . . 0.0 110.38 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 p -90.91 -29.55 17.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.136 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 12.9 m -104.89 148.4 26.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 44.9 t -63.72 106.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.615 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.598 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 35.8 Cg_exo -56.92 98.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.748 1.632 . . . . 0.0 111.538 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -125.24 166.45 16.46 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.342 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.498 HG23 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -64.39 107.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.135 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.511 -178.959 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.8 m -66.99 125.38 25.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -147.9 66.19 1.1 Allowed 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.341 -0.849 . . . . 0.0 110.753 -160.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 88.78 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.498 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.0 m -69.3 149.49 97.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.28 128.51 21.7 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.854 1.703 . . . . 0.0 111.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.66 161.28 28.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.513 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.472 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.5 ttmt -59.59 145.36 44.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.697 0.284 . . . . 0.0 110.566 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.24 -15.32 16.67 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.72 132.36 11.36 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.139 -0.35 . . . . 0.0 110.52 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.638 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 28.0 m-90 -113.52 74.88 2.33 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.264 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -56.06 -40.98 81.52 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.209 1.939 . . . . 0.0 112.417 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -62.82 -6.8 4.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.455 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.514 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 14.3 mt -83.36 -20.88 33.45 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.12 116.0 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.701 0.286 . . . . 0.0 110.791 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.41 38.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.407 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' O ' HG22 ' A' ' 62' ' ' VAL . 1.9 tppm? -93.56 161.26 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.507 0.194 . . . . 0.0 110.705 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -62.7 141.84 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.34 -29.35 46.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.427 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.87 -49.74 35.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.371 . . . . 0.0 110.69 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 10.8 tpt -63.7 -40.97 98.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.423 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -60.02 -54.58 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.991 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -52.18 -44.6 64.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.573 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.66 95.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -59.8 -43.08 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.423 HG22 ' O ' ' A' ' 21' ' ' ALA . 44.3 t -66.72 -52.31 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.429 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 8.0 mt-10 -67.11 -24.02 65.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.319 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -84.98 -56.14 3.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.683 0.278 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.49 -31.9 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.143 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.453 ' OD1' HG12 ' A' ' 32' ' ' VAL . 53.2 t-20 -125.05 80.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.713 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -4.79 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -98.72 6.14 47.15 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.629 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.453 HG12 ' OD1' ' A' ' 29' ' ' ASN . 5.8 m -138.4 165.95 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.32 . . . . 0.0 111.358 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.44 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -128.63 132.84 48.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.346 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.09 127.44 44.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.44 HG13 ' CE1' ' A' ' 33' ' ' HIS . 2.5 mp -104.53 108.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.544 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 11.2 p -78.86 121.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.592 0.71 . . . . 0.0 110.874 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.578 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -146.72 155.34 42.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.296 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.483 ' HG3' HG22 ' A' ' 56' ' ' VAL . 9.2 mtmt -89.55 165.76 14.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.305 0.574 . . . . 0.0 112.264 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 122.17 6.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.518 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.97 4.89 62.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.88 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.57 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.7 t -65.73 -173.93 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.89 87.06 6.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.2 ptm -121.13 105.87 11.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.059 0.457 . . . . 0.0 110.481 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -63.52 150.9 42.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.009 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -79.65 -23.5 42.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -45.52 155.0 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.847 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 37.5 t80 -99.41 136.18 39.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.005 0.431 . . . . 0.0 111.385 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -153.0 110.11 3.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.386 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.509 ' O ' HG12 ' A' ' 68' ' ' ILE . 23.5 m -58.37 -38.82 78.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.892 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.436 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 18.6 p-10 -79.25 5.55 12.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.33 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HG3' HD12 ' A' ' 35' ' ' ILE . 42.0 ttp180 -127.25 131.48 50.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.982 0.42 . . . . 0.0 111.206 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 59.8 t -134.23 117.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.128 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 5.0 m95 -78.77 140.34 38.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 110.614 -179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.544 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 64.5 t -128.05 87.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.578 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mt -79.62 128.92 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.152 0.501 . . . . 0.0 111.645 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.2 m -126.92 164.21 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -84.72 -171.49 3.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.029 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 -9.2 12.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.941 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -5.67 20.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.63 20.17 38.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.365 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.5 t -97.35 132.36 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 16' ' ' LYS . 60.0 t -66.43 110.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.781 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -87.87 -35.73 17.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.438 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.1 m -105.65 156.56 18.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 111.377 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.416 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 3.8 t -66.82 128.18 93.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.437 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.638 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 15.6 Cg_endo -86.34 96.34 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.431 2.087 . . . . 0.0 110.766 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -128.54 153.15 47.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.19 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.509 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.7 OUTLIER -44.11 103.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.159 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.504 -179.328 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 t -64.85 121.8 15.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -158.38 75.3 0.73 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.728 -163.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.4 94.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.4 m -138.43 146.44 51.15 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.22 155.82 11.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.172 1.915 . . . . 0.0 112.092 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.27 -168.82 44.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.59 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.602 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 1.7 ttmp? -88.42 154.9 20.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.284 . . . . 0.0 110.763 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -114.57 -2.05 13.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -157.61 130.51 7.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.118 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.602 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.2 m-90 -119.49 74.16 16.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.55 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -55.7 -39.3 91.93 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.219 1.946 . . . . 0.0 111.986 179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -62.01 -9.68 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.193 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.507 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 42.4 mt -83.97 -23.67 30.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.797 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 41.0 t -58.26 111.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -7.63 29.44 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.177 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.95 166.01 11.48 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.532 0.206 . . . . 0.0 110.621 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -63.62 142.7 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.31 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.12 42.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.844 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -68.97 -42.18 76.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -65.68 -35.22 80.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.906 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.46 -60.1 3.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.043 179.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -49.33 -50.17 40.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.11 86.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.417 ' CB ' HD23 ' A' ' 13' ' ' LEU . 94.6 m -60.11 -43.4 95.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.767 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 21.6 t -67.86 -51.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.23 -29.07 69.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -81.5 -57.19 3.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.53 -30.83 71.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.412 ' CG ' HG21 ' A' ' 32' ' ' VAL . 46.7 t-20 -127.11 78.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.276 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -64.62 1.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.965 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -98.36 -5.35 32.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.573 0.225 . . . . 0.0 111.482 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.549 ' HB ' ' HA ' ' A' ' 50' ' ' ASP . 17.9 m -148.69 166.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.422 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -129.47 152.91 48.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 111.361 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.3 147.93 35.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.34 -179.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 2.5 mp -112.6 114.35 46.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.791 179.614 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.58 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 57.5 t -83.25 111.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 111.345 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -135.27 154.72 51.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.535 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.521 ' HG3' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -85.54 157.2 20.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 0.0 111.527 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 113.61 1.18 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.718 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.79 -9.4 11.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.162 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 46.5 t -66.01 -174.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 97.67 11.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.119 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.462 ' HA ' ' CZ2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -124.83 103.69 8.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.56 160.09 23.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.27 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -87.84 -23.36 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.51 140.39 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.059 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.489 ' CE2' HG23 ' A' ' 68' ' ' ILE . 42.6 t80 -84.06 131.03 34.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.181 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -146.48 110.92 5.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.468 ' O ' HG12 ' A' ' 68' ' ' ILE . 98.3 m -59.05 -38.22 78.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.287 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.549 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 11.6 p-10 -78.8 -6.14 55.22 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.395 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 41.3 ttp180 -119.21 105.96 11.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.989 0.424 . . . . 0.0 111.694 -179.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.414 HG21 ' HA ' ' A' ' 68' ' ' ILE . 62.0 t -106.65 119.26 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CZ2' ' HA ' ' A' ' 43' ' ' MET . 1.3 m95 -78.37 136.8 37.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 -178.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.58 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 49.0 t -127.64 84.0 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.051 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.572 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.2 mt -79.67 121.52 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.071 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.636 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.0 m -119.91 161.3 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.999 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -80.0 -171.48 2.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.272 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -20.47 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.612 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.73 -7.36 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.43 23.86 27.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.936 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.636 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.7 t -96.57 134.21 35.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 42.8 t -67.77 104.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.017 0.437 . . . . 0.0 110.888 -179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -88.04 -34.74 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.507 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.17 157.27 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.922 0.392 . . . . 0.0 111.502 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 4.3 t -71.84 106.24 1.88 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.639 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 64' ' ' SER . 36.2 Cg_exo -58.06 103.39 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.688 1.592 . . . . 0.0 110.84 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.78 143.63 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.332 0.587 . . . . 0.0 111.474 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.489 HG23 ' CE2' ' A' ' 47' ' ' PHE . 0.6 OUTLIER -41.81 107.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.685 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.083 -179.119 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.326 60.5 p 71.09 -61.49 0.48 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.69 61.84 0.67 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 110.822 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.64 95.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 56.1 m -97.78 158.37 33.06 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.958 -179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_exo -43.61 133.05 7.5 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.548 2.166 . . . . 0.0 112.848 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 88.38 154.76 28.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.721 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.549 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.1 ttmm -49.54 146.04 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 111.205 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -103.46 -16.72 15.49 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.513 ' O ' ' HD3' ' A' ' 7' ' ' LYS . . . -146.96 149.99 34.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.549 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.8 m-90 -134.56 67.64 71.71 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.229 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.7 Cg_endo -55.91 -33.08 87.77 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.101 1.867 . . . . 0.0 111.439 179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.24 -12.48 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.666 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.527 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 21.4 mt -82.21 -20.3 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.2 t -61.91 111.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.15 -2.99 29.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.64 177.09 4.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -72.29 135.58 46.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.563 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.23 -30.51 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.038 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -70.94 -47.25 60.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.876 0.37 . . . . 0.0 110.399 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.4 tpt -63.18 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.783 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.54 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.577 179.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.01 -39.59 59.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.36 90.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.7 m -60.0 -42.54 94.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.403 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 19.0 t -64.41 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.01 -29.68 70.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.334 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -76.44 -54.35 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.37 -40.71 85.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.776 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.8 t-20 -115.44 80.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -64.96 -5.52 6.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.796 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 -0.66 56.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.548 0.213 . . . . 0.0 111.262 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.504 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 4.3 m -139.09 171.78 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -136.46 137.81 40.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.83 133.2 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.761 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 HG12 ' CE1' ' A' ' 33' ' ' HIS . 45.1 mt -102.14 119.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.439 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.412 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 63.1 t -87.12 115.83 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.286 0.565 . . . . 0.0 111.275 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -138.82 156.14 47.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.899 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 151.64 21.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.278 0.561 . . . . 0.0 111.781 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.37 113.93 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.183 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.1 23.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -72.76 -164.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.98 99.1 12.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.91 96.9 5.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 111.422 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.48 155.96 39.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.428 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -87.15 -24.97 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.274 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.84 141.06 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -88.53 125.67 34.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.29 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.404 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.5 mtm180 -145.33 111.03 5.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.236 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.504 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 73.9 m -60.49 -32.78 71.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.637 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -78.94 -4.56 50.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.408 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.404 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 54.9 ttp180 -120.73 124.26 44.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.435 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 69.8 t -123.54 119.39 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.398 178.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.461 ' CZ3' ' CD2' ' A' ' 37' ' ' LEU . 1.1 m95 -78.71 131.35 36.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.841 0.353 . . . . 0.0 111.177 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.412 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 5.5 t -122.88 91.95 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -85.72 125.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.685 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.8 m -125.16 164.79 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.492 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -89.94 -177.17 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.91 -20.76 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.316 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -88.49 -22.2 23.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.162 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.1 22.26 9.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.206 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 36.8 t -98.19 144.67 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 47.6 t -75.28 110.85 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.648 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -91.53 -33.68 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -101.96 148.46 25.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 47.8 t -67.64 108.47 2.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.214 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.3 Cg_exo -62.73 117.55 4.44 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.138 1.892 . . . . 0.0 111.471 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -151.8 143.89 23.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.98 0.419 . . . . 0.0 110.792 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.42 HD12 HG12 ' A' ' 32' ' ' VAL . 1.6 mt -40.3 122.69 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.048 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' THR . . . . . 0.412 HG23 ' OXT' ' A' ' 69' ' ' THR . 2.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.134 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.6 t 68.53 110.0 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.47 77.87 0.71 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 119.793 -1.817 . . . . 0.0 110.721 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 46.82 83.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.9 t -112.86 128.44 25.59 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.524 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 22.1 Cg_exo -64.24 160.83 36.74 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.858 1.705 . . . . 0.0 111.76 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 54.98 174.5 0.1 OUTLIER Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.531 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.455 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 32.2 ttmt -59.0 154.12 16.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.727 0.299 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.497 ' HA ' HD13 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -108.1 -20.4 13.17 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.444 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -147.71 127.04 13.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.531 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 22.7 m-90 -108.65 74.14 0.53 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.851 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -59.35 -37.06 92.68 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.047 1.831 . . . . 0.0 111.819 179.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -63.34 -9.59 12.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.865 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.524 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 13.4 mt -80.88 -24.38 38.34 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.515 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.3 t -55.68 112.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.955 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -6.99 24.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.407 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.8 mmtp -102.69 160.38 14.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.287 . . . . 0.0 110.497 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.0 p -56.81 135.81 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.923 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -46.45 -30.61 4.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.171 179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -44.77 64.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.827 0.346 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -32.46 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.032 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -68.04 -60.09 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.545 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.28 -39.73 67.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.755 179.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.413 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -64.12 -44.92 90.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.637 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.405 ' HB ' HD12 ' A' ' 13' ' ' LEU . 89.1 m -59.27 -41.0 87.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 60.2 t -65.11 -57.58 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.107 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.17 -24.17 67.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.413 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 19.8 ttm-85 -80.77 -58.18 3.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.351 . . . . 0.0 110.819 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.05 -37.17 86.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.105 0.479 . . . . 0.0 110.377 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -121.16 78.22 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -0.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.22 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.29 -11.64 32.01 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.349 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.407 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 14.0 m -122.67 171.0 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.85 133.38 45.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.016 179.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 135.11 47.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.574 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.7 mt -104.03 122.81 57.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.567 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.49 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.0 t -91.3 123.02 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -150.6 158.6 44.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.478 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -89.0 159.76 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.098 0.475 . . . . 0.0 111.499 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.77 122.31 5.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.323 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.78 -8.82 43.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.933 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.482 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 32.8 t -68.69 -166.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.354 . . . . 0.0 111.123 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' CH2' ' A' ' 53' ' ' TRP . . . -71.14 93.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.514 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 1.5 ttp -121.18 99.12 6.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.48 151.52 20.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.356 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -79.82 -26.72 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.05 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.99 142.38 2.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -88.05 129.5 35.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.716 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.405 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.3 mtp180 -144.72 108.6 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.236 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -56.12 -43.21 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.282 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -79.48 3.57 18.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.405 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 40.4 ttp180 -126.65 115.71 19.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 57.3 t -116.42 122.47 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.249 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.514 ' CD1' ' HG2' ' A' ' 43' ' ' MET . 1.2 m95 -78.69 125.54 29.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.212 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.49 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.32 85.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.547 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mp -83.27 127.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.154 0.502 . . . . 0.0 111.73 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.635 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.8 m -124.9 163.72 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.242 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -83.55 -178.75 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.54 -22.0 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.855 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -24.43 21.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.335 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.78 22.23 7.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.318 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.635 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.0 t -99.02 140.47 18.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.43 HG12 ' HG3' ' A' ' 66' ' ' PRO . 43.4 t -70.71 112.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.098 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.9 p -94.66 -32.8 13.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.176 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 39.5 t -103.79 151.74 22.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.499 . . . . 0.0 111.543 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.505 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 4.5 t -64.47 114.85 15.83 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.142 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 5.3 Cg_exo -75.41 88.18 1.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.904 1.736 . . . . 0.0 111.451 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.505 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 18.0 p-80 -121.8 144.04 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.118 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.497 HD13 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -38.28 116.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.069 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.768 -179.068 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.107 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.291 50.9 m 76.1 120.05 0.05 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -113.85 59.28 0.67 Allowed 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.896 -1.128 . . . . 0.0 110.653 162.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 81.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.174 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -102.44 137.92 19.53 Favored Pre-proline 0 CA--C 1.517 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -61.11 157.99 36.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.055 1.837 . . . . 0.0 112.57 -179.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.05 168.96 3.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.391 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.601 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 2.8 ttmp? -55.64 149.78 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -103.73 -16.67 15.38 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -154.39 138.15 16.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.601 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 19.9 m-90 -120.49 71.06 17.8 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.84 0.352 . . . . 0.0 111.276 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -54.78 -37.81 92.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.328 2.019 . . . . 0.0 112.003 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -62.19 -9.15 6.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.156 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.498 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 17.1 mt -81.13 -24.21 37.8 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.769 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.3 t -57.93 110.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.845 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.25 15.76 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.404 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -103.91 179.39 4.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.632 0.253 . . . . 0.0 110.625 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -76.04 143.23 41.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.664 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.71 -33.57 12.91 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.009 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.08 -36.92 66.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.987 0.422 . . . . 0.0 110.161 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -39.65 84.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.791 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.406 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -65.66 -58.85 4.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.504 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.66 -41.97 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.08 -45.45 94.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.95 179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.469 ' HB ' HD12 ' A' ' 13' ' ' LEU . 39.9 m -61.3 -41.09 96.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.406 HG22 ' O ' ' A' ' 21' ' ' ALA . 46.9 t -66.64 -54.96 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HG3' ' HA ' ' A' ' 33' ' ' HIS . 9.0 mt-10 -65.6 -23.88 66.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 10.0 ttm-85 -83.61 -53.01 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.824 179.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.67 -36.95 81.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.661 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' CG ' HG21 ' A' ' 32' ' ' VAL . 45.9 t-20 -118.73 79.48 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.702 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -2.65 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.093 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.03 -13.9 28.05 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.695 0.283 . . . . 0.0 111.47 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.533 HG13 ' O ' ' A' ' 49' ' ' CYS . 4.8 m -140.67 164.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.986 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.521 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -132.79 163.51 28.89 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.911 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -117.11 140.94 48.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.063 0.459 . . . . 0.0 111.935 -178.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 28.6 mt -99.58 111.59 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.39 179.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.3 p -81.33 125.68 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 0.0 111.819 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.564 HD12 ' HB3' ' A' ' 41' ' ' SER . 0.5 OUTLIER -155.88 160.1 39.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.195 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.499 ' HG3' HG22 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -89.69 155.04 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 111.627 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -47.91 115.95 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.396 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.78 -7.5 21.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.621 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.564 ' HB3' HD12 ' A' ' 37' ' ' LEU . 32.4 t -70.46 -162.38 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.91 96.88 5.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.0 110.743 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.561 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 10.1 tmm? -119.42 96.14 5.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.91 154.76 24.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.251 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -84.53 -27.93 27.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.67 130.78 5.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 88.9 t80 -80.71 134.56 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.072 0.463 . . . . 0.0 111.8 -179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.417 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 10.4 mtp180 -152.61 109.83 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.533 ' O ' HG13 ' A' ' 32' ' ' VAL . 6.7 m -61.33 -30.36 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.09 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.521 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 17.7 p-10 -79.06 -8.25 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.637 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 39.6 ttp180 -122.26 119.2 30.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.042 0.449 . . . . 0.0 111.699 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 66.4 t -114.93 122.2 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 178.627 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.561 ' CD1' ' HG2' ' A' ' 43' ' ' MET . 1.0 OUTLIER -78.58 129.46 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.539 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.5 t -120.56 92.79 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 7.3 mm -85.15 129.67 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.257 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.615 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.4 m -129.09 164.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -86.0 -168.95 2.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.78 -18.7 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.64 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.02 4.69 51.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.31 24.76 65.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.222 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.615 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 23.3 t -97.54 131.47 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 49.0 t -66.37 106.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.788 -179.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.7 p -93.52 -29.46 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.03 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -103.94 151.14 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.511 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 8.0 t -66.27 118.91 57.76 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.341 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 89.7 Cg_endo -81.73 99.57 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.171 1.914 . . . . 0.0 111.351 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 7.8 p-80 -133.21 147.23 52.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.44 HG12 ' O ' ' A' ' 49' ' ' CYS . 1.0 OUTLIER -36.63 116.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.678 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.571 -179.872 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.5 p -86.44 87.17 7.38 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 64.14 0.6 Allowed 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.342 -1.473 . . . . 0.0 110.836 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -140.34 92.3 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.418 ' O ' ' N ' ' A' ' 6' ' ' GLY . 0.1 OUTLIER -117.12 131.3 24.06 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.525 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 15.8 Cg_exo -66.81 62.57 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.118 1.879 . . . . 0.0 112.014 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . 155.07 176.85 27.74 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.075 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.435 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 5.9 tttp -59.99 156.08 15.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.921 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -113.77 -16.36 12.29 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.34 12.15 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.562 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 28.1 m-90 -108.0 73.95 0.46 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.881 0.372 . . . . 0.0 111.553 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.9 -35.11 94.71 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.281 1.987 . . . . 0.0 111.528 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -64.34 -12.52 43.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.47 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.52 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 23.4 mt -82.01 -22.41 36.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.421 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 40.5 t -55.23 114.99 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 110.619 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.52 -13.11 33.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.245 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -92.72 160.08 15.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.708 0.29 . . . . 0.0 110.59 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -60.73 140.79 57.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.77 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.87 -32.08 8.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.153 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -71.37 -45.26 63.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -38.83 92.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.881 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.402 ' CA ' HD12 ' A' ' 13' ' ' LEU . . . -63.26 -58.95 5.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.465 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.465 ' HA ' ' HB1' ' A' ' 34' ' ' ALA . . . -52.19 -39.22 59.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.66 -45.46 90.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.713 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 10.9 m -60.29 -41.21 92.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 26.4 t -67.32 -51.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.432 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.03 -26.99 67.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.678 0.275 . . . . 0.0 111.155 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -81.02 -56.33 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.39 -36.46 84.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.58 79.59 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -61.17 -5.62 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.231 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -88.69 -1.59 58.15 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.242 -0.286 . . . . 0.0 111.734 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -140.71 170.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.469 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.456 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -135.89 140.89 44.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.465 ' HB1' ' HA ' ' A' ' 22' ' ' ALA . . . -104.83 141.07 37.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.634 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.456 HG13 ' CE1' ' A' ' 33' ' ' HIS . 3.9 mt -114.83 123.09 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.639 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.48 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.7 t -79.82 123.49 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.602 ' CD2' ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -141.49 149.6 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.789 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 155.5 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 0.0 111.55 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.551 ' HG3' HG21 ' A' ' 55' ' ' ILE . 15.3 mt-10 -48.83 115.87 1.42 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.153 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 1.57 37.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.526 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 t -65.77 178.93 0.94 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.993 0.425 . . . . 0.0 110.599 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.07 92.73 9.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.626 ' HE2' HG12 ' A' ' 55' ' ' ILE . 2.0 ptp -112.82 105.08 13.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.979 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.66 152.07 9.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.749 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.63 -27.04 27.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.089 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.2 142.42 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.99 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 68' ' ' ILE . 77.3 t80 -86.9 134.21 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 78.3 mtp180 -148.46 113.88 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -58.87 -41.07 86.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -79.43 2.73 20.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 30.0 ttp180 -125.56 113.49 17.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.976 0.417 . . . . 0.0 111.45 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 60.3 t -117.15 119.34 61.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.933 179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.602 ' CE3' ' CD2' ' A' ' 37' ' ' LEU . 2.3 m95 -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 37.8 t -120.42 87.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.032 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.626 HG12 ' HE2' ' A' ' 43' ' ' MET . 4.3 mt -79.92 122.63 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.335 0.588 . . . . 0.0 111.836 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.661 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.0 m -122.44 163.77 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.254 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -88.99 -168.27 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.21 -17.63 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -97.8 9.85 41.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.29 22.54 77.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.311 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.661 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 44.5 t -97.98 137.61 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.542 HG12 ' HG3' ' A' ' 66' ' ' PRO . 58.2 t -75.58 116.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 63.2 p -95.37 -28.57 14.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.703 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 17.7 m -102.72 148.83 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.304 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 23.3 t -64.18 106.84 1.05 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.37 179.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 24.0 Cg_exo -59.42 99.04 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 121.952 1.768 . . . . 0.0 111.744 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -124.19 156.74 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.293 0.568 . . . . 0.0 111.025 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.441 HG23 ' CE1' ' A' ' 47' ' ' PHE . 0.3 OUTLIER -55.2 114.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.634 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.895 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.023 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 t 53.6 58.5 5.1 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.21 78.5 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 127.233 2.213 . . . . 0.0 110.579 -173.471 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 105.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -120.92 119.17 30.05 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.836 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 8.1 Cg_exo -70.35 163.24 39.47 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.978 1.785 . . . . 0.0 111.732 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.24 173.07 0.79 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.584 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.492 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 7.1 ttmt -57.26 143.27 40.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -99.22 -26.36 14.21 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -142.38 130.64 22.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.843 0.354 . . . . 0.0 110.082 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.657 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 30.1 m-90 -110.86 73.11 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.255 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -59.89 -35.57 93.3 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.363 2.042 . . . . 0.0 111.676 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -63.01 -11.84 21.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.519 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.553 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 35.9 mt -83.69 -22.69 31.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.761 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 43.4 t -56.72 114.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.82 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.98 -11.16 29.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.373 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.39 161.05 13.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.288 . . . . 0.0 110.71 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -58.72 142.24 50.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.402 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -50.87 -31.89 25.22 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.187 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -47.13 63.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -34.49 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.118 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.432 ' CB ' HG22 ' A' ' 62' ' ' VAL . . . -65.27 -60.27 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.768 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.55 -42.23 61.68 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.156 0.503 . . . . 0.0 110.095 179.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -58.59 -48.11 82.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.288 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 13.4 m -59.84 -41.56 91.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.816 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 59.7 t -65.72 -57.09 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.78 0.324 . . . . 0.0 111.111 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.47 -22.58 67.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.721 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.577 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.71 -55.5 3.95 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.116 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.44 -33.14 75.26 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.443 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -127.41 76.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.309 179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -2.64 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.096 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.64 -1.45 57.87 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.406 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 13.3 m -141.39 169.38 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.79 142.6 49.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.385 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.4 136.91 46.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 111.966 -178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 19.3 mt -101.93 108.99 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.647 179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.5 t -79.85 120.95 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.185 0.517 . . . . 0.0 110.659 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.546 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.7 OUTLIER -148.76 159.29 44.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -89.96 161.93 15.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.262 0.553 . . . . 0.0 111.815 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.19 123.49 6.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.527 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.8 -7.35 55.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.985 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.535 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 47.9 t -66.44 -167.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -71.9 94.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.096 0.474 . . . . 0.0 110.236 179.585 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.504 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -123.04 91.98 3.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.385 0.612 . . . . 0.0 111.533 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -81.5 151.98 27.54 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -79.81 -25.0 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.48 159.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.9 t80 -104.54 132.97 50.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.0 111.596 -179.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.411 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 28.0 mtp85 -147.28 110.9 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.838 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.1 t -56.35 -47.5 78.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.198 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -79.22 3.53 17.57 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.818 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.411 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.1 ttp180 -122.22 110.29 15.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 86.9 t -111.91 121.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.504 ' CD1' ' HG2' ' A' ' 43' ' ' MET . 1.3 m95 -78.21 128.9 34.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.31 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.553 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.3 t -121.88 80.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.838 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.546 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.1 mt -80.08 127.63 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.237 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.649 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.9 m -124.09 159.96 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -84.82 -171.39 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.54 -20.63 48.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -95.98 12.76 29.26 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.58 23.9 72.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.967 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.649 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.6 t -96.89 137.58 24.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.46 HG12 ' HG3' ' A' ' 66' ' ' PRO . 44.3 t -75.84 114.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.089 0.471 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -94.55 -34.6 12.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.981 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -94.42 142.26 27.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.3 t -61.87 103.59 0.4 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.321 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.657 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 31.6 Cg_exo -54.47 95.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.603 1.535 . . . . 0.0 111.385 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.4 ' CD2' ' O ' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -128.13 143.25 51.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.119 0.485 . . . . 0.0 110.934 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER -44.23 109.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.663 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.703 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.6 p -56.72 109.51 0.64 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.2 68.16 0.08 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 121.331 -0.856 . . . . 0.0 110.842 -167.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -143.52 78.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.268 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.9 p -84.94 151.78 58.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.7 -174.85 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.309 2.006 . . . . 0.0 112.231 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.15 -179.24 7.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.36 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.599 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.9 ttmt -77.93 151.11 33.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.614 0.245 . . . . 0.0 110.598 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -109.88 -13.07 14.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.9 128.89 11.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.891 0.376 . . . . 0.0 110.056 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.599 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 31.0 m-90 -114.82 70.06 2.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -58.7 -34.11 98.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.164 1.91 . . . . 0.0 111.617 179.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.48 -12.93 35.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.414 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.526 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.7 mt -81.67 -22.64 37.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.708 0.289 . . . . 0.0 110.506 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG22 HG23 ' A' ' 65' ' ' VAL . 46.9 t -56.95 113.46 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -10.99 29.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.321 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 171.74 8.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.643 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 p -68.4 142.53 55.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.912 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.28 -31.67 35.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.035 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -71.08 -46.22 62.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.309 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.14 -35.46 78.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.812 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.28 -63.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.219 179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.57 -35.9 32.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.694 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.11 -46.28 78.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.271 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' HB ' HD12 ' A' ' 13' ' ' LEU . 35.0 m -59.88 -41.37 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.408 HG12 ' CZ3' ' A' ' 10' ' ' TRP . 17.2 t -66.44 -50.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.73 0.3 . . . . 0.0 111.329 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.44 -31.7 72.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.506 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.507 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.25 -51.04 10.0 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.813 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.19 -37.81 81.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 50.1 t-20 -119.55 80.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.121 -179.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -5.86 2.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -96.45 6.53 48.55 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 10.8 m -144.71 169.21 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.338 -179.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.509 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.0 OUTLIER -131.78 138.14 48.45 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.096 0.474 . . . . 0.0 110.852 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.16 131.98 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.6 mp -107.04 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.991 179.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.577 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 47.8 t -80.37 119.59 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 111.257 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.508 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.2 OUTLIER -147.79 153.21 38.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.254 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 157.12 19.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 111.786 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -50.86 118.1 2.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -7.11 31.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -61.43 -178.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.82 92.79 9.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.126 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.23 121.04 31.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.241 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.01 156.56 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -24.79 24.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -48.41 141.51 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.43 ' CE2' HG23 ' A' ' 68' ' ' ILE . 28.9 t80 -83.26 133.77 34.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.494 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 11.2 mtm180 -146.12 114.32 6.63 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.794 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -60.07 -37.83 81.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.509 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -79.79 1.51 26.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.468 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.494 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 41.4 ttp180 -126.77 129.63 48.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.966 0.412 . . . . 0.0 111.429 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG21 ' HA ' ' A' ' 68' ' ' ILE . 44.8 t -128.7 112.77 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 1.8 m95 -78.43 133.73 37.45 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 109.995 -179.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.4 t -119.11 90.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.799 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.533 ' HB ' ' OG ' ' A' ' 64' ' ' SER . 1.8 mp -79.68 119.57 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.641 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.4 m -116.51 161.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.4 -174.09 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.41 -22.07 52.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.593 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -17.14 29.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.23 22.42 13.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.928 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.3 t -99.6 143.97 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 33.5 t -73.75 115.84 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 0.0 111.023 -179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 p -95.7 -31.99 12.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 1.8 p -105.56 159.03 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.401 HG23 HG22 ' A' ' 14' ' ' VAL . 18.3 t -68.07 104.56 0.71 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.825 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.555 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 32.3 Cg_exo -59.05 100.3 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.867 1.711 . . . . 0.0 111.233 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.03 152.56 49.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.262 0.553 . . . . 0.0 111.099 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.466 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER -47.71 109.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.644 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.656 -179.114 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.016 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.8 p 70.01 166.51 0.28 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -106.69 60.86 0.63 Allowed 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.29 -1.506 . . . . 0.0 110.733 155.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.28 97.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 94.4 m -115.22 137.87 23.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.952 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -80.06 168.34 18.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.121 1.881 . . . . 0.0 112.658 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.2 157.75 1.47 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.762 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.494 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.6 ttmm -50.85 147.46 4.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.658 0.266 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -111.19 -1.53 16.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.02 132.37 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.512 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 24.9 m-90 -119.45 72.13 13.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.885 0.374 . . . . 0.0 111.534 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_endo -57.34 -35.71 98.88 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.166 1.91 . . . . 0.0 111.694 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.93 -10.42 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.512 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 16.7 mt -80.35 -22.85 40.98 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.338 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 38.8 t -58.67 112.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.23 22.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -102.88 -174.64 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.623 0.249 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 p -83.03 140.32 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.63 -29.88 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.14 179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.66 -47.9 51.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -64.81 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.425 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -67.57 -62.2 1.53 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.29 -35.93 63.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.037 0.446 . . . . 0.0 110.452 179.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.5 -45.35 79.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.403 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.3 m -59.41 -40.61 87.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.424 HG11 ' CH2' ' A' ' 10' ' ' TRP . 13.7 t -66.39 -56.2 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.73 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.608 0.242 . . . . 0.0 111.331 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.414 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 30.2 ttp180 -80.75 -57.39 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.775 0.321 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.14 -33.13 75.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.444 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.424 ' OD1' HG11 ' A' ' 32' ' ' VAL . 44.7 t-20 -125.62 79.71 1.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -0.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.309 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -100.37 0.18 39.45 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.607 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.424 HG11 ' OD1' ' A' ' 29' ' ' ASN . 10.1 m -129.27 167.98 23.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.47 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.419 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -131.59 124.63 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.41 137.91 38.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.419 HG12 ' CE1' ' A' ' 33' ' ' HIS . 27.7 mt -110.12 119.25 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 68.1 t -83.29 116.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.566 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.559 HD23 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -135.31 154.21 51.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.374 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.53 19.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.231 0.539 . . . . 0.0 111.779 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -45.76 117.89 1.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.476 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 1.09 41.34 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.863 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.463 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 34.4 t -67.61 -167.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 101.08 13.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.94 99.8 6.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 111.638 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -74.47 155.7 37.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.071 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.045 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.18 141.52 1.76 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 86.5 t80 -90.02 133.97 34.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 111.813 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -152.64 111.98 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.273 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 68' ' ' ILE . 73.8 m -58.86 -37.11 75.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.582 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -79.77 -1.42 38.62 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -122.99 108.67 13.19 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.984 0.421 . . . . 0.0 111.57 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 94.4 t -111.88 120.04 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.828 179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.559 ' CE3' HD23 ' A' ' 37' ' ' LEU . 2.5 m95 -78.63 125.24 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.429 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.2 88.13 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.519 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 23.0 mt -80.1 125.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.267 0.556 . . . . 0.0 111.827 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.4 m -124.56 164.6 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.461 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -84.57 -177.11 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -54.6 -25.44 26.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.787 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -88.38 -22.66 23.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.618 0.246 . . . . 0.0 111.358 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.08 22.67 7.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.232 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 58.3 t -96.14 135.41 30.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.18 112.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.911 0.386 . . . . 0.0 110.811 -179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.5 p -97.1 -30.33 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -100.85 147.64 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.136 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.7 103.46 0.43 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.578 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.511 ' HD3' ' O ' ' A' ' 64' ' ' SER . 39.8 Cg_endo -64.76 108.54 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.116 1.877 . . . . 0.0 111.543 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.457 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -137.95 148.7 45.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.173 0.511 . . . . 0.0 111.346 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.475 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.2 OUTLIER -44.28 113.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.61 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.808 -179.224 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 t -77.22 155.78 31.94 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 52.86 60.08 4.03 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.1 2.16 . . . . 0.0 111.221 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -161.54 98.99 1.14 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.295 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 13.8 m -112.67 148.26 38.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.065 0.46 . . . . 0.0 111.403 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.45 153.66 39.98 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.588 2.192 . . . . 0.0 113.161 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.42 170.07 41.28 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.92 179.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.2 ttmm -67.52 157.47 34.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.674 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -115.37 -9.92 12.09 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.43 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -152.69 129.13 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.621 0.248 . . . . 0.0 110.607 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.586 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 26.7 m-90 -115.48 72.85 3.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.767 0.318 . . . . 0.0 111.479 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -60.15 -34.53 94.21 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.166 1.91 . . . . 0.0 111.506 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -64.5 -12.05 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.684 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 17.6 mt -81.94 -20.36 38.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 47.2 t -55.44 114.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.702 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.43 -9.92 33.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.286 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' O ' HG22 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -95.6 157.1 16.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.751 0.31 . . . . 0.0 110.502 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 p -59.37 141.28 54.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.51 -30.27 19.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.32 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.02 -53.15 15.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -37.11 82.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.359 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.434 ' CB ' HG23 ' A' ' 62' ' ' VAL . . . -63.14 -56.68 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.414 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.31 -36.64 63.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.336 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.19 88.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.316 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.0 m -59.72 -44.11 93.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.644 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.5 t -65.09 -51.99 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.404 ' OE2' ' HA ' ' A' ' 33' ' ' HIS . 2.5 mt-10 -64.53 -30.06 71.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.668 0.27 . . . . 0.0 111.449 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -79.5 -55.2 5.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -64.54 -34.59 78.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -124.77 80.02 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.744 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -65.16 -5.71 7.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.559 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -89.85 -2.05 58.12 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.619 HG12 HD13 ' A' ' 68' ' ' ILE . 4.5 m -137.52 171.23 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.487 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -134.2 136.03 43.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.352 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.65 125.45 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.611 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.487 HG13 ' CE1' ' A' ' 33' ' ' HIS . 3.1 mp -94.22 143.12 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.782 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 72.6 t -99.63 114.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.646 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.545 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.1 OUTLIER -142.19 144.91 33.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.986 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 153.31 24.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.337 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 107.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 -10.19 6.05 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -67.58 160.21 28.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.362 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.72 7.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.468 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.462 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -120.55 139.45 52.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.83 0.347 . . . . 0.0 111.008 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.26 161.07 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -96.78 -24.15 16.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -41.88 163.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.333 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -102.23 130.59 48.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 20.9 mtp180 -145.96 113.22 6.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.56 179.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.47 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 43.0 m -58.45 -39.83 80.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.618 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.443 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 23.7 p-10 -79.52 2.68 21.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 43.1 ttp180 -124.92 119.14 27.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.954 0.407 . . . . 0.0 110.983 -179.922 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.02 116.39 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.462 ' CE2' ' HB3' ' A' ' 43' ' ' MET . 1.0 OUTLIER -78.82 124.29 28.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 110.73 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 42.2 t -106.07 87.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 4.1 mp -80.15 114.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.8 m -119.26 165.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.507 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -85.34 -173.48 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.71 -21.69 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -89.63 -13.0 38.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.535 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.83 24.91 16.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.083 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 22.0 t -101.16 134.9 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.434 HG23 ' CB ' ' A' ' 21' ' ' ALA . 91.1 t -68.27 107.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 110.539 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.7 p -90.05 -32.85 16.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.863 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -104.01 152.99 21.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 25.6 t -64.89 106.47 1.01 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.441 -179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.586 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 17.3 Cg_exo -60.81 90.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.825 1.683 . . . . 0.0 111.394 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.43 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -121.0 146.82 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 111.468 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.619 HD13 HG12 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -45.77 117.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.673 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.04 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.4 m 44.28 55.65 5.42 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 118.327 2.714 . . . . 0.0 118.327 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.64 81.9 0.07 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.15 2.18 . . . . 0.0 111.381 -174.695 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.19 94.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.342 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.3 m -115.12 153.19 47.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.18 160.02 14.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.685 2.257 . . . . 0.0 112.928 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 66.67 172.71 5.14 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.666 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.484 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.1 ttmt -67.85 145.59 54.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.705 0.288 . . . . 0.0 110.521 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -105.5 -5.81 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.81 128.31 4.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.689 0.281 . . . . 0.0 110.367 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.522 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 25.3 m-90 -112.62 69.89 1.09 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -55.44 -37.33 94.93 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.011 1.807 . . . . 0.0 111.938 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -65.05 -5.99 7.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.522 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 28.4 mt -84.44 -18.95 34.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.661 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.64 113.56 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.571 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.16 19.86 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.386 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.49 156.36 17.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.583 0.23 . . . . 0.0 110.661 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 7.6 p -56.8 145.73 28.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 111.43 -179.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.425 ' HA3' ' CG2' ' A' ' 62' ' ' VAL . . . -53.76 -32.35 47.45 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.204 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.82 -47.14 66.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -44.13 97.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.271 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -60.25 -52.64 64.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.19 65.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.39 93.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.32 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 39.7 m -61.77 -43.46 98.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.596 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.42 HG22 ' O ' ' A' ' 21' ' ' ALA . 44.5 t -66.9 -48.45 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.192 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.21 -31.05 71.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.395 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -81.62 -53.39 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.022 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -65.17 -33.22 75.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.66 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 -127.99 81.28 2.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.1 ptm180 -63.3 -8.39 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.432 179.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -87.16 -1.32 57.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.605 0.241 . . . . 0.0 111.587 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 3.9 m -140.07 173.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.493 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -134.06 136.5 44.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 179.075 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.5 125.76 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.116 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.455 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 15.4 mt -98.28 111.29 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.571 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.611 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.7 p -79.67 125.29 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.565 0.698 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.419 ' HB2' ' CB ' ' A' ' 41' ' ' SER . 0.3 OUTLIER -156.96 148.86 22.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.023 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.75 158.14 17.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 111.807 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.17 123.69 4.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.201 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.41 -11.98 33.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.419 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 42.4 t -68.27 -166.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.881 0.372 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 100.0 12.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.191 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.21 96.58 4.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.265 0.555 . . . . 0.0 111.328 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.49 150.17 48.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.227 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.31 -25.06 31.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.31 141.13 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -84.78 132.25 34.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.266 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.05 109.38 4.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 55.5 m -59.61 -34.15 72.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.712 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.493 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 9.9 p-10 -79.12 -3.31 44.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.785 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -123.66 135.13 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.13 117.25 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.585 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.455 ' CZ3' HD13 ' A' ' 35' ' ' ILE . 1.8 m95 -78.67 131.37 36.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.094 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 33.8 t -116.0 89.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.014 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 10.4 mm -79.72 121.33 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.358 -179.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.493 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 28.6 m -122.31 163.8 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.206 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -84.09 -177.33 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.347 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.8 -22.1 22.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.602 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -90.73 -21.88 21.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.552 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 22.04 7.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.266 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.1 t -101.27 134.23 42.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.539 HG12 ' HG3' ' A' ' 66' ' ' PRO . 61.3 t -65.33 114.85 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.419 . . . . 0.0 111.081 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -96.9 -33.11 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 68.1 m -105.03 158.57 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 111.36 -179.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.514 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 3.7 t -65.88 117.01 37.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.394 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.539 ' HG3' HG12 ' A' ' 62' ' ' VAL . 2.4 Cg_endo -79.28 93.53 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.552 2.168 . . . . 0.0 110.673 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 12.6 p-80 -125.8 151.41 46.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.088 0.47 . . . . 0.0 111.218 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' HG23 ' A' ' 68' ' ' ILE . 0.3 OUTLIER -40.75 110.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.897 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.655 -179.014 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.032 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.3 t -76.89 78.95 3.47 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-O 122.727 1.251 . . . . 0.0 114.313 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.97 78.16 0.25 Allowed 'General case' 0 C--N 1.352 0.68 0 C-N-CA 127.953 2.501 . . . . 0.0 111.055 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.99 67.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.817 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -133.87 147.08 62.79 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.986 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.03 150.59 88.2 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.795 1.663 . . . . 0.0 111.387 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.87 173.98 44.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.257 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.562 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 31.4 ttmt -66.42 150.5 48.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -107.35 -19.03 13.71 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -149.66 127.5 11.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 0.0 110.081 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.647 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 27.5 m-90 -110.34 68.93 0.54 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.388 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -58.63 -36.56 97.1 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.999 1.799 . . . . 0.0 111.513 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -64.51 -9.36 18.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.922 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.529 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.2 mt -79.95 -21.2 44.07 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.442 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 60.7 t -55.25 117.85 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.48 -14.21 27.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.4 mmtt -95.8 158.72 15.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.666 0.27 . . . . 0.0 110.679 179.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.6 p -57.98 143.59 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.116 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.29 -31.48 20.11 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.255 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -45.92 60.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.712 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -39.01 92.47 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.97 -60.76 3.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.384 179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -51.25 -44.09 61.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.431 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.525 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.97 -45.79 93.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.299 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.6 m -56.86 -43.18 80.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.932 179.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 57.2 t -65.91 -54.08 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.332 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt-10 -63.61 -27.08 68.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.421 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.64 -56.48 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.695 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -61.72 -35.74 78.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 110.025 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -126.02 75.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.64 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -62.58 0.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.464 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -93.56 -5.0 49.93 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.252 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.5 HG13 ' O ' ' A' ' 49' ' ' CYS . 4.2 m -140.51 166.45 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -126.94 145.48 50.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.415 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.26 137.38 46.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 18.1 mt -106.29 113.7 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.616 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.505 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -78.88 120.26 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.389 0.614 . . . . 0.0 111.072 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.437 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.9 OUTLIER -145.12 154.91 42.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.99 -179.129 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 156.75 17.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.315 0.579 . . . . 0.0 112.014 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.61 110.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.06 -3.79 12.81 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.362 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 30.9 t -67.62 -176.01 0.58 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 110.585 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -90.52 101.36 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ptp -127.83 103.77 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 p -63.66 152.54 38.72 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -24.32 36.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.293 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -44.5 147.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.441 ' CE1' HG23 ' A' ' 68' ' ' ILE . 72.2 t80 -93.46 135.16 34.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.435 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.479 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.4 mtm180 -147.97 112.02 5.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.559 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.5 ' O ' HG13 ' A' ' 32' ' ' VAL . 0.5 OUTLIER -59.42 -36.59 76.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -79.75 0.2 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.479 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 44.8 ttp180 -127.91 124.88 38.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 111.444 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 48.6 t -122.84 118.32 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.108 179.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . . . . . . . . . 3.5 m95 -78.47 133.31 37.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 25.5 t -120.43 90.63 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.437 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -81.25 123.78 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.474 0.654 . . . . 0.0 112.184 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.6 m -124.92 165.95 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.01 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -86.73 -172.68 4.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.681 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -21.28 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.501 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.67 -8.68 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.89 25.08 23.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 24.1 t -100.51 135.11 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 41.2 t -72.14 114.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 111.434 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -98.74 -31.01 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 1.2 t -99.73 154.05 18.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 34.0 t -68.52 106.89 1.55 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.748 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.647 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 12.8 Cg_exo -65.69 89.29 0.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.868 1.712 . . . . 0.0 111.012 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -123.76 145.67 48.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.839 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.453 HG12 ' O ' ' A' ' 49' ' ' CYS . 0.1 OUTLIER -41.17 114.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.074 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.803 -179.435 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p -75.86 69.64 2.53 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -160.46 84.66 0.71 Allowed 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.319 -1.488 . . . . 0.0 111.117 168.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -154.01 77.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.632 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.4 p -138.38 143.31 38.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.393 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.49 158.42 57.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.935 1.757 . . . . 0.0 111.975 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.74 173.93 47.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.485 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.502 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 ttmm -69.65 154.36 42.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.584 0.23 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.409 ' OD1' ' HB ' ' A' ' 68' ' ' ILE . 1.8 t-20 -111.46 -6.41 14.45 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.489 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.92 126.7 4.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.315 -0.241 . . . . 0.0 110.362 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.516 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 20.0 m-90 -112.52 73.48 1.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -57.66 -33.47 96.73 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.441 2.094 . . . . 0.0 111.854 179.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.5 -13.08 37.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 21.1 mt -81.33 -22.99 38.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.6 t -60.6 113.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -9.48 20.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.416 ' CD ' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -105.95 177.26 4.91 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -66.47 144.75 56.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 0.0 111.338 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.32 -28.22 66.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.423 179.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -72.7 -53.48 11.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 110.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.5 -30.92 70.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.412 ' CA ' ' HD2' ' A' ' 16' ' ' LYS . . . -65.85 -61.72 1.9 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.283 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.13 -38.17 50.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 110.129 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.91 -45.2 94.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.412 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.41 ' HB ' HD12 ' A' ' 13' ' ' LEU . 11.4 m -58.49 -43.88 89.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . . . . . . . . . 39.2 t -64.28 -60.66 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.074 179.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -59.01 -23.56 62.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 0.0 111.321 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -81.39 -61.04 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.32 . . . . 0.0 111.023 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.11 -31.79 73.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.558 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.419 ' O ' HG21 ' A' ' 32' ' ' VAL . 52.8 t-20 -127.41 80.86 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.726 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.64 -8.08 5.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.02 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.32 -2.68 58.54 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.539 HG13 ' O ' ' A' ' 49' ' ' CYS . 11.6 m -129.45 168.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 0.0 111.552 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.52 ' CE1' ' CD1' ' A' ' 35' ' ' ILE . 0.2 OUTLIER -133.65 135.14 43.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.328 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 52' ' ' VAL . . . -108.1 123.42 48.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.424 . . . . 0.0 111.741 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.52 ' CD1' ' CE1' ' A' ' 33' ' ' HIS . 3.8 mp -97.87 115.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.468 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.467 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 53.4 t -79.72 113.05 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.324 0.583 . . . . 0.0 110.989 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.558 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.3 OUTLIER -134.55 150.16 50.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.962 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -90.02 156.77 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.081 0.467 . . . . 0.0 111.766 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.73 123.88 3.98 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.458 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.1 -3.7 55.39 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.913 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . 0.448 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 12.0 t -67.62 -179.32 1.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.955 0.407 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -86.02 101.68 13.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -129.73 100.05 5.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.098 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 p -59.37 147.31 36.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.099 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.91 -25.06 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.159 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.81 160.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 68.1 t80 -104.0 131.11 51.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.423 . . . . 0.0 111.61 -179.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -145.22 109.36 4.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.308 179.474 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.539 ' O ' HG13 ' A' ' 32' ' ' VAL . 1.3 m -60.01 -33.32 71.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.536 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -79.51 -2.97 44.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.626 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -121.11 142.76 49.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 111.478 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 68' ' ' ILE . 94.2 t -138.68 114.28 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.819 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.555 ' CE3' HD23 ' A' ' 37' ' ' LEU . 2.3 m95 -78.69 131.55 36.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.706 0.288 . . . . 0.0 110.484 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.467 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 11.3 t -119.21 88.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.101 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.558 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mt -79.84 122.15 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.66 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.8 m -121.26 164.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.433 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -87.91 -174.64 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -58.11 -23.48 55.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.55 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -86.04 -20.44 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 111.162 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.67 22.66 10.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.165 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.66 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 19.2 t -98.78 144.7 11.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . 0.405 HG12 ' HD3' ' A' ' 66' ' ' PRO . 48.0 t -75.58 112.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.993 0.425 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 p -94.04 -31.45 14.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.518 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -103.48 154.01 19.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.564 ' O ' ' ND1' ' A' ' 67' ' ' HIS . 5.7 t -66.12 101.36 0.28 Allowed Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.736 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' O ' ' A' ' 64' ' ' SER . 19.1 Cg_endo -57.75 92.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.618 1.545 . . . . 0.0 110.827 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 16.1 p-80 -122.67 153.76 38.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.483 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -48.53 115.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.792 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.941 -179.422 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.6 t -63.99 124.04 20.55 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 118.9 -0.572 . . . . 0.0 112.24 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 62.82 1.04 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 120.171 1.35 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 90.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' CYS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 57.7 m -113.41 142.17 27.1 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.961 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 2.9 Cg_exo -74.61 168.28 25.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.141 1.894 . . . . 0.0 112.316 -179.434 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 63.45 170.46 1.56 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.061 179.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.521 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 33.3 ttmt -66.73 146.83 54.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.795 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -107.03 -4.2 19.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.479 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.32 134.51 7.31 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.528 ' HB3' ' HG ' ' A' ' 13' ' ' LEU . 21.6 m-90 -119.73 68.15 11.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -50.29 -37.35 49.7 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.283 1.989 . . . . 0.0 112.348 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.92 -13.48 25.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.968 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 24.8 mt -80.51 -23.42 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.67 0.272 . . . . 0.0 110.663 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 59.4 t -53.71 112.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.798 179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -12.01 29.96 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.231 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.23 157.11 16.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.786 0.327 . . . . 0.0 110.875 179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -56.82 141.33 44.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.38 -31.59 20.98 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.319 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.35 -45.54 59.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.14 -42.08 99.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.043 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.479 ' O ' HG22 ' A' ' 25' ' ' VAL . . . -62.56 -56.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.711 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.51 64.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.65 -45.23 93.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.5 m -58.27 -42.1 85.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.883 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' VAL . . . . . 0.479 HG22 ' O ' ' A' ' 21' ' ' ALA . 21.8 t -67.35 -58.05 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.337 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.15 -24.89 66.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.46 0.171 . . . . 0.0 111.446 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 17.8 ttp180 -83.9 -58.72 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.833 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.98 -29.55 70.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.999 0.428 . . . . 0.0 110.269 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.468 ' O ' HG21 ' A' ' 32' ' ' VAL . 50.0 t-20 -131.0 85.07 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -8.57 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.25 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.76 -10.03 52.21 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 49' ' ' CYS . 13.7 m -115.06 175.5 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 112.062 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CE1' ' CG1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -143.48 125.36 15.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.549 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 129.63 44.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.12 0.485 . . . . 0.0 112.007 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.443 ' CG1' ' CE1' ' A' ' 33' ' ' HIS . 27.0 mt -106.82 119.64 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.452 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -79.45 132.45 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.369 0.604 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.584 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.4 OUTLIER -157.03 150.94 24.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.17 153.87 20.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.165 0.507 . . . . 0.0 111.585 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -49.06 115.48 1.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.31 -1.85 25.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -69.71 -177.22 1.2 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.839 0.352 . . . . 0.0 110.655 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.52 104.86 17.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' MET . . . . . 0.428 ' HB2' ' HE1' ' A' ' 43' ' ' MET . 0.5 OUTLIER -124.14 106.52 10.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.305 -178.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -56.47 147.76 21.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.079 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 mmpp? -84.54 -26.13 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.954 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.93 138.24 5.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -84.81 130.34 34.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.408 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 3.9 mtp85 -144.71 112.25 6.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' CYS . . . . . 0.591 ' O ' HG13 ' A' ' 32' ' ' VAL . 90.9 m -63.95 -13.67 47.79 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.752 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.408 ' OD1' ' HB3' ' A' ' 48' ' ' ARG . 18.8 p-10 -97.88 -4.7 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.646 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -122.35 143.31 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 111.35 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG21 ' HA ' ' A' ' 68' ' ' ILE . 59.6 t -139.36 118.47 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.645 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TRP . . . . . 0.452 ' CE3' HD23 ' A' ' 37' ' ' LEU . 4.9 m95 -78.42 135.2 37.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.253 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 43.1 t -120.13 89.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.053 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.584 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.0 mt -81.98 126.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.016 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.656 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.8 m -123.47 165.27 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.798 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -88.13 -172.72 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.964 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.62 -21.98 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -95.48 -8.85 34.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.78 21.97 24.72 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.537 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.656 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 t -96.38 140.66 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.4 t -72.65 112.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.804 -179.693 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.1 p -94.45 -32.41 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.567 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.531 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 9.0 t -100.82 146.41 27.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 18.7 t -62.73 101.44 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.509 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.1 Cg_endo -57.91 99.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.034 1.823 . . . . 0.0 111.647 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' HIS . . . . . 0.479 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -127.98 152.83 47.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.115 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.515 ' HA ' HG21 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -49.72 116.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.453 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.7 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.979 -179.353 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 25.5 ttmt -56.11 142.81 35.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.705 0.288 . . . . 0.0 110.68 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -100.77 -11.34 19.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 67' ' ' HIS . . . -155.47 140.2 17.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.699 ' CH2' HG13 ' A' ' 25' ' ' VAL . 17.1 m-90 -121.2 68.58 18.75 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.775 ' HA ' HG13 ' A' ' 65' ' ' VAL . 67.3 Cg_exo -49.74 -36.18 41.07 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.183 1.922 . . . . 0.0 112.177 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -64.12 -8.33 11.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.276 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.9 mt -83.71 -20.1 34.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 11' ' ' PRO . 44.1 t -56.57 114.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.823 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -8.1 31.5 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.35 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 62' ' ' VAL . 3.2 mmtt -99.25 157.9 16.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.312 . . . . 0.0 110.716 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -56.99 139.43 52.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -51.58 -29.16 23.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.512 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.22 -46.69 40.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.401 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 7.0 tpt -65.25 -33.87 77.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.032 0.444 . . . . 0.0 109.829 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -66.4 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.367 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.71 -42.72 57.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.15 -46.13 91.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.429 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -57.03 -40.47 76.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -66.0 -54.98 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.315 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -64.76 -26.05 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.609 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -83.46 -56.22 3.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 111.186 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -63.05 -30.52 71.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.073 0.463 . . . . 0.0 110.322 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' ND2' ' HA3' ' A' ' 6' ' ' GLY . 50.2 t-20 -127.84 85.04 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.783 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -8.17 3.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.233 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -95.04 2.42 55.25 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 49' ' ' CYS . 30.6 m -129.09 167.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 128.44 36.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.673 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.73 144.07 31.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.233 0.54 . . . . 0.0 112.139 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.573 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.3 mt -120.19 143.46 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.159 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 58.3 t -97.49 130.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -157.72 151.88 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.97 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 56' ' ' VAL . 1.3 mtpt -87.31 161.06 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 112.405 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 5.8 tt0 -54.12 119.29 4.89 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.228 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.02 56.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.685 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 3.1 t -64.24 131.9 48.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.06 0.457 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.86 81.85 0.11 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.656 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD13 ' A' ' 37' ' ' LEU . 13.5 mmt -113.94 164.24 14.05 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.886 0.374 . . . . 0.0 111.453 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.2 164.02 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.23 -25.73 7.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.323 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -52.04 171.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 33.4 t80 -97.96 128.4 44.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -143.87 111.2 5.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.501 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.742 ' O ' HG12 ' A' ' 32' ' ' VAL . 18.4 m -60.25 -35.96 76.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 16.2 p-10 -78.81 -3.48 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.442 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 40.8 ttp180 -123.04 129.99 52.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.194 0.521 . . . . 0.0 111.784 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 68' ' ' ILE . 84.6 t -133.16 119.79 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.358 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.86 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.7 m95 -78.9 130.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 55.1 t -113.16 84.38 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.01 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 64' ' ' SER . 2.5 mp -79.87 118.4 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.62 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 29.8 m -122.93 165.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.236 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.17 -172.62 3.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -23.36 61.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.379 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -90.65 2.93 55.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 25.09 64.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.166 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.0 t -100.22 132.88 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 16' ' ' LYS . 46.2 t -68.1 108.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.528 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.6 p -93.06 -33.8 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.155 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 55' ' ' ILE . 22.9 t -102.2 157.15 17.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.1 t -69.58 123.39 88.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HG2' HD12 ' A' ' 13' ' ' LEU . 91.5 Cg_endo -81.99 101.77 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.313 2.009 . . . . 0.0 110.576 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.7 p-80 -132.26 145.98 51.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.08 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -39.34 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.674 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.78 -179.077 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-O 120.944 0.191 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 26.2 ttmt -59.62 154.11 18.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.816 0.341 . . . . 0.0 111.31 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -115.92 -5.55 12.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.439 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -155.32 124.61 6.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.903 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.0 m-90 -111.4 74.93 1.2 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.869 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.861 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.6 Cg_endo -59.49 -35.67 95.34 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.986 1.791 . . . . 0.0 111.604 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -65.0 -9.89 25.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.861 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 26.8 mt -82.81 -19.8 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.719 0.295 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 11' ' ' PRO . 45.2 t -55.47 111.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.6 -9.76 23.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.118 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.0 mmtt -95.43 157.84 15.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.297 . . . . 0.0 110.733 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 p -59.51 138.5 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.763 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.25 -31.63 8.92 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.084 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.38 63.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.985 0.421 . . . . 0.0 110.268 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -33.1 75.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.871 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.67 -59.5 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -55.49 -41.73 73.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.559 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.22 -46.63 89.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.435 HG21 HD21 ' A' ' 13' ' ' LEU . 88.0 m -57.83 -43.75 85.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -63.68 -52.05 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -63.82 -29.14 70.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.519 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -78.66 -57.11 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.836 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.4 -35.22 80.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.438 . . . . 0.0 110.454 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.513 ' CG ' HG22 ' A' ' 32' ' ' VAL . 49.3 t-20 -123.16 78.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -3.15 0.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.609 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.64 -5.05 49.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 29' ' ' ASN . 12.8 m -139.72 168.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.58 146.79 51.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.684 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.06 138.72 44.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.504 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.1 mp -105.09 120.55 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.623 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.5 p -80.43 129.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.895 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.46 152.35 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.19 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.874 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -89.67 155.1 19.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 111.946 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 117.11 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.054 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.98 -1.97 30.09 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 39.7 t -70.11 -172.54 0.56 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.313 . . . . 0.0 110.738 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -88.87 104.82 17.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 100.95 6.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.459 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -58.68 147.55 32.45 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.875 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -80.43 -26.42 38.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.25 161.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.7 t80 -103.81 137.32 41.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -152.49 112.85 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.559 ' O ' HG12 ' A' ' 68' ' ' ILE . 50.3 m -58.45 -37.84 76.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -79.36 -2.82 43.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.48 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -120.63 111.47 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.609 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG21 HG11 ' A' ' 25' ' ' VAL . 78.9 t -113.15 117.64 55.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.895 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.9 m95 -78.71 128.79 33.91 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 7.2 t -116.52 98.93 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 ' CD1' ' A' ' 37' ' ' LEU . 9.0 mm -83.87 122.4 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.874 HG23 ' HG3' ' A' ' 38' ' ' LYS . 30.5 m -126.66 168.35 19.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.423 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.75 -170.93 2.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -18.83 61.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.77 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.56 -1.8 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.14 24.19 38.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.3 t -96.04 131.92 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.9 t -70.92 112.82 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 111.378 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -97.14 -33.07 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 6.8 t -97.86 149.94 21.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.218 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 11' ' ' PRO . 21.3 t -66.92 108.36 2.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.541 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 10' ' ' TRP . 17.2 Cg_exo -62.19 106.14 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.211 1.941 . . . . 0.0 111.594 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 146.68 51.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.418 0.628 . . . . 0.0 111.768 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.571 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -47.51 109.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.668 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.453 ' OXT' HG22 ' A' ' 69' ' ' THR . 11.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.52 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 9' ' ' ALA . 3.6 ttmt -69.67 148.7 48.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.592 0.234 . . . . 0.0 110.546 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -110.34 -0.16 17.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -160.48 125.55 3.83 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.896 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -113.39 67.46 1.23 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.767 0.317 . . . . 0.0 111.151 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.888 ' HA ' HG13 ' A' ' 65' ' ' VAL . 9.6 Cg_endo -52.62 -33.67 59.84 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.386 2.058 . . . . 0.0 111.907 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -64.68 -9.2 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.696 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.845 HD13 ' HB1' ' A' ' 21' ' ' ALA . 18.6 mt -84.18 -18.87 35.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.844 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' PRO . 48.6 t -56.84 113.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.746 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 -12.89 43.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.175 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -89.07 162.31 16.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 110.646 179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 p -63.97 137.53 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.497 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -52.58 -29.74 32.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.364 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -70.1 -54.24 13.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.85 95.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.06 -51.42 69.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.495 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.2 75.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.373 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.65 88.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.498 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -59.64 -45.73 91.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.531 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.896 HG13 ' CH2' ' A' ' 10' ' ' TRP . 40.3 t -64.7 -50.92 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -31.95 73.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 111.419 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -79.4 -56.51 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.181 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.17 -29.31 70.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.708 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.7 t-20 -126.7 79.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -65.14 -2.88 3.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -92.9 -9.78 38.92 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.603 0.24 . . . . 0.0 111.287 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 29' ' ' ASN . 3.0 m -140.3 169.55 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.932 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.88 151.06 51.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.162 0.506 . . . . 0.0 111.129 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.82 137.91 51.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.551 HD11 ' HG3' ' A' ' 51' ' ' ARG . 3.9 mp -104.86 129.07 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.514 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 65.5 t -80.16 128.39 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.04 0.447 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.727 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -150.67 143.36 24.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.518 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 157.2 17.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.95 120.46 2.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.96 55.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.738 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 14.8 t -70.49 -179.7 2.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 110.857 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.64 101.54 14.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.29 104.85 8.16 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.014 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.35 151.44 9.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -27.59 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -46.58 134.99 9.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 68' ' ' ILE . 56.0 t80 -80.44 132.16 35.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.555 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.0 mtm180 -146.9 111.82 5.38 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.602 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' O ' HG11 ' A' ' 32' ' ' VAL . 97.3 m -60.63 -34.11 73.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -79.54 -0.32 32.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.66 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.551 ' HG3' HD11 ' A' ' 35' ' ' ILE . 47.9 ttp180 -126.43 129.49 48.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.433 . . . . 0.0 111.471 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 68' ' ' ILE . 52.7 t -128.32 116.26 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.15 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.727 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.9 m95 -78.76 133.89 37.08 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 29.3 t -115.25 96.38 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 55' ' ' ILE . 4.0 mp -84.47 121.28 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.172 0.51 . . . . 0.0 111.57 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 27.0 m -125.87 162.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.013 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -85.84 -179.7 6.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.92 -20.98 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.53 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.21 -24.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.295 . . . . 0.0 111.227 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.33 21.14 7.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.18 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.6 t -98.28 139.49 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 16' ' ' LYS . 42.9 t -72.6 111.78 7.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.816 0.341 . . . . 0.0 110.756 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -91.19 -31.3 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 48.3 t -107.59 150.13 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.888 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.4 t -64.82 102.14 0.31 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.38 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.9 Cg_endo -58.86 97.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.114 1.876 . . . . 0.0 111.596 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -123.68 157.47 33.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.551 . . . . 0.0 111.347 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -51.09 114.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.535 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.435 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.813 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.47 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 26.4 ttmt -33.23 143.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.634 0.254 . . . . 0.0 111.49 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.916 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.0 p30 -112.23 -0.54 15.47 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -157.12 121.46 4.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.86 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.2 m-90 -108.79 74.81 0.59 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.94 0.4 . . . . 0.0 111.453 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.821 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.8 Cg_endo -60.59 -33.25 93.79 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.208 1.939 . . . . 0.0 111.401 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pm0 -63.7 -14.13 49.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 21' ' ' ALA . 22.2 mt -81.07 -20.63 41.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.645 0.259 . . . . 0.0 110.565 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.41 117.34 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.614 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.76 -14.6 53.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.14 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.17 174.78 8.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.622 0.248 . . . . 0.0 110.516 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 p -75.99 144.01 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.98 -31.62 40.22 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.084 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.4 -52.87 22.77 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.708 0.289 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -29.97 70.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 109.999 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.73 -60.55 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.449 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.1 68.67 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.01 -44.58 84.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.421 ' CB ' HD21 ' A' ' 13' ' ' LEU . 91.6 m -58.85 -43.12 90.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.86 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -65.61 -51.41 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.37 -28.51 69.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.57 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 8.0 mtp180 -81.86 -54.75 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.71 -34.95 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.281 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.415 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.9 t-20 -124.63 80.0 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.656 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -5.46 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -93.53 2.52 56.39 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -137.06 170.61 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 0.0 111.663 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.23 126.65 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.321 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.74 135.98 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.686 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.589 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 34.8 mt -107.38 120.73 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.738 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.631 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.6 p -79.79 128.74 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 111.438 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -157.9 144.72 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.534 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.24 159.31 16.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.584 . . . . 0.0 111.915 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.67 122.05 3.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.46 29.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.594 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 15.4 t -68.09 -178.09 0.96 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 110.71 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.9 102.7 15.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.564 ' HE1' HD12 ' A' ' 55' ' ' ILE . 2.7 ptp -124.51 100.15 6.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -60.09 148.92 34.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.053 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -82.31 -24.56 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.023 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -45.95 159.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -100.82 131.98 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.064 0.459 . . . . 0.0 111.422 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.04 108.17 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 48.8 t -60.56 -36.75 79.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.576 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.64 3.46 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -129.19 128.06 42.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.025 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.0 t -127.64 119.09 50.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.017 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.807 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.4 m95 -78.7 130.52 35.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.182 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 31.1 t -113.83 95.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.934 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.564 HD12 ' HE1' ' A' ' 43' ' ' MET . 5.6 mm -79.99 119.9 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.675 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.6 m -124.94 164.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.254 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -89.72 -171.76 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -18.18 62.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.496 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -96.21 -1.57 47.97 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.502 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.9 t -99.49 137.33 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 21' ' ' ALA . 60.4 t -72.33 109.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.937 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -93.76 -28.04 16.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 t -106.57 157.7 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 111.141 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.0 t -72.19 111.02 9.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 7.8 Cg_exo -67.57 103.55 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.664 1.576 . . . . 0.0 110.517 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.622 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.9 p-80 -131.7 145.2 51.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -40.82 111.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.28 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.655 ' OXT' HG22 ' A' ' 69' ' ' THR . 16.3 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.051 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 CA-C-O 121.062 0.257 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.6 tttt -68.24 149.86 48.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.303 . . . . 0.0 110.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -110.98 -8.33 14.48 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.58 123.81 3.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.865 0.364 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 21.7 m-90 -109.52 74.36 0.68 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.833 ' HA ' HG13 ' A' ' 65' ' ' VAL . 13.2 Cg_endo -56.11 -37.53 96.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.495 2.13 . . . . 0.0 112.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.54 -6.88 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.166 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 21' ' ' ALA . 15.8 mt -85.37 -21.2 28.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.744 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG21 HG22 ' A' ' 65' ' ' VAL . 43.9 t -56.72 113.05 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-O 120.777 0.322 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.17 -10.53 26.82 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.133 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.674 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.08 157.89 15.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.933 0.396 . . . . 0.0 110.928 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 p -56.66 141.66 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.41 -29.38 38.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -72.46 -45.19 60.68 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.514 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.448 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -65.37 -39.07 91.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.75 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -61.56 -58.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.027 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.494 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.71 -38.81 61.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -63.26 -46.21 87.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.244 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.412 ' HB ' HD11 ' A' ' 13' ' ' LEU . 13.1 m -59.97 -42.31 93.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.762 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.63 HG13 ' CH2' ' A' ' 10' ' ' TRP . 60.4 t -65.57 -51.59 61.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.6 -28.5 68.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.749 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 6.0 mpp_? -82.77 -52.32 6.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -67.32 -31.58 71.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 0.0 110.371 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.567 ' CG ' HG22 ' A' ' 32' ' ' VAL . 52.0 t-20 -126.07 76.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.601 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 1.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.196 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -95.45 -13.99 24.12 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.348 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 29' ' ' ASN . 5.1 m -134.05 168.37 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -129.39 140.36 51.37 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.159 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -105.01 134.77 47.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.373 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.528 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 31.5 mt -102.15 116.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.926 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 41.8 t -83.73 118.95 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.998 0.428 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.845 HD13 ' HB3' ' A' ' 41' ' ' SER . 2.2 pp -143.66 156.67 44.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.118 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.76 160.49 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.222 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 115.7 1.73 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.844 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.76 -6.53 20.2 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.361 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.845 ' HB3' HD13 ' A' ' 37' ' ' LEU . 44.8 t -64.93 178.95 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 88.06 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.445 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.5 ptm -111.42 104.88 13.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 110.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.9 p -67.47 153.72 43.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.069 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -24.94 40.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.508 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.29 139.88 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.467 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 68' ' ' ILE . 48.2 t80 -85.76 128.34 34.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HD3' ' NH1' ' A' ' 51' ' ' ARG . 69.3 mtp180 -145.73 112.68 6.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.511 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.448 ' O ' HG12 ' A' ' 68' ' ' ILE . 33.0 m -59.11 -38.71 80.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 19.3 p-10 -78.36 -0.17 27.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NH1' ' HD3' ' A' ' 48' ' ' ARG . 39.3 ttp180 -128.62 106.37 8.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.17 0.509 . . . . 0.0 111.826 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG13 ' C ' ' A' ' 67' ' ' HIS . 43.2 t -105.92 120.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.618 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.0 m95 -78.39 132.68 37.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.672 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 66' ' ' PRO . 54.6 t -123.4 87.73 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.955 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -79.95 124.1 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.71 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.844 HG23 ' HG3' ' A' ' 38' ' ' LYS . 15.9 m -121.36 162.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -91.97 -170.61 2.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.622 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 15.4 t70 -54.76 -22.7 14.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 22.41 12.18 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.0 56.34 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.626 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.9 t -93.81 138.31 20.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 16' ' ' LYS . 43.7 t -76.31 112.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.143 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -93.34 -33.81 13.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.133 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.52 151.56 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.687 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.833 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.0 t -67.06 104.53 0.64 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HB3' HG22 ' A' ' 54' ' ' VAL . 20.5 Cg_endo -60.32 99.84 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.744 1.629 . . . . 0.0 111.309 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.549 ' C ' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -130.09 150.21 51.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.487 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -46.33 112.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.734 -179.458 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.202 0 CA-C-O 120.843 0.135 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.3 ttmm -65.64 151.04 47.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -110.8 -14.92 13.92 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -148.99 130.9 15.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.3 m-90 -116.71 67.35 3.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.457 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.884 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.81 -34.41 91.19 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.211 1.941 . . . . 0.0 111.84 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.85 -10.44 20.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.636 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 20.1 mt -81.76 -23.2 36.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 65' ' ' VAL . 43.6 t -55.32 118.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.09 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.86 44.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.608 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.67 -175.4 3.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.514 0.197 . . . . 0.0 110.558 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 p -83.68 142.51 30.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.723 0.297 . . . . 0.0 110.834 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.65 -32.15 38.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.866 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -47.8 67.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.256 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 tpt -64.11 -34.35 77.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.42 -61.0 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.372 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -53.94 -40.14 66.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.02 -44.61 96.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -61.39 -42.35 98.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.798 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.8 t -63.18 -49.04 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.92 -31.42 70.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.489 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 7.4 mtp85 -77.48 -50.74 12.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.17 -37.54 72.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.671 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.6 t-20 -119.44 78.18 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -0.07 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.834 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -94.86 -9.8 33.24 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.637 0.256 . . . . 0.0 111.328 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.671 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.0 m -138.97 168.0 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.176 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -128.23 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.351 0.596 . . . . 0.0 111.942 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.83 131.17 55.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.0 mt -103.16 127.16 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 44.8 t -83.85 121.18 36.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 111.323 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.913 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -146.69 155.71 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.737 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.09 162.22 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.256 0.551 . . . . 0.0 112.061 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 55' ' ' ILE . 1.4 mm-40 -52.73 125.24 16.12 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.206 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.83 -2.91 62.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.867 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.418 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 2.9 t -57.44 134.64 56.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.54 81.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.601 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 28.6 mmt -124.73 130.2 51.95 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.845 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -56.68 152.94 11.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -23.38 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.74 152.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.466 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE2' HG22 ' A' ' 68' ' ' ILE . 51.1 t80 -93.36 133.07 36.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.116 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -149.35 110.67 4.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -59.67 -35.86 75.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 32' ' ' VAL . 12.2 p-10 -78.6 0.85 24.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 44.8 ttp180 -129.63 129.92 44.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.391 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 67' ' ' HIS . 41.1 t -126.79 118.04 49.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.973 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.913 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.7 m95 -78.7 132.88 37.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 110.229 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.2 t -114.86 83.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.6 mt -79.85 121.99 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.538 0.685 . . . . 0.0 111.466 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.5 m -125.95 165.34 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.291 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -84.19 -175.55 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 38' ' ' LYS . 2.9 t70 -59.58 -18.87 44.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.436 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -89.54 -19.9 24.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.86 20.24 13.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.958 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.5 t -95.68 132.93 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.631 HG21 ' HB2' ' A' ' 21' ' ' ALA . 40.3 t -69.29 111.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.937 0.399 . . . . 0.0 110.38 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 p -90.91 -29.55 17.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.136 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 12.9 m -104.89 148.4 26.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.884 HG13 ' HA ' ' A' ' 11' ' ' PRO . 44.9 t -63.72 106.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.615 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.62 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 35.8 Cg_exo -56.92 98.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.748 1.632 . . . . 0.0 111.538 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.641 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -125.24 166.45 16.46 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.342 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -64.39 107.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.135 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.511 -178.959 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.5 ttmt -59.59 145.36 44.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.697 0.284 . . . . 0.0 110.566 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.24 -15.32 16.67 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.72 132.36 11.36 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.139 -0.35 . . . . 0.0 110.52 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.809 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.0 m-90 -113.52 74.88 2.33 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.264 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.5 Cg_endo -56.06 -40.98 81.52 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.209 1.939 . . . . 0.0 112.417 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -62.82 -6.8 4.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.455 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 ' HG2' ' A' ' 66' ' ' PRO . 14.3 mt -83.36 -20.88 33.45 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.12 116.0 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.701 0.286 . . . . 0.0 110.791 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.41 38.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.407 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.9 tppm? -93.56 161.26 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.507 0.194 . . . . 0.0 110.705 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -62.7 141.84 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.34 -29.35 46.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.427 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.87 -49.74 35.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.371 . . . . 0.0 110.69 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.432 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 10.8 tpt -63.7 -40.97 98.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.02 -54.58 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.991 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -52.18 -44.6 64.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.573 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.66 95.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -59.8 -43.08 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.809 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.3 t -66.72 -52.31 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 8.0 mt-10 -67.11 -24.02 65.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.319 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -84.98 -56.14 3.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.683 0.278 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.49 -31.9 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.143 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 32' ' ' VAL . 53.2 t-20 -125.05 80.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.713 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -4.79 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -98.72 6.14 47.15 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.629 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 29' ' ' ASN . 5.8 m -138.4 165.95 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.32 . . . . 0.0 111.358 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.753 ' CE1' HD11 ' A' ' 35' ' ' ILE . 2.4 p-80 -128.63 132.84 48.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.346 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.09 127.44 44.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.753 HD11 ' CE1' ' A' ' 33' ' ' HIS . 2.5 mp -104.53 108.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.581 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 11.2 p -78.86 121.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.592 0.71 . . . . 0.0 110.874 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -146.72 155.34 42.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.296 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.672 ' HG3' HG23 ' A' ' 56' ' ' VAL . 9.2 mtmt -89.55 165.76 14.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.305 0.574 . . . . 0.0 112.264 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 122.17 6.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.518 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.97 4.89 62.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.88 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.598 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.7 t -65.73 -173.93 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.89 87.06 6.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.2 ptm -121.13 105.87 11.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.059 0.457 . . . . 0.0 110.481 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -63.52 150.9 42.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.009 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -79.65 -23.5 42.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -45.52 155.0 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.847 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 37.5 t80 -99.41 136.18 39.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.005 0.431 . . . . 0.0 111.385 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -153.0 110.11 3.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.386 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.526 ' O ' HG12 ' A' ' 68' ' ' ILE . 23.5 m -58.37 -38.82 78.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.892 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HA ' HG12 ' A' ' 32' ' ' VAL . 18.6 p-10 -79.25 5.55 12.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.33 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -127.25 131.48 50.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.982 0.42 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 68' ' ' ILE . 59.8 t -134.23 117.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.582 ' CE3' HD21 ' A' ' 37' ' ' LEU . 5.0 m95 -78.77 140.34 38.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 110.614 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 64.5 t -128.05 87.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mt -79.62 128.92 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.152 0.501 . . . . 0.0 111.645 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG23 ' HG3' ' A' ' 38' ' ' LYS . 31.2 m -126.92 164.21 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -84.72 -171.49 3.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.029 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 -9.2 12.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.941 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -5.67 20.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.63 20.17 38.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.365 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.5 t -97.35 132.36 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 56' ' ' VAL . 60.0 t -66.43 110.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.781 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -87.87 -35.73 17.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.1 m -105.65 156.56 18.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 111.377 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.8 t -66.82 128.18 93.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.437 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 13' ' ' LEU . 15.6 Cg_endo -86.34 96.34 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.431 2.087 . . . . 0.0 110.766 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -128.54 153.15 47.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.19 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -44.11 103.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.159 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.504 -179.328 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.633 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 1.7 ttmp? -88.42 154.9 20.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.284 . . . . 0.0 110.763 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -114.57 -2.05 13.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -157.61 130.51 7.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.633 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.2 m-90 -119.49 74.16 16.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.55 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.81 ' HA ' HG13 ' A' ' 65' ' ' VAL . 40.6 Cg_exo -55.7 -39.3 91.93 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.219 1.946 . . . . 0.0 111.986 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -62.01 -9.68 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.193 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 21' ' ' ALA . 42.4 mt -83.97 -23.67 30.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.797 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.513 HG21 HG22 ' A' ' 65' ' ' VAL . 41.0 t -58.26 111.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -7.63 29.44 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.177 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.95 166.01 11.48 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.532 0.206 . . . . 0.0 110.621 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -63.62 142.7 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.31 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.12 42.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.844 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -68.97 -42.18 76.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -65.68 -35.22 80.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.906 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -64.46 -60.1 3.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 36' ' ' VAL . . . -49.33 -50.17 40.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.11 86.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.426 ' CB ' HD21 ' A' ' 13' ' ' LEU . 94.6 m -60.11 -43.4 95.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.767 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.615 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.6 t -67.86 -51.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.23 -29.07 69.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -81.5 -57.19 3.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.53 -30.83 71.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.775 ' CG ' HG22 ' A' ' 32' ' ' VAL . 46.7 t-20 -127.11 78.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.276 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -64.62 1.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.965 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -98.36 -5.35 32.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.573 0.225 . . . . 0.0 111.482 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.775 HG22 ' CG ' ' A' ' 29' ' ' ASN . 17.9 m -148.69 166.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.422 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -129.47 152.91 48.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -112.3 147.93 35.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.34 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' A' ' 51' ' ' ARG . 2.5 mp -112.6 114.35 46.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.791 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 54' ' ' VAL . 57.5 t -83.25 111.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 111.345 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.669 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -135.27 154.72 51.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.535 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -85.54 157.2 20.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 0.0 111.527 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 113.61 1.18 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.718 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.79 -9.4 11.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.162 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.5 t -66.01 -174.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 97.67 11.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.119 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.635 ' CE ' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -124.83 103.69 8.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.56 160.09 23.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.27 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -87.84 -23.36 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.51 140.39 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.059 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.6 t80 -84.06 131.03 34.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.181 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -146.48 110.92 5.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.49 ' O ' HG12 ' A' ' 68' ' ' ILE . 98.3 m -59.05 -38.22 78.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.287 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 11.6 p-10 -78.8 -6.14 55.22 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.395 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HG3' HD11 ' A' ' 35' ' ' ILE . 41.3 ttp180 -119.21 105.96 11.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.989 0.424 . . . . 0.0 111.694 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 62.0 t -106.65 119.26 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.669 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.37 136.8 37.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 -178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 36' ' ' VAL . 49.0 t -127.64 84.0 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.051 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 43' ' ' MET . 4.2 mt -79.67 121.52 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.071 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.0 m -119.91 161.3 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.999 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -80.0 -171.48 2.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.272 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -20.47 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.612 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.73 -7.36 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.43 23.86 27.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.936 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.7 t -96.57 134.21 35.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.852 HG21 ' HB2' ' A' ' 21' ' ' ALA . 42.8 t -67.77 104.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.017 0.437 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -88.04 -34.74 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.17 157.27 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.922 0.392 . . . . 0.0 111.502 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.3 t -71.84 106.24 1.88 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.639 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 36.2 Cg_exo -58.06 103.39 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.688 1.592 . . . . 0.0 110.84 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.78 143.63 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.332 0.587 . . . . 0.0 111.474 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -41.81 107.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.685 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.083 -179.119 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.721 -0.152 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.1 ttmm -49.54 146.04 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 111.205 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -103.46 -16.72 15.49 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 7' ' ' LYS . . . -146.96 149.99 34.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.833 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.8 m-90 -134.56 67.64 71.71 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.229 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.853 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.7 Cg_endo -55.91 -33.08 87.77 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.101 1.867 . . . . 0.0 111.439 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.24 -12.48 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.666 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.4 mt -82.21 -20.3 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.883 HG21 HG22 ' A' ' 65' ' ' VAL . 38.2 t -61.91 111.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.15 -2.99 29.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.64 177.09 4.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -72.29 135.58 46.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.563 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.23 -30.51 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.038 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -70.94 -47.25 60.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.876 0.37 . . . . 0.0 110.399 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.4 tpt -63.18 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.783 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.54 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.577 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.01 -39.59 59.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.36 90.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.7 m -60.0 -42.54 94.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.833 HG13 ' CH2' ' A' ' 10' ' ' TRP . 19.0 t -64.41 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.01 -29.68 70.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.334 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -76.44 -54.35 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.37 -40.71 85.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.776 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.641 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.8 t-20 -115.44 80.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -64.96 -5.52 6.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.796 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 -0.66 56.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.548 0.213 . . . . 0.0 111.262 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.641 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.3 m -139.09 171.78 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 137.81 40.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.83 133.2 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.761 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.1 mt -102.14 119.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.439 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG22 HG11 ' A' ' 54' ' ' VAL . 63.1 t -87.12 115.83 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.286 0.565 . . . . 0.0 111.275 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.873 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -138.82 156.14 47.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.899 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 151.64 21.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.278 0.561 . . . . 0.0 111.781 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.37 113.93 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.183 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.1 23.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -72.76 -164.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.98 99.1 12.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.91 96.9 5.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 111.422 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.48 155.96 39.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.428 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -87.15 -24.97 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.274 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.84 141.06 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -88.53 125.67 34.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.29 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.5 mtm180 -145.33 111.03 5.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.236 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.504 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 73.9 m -60.49 -32.78 71.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.637 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -78.94 -4.56 50.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.408 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 54.9 ttp180 -120.73 124.26 44.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.435 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 25' ' ' VAL . 69.8 t -123.54 119.39 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.398 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.873 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.1 m95 -78.71 131.35 36.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.841 0.353 . . . . 0.0 111.177 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 54' ' ' VAL . 5.5 t -122.88 91.95 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -85.72 125.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.685 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.8 m -125.16 164.79 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.492 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -89.94 -177.17 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.91 -20.76 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.316 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -88.49 -22.2 23.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.162 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.1 22.26 9.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.206 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 36.8 t -98.19 144.67 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 21' ' ' ALA . 47.6 t -75.28 110.85 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -91.53 -33.68 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.569 ' CB ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -101.96 148.46 25.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.883 HG22 HG21 ' A' ' 14' ' ' VAL . 47.8 t -67.64 108.47 2.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.214 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.3 Cg_exo -62.73 117.55 4.44 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.138 1.892 . . . . 0.0 111.471 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 143.89 23.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.98 0.419 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' CG2' ' HA ' ' A' ' 49' ' ' CYS . 1.6 mt -40.3 122.69 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.048 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.577 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.189 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 32.2 ttmt -59.0 154.12 16.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.727 0.299 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.585 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -108.1 -20.4 13.17 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -147.71 127.04 13.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.693 ' CH2' HG13 ' A' ' 25' ' ' VAL . 22.7 m-90 -108.65 74.14 0.53 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.851 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.35 -37.06 92.68 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.047 1.831 . . . . 0.0 111.819 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -63.34 -9.59 12.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.865 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 21' ' ' ALA . 13.4 mt -80.88 -24.38 38.34 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.515 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 40.3 t -55.68 112.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.955 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -6.99 24.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.407 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.734 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 mmtp -102.69 160.38 14.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.287 . . . . 0.0 110.497 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.0 p -56.81 135.81 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.923 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -46.45 -30.61 4.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.171 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -44.77 64.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.827 0.346 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -32.46 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.032 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.762 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -68.04 -60.09 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.28 -39.73 67.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.755 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -64.12 -44.92 90.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.637 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.1 m -59.27 -41.0 87.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 52' ' ' VAL . 60.2 t -65.11 -57.58 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.107 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.17 -24.17 67.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 19.8 ttm-85 -80.77 -58.18 3.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.351 . . . . 0.0 110.819 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.05 -37.17 86.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.105 0.479 . . . . 0.0 110.377 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.464 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -121.16 78.22 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -0.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.22 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.29 -11.64 32.01 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.349 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' CG ' ' A' ' 29' ' ' ASN . 14.0 m -122.67 171.0 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -130.85 133.38 45.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.016 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 135.11 47.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.574 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 33' ' ' HIS . 28.7 mt -104.03 122.81 57.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.567 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 22' ' ' ALA . 60.0 t -91.3 123.02 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.722 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -150.6 158.6 44.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.478 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -89.0 159.76 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.098 0.475 . . . . 0.0 111.499 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.77 122.31 5.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.323 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.78 -8.82 43.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.933 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 32.8 t -68.69 -166.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.354 . . . . 0.0 111.123 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' CH2' ' A' ' 53' ' ' TRP . . . -71.14 93.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.543 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 1.5 ttp -121.18 99.12 6.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.48 151.52 20.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.356 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -79.82 -26.72 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.05 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.99 142.38 2.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -88.05 129.5 35.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.716 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.3 mtp180 -144.72 108.6 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.236 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -56.12 -43.21 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.282 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -79.48 3.57 18.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 40.4 ttp180 -126.65 115.71 19.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 25' ' ' VAL . 57.3 t -116.42 122.47 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.249 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.722 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.2 m95 -78.69 125.54 29.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.212 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.32 85.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mp -83.27 127.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.154 0.502 . . . . 0.0 111.73 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.8 m -124.9 163.72 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.242 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -83.55 -178.75 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.54 -22.0 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.855 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -24.43 21.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.335 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.78 22.23 7.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.318 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.0 t -99.02 140.47 18.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.4 t -70.71 112.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.098 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.9 p -94.66 -32.8 13.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.176 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 39.5 t -103.79 151.74 22.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.499 . . . . 0.0 111.543 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.5 t -64.47 114.85 15.83 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.142 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.554 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 5.3 Cg_exo -75.41 88.18 1.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.904 1.736 . . . . 0.0 111.451 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 18.0 p-80 -121.8 144.04 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.118 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -38.28 116.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.069 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.768 -179.068 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.122 0 CA-C-O 120.956 0.198 . . . . 0.0 113.391 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.64 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 2.8 ttmp? -55.64 149.78 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.73 -16.67 15.38 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -154.39 138.15 16.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.719 ' CH2' HG13 ' A' ' 25' ' ' VAL . 19.9 m-90 -120.49 71.06 17.8 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.84 0.352 . . . . 0.0 111.276 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -54.78 -37.81 92.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.328 2.019 . . . . 0.0 112.003 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -62.19 -9.15 6.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.156 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.1 mt -81.13 -24.21 37.8 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.769 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 65' ' ' VAL . 48.3 t -57.93 110.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.25 15.76 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.404 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -103.91 179.39 4.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.632 0.253 . . . . 0.0 110.625 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -76.04 143.23 41.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.664 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.71 -33.57 12.91 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.009 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.08 -36.92 66.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.987 0.422 . . . . 0.0 110.161 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -39.65 84.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.791 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.66 -58.85 4.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.504 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.66 -41.97 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.08 -45.45 94.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.95 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.444 ' CB ' HD21 ' A' ' 13' ' ' LEU . 39.9 m -61.3 -41.09 96.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' CH2' ' A' ' 10' ' ' TRP . 46.9 t -66.64 -54.96 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 33' ' ' HIS . 9.0 mt-10 -65.6 -23.88 66.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 10.0 ttm-85 -83.61 -53.01 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.824 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.67 -36.95 81.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.661 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.747 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -118.73 79.48 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.702 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -2.65 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.093 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.03 -13.9 28.05 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.695 0.283 . . . . 0.0 111.47 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.747 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.8 m -140.67 164.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.986 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -132.79 163.51 28.89 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.911 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB1' HG23 ' A' ' 54' ' ' VAL . . . -117.11 140.94 48.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.063 0.459 . . . . 0.0 111.935 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 28.6 mt -99.58 111.59 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.39 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.3 p -81.33 125.68 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 0.0 111.819 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 41' ' ' SER . 0.5 OUTLIER -155.88 160.1 39.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.195 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -89.69 155.04 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 111.627 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -47.91 115.95 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.396 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.78 -7.5 21.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.621 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.658 ' HB3' HD13 ' A' ' 37' ' ' LEU . 32.4 t -70.46 -162.38 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.91 96.88 5.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.0 110.743 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.593 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 10.1 tmm? -119.42 96.14 5.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.91 154.76 24.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.251 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -84.53 -27.93 27.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.67 130.78 5.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 68' ' ' ILE . 88.9 t80 -80.71 134.56 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.072 0.463 . . . . 0.0 111.8 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 10.4 mtp180 -152.61 109.83 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' O ' HG11 ' A' ' 32' ' ' VAL . 6.7 m -61.33 -30.36 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.09 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 17.7 p-10 -79.06 -8.25 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.637 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 39.6 ttp180 -122.26 119.2 30.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.042 0.449 . . . . 0.0 111.699 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 66.4 t -114.93 122.2 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.613 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -78.58 129.46 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.5 t -120.56 92.79 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 37' ' ' LEU . 7.3 mm -85.15 129.67 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.257 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 62' ' ' VAL . 26.4 m -129.09 164.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -86.0 -168.95 2.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.78 -18.7 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.64 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.02 4.69 51.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.31 24.76 65.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.222 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 23.3 t -97.54 131.47 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 21' ' ' ALA . 49.0 t -66.37 106.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.788 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.7 p -93.52 -29.46 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.03 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -103.94 151.14 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 11' ' ' PRO . 8.0 t -66.27 118.91 57.76 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.341 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 13' ' ' LEU . 89.7 Cg_endo -81.73 99.57 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.171 1.914 . . . . 0.0 111.351 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 7.8 p-80 -133.21 147.23 52.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.499 ' HA ' HG22 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -36.63 116.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.678 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.571 -179.872 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 tttp -59.99 156.08 15.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.921 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.906 ' HA ' HD12 ' A' ' 68' ' ' ILE . 14.9 m-80 -113.77 -16.36 12.29 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.34 12.15 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.1 m-90 -108.0 73.95 0.46 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.881 0.372 . . . . 0.0 111.553 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.824 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -59.9 -35.11 94.71 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.281 1.987 . . . . 0.0 111.528 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -64.34 -12.52 43.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.47 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' HA ' ' A' ' 21' ' ' ALA . 23.4 mt -82.01 -22.41 36.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.421 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.539 HG21 HG22 ' A' ' 65' ' ' VAL . 40.5 t -55.23 114.99 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 110.619 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.52 -13.11 33.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.245 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -92.72 160.08 15.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.708 0.29 . . . . 0.0 110.59 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -60.73 140.79 57.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.77 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.87 -32.08 8.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.153 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -71.37 -45.26 63.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -38.83 92.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.881 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.26 -58.95 5.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.465 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -52.19 -39.22 59.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.66 -45.46 90.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.713 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.554 ' CB ' HD21 ' A' ' 13' ' ' LEU . 10.9 m -60.29 -41.21 92.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 26.4 t -67.32 -51.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.03 -26.99 67.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.678 0.275 . . . . 0.0 111.155 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -81.02 -56.33 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.39 -36.46 84.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.58 79.59 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -61.17 -5.62 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.231 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -88.69 -1.59 58.15 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.242 -0.286 . . . . 0.0 111.734 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -140.71 170.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.469 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.435 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -135.89 140.89 44.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -104.83 141.07 37.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.634 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 33' ' ' HIS . 3.9 mt -114.83 123.09 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.639 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.7 t -79.82 123.49 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.689 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -141.49 149.6 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.789 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 155.5 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 0.0 111.55 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 55' ' ' ILE . 15.3 mt-10 -48.83 115.87 1.42 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.153 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 1.57 37.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.526 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 t -65.77 178.93 0.94 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.993 0.425 . . . . 0.0 110.599 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.07 92.73 9.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.893 ' HE1' HG12 ' A' ' 55' ' ' ILE . 2.0 ptp -112.82 105.08 13.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.979 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.66 152.07 9.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.749 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.63 -27.04 27.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.089 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.2 142.42 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.99 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.527 ' CE1' HG22 ' A' ' 68' ' ' ILE . 77.3 t80 -86.9 134.21 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 78.3 mtp180 -148.46 113.88 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -58.87 -41.07 86.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -79.43 2.73 20.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.0 ttp180 -125.56 113.49 17.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.976 0.417 . . . . 0.0 111.45 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.3 t -117.15 119.34 61.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.933 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.689 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 37.8 t -120.42 87.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.032 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.893 HG12 ' HE1' ' A' ' 43' ' ' MET . 4.3 mt -79.92 122.63 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.335 0.588 . . . . 0.0 111.836 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.0 m -122.44 163.77 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.254 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -88.99 -168.27 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.21 -17.63 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -97.8 9.85 41.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.29 22.54 77.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.311 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 44.5 t -97.98 137.61 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 66' ' ' PRO . 58.2 t -75.58 116.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' THR . . . . . 0.579 HG21 ' OE2' ' A' ' 39' ' ' GLU . 63.2 p -95.37 -28.57 14.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.48 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 17.7 m -102.72 148.83 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.304 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 11' ' ' PRO . 23.3 t -64.18 106.84 1.05 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.37 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.584 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 24.0 Cg_exo -59.42 99.04 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 121.952 1.768 . . . . 0.0 111.744 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -124.19 156.74 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.293 0.568 . . . . 0.0 111.025 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.2 114.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.634 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.895 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.166 0 N-CA-C 112.584 -0.207 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 7.1 ttmt -57.26 143.27 40.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -99.22 -26.36 14.21 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -142.38 130.64 22.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.843 0.354 . . . . 0.0 110.082 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.684 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 30.1 m-90 -110.86 73.11 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.255 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.855 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -59.89 -35.57 93.3 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.363 2.042 . . . . 0.0 111.676 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -63.01 -11.84 21.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.519 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' A' ' 21' ' ' ALA . 35.9 mt -83.69 -22.69 31.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.761 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG21 HG22 ' A' ' 65' ' ' VAL . 43.4 t -56.72 114.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.82 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.98 -11.16 29.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.373 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -97.39 161.05 13.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.288 . . . . 0.0 110.71 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -58.72 142.24 50.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -50.87 -31.89 25.22 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.187 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -47.13 63.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -34.49 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.118 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.27 -60.27 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.768 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -51.55 -42.23 61.68 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.156 0.503 . . . . 0.0 110.095 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -58.59 -48.11 82.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.288 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.615 ' CB ' HD21 ' A' ' 13' ' ' LEU . 13.4 m -59.84 -41.56 91.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG13 ' CH2' ' A' ' 10' ' ' TRP . 59.7 t -65.72 -57.09 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.78 0.324 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.47 -22.58 67.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.721 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.71 -55.5 3.95 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.116 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.44 -33.14 75.26 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.443 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.41 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.8 t-20 -127.41 76.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.309 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -2.64 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.096 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -90.64 -1.45 57.87 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' CG ' ' A' ' 29' ' ' ASN . 13.3 m -141.39 169.38 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 142.6 49.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.385 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -107.4 136.91 46.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 111.966 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 51' ' ' ARG . 19.3 mt -101.93 108.99 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.647 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.5 t -79.85 120.95 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.185 0.517 . . . . 0.0 110.659 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -148.76 159.29 44.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -89.96 161.93 15.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.262 0.553 . . . . 0.0 111.815 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.19 123.49 6.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.527 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.8 -7.35 55.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.985 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 47.9 t -66.44 -167.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.419 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -71.9 94.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.096 0.474 . . . . 0.0 110.236 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.526 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -123.04 91.98 3.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.385 0.612 . . . . 0.0 111.533 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -81.5 151.98 27.54 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -79.81 -25.0 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.48 159.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.9 t80 -104.54 132.97 50.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.0 111.596 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 28.0 mtp85 -147.28 110.9 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.838 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.1 t -56.35 -47.5 78.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.198 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -79.22 3.53 17.57 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.818 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.1 ttp180 -122.22 110.29 15.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 68' ' ' ILE . 86.9 t -111.91 121.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.21 128.9 34.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.31 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.3 t -121.88 80.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.838 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.1 mt -80.08 127.63 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.237 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.9 m -124.09 159.96 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -84.82 -171.39 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.54 -20.63 48.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -95.98 12.76 29.26 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.58 23.9 72.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.967 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.6 t -96.89 137.58 24.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 66' ' ' PRO . 44.3 t -75.84 114.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.089 0.471 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -94.55 -34.6 12.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.981 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -94.42 142.26 27.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -61.87 103.59 0.4 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 31.6 Cg_exo -54.47 95.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.603 1.535 . . . . 0.0 111.385 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -128.13 143.25 51.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.119 0.485 . . . . 0.0 110.934 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.612 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -44.23 109.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.663 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.703 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.36 -0.296 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.9 ttmt -77.93 151.11 33.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.614 0.245 . . . . 0.0 110.598 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -109.88 -13.07 14.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.9 128.89 11.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.891 0.376 . . . . 0.0 110.056 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.843 ' CH2' HG13 ' A' ' 25' ' ' VAL . 31.0 m-90 -114.82 70.06 2.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.4 Cg_endo -58.7 -34.11 98.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.164 1.91 . . . . 0.0 111.617 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.48 -12.93 35.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.414 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.7 mt -81.67 -22.64 37.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.708 0.289 . . . . 0.0 110.506 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 65' ' ' VAL . 46.9 t -56.95 113.46 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -10.99 29.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.321 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 171.74 8.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.643 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 p -68.4 142.53 55.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.912 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.28 -31.67 35.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.035 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -71.08 -46.22 62.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.309 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.14 -35.46 78.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.812 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.28 -63.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.219 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -50.57 -35.9 32.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.694 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.11 -46.28 78.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.271 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 13' ' ' LEU . 35.0 m -59.88 -41.37 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 10' ' ' TRP . 17.2 t -66.44 -50.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.73 0.3 . . . . 0.0 111.329 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.44 -31.7 72.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.506 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.25 -51.04 10.0 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.813 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.19 -37.81 81.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.582 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.1 t-20 -119.55 80.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.121 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -5.86 2.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -96.45 6.53 48.55 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.582 HG22 ' CG ' ' A' ' 29' ' ' ASN . 10.8 m -144.71 169.21 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.338 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.936 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -131.78 138.14 48.45 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.096 0.474 . . . . 0.0 110.852 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.16 131.98 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.936 HD11 ' CE1' ' A' ' 33' ' ' HIS . 3.6 mp -107.04 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.991 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 47.8 t -80.37 119.59 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 111.257 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.765 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -147.79 153.21 38.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.254 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 157.12 19.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 111.786 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 55' ' ' ILE . 4.0 pt-20 -50.86 118.1 2.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -7.11 31.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -61.43 -178.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.82 92.79 9.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.126 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.23 121.04 31.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.241 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.01 156.56 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -24.79 24.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -48.41 141.51 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 68' ' ' ILE . 28.9 t80 -83.26 133.77 34.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 11.2 mtm180 -146.12 114.32 6.63 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.794 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -60.07 -37.83 81.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HA ' HG12 ' A' ' 32' ' ' VAL . 12.2 p-10 -79.79 1.51 26.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.468 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 41.4 ttp180 -126.77 129.63 48.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.966 0.412 . . . . 0.0 111.429 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 25' ' ' VAL . 44.8 t -128.7 112.77 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.765 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.43 133.73 37.45 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 109.995 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.4 t -119.11 90.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.799 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 64' ' ' SER . 1.8 mp -79.68 119.57 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.4 m -116.51 161.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.4 -174.09 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.41 -22.07 52.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.593 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -17.14 29.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.23 22.42 13.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.928 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.3 t -99.6 143.97 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' A' ' 21' ' ' ALA . 33.5 t -73.75 115.84 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 0.0 111.023 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 p -95.7 -31.99 12.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 p -105.56 159.03 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -68.07 104.56 0.71 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.825 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 32.3 Cg_exo -59.05 100.3 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.867 1.711 . . . . 0.0 111.233 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 152.56 49.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.262 0.553 . . . . 0.0 111.099 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -47.71 109.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.644 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.656 -179.114 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 120.925 0.181 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.6 ttmm -50.85 147.46 4.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.658 0.266 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -111.19 -1.53 16.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.02 132.37 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.877 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.9 m-90 -119.45 72.13 13.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.885 0.374 . . . . 0.0 111.534 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.915 ' HA ' HG13 ' A' ' 65' ' ' VAL . 15.2 Cg_endo -57.34 -35.71 98.88 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.166 1.91 . . . . 0.0 111.694 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.93 -10.42 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 16.7 mt -80.35 -22.85 40.98 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.338 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 65' ' ' VAL . 38.8 t -58.67 112.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.23 22.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -102.88 -174.64 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.623 0.249 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 p -83.03 140.32 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -49.63 -29.88 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.14 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.66 -47.9 51.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.427 ' HA ' ' HE2' ' A' ' 20' ' ' MET . 0.0 OUTLIER -64.81 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.57 -62.2 1.53 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.29 -35.93 63.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.037 0.446 . . . . 0.0 110.452 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.5 -45.35 79.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.403 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.3 m -59.41 -40.61 87.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.877 HG13 ' CH2' ' A' ' 10' ' ' TRP . 13.7 t -66.39 -56.2 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.73 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.608 0.242 . . . . 0.0 111.331 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 30.2 ttp180 -80.75 -57.39 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.775 0.321 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.14 -33.13 75.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.444 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' OD1' HG13 ' A' ' 32' ' ' VAL . 44.7 t-20 -125.62 79.71 1.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -0.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.309 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -100.37 0.18 39.45 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.607 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 68' ' ' ILE . 10.1 m -129.27 167.98 23.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.47 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.464 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -131.59 124.63 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.41 137.91 38.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 33' ' ' HIS . 27.7 mt -110.12 119.25 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 68.1 t -83.29 116.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.566 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.78 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -135.31 154.21 51.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.374 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.53 19.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.231 0.539 . . . . 0.0 111.779 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -45.76 117.89 1.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.476 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 1.09 41.34 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.863 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 34.4 t -67.61 -167.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 101.08 13.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.94 99.8 6.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 111.638 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -74.47 155.7 37.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.071 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.045 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.18 141.52 1.76 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.5 t80 -90.02 133.97 34.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 111.813 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -152.64 111.98 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.273 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.499 ' O ' HG12 ' A' ' 68' ' ' ILE . 73.8 m -58.86 -37.11 75.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.582 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -79.77 -1.42 38.62 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -122.99 108.67 13.19 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.984 0.421 . . . . 0.0 111.57 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 68' ' ' ILE . 94.4 t -111.88 120.04 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.828 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.78 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.5 m95 -78.63 125.24 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.429 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.2 88.13 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 23.0 mt -80.1 125.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.267 0.556 . . . . 0.0 111.827 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.4 m -124.56 164.6 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.461 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -84.57 -177.11 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -54.6 -25.44 26.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.787 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -88.38 -22.66 23.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.618 0.246 . . . . 0.0 111.358 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.08 22.67 7.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.232 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 58.3 t -96.14 135.41 30.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' A' ' 21' ' ' ALA . 61.5 t -70.18 112.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.911 0.386 . . . . 0.0 110.811 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.5 p -97.1 -30.33 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.547 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -100.85 147.64 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.136 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.9 t -64.7 103.46 0.43 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 64' ' ' SER . 39.8 Cg_endo -64.76 108.54 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.116 1.877 . . . . 0.0 111.543 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -137.95 148.7 45.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.173 0.511 . . . . 0.0 111.346 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.752 HD11 HG11 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.28 113.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.61 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.808 -179.224 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-O 121.066 0.259 . . . . 0.0 112.92 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.2 ttmm -67.52 157.47 34.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.674 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -115.37 -9.92 12.09 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -152.69 129.13 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.621 0.248 . . . . 0.0 110.607 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.831 ' CH2' HG13 ' A' ' 25' ' ' VAL . 26.7 m-90 -115.48 72.85 3.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.767 0.318 . . . . 0.0 111.479 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.892 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.15 -34.53 94.21 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.166 1.91 . . . . 0.0 111.506 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -64.5 -12.05 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.684 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.6 mt -81.94 -20.36 38.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 11' ' ' PRO . 47.2 t -55.44 114.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.43 -9.92 33.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.286 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -95.6 157.1 16.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.751 0.31 . . . . 0.0 110.502 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 p -59.37 141.28 54.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.51 -30.27 19.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.32 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.02 -53.15 15.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -37.11 82.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.359 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.14 -56.68 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.414 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.31 -36.64 63.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.336 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.19 88.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.316 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.0 m -59.72 -44.11 93.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.644 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.831 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.5 t -65.09 -51.99 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 33' ' ' HIS . 2.5 mt-10 -64.53 -30.06 71.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.668 0.27 . . . . 0.0 111.449 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -79.5 -55.2 5.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -64.54 -34.59 78.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.554 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.4 t-20 -124.77 80.02 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.744 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -65.16 -5.71 7.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.559 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -89.85 -2.05 58.12 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 68' ' ' ILE . 4.5 m -137.52 171.23 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.573 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -134.2 136.03 43.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.352 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.65 125.45 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.611 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.889 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 3.1 mp -94.22 143.12 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.782 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 72.6 t -99.63 114.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.646 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -142.19 144.91 33.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.986 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 153.31 24.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.337 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 107.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 -10.19 6.05 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -67.58 160.21 28.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.362 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.72 7.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.468 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.513 ' HG2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -120.55 139.45 52.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.83 0.347 . . . . 0.0 111.008 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.26 161.07 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -96.78 -24.15 16.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -41.88 163.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.333 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -102.23 130.59 48.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 20.9 mtp180 -145.96 113.22 6.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.56 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 68' ' ' ILE . 43.0 m -58.45 -39.83 80.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.618 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -79.52 2.68 21.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD11 ' A' ' 35' ' ' ILE . 43.1 ttp180 -124.92 119.14 27.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.954 0.407 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 25' ' ' VAL . 48.6 t -122.02 116.39 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -78.82 124.29 28.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 110.73 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 42.2 t -106.07 87.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 55' ' ' ILE . 4.1 mp -80.15 114.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.8 m -119.26 165.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.507 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -85.34 -173.48 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.71 -21.69 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -89.63 -13.0 38.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.535 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.83 24.91 16.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.083 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 22.0 t -101.16 134.9 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 66' ' ' PRO . 91.1 t -68.27 107.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 110.539 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.7 p -90.05 -32.85 16.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.863 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -104.01 152.99 21.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 11' ' ' PRO . 25.6 t -64.89 106.47 1.01 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.441 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HG3' HG11 ' A' ' 62' ' ' VAL . 17.3 Cg_exo -60.81 90.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.825 1.683 . . . . 0.0 111.394 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.0 146.82 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 111.468 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -45.77 117.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.673 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.666 -0.174 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.1 ttmt -67.85 145.59 54.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.705 0.288 . . . . 0.0 110.521 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' HD12 ' A' ' 68' ' ' ILE . 15.4 m-20 -105.5 -5.81 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.81 128.31 4.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.689 0.281 . . . . 0.0 110.367 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.776 ' CH2' HG13 ' A' ' 25' ' ' VAL . 25.3 m-90 -112.62 69.89 1.09 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.44 -37.33 94.93 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.011 1.807 . . . . 0.0 111.938 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -65.05 -5.99 7.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 28.4 mt -84.44 -18.95 34.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.661 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.64 113.56 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.571 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.16 19.86 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.386 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.49 156.36 17.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.583 0.23 . . . . 0.0 110.661 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 7.6 p -56.8 145.73 28.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 111.43 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -53.76 -32.35 47.45 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.204 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.82 -47.14 66.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -44.13 97.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.271 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.25 -52.64 64.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.19 65.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.39 93.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.32 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.416 HG21 HD21 ' A' ' 13' ' ' LEU . 39.7 m -61.77 -43.46 98.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.596 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.776 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.5 t -66.9 -48.45 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.192 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.21 -31.05 71.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.395 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -81.62 -53.39 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.022 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -65.17 -33.22 75.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.66 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' CG ' ' HA3' ' A' ' 6' ' ' GLY . 55.6 t-20 -127.99 81.28 2.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 30' ' ' ARG . 1.1 ptm180 -63.3 -8.39 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.432 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -87.16 -1.32 57.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.605 0.241 . . . . 0.0 111.587 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 3.9 m -140.07 173.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.06 136.5 44.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.5 125.76 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.116 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.63 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 15.4 mt -98.28 111.29 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.571 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.662 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.7 p -79.67 125.29 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.565 0.698 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.96 148.86 22.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.023 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.75 158.14 17.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 111.807 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.17 123.69 4.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.201 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.41 -11.98 33.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 42.4 t -68.27 -166.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.881 0.372 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 100.0 12.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.191 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.21 96.58 4.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.265 0.555 . . . . 0.0 111.328 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.49 150.17 48.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.227 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.31 -25.06 31.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.31 141.13 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -84.78 132.25 34.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.266 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.05 109.38 4.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 55.5 m -59.61 -34.15 72.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.712 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -79.12 -3.31 44.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.785 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -123.66 135.13 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.13 117.25 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.585 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.679 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.67 131.37 36.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.094 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.662 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 33.8 t -116.0 89.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.014 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 10.4 mm -79.72 121.33 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.358 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 18' ' ' GLY . 28.6 m -122.31 163.8 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.206 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -84.09 -177.33 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.347 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.8 -22.1 22.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.602 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -90.73 -21.88 21.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.552 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 22.04 7.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.266 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.1 t -101.27 134.23 42.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 66' ' ' PRO . 61.3 t -65.33 114.85 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.419 . . . . 0.0 111.081 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -96.9 -33.11 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 68.1 m -105.03 158.57 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 111.36 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.7 t -65.88 117.01 37.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.394 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 62' ' ' VAL . 2.4 Cg_endo -79.28 93.53 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.552 2.168 . . . . 0.0 110.673 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 12.6 p-80 -125.8 151.41 46.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.088 0.47 . . . . 0.0 111.218 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -40.75 110.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.897 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.655 -179.014 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 31.4 ttmt -66.42 150.5 48.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.594 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.35 -19.03 13.71 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -149.66 127.5 11.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 0.0 110.081 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.714 ' CH2' HG13 ' A' ' 25' ' ' VAL . 27.5 m-90 -110.34 68.93 0.54 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.388 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.878 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.5 Cg_endo -58.63 -36.56 97.1 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.999 1.799 . . . . 0.0 111.513 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -64.51 -9.36 18.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.922 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.2 mt -79.95 -21.2 44.07 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.442 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 60.7 t -55.25 117.85 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.48 -14.21 27.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.4 mmtt -95.8 158.72 15.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.666 0.27 . . . . 0.0 110.679 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.6 p -57.98 143.59 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.116 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.29 -31.48 20.11 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.255 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -45.92 60.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.712 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -39.01 92.47 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -62.97 -60.76 3.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.384 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.503 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -51.25 -44.09 61.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.431 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.97 -45.79 93.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.299 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.44 HG21 HD21 ' A' ' 13' ' ' LEU . 91.6 m -56.86 -43.18 80.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.714 HG13 ' CH2' ' A' ' 10' ' ' TRP . 57.2 t -65.91 -54.08 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.332 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt-10 -63.61 -27.08 68.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.421 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.64 -56.48 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.695 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -61.72 -35.74 78.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 110.025 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -126.02 75.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.64 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -62.58 0.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.464 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -93.56 -5.0 49.93 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.252 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 49' ' ' CYS . 4.2 m -140.51 166.45 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -126.94 145.48 50.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.415 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.26 137.38 46.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.489 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 18.1 mt -106.29 113.7 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.616 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -78.88 120.26 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.389 0.614 . . . . 0.0 111.072 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.648 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.9 OUTLIER -145.12 154.91 42.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.99 -179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 156.75 17.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.315 0.579 . . . . 0.0 112.014 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.61 110.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.06 -3.79 12.81 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.362 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 30.9 t -67.62 -176.01 0.58 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 110.585 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -90.52 101.36 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ptp -127.83 103.77 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 p -63.66 152.54 38.72 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -24.32 36.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.293 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -44.5 147.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 68' ' ' ILE . 72.2 t80 -93.46 135.16 34.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.435 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.4 mtm180 -147.97 112.02 5.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.559 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.503 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.5 OUTLIER -59.42 -36.59 76.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -79.75 0.2 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 44.8 ttp180 -127.91 124.88 38.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 111.444 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 68' ' ' ILE . 48.6 t -122.84 118.32 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.108 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.648 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.5 m95 -78.47 133.31 37.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 25.5 t -120.43 90.63 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -81.25 123.78 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.474 0.654 . . . . 0.0 112.184 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.6 m -124.92 165.95 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.01 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -86.73 -172.68 4.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.681 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -21.28 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.501 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.67 -8.68 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.89 25.08 23.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 24.1 t -100.51 135.11 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 16' ' ' LYS . 41.2 t -72.14 114.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 111.434 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -98.74 -31.01 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.507 ' CB ' HD13 ' A' ' 55' ' ' ILE . 1.2 t -99.73 154.05 18.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.878 HG13 ' HA ' ' A' ' 11' ' ' PRO . 34.0 t -68.52 106.89 1.55 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.748 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.673 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 12.8 Cg_exo -65.69 89.29 0.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.868 1.712 . . . . 0.0 111.012 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -123.76 145.67 48.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.839 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -41.17 114.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.074 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.803 -179.435 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 ttmm -69.65 154.36 42.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.584 0.23 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' A' ' 68' ' ' ILE . 1.8 t-20 -111.46 -6.41 14.45 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.92 126.7 4.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.315 -0.241 . . . . 0.0 110.362 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.798 ' CH2' HG13 ' A' ' 25' ' ' VAL . 20.0 m-90 -112.52 73.48 1.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.922 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -57.66 -33.47 96.73 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.441 2.094 . . . . 0.0 111.854 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.5 -13.08 37.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.1 mt -81.33 -22.99 38.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 65' ' ' VAL . 24.6 t -60.6 113.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -9.48 20.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -105.95 177.26 4.91 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -66.47 144.75 56.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 0.0 111.338 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -60.32 -28.22 66.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.423 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -72.7 -53.48 11.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 110.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.428 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.5 -30.92 70.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.704 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.85 -61.72 1.9 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.283 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.13 -38.17 50.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 110.129 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.91 -45.2 94.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.412 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.439 ' CB ' HD21 ' A' ' 13' ' ' LEU . 11.4 m -58.49 -43.88 89.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.798 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.2 t -64.28 -60.66 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -59.01 -23.56 62.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 0.0 111.321 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 5.4 tpp180 -81.39 -61.04 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.32 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.11 -31.79 73.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.558 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -127.41 80.86 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.726 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.64 -8.08 5.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.02 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.32 -2.68 58.54 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 49' ' ' CYS . 11.6 m -129.45 168.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 0.0 111.552 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 1.031 ' CE1' HD11 ' A' ' 35' ' ' ILE . 1.8 p-80 -133.65 135.14 43.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . . . -108.1 123.42 48.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.424 . . . . 0.0 111.741 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 1.031 HD11 ' CE1' ' A' ' 33' ' ' HIS . 3.8 mp -97.87 115.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.468 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 53.4 t -79.72 113.05 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.324 0.583 . . . . 0.0 110.989 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.904 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -134.55 150.16 50.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.962 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -90.02 156.77 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.081 0.467 . . . . 0.0 111.766 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.73 123.88 3.98 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.458 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.1 -3.7 55.39 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.913 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 12.0 t -67.62 -179.32 1.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.955 0.407 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -86.02 101.68 13.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -129.73 100.05 5.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.098 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 p -59.37 147.31 36.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.099 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.91 -25.06 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.159 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.81 160.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.405 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.1 t80 -104.0 131.11 51.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.423 . . . . 0.0 111.61 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 48' ' ' ARG . 5.2 mtm180 -145.22 109.36 4.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.308 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -60.01 -33.32 71.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.536 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -79.51 -2.97 44.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.626 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 33' ' ' HIS . 47.5 ttp180 -121.11 142.76 49.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 111.478 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.511 HG21 HG11 ' A' ' 25' ' ' VAL . 94.2 t -138.68 114.28 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.819 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.904 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.69 131.55 36.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.706 0.288 . . . . 0.0 110.484 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 66' ' ' PRO . 11.3 t -119.21 88.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.101 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mt -79.84 122.15 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.8 m -121.26 164.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.433 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -87.91 -174.64 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -58.11 -23.48 55.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.55 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -86.04 -20.44 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 111.162 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.67 22.66 10.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.165 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 19.2 t -98.78 144.7 11.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.55 HG11 ' HD3' ' A' ' 66' ' ' PRO . 48.0 t -75.58 112.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.993 0.425 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 p -94.04 -31.45 14.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.558 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -103.48 154.01 19.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.922 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.7 t -66.12 101.36 0.28 Allowed Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.736 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 54' ' ' VAL . 19.1 Cg_endo -57.75 92.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.618 1.545 . . . . 0.0 110.827 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 16.1 p-80 -122.67 153.76 38.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.53 115.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.792 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.941 -179.422 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.249 0 CA-C-O 121.042 0.245 . . . . 0.0 113.061 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 33.3 ttmt -66.73 146.83 54.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.795 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.728 ' HA ' HD12 ' A' ' 68' ' ' ILE . 10.1 m-20 -107.03 -4.2 19.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.32 134.51 7.31 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.808 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -119.73 68.15 11.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.852 ' HA ' HG13 ' A' ' 65' ' ' VAL . 54.5 Cg_exo -50.29 -37.35 49.7 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.283 1.989 . . . . 0.0 112.348 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.92 -13.48 25.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.968 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD22 ' HA ' ' A' ' 21' ' ' ALA . 24.8 mt -80.51 -23.42 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.67 0.272 . . . . 0.0 110.663 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.612 HG21 HG22 ' A' ' 65' ' ' VAL . 59.4 t -53.71 112.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.798 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -12.01 29.96 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.231 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -94.23 157.11 16.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.786 0.327 . . . . 0.0 110.875 179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -56.82 141.33 44.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.38 -31.59 20.98 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.319 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.35 -45.54 59.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.14 -42.08 99.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.043 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -62.56 -56.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.711 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.51 64.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.65 -45.23 93.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.5 m -58.27 -42.1 85.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.883 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' VAL . . . . . 0.808 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -67.35 -58.05 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.337 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.15 -24.89 66.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.46 0.171 . . . . 0.0 111.446 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 17.8 ttp180 -83.9 -58.72 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.833 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.98 -29.55 70.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.999 0.428 . . . . 0.0 110.269 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 32' ' ' VAL . 50.0 t-20 -131.0 85.07 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -8.57 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.25 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.76 -10.03 52.21 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 49' ' ' CYS . 13.7 m -115.06 175.5 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 112.062 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' HIS . . . . . 0.56 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -143.48 125.36 15.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.549 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 129.63 44.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.12 0.485 . . . . 0.0 112.007 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.624 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 27.0 mt -106.82 119.64 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -79.45 132.45 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.369 0.604 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.826 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -157.03 150.94 24.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.17 153.87 20.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.165 0.507 . . . . 0.0 111.585 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 55' ' ' ILE . 10.9 pt-20 -49.06 115.48 1.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.31 -1.85 25.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -69.71 -177.22 1.2 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.839 0.352 . . . . 0.0 110.655 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.52 104.86 17.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -124.14 106.52 10.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.305 -178.367 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -56.47 147.76 21.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.079 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 mmpp? -84.54 -26.13 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.954 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.93 138.24 5.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -84.81 130.34 34.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 3.9 mtp85 -144.71 112.25 6.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' CYS . . . . . 0.957 ' O ' HG12 ' A' ' 32' ' ' VAL . 90.9 m -63.95 -13.67 47.79 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.752 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 48' ' ' ARG . 18.8 p-10 -97.88 -4.7 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.646 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG3' ' CE1' ' A' ' 33' ' ' HIS . 52.0 ttp180 -122.35 143.31 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 111.35 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 25' ' ' VAL . 59.6 t -139.36 118.47 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.645 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TRP . . . . . 0.826 ' CE3' HD21 ' A' ' 37' ' ' LEU . 4.9 m95 -78.42 135.2 37.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.253 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 43.1 t -120.13 89.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.053 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 43' ' ' MET . 6.0 mt -81.98 126.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.016 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.8 m -123.47 165.27 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.798 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -88.13 -172.72 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.964 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.62 -21.98 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -95.48 -8.85 34.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.78 21.97 24.72 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.537 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 t -96.38 140.66 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 16' ' ' LYS . 40.4 t -72.65 112.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.804 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.1 p -94.45 -32.41 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.567 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.563 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 9.0 t -100.82 146.41 27.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.7 t -62.73 101.44 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.1 Cg_endo -57.91 99.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.034 1.823 . . . . 0.0 111.647 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -127.98 152.83 47.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.115 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -49.72 116.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.453 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' THR . . . . . 0.402 ' OXT' HG22 ' A' ' 69' ' ' THR . 5.7 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.979 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.051 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.7 t -75.65 94.88 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtp-105 -152.67 70.91 0.91 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.748 1.219 . . . . 0.0 110.953 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -151.12 88.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.3 m -88.37 148.28 42.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.802 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.72 160.84 47.88 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.133 1.889 . . . . 0.0 112.162 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . 74.43 158.46 6.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.443 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 25.5 ttmt -56.11 142.81 35.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.705 0.288 . . . . 0.0 110.68 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -100.77 -11.34 19.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 67' ' ' HIS . . . -155.47 140.2 17.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.699 ' CH2' HG13 ' A' ' 25' ' ' VAL . 17.1 m-90 -121.2 68.58 18.75 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.775 ' HA ' HG13 ' A' ' 65' ' ' VAL . 67.3 Cg_exo -49.74 -36.18 41.07 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.183 1.922 . . . . 0.0 112.177 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -64.12 -8.33 11.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.276 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.9 mt -83.71 -20.1 34.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 11' ' ' PRO . 44.1 t -56.57 114.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.823 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -8.1 31.5 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.35 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 62' ' ' VAL . 3.2 mmtt -99.25 157.9 16.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.312 . . . . 0.0 110.716 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -56.99 139.43 52.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -51.58 -29.16 23.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.512 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.22 -46.69 40.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.401 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 7.0 tpt -65.25 -33.87 77.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.032 0.444 . . . . 0.0 109.829 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -66.4 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.367 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.71 -42.72 57.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.15 -46.13 91.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.429 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -57.03 -40.47 76.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -66.0 -54.98 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.315 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -64.76 -26.05 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.609 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -83.46 -56.22 3.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 111.186 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -63.05 -30.52 71.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.073 0.463 . . . . 0.0 110.322 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' ND2' ' HA3' ' A' ' 6' ' ' GLY . 50.2 t-20 -127.84 85.04 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.783 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -8.17 3.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.233 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -95.04 2.42 55.25 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 49' ' ' CYS . 30.6 m -129.09 167.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 128.44 36.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.673 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.73 144.07 31.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.233 0.54 . . . . 0.0 112.139 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.573 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.3 mt -120.19 143.46 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.159 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 58.3 t -97.49 130.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -157.72 151.88 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.97 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 56' ' ' VAL . 1.3 mtpt -87.31 161.06 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 112.405 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 5.8 tt0 -54.12 119.29 4.89 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.228 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.02 56.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.685 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 3.1 t -64.24 131.9 48.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.06 0.457 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.86 81.85 0.11 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.656 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD13 ' A' ' 37' ' ' LEU . 13.5 mmt -113.94 164.24 14.05 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.886 0.374 . . . . 0.0 111.453 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.2 164.02 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.23 -25.73 7.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.323 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -52.04 171.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 33.4 t80 -97.96 128.4 44.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -143.87 111.2 5.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.501 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.742 ' O ' HG12 ' A' ' 32' ' ' VAL . 18.4 m -60.25 -35.96 76.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 16.2 p-10 -78.81 -3.48 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.442 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 40.8 ttp180 -123.04 129.99 52.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.194 0.521 . . . . 0.0 111.784 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 68' ' ' ILE . 84.6 t -133.16 119.79 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.358 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.86 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.7 m95 -78.9 130.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 55.1 t -113.16 84.38 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.01 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 64' ' ' SER . 2.5 mp -79.87 118.4 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.62 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 29.8 m -122.93 165.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.236 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.17 -172.62 3.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -23.36 61.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.379 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -90.65 2.93 55.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 25.09 64.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.166 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.0 t -100.22 132.88 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 16' ' ' LYS . 46.2 t -68.1 108.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.528 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.6 p -93.06 -33.8 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.155 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 55' ' ' ILE . 22.9 t -102.2 157.15 17.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.1 t -69.58 123.39 88.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HG2' HD12 ' A' ' 13' ' ' LEU . 91.5 Cg_endo -81.99 101.77 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.313 2.009 . . . . 0.0 110.576 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.7 p-80 -132.26 145.98 51.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.08 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -39.34 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.674 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.78 -179.077 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.3 p -74.11 82.37 1.78 Allowed 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.53 60.01 1.21 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.303 1.041 . . . . 0.0 110.927 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -151.35 89.23 1.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.335 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.69 136.77 83.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 164.69 34.47 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.06 1.84 . . . . 0.0 112.541 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.34 163.89 10.36 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.735 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 26.2 ttmt -59.62 154.11 18.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.816 0.341 . . . . 0.0 111.31 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -115.92 -5.55 12.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.439 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -155.32 124.61 6.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.903 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.0 m-90 -111.4 74.93 1.2 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.869 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.861 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.6 Cg_endo -59.49 -35.67 95.34 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.986 1.791 . . . . 0.0 111.604 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -65.0 -9.89 25.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.861 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 26.8 mt -82.81 -19.8 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.719 0.295 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 11' ' ' PRO . 45.2 t -55.47 111.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.6 -9.76 23.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.118 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.0 mmtt -95.43 157.84 15.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.297 . . . . 0.0 110.733 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 p -59.51 138.5 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.763 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.25 -31.63 8.92 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.084 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.38 63.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.985 0.421 . . . . 0.0 110.268 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -33.1 75.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.871 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.67 -59.5 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -55.49 -41.73 73.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.559 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.22 -46.63 89.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.435 HG21 HD21 ' A' ' 13' ' ' LEU . 88.0 m -57.83 -43.75 85.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -63.68 -52.05 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -63.82 -29.14 70.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.519 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -78.66 -57.11 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.836 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.4 -35.22 80.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.438 . . . . 0.0 110.454 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.513 ' CG ' HG22 ' A' ' 32' ' ' VAL . 49.3 t-20 -123.16 78.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -3.15 0.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.609 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.64 -5.05 49.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 29' ' ' ASN . 12.8 m -139.72 168.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -133.58 146.79 51.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.684 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.06 138.72 44.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.504 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.1 mp -105.09 120.55 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.623 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.5 p -80.43 129.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.895 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.46 152.35 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.19 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.874 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -89.67 155.1 19.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 111.946 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 117.11 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.054 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.98 -1.97 30.09 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 39.7 t -70.11 -172.54 0.56 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.313 . . . . 0.0 110.738 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -88.87 104.82 17.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 100.95 6.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.459 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -58.68 147.55 32.45 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.875 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -80.43 -26.42 38.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.25 161.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.7 t80 -103.81 137.32 41.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -152.49 112.85 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.559 ' O ' HG12 ' A' ' 68' ' ' ILE . 50.3 m -58.45 -37.84 76.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.7 p-10 -79.36 -2.82 43.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.48 -179.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -120.63 111.47 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.609 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG21 HG11 ' A' ' 25' ' ' VAL . 78.9 t -113.15 117.64 55.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.895 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.9 m95 -78.71 128.79 33.91 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 7.2 t -116.52 98.93 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 ' CD1' ' A' ' 37' ' ' LEU . 9.0 mm -83.87 122.4 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.874 HG23 ' HG3' ' A' ' 38' ' ' LYS . 30.5 m -126.66 168.35 19.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.423 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.75 -170.93 2.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -18.83 61.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.77 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.56 -1.8 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.14 24.19 38.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.3 t -96.04 131.92 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.9 t -70.92 112.82 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 111.378 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -97.14 -33.07 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 6.8 t -97.86 149.94 21.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.218 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 11' ' ' PRO . 21.3 t -66.92 108.36 2.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.541 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 10' ' ' TRP . 17.2 Cg_exo -62.19 106.14 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.211 1.941 . . . . 0.0 111.594 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.13 146.68 51.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.418 0.628 . . . . 0.0 111.768 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.571 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -47.51 109.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.668 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.453 ' OXT' HG22 ' A' ' 69' ' ' THR . 11.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.52 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.043 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.345 69.7 p 64.62 -93.37 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 58.87 80.11 0.2 Allowed 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.928 2.491 . . . . 0.0 111.233 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.42 98.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.76 151.53 40.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 111.203 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.49 153.0 30.56 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.313 2.008 . . . . 0.0 112.542 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 172.12 10.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.662 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 9' ' ' ALA . 3.6 ttmt -69.67 148.7 48.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.592 0.234 . . . . 0.0 110.546 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -110.34 -0.16 17.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -160.48 125.55 3.83 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.896 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -113.39 67.46 1.23 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.767 0.317 . . . . 0.0 111.151 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.888 ' HA ' HG13 ' A' ' 65' ' ' VAL . 9.6 Cg_endo -52.62 -33.67 59.84 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.386 2.058 . . . . 0.0 111.907 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -64.68 -9.2 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.696 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.845 HD13 ' HB1' ' A' ' 21' ' ' ALA . 18.6 mt -84.18 -18.87 35.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.844 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' PRO . 48.6 t -56.84 113.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.746 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 -12.89 43.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.175 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -89.07 162.31 16.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 110.646 179.58 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 p -63.97 137.53 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.497 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -52.58 -29.74 32.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.364 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -70.1 -54.24 13.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.85 95.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.06 -51.42 69.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.495 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.2 75.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.373 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.65 88.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.498 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -59.64 -45.73 91.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.531 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.896 HG13 ' CH2' ' A' ' 10' ' ' TRP . 40.3 t -64.7 -50.92 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -31.95 73.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 111.419 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -79.4 -56.51 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.181 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.17 -29.31 70.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.708 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.7 t-20 -126.7 79.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -65.14 -2.88 3.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -92.9 -9.78 38.92 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.603 0.24 . . . . 0.0 111.287 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 29' ' ' ASN . 3.0 m -140.3 169.55 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.932 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.88 151.06 51.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.162 0.506 . . . . 0.0 111.129 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.82 137.91 51.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.551 HD11 ' HG3' ' A' ' 51' ' ' ARG . 3.9 mp -104.86 129.07 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.514 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 65.5 t -80.16 128.39 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.04 0.447 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.727 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -150.67 143.36 24.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.518 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 157.2 17.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.95 120.46 2.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.96 55.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.738 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 14.8 t -70.49 -179.7 2.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 110.857 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.64 101.54 14.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.29 104.85 8.16 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.014 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.35 151.44 9.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -27.59 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -46.58 134.99 9.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 68' ' ' ILE . 56.0 t80 -80.44 132.16 35.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.555 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.0 mtm180 -146.9 111.82 5.38 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.602 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' O ' HG11 ' A' ' 32' ' ' VAL . 97.3 m -60.63 -34.11 73.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -79.54 -0.32 32.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.66 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.551 ' HG3' HD11 ' A' ' 35' ' ' ILE . 47.9 ttp180 -126.43 129.49 48.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.433 . . . . 0.0 111.471 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 68' ' ' ILE . 52.7 t -128.32 116.26 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.15 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.727 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.9 m95 -78.76 133.89 37.08 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 29.3 t -115.25 96.38 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.596 ' H ' HD12 ' A' ' 55' ' ' ILE . 4.0 mp -84.47 121.28 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.172 0.51 . . . . 0.0 111.57 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 27.0 m -125.87 162.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.013 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -85.84 -179.7 6.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.92 -20.98 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.53 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.21 -24.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.295 . . . . 0.0 111.227 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.33 21.14 7.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.18 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.6 t -98.28 139.49 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 16' ' ' LYS . 42.9 t -72.6 111.78 7.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.816 0.341 . . . . 0.0 110.756 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -91.19 -31.3 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 48.3 t -107.59 150.13 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.888 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.4 t -64.82 102.14 0.31 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.38 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.9 Cg_endo -58.86 97.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.114 1.876 . . . . 0.0 111.596 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -123.68 157.47 33.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.551 . . . . 0.0 111.347 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -51.09 114.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.535 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.435 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.813 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.4 m -60.03 145.45 46.34 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.96 72.62 0.72 Allowed 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.918 -1.114 . . . . 0.0 110.747 -160.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.52 74.36 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.11 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 68' ' ' ILE . 2.5 m -111.12 128.22 25.68 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.519 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 12.6 Cg_exo -69.56 63.46 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.981 1.788 . . . . 0.0 111.595 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . 142.26 148.5 5.0 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.298 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 26.4 ttmt -33.23 143.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.634 0.254 . . . . 0.0 111.49 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.916 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.0 p30 -112.23 -0.54 15.47 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -157.12 121.46 4.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.86 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.2 m-90 -108.79 74.81 0.59 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.94 0.4 . . . . 0.0 111.453 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.821 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.8 Cg_endo -60.59 -33.25 93.79 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.208 1.939 . . . . 0.0 111.401 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pm0 -63.7 -14.13 49.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 21' ' ' ALA . 22.2 mt -81.07 -20.63 41.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.645 0.259 . . . . 0.0 110.565 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.41 117.34 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.614 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.76 -14.6 53.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.14 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.17 174.78 8.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.622 0.248 . . . . 0.0 110.516 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 p -75.99 144.01 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.98 -31.62 40.22 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.084 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.4 -52.87 22.77 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.708 0.289 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -29.97 70.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 109.999 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.73 -60.55 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.449 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.1 68.67 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.01 -44.58 84.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.421 ' CB ' HD21 ' A' ' 13' ' ' LEU . 91.6 m -58.85 -43.12 90.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.86 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -65.61 -51.41 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.37 -28.51 69.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.57 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 8.0 mtp180 -81.86 -54.75 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.71 -34.95 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.281 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.9 t-20 -124.63 80.0 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.656 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -5.46 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -93.53 2.52 56.39 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -137.06 170.61 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 0.0 111.663 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.23 126.65 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.321 179.796 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.74 135.98 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.686 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.589 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 34.8 mt -107.38 120.73 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.738 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.631 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.6 p -79.79 128.74 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 111.438 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -157.9 144.72 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.534 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.24 159.31 16.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.584 . . . . 0.0 111.915 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.67 122.05 3.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.46 29.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.594 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 15.4 t -68.09 -178.09 0.96 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 110.71 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.9 102.7 15.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.564 ' HE1' HD12 ' A' ' 55' ' ' ILE . 2.7 ptp -124.51 100.15 6.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -60.09 148.92 34.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.053 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -82.31 -24.56 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.023 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -45.95 159.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -100.82 131.98 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.064 0.459 . . . . 0.0 111.422 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.04 108.17 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 48.8 t -60.56 -36.75 79.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.576 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.64 3.46 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -129.19 128.06 42.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.025 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.0 t -127.64 119.09 50.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.017 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.807 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.4 m95 -78.7 130.52 35.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.182 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 31.1 t -113.83 95.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.934 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.564 HD12 ' HE1' ' A' ' 43' ' ' MET . 5.6 mm -79.99 119.9 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.675 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.6 m -124.94 164.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.254 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -89.72 -171.76 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -18.18 62.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.496 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -96.21 -1.57 47.97 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.502 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.9 t -99.49 137.33 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 21' ' ' ALA . 60.4 t -72.33 109.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.937 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -93.76 -28.04 16.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 t -106.57 157.7 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 111.141 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.0 t -72.19 111.02 9.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 7.8 Cg_exo -67.57 103.55 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.664 1.576 . . . . 0.0 110.517 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.622 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.9 p-80 -131.7 145.2 51.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -40.82 111.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.28 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.655 ' OXT' HG22 ' A' ' 69' ' ' THR . 16.3 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.051 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.356 82.8 p 71.66 -88.33 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 124.898 1.279 . . . . 0.0 114.024 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -103.22 52.5 0.78 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.07 1.348 . . . . 0.0 110.416 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.6 mtt-85 -153.68 84.24 1.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.263 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 m -129.76 144.12 51.74 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.27 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.94 -178.31 4.06 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.137 1.891 . . . . 0.0 112.439 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.62 169.82 7.2 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.154 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.6 tttt -68.24 149.86 48.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.303 . . . . 0.0 110.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -110.98 -8.33 14.48 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.58 123.81 3.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.865 0.364 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 21.7 m-90 -109.52 74.36 0.68 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.833 ' HA ' HG13 ' A' ' 65' ' ' VAL . 13.2 Cg_endo -56.11 -37.53 96.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.495 2.13 . . . . 0.0 112.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.54 -6.88 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.166 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 21' ' ' ALA . 15.8 mt -85.37 -21.2 28.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.744 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG21 HG22 ' A' ' 65' ' ' VAL . 43.9 t -56.72 113.05 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-O 120.777 0.322 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.17 -10.53 26.82 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.133 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.674 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.08 157.89 15.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.933 0.396 . . . . 0.0 110.928 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 p -56.66 141.66 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.41 -29.38 38.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -72.46 -45.19 60.68 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.514 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.448 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -65.37 -39.07 91.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.75 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -61.56 -58.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.027 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.494 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.71 -38.81 61.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -63.26 -46.21 87.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.244 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.412 ' HB ' HD11 ' A' ' 13' ' ' LEU . 13.1 m -59.97 -42.31 93.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.762 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.63 HG13 ' CH2' ' A' ' 10' ' ' TRP . 60.4 t -65.57 -51.59 61.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.6 -28.5 68.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.749 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 6.0 mpp_? -82.77 -52.32 6.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -67.32 -31.58 71.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 0.0 110.371 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.567 ' CG ' HG22 ' A' ' 32' ' ' VAL . 52.0 t-20 -126.07 76.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.601 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 1.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.196 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -95.45 -13.99 24.12 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.348 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 29' ' ' ASN . 5.1 m -134.05 168.37 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.1 p-80 -129.39 140.36 51.37 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.159 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -105.01 134.77 47.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.373 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.528 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 31.5 mt -102.15 116.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.926 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 41.8 t -83.73 118.95 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.998 0.428 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.845 HD13 ' HB3' ' A' ' 41' ' ' SER . 2.2 pp -143.66 156.67 44.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.118 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.76 160.49 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.222 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 115.7 1.73 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.844 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.76 -6.53 20.2 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.361 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.845 ' HB3' HD13 ' A' ' 37' ' ' LEU . 44.8 t -64.93 178.95 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 88.06 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.445 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.5 ptm -111.42 104.88 13.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 110.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.9 p -67.47 153.72 43.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.069 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -24.94 40.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.508 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.29 139.88 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.467 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 68' ' ' ILE . 48.2 t80 -85.76 128.34 34.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HD3' ' NH1' ' A' ' 51' ' ' ARG . 69.3 mtp180 -145.73 112.68 6.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.511 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.448 ' O ' HG12 ' A' ' 68' ' ' ILE . 33.0 m -59.11 -38.71 80.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 19.3 p-10 -78.36 -0.17 27.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NH1' ' HD3' ' A' ' 48' ' ' ARG . 39.3 ttp180 -128.62 106.37 8.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.17 0.509 . . . . 0.0 111.826 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG13 ' C ' ' A' ' 67' ' ' HIS . 43.2 t -105.92 120.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.618 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.0 m95 -78.39 132.68 37.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.672 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 66' ' ' PRO . 54.6 t -123.4 87.73 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.955 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -79.95 124.1 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.71 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.844 HG23 ' HG3' ' A' ' 38' ' ' LYS . 15.9 m -121.36 162.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -91.97 -170.61 2.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.622 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 15.4 t70 -54.76 -22.7 14.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 22.41 12.18 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.0 56.34 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.626 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.9 t -93.81 138.31 20.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 16' ' ' LYS . 43.7 t -76.31 112.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.143 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -93.34 -33.81 13.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.133 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.52 151.56 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.687 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.833 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.0 t -67.06 104.53 0.64 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HB3' HG22 ' A' ' 54' ' ' VAL . 20.5 Cg_endo -60.32 99.84 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.744 1.629 . . . . 0.0 111.309 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.549 ' C ' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -130.09 150.21 51.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.487 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -46.33 112.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.734 -179.458 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.058 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.4 49.2 m 87.08 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -154.94 73.77 0.89 Allowed 'General case' 0 C--N 1.357 0.919 0 CA-C-N 121.637 2.017 . . . . 0.0 111.042 -161.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 82.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.682 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 18.1 p -85.79 143.68 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 23.1 Cg_exo -63.23 -176.83 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.35 2.033 . . . . 0.0 112.703 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.85 168.81 0.21 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.026 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.3 ttmm -65.64 151.04 47.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -110.8 -14.92 13.92 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -148.99 130.9 15.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.3 m-90 -116.71 67.35 3.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.457 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.884 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.81 -34.41 91.19 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.211 1.941 . . . . 0.0 111.84 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.85 -10.44 20.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.636 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 20.1 mt -81.76 -23.2 36.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 65' ' ' VAL . 43.6 t -55.32 118.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.09 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.86 44.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.608 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.67 -175.4 3.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.514 0.197 . . . . 0.0 110.558 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 p -83.68 142.51 30.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.723 0.297 . . . . 0.0 110.834 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.65 -32.15 38.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.866 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -47.8 67.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.256 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 tpt -64.11 -34.35 77.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.42 -61.0 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.372 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -53.94 -40.14 66.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.02 -44.61 96.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -61.39 -42.35 98.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.798 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.8 t -63.18 -49.04 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.92 -31.42 70.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.489 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 7.4 mtp85 -77.48 -50.74 12.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.17 -37.54 72.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.671 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.6 t-20 -119.44 78.18 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -0.07 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.834 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 17.7 t-20 -94.86 -9.8 33.24 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.637 0.256 . . . . 0.0 111.328 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.671 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.0 m -138.97 168.0 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.176 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 7.2 p-80 -128.23 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.351 0.596 . . . . 0.0 111.942 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.83 131.17 55.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.0 mt -103.16 127.16 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 44.8 t -83.85 121.18 36.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 111.323 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.913 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -146.69 155.71 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.737 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.09 162.22 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.256 0.551 . . . . 0.0 112.061 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 55' ' ' ILE . 1.4 mm-40 -52.73 125.24 16.12 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.206 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.83 -2.91 62.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.867 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.418 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 2.9 t -57.44 134.64 56.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.54 81.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.601 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 28.6 mmt -124.73 130.2 51.95 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.845 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -56.68 152.94 11.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -23.38 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.74 152.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.466 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE2' HG22 ' A' ' 68' ' ' ILE . 51.1 t80 -93.36 133.07 36.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.116 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -149.35 110.67 4.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -59.67 -35.86 75.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.449 ' HA ' HG12 ' A' ' 32' ' ' VAL . 12.2 p-10 -78.6 0.85 24.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 44.8 ttp180 -129.63 129.92 44.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.391 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 67' ' ' HIS . 41.1 t -126.79 118.04 49.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.973 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.913 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.7 m95 -78.7 132.88 37.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 110.229 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.2 t -114.86 83.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.6 mt -79.85 121.99 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.538 0.685 . . . . 0.0 111.466 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.5 m -125.95 165.34 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.291 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -84.19 -175.55 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 38' ' ' LYS . 2.9 t70 -59.58 -18.87 44.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.436 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -89.54 -19.9 24.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.86 20.24 13.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.958 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.5 t -95.68 132.93 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.631 HG21 ' HB2' ' A' ' 21' ' ' ALA . 40.3 t -69.29 111.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.937 0.399 . . . . 0.0 110.38 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 p -90.91 -29.55 17.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.136 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 12.9 m -104.89 148.4 26.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.884 HG13 ' HA ' ' A' ' 11' ' ' PRO . 44.9 t -63.72 106.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.615 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.62 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 35.8 Cg_exo -56.92 98.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.748 1.632 . . . . 0.0 111.538 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.641 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -125.24 166.45 16.46 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.342 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -64.39 107.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.135 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.511 -178.959 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.8 m -66.99 125.38 25.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -147.9 66.19 1.1 Allowed 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.341 -0.849 . . . . 0.0 110.753 -160.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 88.78 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.498 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.0 m -69.3 149.49 97.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -64.28 128.51 21.7 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.854 1.703 . . . . 0.0 111.589 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.66 161.28 28.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.513 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.5 ttmt -59.59 145.36 44.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.697 0.284 . . . . 0.0 110.566 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.24 -15.32 16.67 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.72 132.36 11.36 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.139 -0.35 . . . . 0.0 110.52 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.809 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.0 m-90 -113.52 74.88 2.33 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.264 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.5 Cg_endo -56.06 -40.98 81.52 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.209 1.939 . . . . 0.0 112.417 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -62.82 -6.8 4.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.455 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 ' HG2' ' A' ' 66' ' ' PRO . 14.3 mt -83.36 -20.88 33.45 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.12 116.0 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.701 0.286 . . . . 0.0 110.791 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.41 38.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.407 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.9 tppm? -93.56 161.26 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.507 0.194 . . . . 0.0 110.705 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -62.7 141.84 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.34 -29.35 46.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.427 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.87 -49.74 35.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.371 . . . . 0.0 110.69 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.432 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 10.8 tpt -63.7 -40.97 98.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.02 -54.58 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.991 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -52.18 -44.6 64.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.573 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.66 95.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -59.8 -43.08 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.809 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.3 t -66.72 -52.31 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 8.0 mt-10 -67.11 -24.02 65.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.319 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -84.98 -56.14 3.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.683 0.278 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.49 -31.9 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.143 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 32' ' ' VAL . 53.2 t-20 -125.05 80.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.713 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -4.79 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.1 t-20 -98.72 6.14 47.15 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.629 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 29' ' ' ASN . 5.8 m -138.4 165.95 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.32 . . . . 0.0 111.358 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.753 ' CE1' HD11 ' A' ' 35' ' ' ILE . 2.4 p-80 -128.63 132.84 48.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.346 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.09 127.44 44.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.753 HD11 ' CE1' ' A' ' 33' ' ' HIS . 2.5 mp -104.53 108.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.581 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 11.2 p -78.86 121.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.592 0.71 . . . . 0.0 110.874 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -146.72 155.34 42.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.296 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.672 ' HG3' HG23 ' A' ' 56' ' ' VAL . 9.2 mtmt -89.55 165.76 14.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.305 0.574 . . . . 0.0 112.264 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 122.17 6.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.518 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.97 4.89 62.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.88 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.598 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.7 t -65.73 -173.93 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.89 87.06 6.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.2 ptm -121.13 105.87 11.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.059 0.457 . . . . 0.0 110.481 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -63.52 150.9 42.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.009 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -79.65 -23.5 42.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -45.52 155.0 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.847 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 37.5 t80 -99.41 136.18 39.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.005 0.431 . . . . 0.0 111.385 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -153.0 110.11 3.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.386 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.526 ' O ' HG12 ' A' ' 68' ' ' ILE . 23.5 m -58.37 -38.82 78.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.892 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' HA ' HG12 ' A' ' 32' ' ' VAL . 18.6 p-10 -79.25 5.55 12.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.33 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -127.25 131.48 50.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.982 0.42 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 68' ' ' ILE . 59.8 t -134.23 117.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.582 ' CE3' HD21 ' A' ' 37' ' ' LEU . 5.0 m95 -78.77 140.34 38.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 110.614 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 64.5 t -128.05 87.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mt -79.62 128.92 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.152 0.501 . . . . 0.0 111.645 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG23 ' HG3' ' A' ' 38' ' ' LYS . 31.2 m -126.92 164.21 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -84.72 -171.49 3.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.029 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 -9.2 12.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.941 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -5.67 20.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.63 20.17 38.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.365 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.5 t -97.35 132.36 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 56' ' ' VAL . 60.0 t -66.43 110.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.781 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -87.87 -35.73 17.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.1 m -105.65 156.56 18.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 111.377 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.8 t -66.82 128.18 93.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.437 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 13' ' ' LEU . 15.6 Cg_endo -86.34 96.34 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.431 2.087 . . . . 0.0 110.766 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -128.54 153.15 47.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.19 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -44.11 103.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.159 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.504 -179.328 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 t -64.85 121.8 15.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -158.38 75.3 0.73 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.728 -163.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.4 94.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.4 m -138.43 146.44 51.15 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.22 155.82 11.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.172 1.915 . . . . 0.0 112.092 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.27 -168.82 44.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.59 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.633 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 1.7 ttmp? -88.42 154.9 20.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.284 . . . . 0.0 110.763 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -114.57 -2.05 13.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -157.61 130.51 7.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.633 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.2 m-90 -119.49 74.16 16.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.55 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.81 ' HA ' HG13 ' A' ' 65' ' ' VAL . 40.6 Cg_exo -55.7 -39.3 91.93 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.219 1.946 . . . . 0.0 111.986 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -62.01 -9.68 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.193 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 21' ' ' ALA . 42.4 mt -83.97 -23.67 30.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.797 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.513 HG21 HG22 ' A' ' 65' ' ' VAL . 41.0 t -58.26 111.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -7.63 29.44 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.177 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.95 166.01 11.48 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.532 0.206 . . . . 0.0 110.621 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -63.62 142.7 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.31 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.12 42.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.844 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -68.97 -42.18 76.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -65.68 -35.22 80.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.906 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -64.46 -60.1 3.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 36' ' ' VAL . . . -49.33 -50.17 40.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.11 86.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.426 ' CB ' HD21 ' A' ' 13' ' ' LEU . 94.6 m -60.11 -43.4 95.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.767 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.615 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.6 t -67.86 -51.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.23 -29.07 69.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -81.5 -57.19 3.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.53 -30.83 71.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.775 ' CG ' HG22 ' A' ' 32' ' ' VAL . 46.7 t-20 -127.11 78.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.276 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -64.62 1.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.965 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -98.36 -5.35 32.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.573 0.225 . . . . 0.0 111.482 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.775 HG22 ' CG ' ' A' ' 29' ' ' ASN . 17.9 m -148.69 166.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.422 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 1.4 p80 -129.47 152.91 48.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 111.361 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -112.3 147.93 35.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.34 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' A' ' 51' ' ' ARG . 2.5 mp -112.6 114.35 46.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.791 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 54' ' ' VAL . 57.5 t -83.25 111.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 111.345 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.669 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -135.27 154.72 51.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.535 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -85.54 157.2 20.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 0.0 111.527 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 113.61 1.18 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.718 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.79 -9.4 11.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.162 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.5 t -66.01 -174.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 97.67 11.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.119 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.635 ' CE ' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -124.83 103.69 8.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.56 160.09 23.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.27 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -87.84 -23.36 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.51 140.39 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.059 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.6 t80 -84.06 131.03 34.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.181 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -146.48 110.92 5.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.49 ' O ' HG12 ' A' ' 68' ' ' ILE . 98.3 m -59.05 -38.22 78.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.287 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 11.6 p-10 -78.8 -6.14 55.22 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.395 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HG3' HD11 ' A' ' 35' ' ' ILE . 41.3 ttp180 -119.21 105.96 11.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.989 0.424 . . . . 0.0 111.694 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 62.0 t -106.65 119.26 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.669 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.37 136.8 37.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 -178.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 36' ' ' VAL . 49.0 t -127.64 84.0 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.051 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 43' ' ' MET . 4.2 mt -79.67 121.52 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.071 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.0 m -119.91 161.3 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.999 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -80.0 -171.48 2.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.272 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -20.47 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.612 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.73 -7.36 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.43 23.86 27.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.936 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.7 t -96.57 134.21 35.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.852 HG21 ' HB2' ' A' ' 21' ' ' ALA . 42.8 t -67.77 104.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.017 0.437 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -88.04 -34.74 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.17 157.27 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.922 0.392 . . . . 0.0 111.502 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.3 t -71.84 106.24 1.88 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.639 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 36.2 Cg_exo -58.06 103.39 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.688 1.592 . . . . 0.0 110.84 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -136.78 143.63 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.332 0.587 . . . . 0.0 111.474 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -41.81 107.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.685 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.083 -179.119 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.326 60.5 p 71.09 -61.49 0.48 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.69 61.84 0.67 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 110.822 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.64 95.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.1 m -97.78 158.37 33.06 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 93.9 Cg_exo -43.61 133.05 7.5 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.548 2.166 . . . . 0.0 112.848 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 88.38 154.76 28.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.721 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.1 ttmm -49.54 146.04 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 111.205 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -103.46 -16.72 15.49 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 7' ' ' LYS . . . -146.96 149.99 34.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.833 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.8 m-90 -134.56 67.64 71.71 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.229 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.853 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.7 Cg_endo -55.91 -33.08 87.77 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.101 1.867 . . . . 0.0 111.439 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.24 -12.48 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.666 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.4 mt -82.21 -20.3 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.883 HG21 HG22 ' A' ' 65' ' ' VAL . 38.2 t -61.91 111.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.15 -2.99 29.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.64 177.09 4.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -72.29 135.58 46.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.563 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.23 -30.51 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.038 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -70.94 -47.25 60.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.876 0.37 . . . . 0.0 110.399 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.4 tpt -63.18 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.783 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.54 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.577 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.01 -39.59 59.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.36 90.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.7 m -60.0 -42.54 94.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.833 HG13 ' CH2' ' A' ' 10' ' ' TRP . 19.0 t -64.41 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.01 -29.68 70.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.334 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -76.44 -54.35 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.37 -40.71 85.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.776 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.641 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.8 t-20 -115.44 80.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -64.96 -5.52 6.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.796 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 -0.66 56.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.548 0.213 . . . . 0.0 111.262 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.641 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.3 m -139.09 171.78 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -136.46 137.81 40.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.83 133.2 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.761 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 45.1 mt -102.14 119.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.439 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG22 HG11 ' A' ' 54' ' ' VAL . 63.1 t -87.12 115.83 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.286 0.565 . . . . 0.0 111.275 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.873 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -138.82 156.14 47.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.899 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 151.64 21.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.278 0.561 . . . . 0.0 111.781 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.37 113.93 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.183 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.1 23.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -72.76 -164.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.98 99.1 12.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.91 96.9 5.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 111.422 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.48 155.96 39.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.428 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -87.15 -24.97 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.274 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.84 141.06 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -88.53 125.67 34.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.29 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.5 mtm180 -145.33 111.03 5.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.236 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.504 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 73.9 m -60.49 -32.78 71.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.637 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -78.94 -4.56 50.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.408 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 54.9 ttp180 -120.73 124.26 44.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.435 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 25' ' ' VAL . 69.8 t -123.54 119.39 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.398 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.873 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.1 m95 -78.71 131.35 36.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.841 0.353 . . . . 0.0 111.177 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.545 HG12 ' O ' ' A' ' 54' ' ' VAL . 5.5 t -122.88 91.95 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -85.72 125.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.685 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.8 m -125.16 164.79 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.492 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -89.94 -177.17 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.91 -20.76 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.316 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -88.49 -22.2 23.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.162 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.1 22.26 9.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.206 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 36.8 t -98.19 144.67 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 21' ' ' ALA . 47.6 t -75.28 110.85 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -91.53 -33.68 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.569 ' CB ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -101.96 148.46 25.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.883 HG22 HG21 ' A' ' 14' ' ' VAL . 47.8 t -67.64 108.47 2.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.214 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.3 Cg_exo -62.73 117.55 4.44 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.138 1.892 . . . . 0.0 111.471 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -151.8 143.89 23.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.98 0.419 . . . . 0.0 110.792 -179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' CG2' ' HA ' ' A' ' 49' ' ' CYS . 1.6 mt -40.3 122.69 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.048 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.577 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.134 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.6 t 68.53 110.0 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.47 77.87 0.71 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 119.793 -1.817 . . . . 0.0 110.721 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 46.82 83.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.9 t -112.86 128.44 25.59 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.524 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 22.1 Cg_exo -64.24 160.83 36.74 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.858 1.705 . . . . 0.0 111.76 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 54.98 174.5 0.1 OUTLIER Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.531 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 32.2 ttmt -59.0 154.12 16.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.727 0.299 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.585 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -108.1 -20.4 13.17 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -147.71 127.04 13.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.693 ' CH2' HG13 ' A' ' 25' ' ' VAL . 22.7 m-90 -108.65 74.14 0.53 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.851 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.35 -37.06 92.68 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.047 1.831 . . . . 0.0 111.819 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -63.34 -9.59 12.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.865 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 21' ' ' ALA . 13.4 mt -80.88 -24.38 38.34 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.515 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 40.3 t -55.68 112.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.955 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -6.99 24.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.407 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.734 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 mmtp -102.69 160.38 14.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.287 . . . . 0.0 110.497 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.0 p -56.81 135.81 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.923 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -46.45 -30.61 4.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.171 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -44.77 64.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.827 0.346 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -32.46 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.032 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.762 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -68.04 -60.09 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.28 -39.73 67.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.755 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -64.12 -44.92 90.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.637 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.1 m -59.27 -41.0 87.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 52' ' ' VAL . 60.2 t -65.11 -57.58 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.107 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.17 -24.17 67.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 19.8 ttm-85 -80.77 -58.18 3.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.351 . . . . 0.0 110.819 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.05 -37.17 86.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.105 0.479 . . . . 0.0 110.377 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.464 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -121.16 78.22 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -0.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.22 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.29 -11.64 32.01 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.349 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' CG ' ' A' ' 29' ' ' ASN . 14.0 m -122.67 171.0 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -130.85 133.38 45.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.016 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 135.11 47.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.574 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 33' ' ' HIS . 28.7 mt -104.03 122.81 57.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.567 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 22' ' ' ALA . 60.0 t -91.3 123.02 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.722 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -150.6 158.6 44.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.478 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -89.0 159.76 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.098 0.475 . . . . 0.0 111.499 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.77 122.31 5.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.323 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.78 -8.82 43.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.933 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 32.8 t -68.69 -166.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.354 . . . . 0.0 111.123 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' CH2' ' A' ' 53' ' ' TRP . . . -71.14 93.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.543 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 1.5 ttp -121.18 99.12 6.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.48 151.52 20.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.356 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -79.82 -26.72 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.05 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.99 142.38 2.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -88.05 129.5 35.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.716 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.3 mtp180 -144.72 108.6 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.236 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -56.12 -43.21 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.282 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -79.48 3.57 18.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 40.4 ttp180 -126.65 115.71 19.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 25' ' ' VAL . 57.3 t -116.42 122.47 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.249 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.722 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.2 m95 -78.69 125.54 29.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.212 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.32 85.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mp -83.27 127.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.154 0.502 . . . . 0.0 111.73 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.8 m -124.9 163.72 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.242 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -83.55 -178.75 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.54 -22.0 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.855 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -24.43 21.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.335 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.78 22.23 7.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.318 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.0 t -99.02 140.47 18.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.4 t -70.71 112.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.098 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.9 p -94.66 -32.8 13.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.176 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 39.5 t -103.79 151.74 22.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.499 . . . . 0.0 111.543 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.5 t -64.47 114.85 15.83 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.142 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.554 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 5.3 Cg_exo -75.41 88.18 1.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.904 1.736 . . . . 0.0 111.451 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 18.0 p-80 -121.8 144.04 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.118 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -38.28 116.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.069 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.768 -179.068 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.107 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.291 50.9 m 76.1 120.05 0.05 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -113.85 59.28 0.67 Allowed 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.896 -1.128 . . . . 0.0 110.653 162.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 81.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.174 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -102.44 137.92 19.53 Favored Pre-proline 0 CA--C 1.517 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 30.6 Cg_exo -61.11 157.99 36.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.055 1.837 . . . . 0.0 112.57 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.05 168.96 3.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.391 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.64 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 2.8 ttmp? -55.64 149.78 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -103.73 -16.67 15.38 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -154.39 138.15 16.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.719 ' CH2' HG13 ' A' ' 25' ' ' VAL . 19.9 m-90 -120.49 71.06 17.8 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.84 0.352 . . . . 0.0 111.276 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -54.78 -37.81 92.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.328 2.019 . . . . 0.0 112.003 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -62.19 -9.15 6.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.156 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.1 mt -81.13 -24.21 37.8 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.769 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 65' ' ' VAL . 48.3 t -57.93 110.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.25 15.76 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.404 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -103.91 179.39 4.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.632 0.253 . . . . 0.0 110.625 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -76.04 143.23 41.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.664 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.71 -33.57 12.91 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.009 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.08 -36.92 66.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.987 0.422 . . . . 0.0 110.161 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -39.65 84.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.791 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.66 -58.85 4.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.504 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.66 -41.97 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.08 -45.45 94.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.95 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.444 ' CB ' HD21 ' A' ' 13' ' ' LEU . 39.9 m -61.3 -41.09 96.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' CH2' ' A' ' 10' ' ' TRP . 46.9 t -66.64 -54.96 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 33' ' ' HIS . 9.0 mt-10 -65.6 -23.88 66.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 10.0 ttm-85 -83.61 -53.01 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.824 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.67 -36.95 81.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.661 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.747 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -118.73 79.48 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.702 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -2.65 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.093 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.03 -13.9 28.05 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.695 0.283 . . . . 0.0 111.47 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.747 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.8 m -140.67 164.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.986 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.488 ' HA ' ' HG3' ' A' ' 26' ' ' GLU . 0.0 OUTLIER -132.79 163.51 28.89 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.911 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB1' HG23 ' A' ' 54' ' ' VAL . . . -117.11 140.94 48.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.063 0.459 . . . . 0.0 111.935 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 28.6 mt -99.58 111.59 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.39 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.3 p -81.33 125.68 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 0.0 111.819 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 41' ' ' SER . 0.5 OUTLIER -155.88 160.1 39.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.195 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -89.69 155.04 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 111.627 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -47.91 115.95 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.396 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.78 -7.5 21.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.621 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.658 ' HB3' HD13 ' A' ' 37' ' ' LEU . 32.4 t -70.46 -162.38 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.91 96.88 5.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.0 110.743 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.593 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 10.1 tmm? -119.42 96.14 5.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.91 154.76 24.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.251 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -84.53 -27.93 27.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.67 130.78 5.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 68' ' ' ILE . 88.9 t80 -80.71 134.56 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.072 0.463 . . . . 0.0 111.8 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 10.4 mtp180 -152.61 109.83 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' O ' HG11 ' A' ' 32' ' ' VAL . 6.7 m -61.33 -30.36 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.09 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.459 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 17.7 p-10 -79.06 -8.25 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.637 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 39.6 ttp180 -122.26 119.2 30.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.042 0.449 . . . . 0.0 111.699 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 66.4 t -114.93 122.2 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.613 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -78.58 129.46 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.5 t -120.56 92.79 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 37' ' ' LEU . 7.3 mm -85.15 129.67 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.257 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 62' ' ' VAL . 26.4 m -129.09 164.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -86.0 -168.95 2.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.78 -18.7 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.64 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.02 4.69 51.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.31 24.76 65.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.222 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 23.3 t -97.54 131.47 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 21' ' ' ALA . 49.0 t -66.37 106.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.788 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.7 p -93.52 -29.46 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.03 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -103.94 151.14 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 11' ' ' PRO . 8.0 t -66.27 118.91 57.76 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.341 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 13' ' ' LEU . 89.7 Cg_endo -81.73 99.57 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.171 1.914 . . . . 0.0 111.351 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 7.8 p-80 -133.21 147.23 52.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.499 ' HA ' HG22 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -36.63 116.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.678 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.571 -179.872 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.5 p -86.44 87.17 7.38 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 64.14 0.6 Allowed 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.342 -1.473 . . . . 0.0 110.836 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -140.34 92.3 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -117.12 131.3 24.06 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.525 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 15.8 Cg_exo -66.81 62.57 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.118 1.879 . . . . 0.0 112.014 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . 155.07 176.85 27.74 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.075 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 tttp -59.99 156.08 15.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.921 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.906 ' HA ' HD12 ' A' ' 68' ' ' ILE . 14.9 m-80 -113.77 -16.36 12.29 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.34 12.15 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.1 m-90 -108.0 73.95 0.46 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.881 0.372 . . . . 0.0 111.553 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.824 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -59.9 -35.11 94.71 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.281 1.987 . . . . 0.0 111.528 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -64.34 -12.52 43.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.47 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' HA ' ' A' ' 21' ' ' ALA . 23.4 mt -82.01 -22.41 36.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.421 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.539 HG21 HG22 ' A' ' 65' ' ' VAL . 40.5 t -55.23 114.99 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 110.619 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.52 -13.11 33.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.245 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -92.72 160.08 15.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.708 0.29 . . . . 0.0 110.59 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -60.73 140.79 57.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.77 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.87 -32.08 8.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.153 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -71.37 -45.26 63.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -38.83 92.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.881 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.26 -58.95 5.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.465 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -52.19 -39.22 59.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.66 -45.46 90.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.713 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.554 ' CB ' HD21 ' A' ' 13' ' ' LEU . 10.9 m -60.29 -41.21 92.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 26.4 t -67.32 -51.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.03 -26.99 67.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.678 0.275 . . . . 0.0 111.155 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -81.02 -56.33 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.39 -36.46 84.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.58 79.59 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -61.17 -5.62 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.231 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.427 ' ND2' ' HG2' ' A' ' 5' ' ' PRO . 21.7 t-20 -88.69 -1.59 58.15 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.242 -0.286 . . . . 0.0 111.734 -179.785 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -140.71 170.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.469 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.435 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.7 OUTLIER -135.89 140.89 44.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -104.83 141.07 37.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.634 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.435 HD11 ' CE1' ' A' ' 33' ' ' HIS . 3.9 mt -114.83 123.09 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.639 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.7 t -79.82 123.49 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.689 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -141.49 149.6 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.789 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 155.5 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 0.0 111.55 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 55' ' ' ILE . 15.3 mt-10 -48.83 115.87 1.42 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.153 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 1.57 37.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.526 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 t -65.77 178.93 0.94 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.993 0.425 . . . . 0.0 110.599 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.07 92.73 9.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.893 ' HE1' HG12 ' A' ' 55' ' ' ILE . 2.0 ptp -112.82 105.08 13.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.979 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.66 152.07 9.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.749 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.63 -27.04 27.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.089 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.2 142.42 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.99 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.527 ' CE1' HG22 ' A' ' 68' ' ' ILE . 77.3 t80 -86.9 134.21 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 78.3 mtp180 -148.46 113.88 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -58.87 -41.07 86.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -79.43 2.73 20.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.0 ttp180 -125.56 113.49 17.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.976 0.417 . . . . 0.0 111.45 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.3 t -117.15 119.34 61.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.933 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.689 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 37.8 t -120.42 87.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.032 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.893 HG12 ' HE1' ' A' ' 43' ' ' MET . 4.3 mt -79.92 122.63 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.335 0.588 . . . . 0.0 111.836 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.0 m -122.44 163.77 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.254 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -88.99 -168.27 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.21 -17.63 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -97.8 9.85 41.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.29 22.54 77.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.311 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 44.5 t -97.98 137.61 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 66' ' ' PRO . 58.2 t -75.58 116.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' THR . . . . . 0.579 HG21 ' OE2' ' A' ' 39' ' ' GLU . 63.2 p -95.37 -28.57 14.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.48 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 17.7 m -102.72 148.83 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.304 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 11' ' ' PRO . 23.3 t -64.18 106.84 1.05 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.37 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.584 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 24.0 Cg_exo -59.42 99.04 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 121.952 1.768 . . . . 0.0 111.744 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -124.19 156.74 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.293 0.568 . . . . 0.0 111.025 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.2 114.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.634 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.895 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.023 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 t 53.6 58.5 5.1 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.21 78.5 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 127.233 2.213 . . . . 0.0 110.579 -173.471 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 105.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -120.92 119.17 30.05 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.836 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 8.1 Cg_exo -70.35 163.24 39.47 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.978 1.785 . . . . 0.0 111.732 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.24 173.07 0.79 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.584 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 7.1 ttmt -57.26 143.27 40.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -99.22 -26.36 14.21 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -142.38 130.64 22.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.843 0.354 . . . . 0.0 110.082 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.684 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 30.1 m-90 -110.86 73.11 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.255 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.855 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -59.89 -35.57 93.3 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.363 2.042 . . . . 0.0 111.676 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -63.01 -11.84 21.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.519 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' A' ' 21' ' ' ALA . 35.9 mt -83.69 -22.69 31.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.761 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG21 HG22 ' A' ' 65' ' ' VAL . 43.4 t -56.72 114.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.82 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.98 -11.16 29.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.373 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -97.39 161.05 13.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.288 . . . . 0.0 110.71 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -58.72 142.24 50.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -50.87 -31.89 25.22 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.187 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -47.13 63.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -34.49 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.118 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.27 -60.27 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.768 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -51.55 -42.23 61.68 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.156 0.503 . . . . 0.0 110.095 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -58.59 -48.11 82.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.288 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.615 ' CB ' HD21 ' A' ' 13' ' ' LEU . 13.4 m -59.84 -41.56 91.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG13 ' CH2' ' A' ' 10' ' ' TRP . 59.7 t -65.72 -57.09 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.78 0.324 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.47 -22.58 67.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.721 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.71 -55.5 3.95 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.116 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.44 -33.14 75.26 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.443 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.41 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.8 t-20 -127.41 76.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.309 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -2.64 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.096 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -90.64 -1.45 57.87 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' CG ' ' A' ' 29' ' ' ASN . 13.3 m -141.39 169.38 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -132.79 142.6 49.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.385 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -107.4 136.91 46.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 111.966 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 51' ' ' ARG . 19.3 mt -101.93 108.99 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.647 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.5 t -79.85 120.95 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.185 0.517 . . . . 0.0 110.659 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -148.76 159.29 44.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -89.96 161.93 15.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.262 0.553 . . . . 0.0 111.815 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.19 123.49 6.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.527 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.8 -7.35 55.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.985 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 47.9 t -66.44 -167.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -71.9 94.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.096 0.474 . . . . 0.0 110.236 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.526 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -123.04 91.98 3.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.385 0.612 . . . . 0.0 111.533 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -81.5 151.98 27.54 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -79.81 -25.0 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.48 159.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.9 t80 -104.54 132.97 50.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.0 111.596 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 28.0 mtp85 -147.28 110.9 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.838 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.1 t -56.35 -47.5 78.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.198 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -79.22 3.53 17.57 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.818 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.1 ttp180 -122.22 110.29 15.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 68' ' ' ILE . 86.9 t -111.91 121.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.21 128.9 34.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.31 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.3 t -121.88 80.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.838 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.1 mt -80.08 127.63 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.237 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.9 m -124.09 159.96 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -84.82 -171.39 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.54 -20.63 48.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -95.98 12.76 29.26 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.58 23.9 72.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.967 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.6 t -96.89 137.58 24.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 66' ' ' PRO . 44.3 t -75.84 114.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.089 0.471 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -94.55 -34.6 12.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.981 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -94.42 142.26 27.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -61.87 103.59 0.4 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 31.6 Cg_exo -54.47 95.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.603 1.535 . . . . 0.0 111.385 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -128.13 143.25 51.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.119 0.485 . . . . 0.0 110.934 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.612 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -44.23 109.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.663 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.703 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.6 p -56.72 109.51 0.64 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.2 68.16 0.08 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 121.331 -0.856 . . . . 0.0 110.842 -167.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -143.52 78.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.268 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.9 p -84.94 151.78 58.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.7 -174.85 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.309 2.006 . . . . 0.0 112.231 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.15 -179.24 7.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.36 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.9 ttmt -77.93 151.11 33.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.614 0.245 . . . . 0.0 110.598 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -109.88 -13.07 14.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.9 128.89 11.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.891 0.376 . . . . 0.0 110.056 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.843 ' CH2' HG13 ' A' ' 25' ' ' VAL . 31.0 m-90 -114.82 70.06 2.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.4 Cg_endo -58.7 -34.11 98.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.164 1.91 . . . . 0.0 111.617 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.48 -12.93 35.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.414 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.7 mt -81.67 -22.64 37.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.708 0.289 . . . . 0.0 110.506 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 65' ' ' VAL . 46.9 t -56.95 113.46 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -10.99 29.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.321 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 171.74 8.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.643 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 p -68.4 142.53 55.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.912 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.28 -31.67 35.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.035 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -71.08 -46.22 62.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.309 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.14 -35.46 78.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.812 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.28 -63.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.219 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -50.57 -35.9 32.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.694 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.11 -46.28 78.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.271 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 13' ' ' LEU . 35.0 m -59.88 -41.37 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 10' ' ' TRP . 17.2 t -66.44 -50.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.73 0.3 . . . . 0.0 111.329 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.44 -31.7 72.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.506 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.25 -51.04 10.0 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.813 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.19 -37.81 81.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.582 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.1 t-20 -119.55 80.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.121 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -5.86 2.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -96.45 6.53 48.55 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.582 HG22 ' CG ' ' A' ' 29' ' ' ASN . 10.8 m -144.71 169.21 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.338 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.936 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -131.78 138.14 48.45 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.096 0.474 . . . . 0.0 110.852 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.16 131.98 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.936 HD11 ' CE1' ' A' ' 33' ' ' HIS . 3.6 mp -107.04 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.991 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 47.8 t -80.37 119.59 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 111.257 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.765 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -147.79 153.21 38.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.254 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 157.12 19.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 111.786 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 55' ' ' ILE . 4.0 pt-20 -50.86 118.1 2.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -7.11 31.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -61.43 -178.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.82 92.79 9.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.126 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.23 121.04 31.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.241 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.01 156.56 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -24.79 24.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -48.41 141.51 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 68' ' ' ILE . 28.9 t80 -83.26 133.77 34.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 11.2 mtm180 -146.12 114.32 6.63 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.794 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -60.07 -37.83 81.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.402 ' HA ' HG12 ' A' ' 32' ' ' VAL . 12.2 p-10 -79.79 1.51 26.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.468 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 41.4 ttp180 -126.77 129.63 48.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.966 0.412 . . . . 0.0 111.429 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 25' ' ' VAL . 44.8 t -128.7 112.77 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.765 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.43 133.73 37.45 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 109.995 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.4 t -119.11 90.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.799 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 64' ' ' SER . 1.8 mp -79.68 119.57 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.4 m -116.51 161.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.4 -174.09 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.41 -22.07 52.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.593 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -17.14 29.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.23 22.42 13.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.928 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.3 t -99.6 143.97 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' A' ' 21' ' ' ALA . 33.5 t -73.75 115.84 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 0.0 111.023 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 p -95.7 -31.99 12.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 p -105.56 159.03 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -68.07 104.56 0.71 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.825 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 32.3 Cg_exo -59.05 100.3 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.867 1.711 . . . . 0.0 111.233 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -130.03 152.56 49.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.262 0.553 . . . . 0.0 111.099 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -47.71 109.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.644 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.656 -179.114 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.016 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.8 p 70.01 166.51 0.28 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -106.69 60.86 0.63 Allowed 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.29 -1.506 . . . . 0.0 110.733 155.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.28 97.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 94.4 m -115.22 137.87 23.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.952 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HG2' ' CB ' ' A' ' 31' ' ' ASN . 97.2 Cg_endo -80.06 168.34 18.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.121 1.881 . . . . 0.0 112.658 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.2 157.75 1.47 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.762 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.6 ttmm -50.85 147.46 4.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.658 0.266 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -111.19 -1.53 16.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.02 132.37 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.877 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.9 m-90 -119.45 72.13 13.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.885 0.374 . . . . 0.0 111.534 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.915 ' HA ' HG13 ' A' ' 65' ' ' VAL . 15.2 Cg_endo -57.34 -35.71 98.88 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.166 1.91 . . . . 0.0 111.694 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.93 -10.42 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 16.7 mt -80.35 -22.85 40.98 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.338 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 65' ' ' VAL . 38.8 t -58.67 112.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.23 22.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -102.88 -174.64 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.623 0.249 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 p -83.03 140.32 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -49.63 -29.88 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.14 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.66 -47.9 51.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.427 ' HA ' ' HE2' ' A' ' 20' ' ' MET . 0.0 OUTLIER -64.81 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.57 -62.2 1.53 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.29 -35.93 63.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.037 0.446 . . . . 0.0 110.452 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.5 -45.35 79.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.403 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.3 m -59.41 -40.61 87.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.877 HG13 ' CH2' ' A' ' 10' ' ' TRP . 13.7 t -66.39 -56.2 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.73 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.608 0.242 . . . . 0.0 111.331 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 30.2 ttp180 -80.75 -57.39 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.775 0.321 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.14 -33.13 75.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.444 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' OD1' HG13 ' A' ' 32' ' ' VAL . 44.7 t-20 -125.62 79.71 1.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -0.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.309 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . 27.5 t-20 -100.37 0.18 39.45 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.607 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 68' ' ' ILE . 10.1 m -129.27 167.98 23.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.47 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.464 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -131.59 124.63 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.41 137.91 38.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 33' ' ' HIS . 27.7 mt -110.12 119.25 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 68.1 t -83.29 116.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.566 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.78 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -135.31 154.21 51.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.374 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.53 19.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.231 0.539 . . . . 0.0 111.779 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -45.76 117.89 1.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.476 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 1.09 41.34 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.863 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 34.4 t -67.61 -167.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 101.08 13.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.94 99.8 6.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 111.638 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -74.47 155.7 37.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.071 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.045 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.18 141.52 1.76 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.5 t80 -90.02 133.97 34.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 111.813 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -152.64 111.98 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.273 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.499 ' O ' HG12 ' A' ' 68' ' ' ILE . 73.8 m -58.86 -37.11 75.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.582 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -79.77 -1.42 38.62 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -122.99 108.67 13.19 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.984 0.421 . . . . 0.0 111.57 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 68' ' ' ILE . 94.4 t -111.88 120.04 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.828 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.78 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.5 m95 -78.63 125.24 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.429 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.2 88.13 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 23.0 mt -80.1 125.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.267 0.556 . . . . 0.0 111.827 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.4 m -124.56 164.6 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.461 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -84.57 -177.11 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -54.6 -25.44 26.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.787 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -88.38 -22.66 23.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.618 0.246 . . . . 0.0 111.358 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.08 22.67 7.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.232 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 58.3 t -96.14 135.41 30.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' A' ' 21' ' ' ALA . 61.5 t -70.18 112.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.911 0.386 . . . . 0.0 110.811 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.5 p -97.1 -30.33 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.547 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -100.85 147.64 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.136 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.9 t -64.7 103.46 0.43 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 64' ' ' SER . 39.8 Cg_endo -64.76 108.54 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.116 1.877 . . . . 0.0 111.543 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -137.95 148.7 45.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.173 0.511 . . . . 0.0 111.346 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.752 HD11 HG11 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.28 113.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.61 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.808 -179.224 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 t -77.22 155.78 31.94 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 52.86 60.08 4.03 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.1 2.16 . . . . 0.0 111.221 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -161.54 98.99 1.14 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.295 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 13.8 m -112.67 148.26 38.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.065 0.46 . . . . 0.0 111.403 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 31.9 Cg_exo -57.45 153.66 39.98 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.588 2.192 . . . . 0.0 113.161 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 80.42 170.07 41.28 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.92 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.2 ttmm -67.52 157.47 34.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.674 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -115.37 -9.92 12.09 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -152.69 129.13 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.621 0.248 . . . . 0.0 110.607 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.831 ' CH2' HG13 ' A' ' 25' ' ' VAL . 26.7 m-90 -115.48 72.85 3.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.767 0.318 . . . . 0.0 111.479 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.892 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.15 -34.53 94.21 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.166 1.91 . . . . 0.0 111.506 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -64.5 -12.05 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.684 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.6 mt -81.94 -20.36 38.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 11' ' ' PRO . 47.2 t -55.44 114.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.43 -9.92 33.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.286 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -95.6 157.1 16.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.751 0.31 . . . . 0.0 110.502 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 p -59.37 141.28 54.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.51 -30.27 19.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.32 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.02 -53.15 15.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -37.11 82.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.359 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.14 -56.68 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.414 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.31 -36.64 63.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.336 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.19 88.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.316 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.0 m -59.72 -44.11 93.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.644 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.831 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.5 t -65.09 -51.99 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 33' ' ' HIS . 2.5 mt-10 -64.53 -30.06 71.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.668 0.27 . . . . 0.0 111.449 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -79.5 -55.2 5.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -64.54 -34.59 78.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.554 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.4 t-20 -124.77 80.02 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.744 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -65.16 -5.71 7.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.559 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -89.85 -2.05 58.12 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 68' ' ' ILE . 4.5 m -137.52 171.23 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.573 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -134.2 136.03 43.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.352 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.65 125.45 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.611 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.889 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 3.1 mp -94.22 143.12 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.782 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 72.6 t -99.63 114.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.646 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -142.19 144.91 33.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.986 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 153.31 24.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.337 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 107.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 -10.19 6.05 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -67.58 160.21 28.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.362 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.72 7.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.468 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.513 ' HG2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -120.55 139.45 52.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.83 0.347 . . . . 0.0 111.008 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.26 161.07 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -96.78 -24.15 16.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -41.88 163.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.333 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -102.23 130.59 48.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 20.9 mtp180 -145.96 113.22 6.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.56 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 68' ' ' ILE . 43.0 m -58.45 -39.83 80.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.618 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.7 p-10 -79.52 2.68 21.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD11 ' A' ' 35' ' ' ILE . 43.1 ttp180 -124.92 119.14 27.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.954 0.407 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 25' ' ' VAL . 48.6 t -122.02 116.39 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -78.82 124.29 28.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 110.73 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 42.2 t -106.07 87.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.65 ' H ' HD12 ' A' ' 55' ' ' ILE . 4.1 mp -80.15 114.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.8 m -119.26 165.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.507 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -85.34 -173.48 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.71 -21.69 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -89.63 -13.0 38.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.535 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.83 24.91 16.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.083 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 22.0 t -101.16 134.9 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 66' ' ' PRO . 91.1 t -68.27 107.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 110.539 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.7 p -90.05 -32.85 16.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.863 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -104.01 152.99 21.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 11' ' ' PRO . 25.6 t -64.89 106.47 1.01 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.441 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HG3' HG11 ' A' ' 62' ' ' VAL . 17.3 Cg_exo -60.81 90.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.825 1.683 . . . . 0.0 111.394 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -121.0 146.82 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 111.468 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -45.77 117.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.673 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.04 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.4 m 44.28 55.65 5.42 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 118.327 2.714 . . . . 0.0 118.327 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.64 81.9 0.07 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.15 2.18 . . . . 0.0 111.381 -174.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.19 94.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.342 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.3 m -115.12 153.19 47.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.18 160.02 14.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.685 2.257 . . . . 0.0 112.928 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 66.67 172.71 5.14 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.666 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.1 ttmt -67.85 145.59 54.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.705 0.288 . . . . 0.0 110.521 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' HD12 ' A' ' 68' ' ' ILE . 15.4 m-20 -105.5 -5.81 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.81 128.31 4.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.689 0.281 . . . . 0.0 110.367 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.776 ' CH2' HG13 ' A' ' 25' ' ' VAL . 25.3 m-90 -112.62 69.89 1.09 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.44 -37.33 94.93 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.011 1.807 . . . . 0.0 111.938 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -65.05 -5.99 7.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 28.4 mt -84.44 -18.95 34.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.661 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.64 113.56 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.571 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.16 19.86 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.386 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.49 156.36 17.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.583 0.23 . . . . 0.0 110.661 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 7.6 p -56.8 145.73 28.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 111.43 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -53.76 -32.35 47.45 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.204 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.82 -47.14 66.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -44.13 97.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.271 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.25 -52.64 64.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.19 65.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.39 93.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.32 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.416 HG21 HD21 ' A' ' 13' ' ' LEU . 39.7 m -61.77 -43.46 98.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.596 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.776 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.5 t -66.9 -48.45 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.192 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.21 -31.05 71.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.395 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -81.62 -53.39 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.022 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -65.17 -33.22 75.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.66 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' CG ' ' HA3' ' A' ' 6' ' ' GLY . 55.6 t-20 -127.99 81.28 2.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 30' ' ' ARG . 1.1 ptm180 -63.3 -8.39 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.432 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -87.16 -1.32 57.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.605 0.241 . . . . 0.0 111.587 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 3.9 m -140.07 173.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -134.06 136.5 44.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 179.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.5 125.76 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.116 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.63 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 15.4 mt -98.28 111.29 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.571 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.662 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.7 p -79.67 125.29 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.565 0.698 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.96 148.86 22.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.023 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.75 158.14 17.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 111.807 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.17 123.69 4.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.201 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.41 -11.98 33.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 42.4 t -68.27 -166.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.881 0.372 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 100.0 12.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.191 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.21 96.58 4.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.265 0.555 . . . . 0.0 111.328 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.49 150.17 48.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.227 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.31 -25.06 31.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.31 141.13 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -84.78 132.25 34.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.266 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.05 109.38 4.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 55.5 m -59.61 -34.15 72.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.712 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 9.9 p-10 -79.12 -3.31 44.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.785 -179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -123.66 135.13 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.13 117.25 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.585 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.679 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.67 131.37 36.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.094 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.662 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 33.8 t -116.0 89.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.014 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 10.4 mm -79.72 121.33 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.358 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 18' ' ' GLY . 28.6 m -122.31 163.8 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.206 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -84.09 -177.33 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.347 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.8 -22.1 22.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.602 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -90.73 -21.88 21.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.552 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 22.04 7.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.266 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.1 t -101.27 134.23 42.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 66' ' ' PRO . 61.3 t -65.33 114.85 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.419 . . . . 0.0 111.081 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -96.9 -33.11 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 68.1 m -105.03 158.57 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 111.36 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.7 t -65.88 117.01 37.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.394 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 62' ' ' VAL . 2.4 Cg_endo -79.28 93.53 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.552 2.168 . . . . 0.0 110.673 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 12.6 p-80 -125.8 151.41 46.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.088 0.47 . . . . 0.0 111.218 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -40.75 110.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.897 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.655 -179.014 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.032 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.3 t -76.89 78.95 3.47 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-O 122.727 1.251 . . . . 0.0 114.313 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.97 78.16 0.25 Allowed 'General case' 0 C--N 1.352 0.68 0 C-N-CA 127.953 2.501 . . . . 0.0 111.055 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.99 67.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.817 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -133.87 147.08 62.79 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.986 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.03 150.59 88.2 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.795 1.663 . . . . 0.0 111.387 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.87 173.98 44.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.257 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 31.4 ttmt -66.42 150.5 48.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.594 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.35 -19.03 13.71 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -149.66 127.5 11.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 0.0 110.081 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.714 ' CH2' HG13 ' A' ' 25' ' ' VAL . 27.5 m-90 -110.34 68.93 0.54 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.388 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.878 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.5 Cg_endo -58.63 -36.56 97.1 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.999 1.799 . . . . 0.0 111.513 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -64.51 -9.36 18.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.922 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.2 mt -79.95 -21.2 44.07 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.442 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 60.7 t -55.25 117.85 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.48 -14.21 27.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.4 mmtt -95.8 158.72 15.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.666 0.27 . . . . 0.0 110.679 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.6 p -57.98 143.59 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.116 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.29 -31.48 20.11 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.255 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -45.92 60.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.712 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -39.01 92.47 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -62.97 -60.76 3.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.384 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.503 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -51.25 -44.09 61.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.431 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.97 -45.79 93.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.299 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.44 HG21 HD21 ' A' ' 13' ' ' LEU . 91.6 m -56.86 -43.18 80.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.714 HG13 ' CH2' ' A' ' 10' ' ' TRP . 57.2 t -65.91 -54.08 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.332 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt-10 -63.61 -27.08 68.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.421 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.64 -56.48 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.695 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -61.72 -35.74 78.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 110.025 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -126.02 75.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.64 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -62.58 0.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.464 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -93.56 -5.0 49.93 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.252 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 49' ' ' CYS . 4.2 m -140.51 166.45 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -126.94 145.48 50.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.415 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.26 137.38 46.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.489 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 18.1 mt -106.29 113.7 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.616 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -78.88 120.26 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.389 0.614 . . . . 0.0 111.072 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.648 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.9 OUTLIER -145.12 154.91 42.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.99 -179.129 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 156.75 17.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.315 0.579 . . . . 0.0 112.014 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.61 110.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.06 -3.79 12.81 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.362 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 30.9 t -67.62 -176.01 0.58 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 110.585 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -90.52 101.36 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ptp -127.83 103.77 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 p -63.66 152.54 38.72 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -24.32 36.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.293 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -44.5 147.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 68' ' ' ILE . 72.2 t80 -93.46 135.16 34.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.435 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.4 mtm180 -147.97 112.02 5.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.559 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.503 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.5 OUTLIER -59.42 -36.59 76.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -79.75 0.2 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 44.8 ttp180 -127.91 124.88 38.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 111.444 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 68' ' ' ILE . 48.6 t -122.84 118.32 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.108 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.648 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.5 m95 -78.47 133.31 37.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 25.5 t -120.43 90.63 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -81.25 123.78 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.474 0.654 . . . . 0.0 112.184 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.6 m -124.92 165.95 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.01 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -86.73 -172.68 4.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.681 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -21.28 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.501 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.67 -8.68 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.89 25.08 23.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 24.1 t -100.51 135.11 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 16' ' ' LYS . 41.2 t -72.14 114.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 111.434 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -98.74 -31.01 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.507 ' CB ' HD13 ' A' ' 55' ' ' ILE . 1.2 t -99.73 154.05 18.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.878 HG13 ' HA ' ' A' ' 11' ' ' PRO . 34.0 t -68.52 106.89 1.55 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.748 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.673 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 12.8 Cg_exo -65.69 89.29 0.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.868 1.712 . . . . 0.0 111.012 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.4 OUTLIER -123.76 145.67 48.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.839 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -41.17 114.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.074 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.803 -179.435 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p -75.86 69.64 2.53 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -160.46 84.66 0.71 Allowed 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.319 -1.488 . . . . 0.0 111.117 168.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -154.01 77.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.632 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.4 p -138.38 143.31 38.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.393 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HG2' ' CB ' ' A' ' 31' ' ' ASN . 43.8 Cg_endo -69.49 158.42 57.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.935 1.757 . . . . 0.0 111.975 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.74 173.93 47.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.485 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 ttmm -69.65 154.36 42.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.584 0.23 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' A' ' 68' ' ' ILE . 1.8 t-20 -111.46 -6.41 14.45 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.92 126.7 4.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.315 -0.241 . . . . 0.0 110.362 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.798 ' CH2' HG13 ' A' ' 25' ' ' VAL . 20.0 m-90 -112.52 73.48 1.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.922 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -57.66 -33.47 96.73 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.441 2.094 . . . . 0.0 111.854 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.5 -13.08 37.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.1 mt -81.33 -22.99 38.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 65' ' ' VAL . 24.6 t -60.6 113.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -9.48 20.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -105.95 177.26 4.91 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -66.47 144.75 56.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 0.0 111.338 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -60.32 -28.22 66.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.423 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -72.7 -53.48 11.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 110.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.428 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.5 -30.92 70.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.704 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.85 -61.72 1.9 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.283 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.13 -38.17 50.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 110.129 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.91 -45.2 94.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.412 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.439 ' CB ' HD21 ' A' ' 13' ' ' LEU . 11.4 m -58.49 -43.88 89.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.798 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.2 t -64.28 -60.66 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -59.01 -23.56 62.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 0.0 111.321 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 5.4 tpp180 -81.39 -61.04 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.32 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.11 -31.79 73.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.558 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -127.41 80.86 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.726 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.64 -8.08 5.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.02 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . 27.9 t-20 -89.32 -2.68 58.54 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 49' ' ' CYS . 11.6 m -129.45 168.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 0.0 111.552 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 1.031 ' CE1' HD11 ' A' ' 35' ' ' ILE . 1.8 p-80 -133.65 135.14 43.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.328 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . . . -108.1 123.42 48.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.424 . . . . 0.0 111.741 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 1.031 HD11 ' CE1' ' A' ' 33' ' ' HIS . 3.8 mp -97.87 115.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.468 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 53.4 t -79.72 113.05 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.324 0.583 . . . . 0.0 110.989 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.904 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -134.55 150.16 50.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.962 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -90.02 156.77 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.081 0.467 . . . . 0.0 111.766 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.73 123.88 3.98 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.458 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.1 -3.7 55.39 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.913 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 12.0 t -67.62 -179.32 1.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.955 0.407 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -86.02 101.68 13.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -129.73 100.05 5.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.098 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 p -59.37 147.31 36.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.099 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.91 -25.06 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.159 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.81 160.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.405 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.1 t80 -104.0 131.11 51.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.423 . . . . 0.0 111.61 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 48' ' ' ARG . 5.2 mtm180 -145.22 109.36 4.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.308 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -60.01 -33.32 71.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.536 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -79.51 -2.97 44.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.626 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.435 ' HG3' ' CE1' ' A' ' 33' ' ' HIS . 47.5 ttp180 -121.11 142.76 49.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 111.478 -179.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.511 HG21 HG11 ' A' ' 25' ' ' VAL . 94.2 t -138.68 114.28 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.819 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.904 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.69 131.55 36.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.706 0.288 . . . . 0.0 110.484 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 66' ' ' PRO . 11.3 t -119.21 88.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.101 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mt -79.84 122.15 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.8 m -121.26 164.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.433 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -87.91 -174.64 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -58.11 -23.48 55.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.55 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -86.04 -20.44 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 111.162 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.67 22.66 10.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.165 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 19.2 t -98.78 144.7 11.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.55 HG11 ' HD3' ' A' ' 66' ' ' PRO . 48.0 t -75.58 112.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.993 0.425 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 p -94.04 -31.45 14.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.558 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -103.48 154.01 19.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.922 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.7 t -66.12 101.36 0.28 Allowed Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.736 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 54' ' ' VAL . 19.1 Cg_endo -57.75 92.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.618 1.545 . . . . 0.0 110.827 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 16.1 p-80 -122.67 153.76 38.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.53 115.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.792 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.941 -179.422 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.6 t -63.99 124.04 20.55 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 118.9 -0.572 . . . . 0.0 112.24 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 62.82 1.04 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 120.171 1.35 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 90.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.7 m -113.41 142.17 27.1 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.961 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 168.28 25.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.141 1.894 . . . . 0.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . 63.45 170.46 1.56 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.061 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 33.3 ttmt -66.73 146.83 54.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.795 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.728 ' HA ' HD12 ' A' ' 68' ' ' ILE . 10.1 m-20 -107.03 -4.2 19.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.32 134.51 7.31 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.808 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -119.73 68.15 11.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.852 ' HA ' HG13 ' A' ' 65' ' ' VAL . 54.5 Cg_exo -50.29 -37.35 49.7 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.283 1.989 . . . . 0.0 112.348 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.92 -13.48 25.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.968 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD22 ' HA ' ' A' ' 21' ' ' ALA . 24.8 mt -80.51 -23.42 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.67 0.272 . . . . 0.0 110.663 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.612 HG21 HG22 ' A' ' 65' ' ' VAL . 59.4 t -53.71 112.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.798 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -12.01 29.96 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.231 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -94.23 157.11 16.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.786 0.327 . . . . 0.0 110.875 179.765 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -56.82 141.33 44.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.38 -31.59 20.98 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.319 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.35 -45.54 59.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.14 -42.08 99.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.043 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -62.56 -56.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.711 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.51 64.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.65 -45.23 93.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.5 m -58.27 -42.1 85.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.883 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' VAL . . . . . 0.808 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -67.35 -58.05 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.337 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.15 -24.89 66.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.46 0.171 . . . . 0.0 111.446 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 17.8 ttp180 -83.9 -58.72 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.833 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.98 -29.55 70.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.999 0.428 . . . . 0.0 110.269 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 32' ' ' VAL . 50.0 t-20 -131.0 85.07 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -8.57 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.25 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.76 -10.03 52.21 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 49' ' ' CYS . 13.7 m -115.06 175.5 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 112.062 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' HIS . . . . . 0.56 ' CE1' HD11 ' A' ' 35' ' ' ILE . 0.6 OUTLIER -143.48 125.36 15.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.549 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 129.63 44.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.12 0.485 . . . . 0.0 112.007 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.624 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 27.0 mt -106.82 119.64 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -79.45 132.45 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.369 0.604 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.826 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -157.03 150.94 24.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.17 153.87 20.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.165 0.507 . . . . 0.0 111.585 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 55' ' ' ILE . 10.9 pt-20 -49.06 115.48 1.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.31 -1.85 25.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -69.71 -177.22 1.2 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.839 0.352 . . . . 0.0 110.655 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.52 104.86 17.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -124.14 106.52 10.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.305 -178.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -56.47 147.76 21.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.079 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 mmpp? -84.54 -26.13 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.954 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.93 138.24 5.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -84.81 130.34 34.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 3.9 mtp85 -144.71 112.25 6.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' CYS . . . . . 0.957 ' O ' HG12 ' A' ' 32' ' ' VAL . 90.9 m -63.95 -13.67 47.79 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.752 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 48' ' ' ARG . 18.8 p-10 -97.88 -4.7 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.646 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.438 ' HG3' ' CE1' ' A' ' 33' ' ' HIS . 52.0 ttp180 -122.35 143.31 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 111.35 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 25' ' ' VAL . 59.6 t -139.36 118.47 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.645 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TRP . . . . . 0.826 ' CE3' HD21 ' A' ' 37' ' ' LEU . 4.9 m95 -78.42 135.2 37.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.253 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 43.1 t -120.13 89.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.053 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 43' ' ' MET . 6.0 mt -81.98 126.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.016 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.8 m -123.47 165.27 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.798 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -88.13 -172.72 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.964 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.62 -21.98 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -95.48 -8.85 34.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.78 21.97 24.72 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.537 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 t -96.38 140.66 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 16' ' ' LYS . 40.4 t -72.65 112.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.804 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.1 p -94.45 -32.41 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.567 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.563 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 9.0 t -100.82 146.41 27.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.7 t -62.73 101.44 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.1 Cg_endo -57.91 99.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.034 1.823 . . . . 0.0 111.647 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER -127.98 152.83 47.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.115 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -49.72 116.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.453 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' THR . . . . . 0.402 ' OXT' HG22 ' A' ' 69' ' ' THR . 5.7 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.979 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.287 0 N-CA-C 112.443 -0.263 . . . . 0.0 112.443 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 25.5 ttmt -56.11 142.81 35.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.705 0.288 . . . . 0.0 110.68 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -100.77 -11.34 19.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 67' ' ' HIS . . . -155.47 140.2 17.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.699 ' CH2' HG13 ' A' ' 25' ' ' VAL . 17.1 m-90 -121.2 68.58 18.75 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.775 ' HA ' HG13 ' A' ' 65' ' ' VAL . 67.3 Cg_exo -49.74 -36.18 41.07 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.183 1.922 . . . . 0.0 112.177 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -64.12 -8.33 11.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.276 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.9 mt -83.71 -20.1 34.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 11' ' ' PRO . 44.1 t -56.57 114.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.823 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -8.1 31.5 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.35 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 62' ' ' VAL . 3.2 mmtt -99.25 157.9 16.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.312 . . . . 0.0 110.716 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -56.99 139.43 52.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -51.58 -29.16 23.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.512 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.22 -46.69 40.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.401 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 7.0 tpt -65.25 -33.87 77.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.032 0.444 . . . . 0.0 109.829 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -66.4 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.367 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.71 -42.72 57.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.15 -46.13 91.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.429 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -57.03 -40.47 76.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -66.0 -54.98 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.315 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -64.76 -26.05 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.609 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -83.46 -56.22 3.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 111.186 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -63.05 -30.52 71.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.073 0.463 . . . . 0.0 110.322 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.493 ' ND2' ' HA3' ' A' ' 6' ' ' GLY . 50.2 t-20 -127.84 85.04 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.783 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -8.17 3.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.233 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -95.04 2.42 55.25 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 49' ' ' CYS . 30.6 m -129.09 167.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 128.44 36.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.673 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.73 144.07 31.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.233 0.54 . . . . 0.0 112.139 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.573 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.3 mt -120.19 143.46 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.159 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 58.3 t -97.49 130.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -157.72 151.88 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.97 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 56' ' ' VAL . 1.3 mtpt -87.31 161.06 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 112.405 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 5.8 tt0 -54.12 119.29 4.89 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.228 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.02 56.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.685 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 3.1 t -64.24 131.9 48.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.06 0.457 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.86 81.85 0.11 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.656 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD13 ' A' ' 37' ' ' LEU . 13.5 mmt -113.94 164.24 14.05 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.886 0.374 . . . . 0.0 111.453 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.2 164.02 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.23 -25.73 7.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.323 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -52.04 171.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 33.4 t80 -97.96 128.4 44.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -143.87 111.2 5.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.501 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.742 ' O ' HG12 ' A' ' 32' ' ' VAL . 18.4 m -60.25 -35.96 76.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 16.2 p-10 -78.81 -3.48 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.442 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 40.8 ttp180 -123.04 129.99 52.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.194 0.521 . . . . 0.0 111.784 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 68' ' ' ILE . 84.6 t -133.16 119.79 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.358 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.86 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.7 m95 -78.9 130.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 55.1 t -113.16 84.38 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.01 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 64' ' ' SER . 2.5 mp -79.87 118.4 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.62 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 29.8 m -122.93 165.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.236 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.17 -172.62 3.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -23.36 61.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.379 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -90.65 2.93 55.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 25.09 64.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.166 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.0 t -100.22 132.88 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 16' ' ' LYS . 46.2 t -68.1 108.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.528 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.6 p -93.06 -33.8 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.155 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 55' ' ' ILE . 22.9 t -102.2 157.15 17.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.1 t -69.58 123.39 88.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HG2' HD12 ' A' ' 13' ' ' LEU . 91.5 Cg_endo -81.99 101.77 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.313 2.009 . . . . 0.0 110.576 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.7 p-80 -132.26 145.98 51.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.08 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -39.34 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.674 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.78 -179.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.406 0 CA-C-O 120.944 0.191 . . . . 0.0 112.735 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 26.2 ttmt -59.62 154.11 18.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.816 0.341 . . . . 0.0 111.31 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -115.92 -5.55 12.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.439 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -155.32 124.61 6.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.903 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.0 m-90 -111.4 74.93 1.2 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.869 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.861 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.6 Cg_endo -59.49 -35.67 95.34 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.986 1.791 . . . . 0.0 111.604 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -65.0 -9.89 25.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.861 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 26.8 mt -82.81 -19.8 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.719 0.295 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 11' ' ' PRO . 45.2 t -55.47 111.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.6 -9.76 23.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.118 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.0 mmtt -95.43 157.84 15.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.297 . . . . 0.0 110.733 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 p -59.51 138.5 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.763 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.25 -31.63 8.92 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.084 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.38 63.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.985 0.421 . . . . 0.0 110.268 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -33.1 75.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.871 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.67 -59.5 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -55.49 -41.73 73.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.559 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.22 -46.63 89.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.435 HG21 HD21 ' A' ' 13' ' ' LEU . 88.0 m -57.83 -43.75 85.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.903 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -63.68 -52.05 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -63.82 -29.14 70.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.519 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -78.66 -57.11 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.836 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.4 -35.22 80.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.438 . . . . 0.0 110.454 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.513 ' CG ' HG22 ' A' ' 32' ' ' VAL . 49.3 t-20 -123.16 78.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -3.15 0.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.609 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.64 -5.05 49.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 29' ' ' ASN . 12.8 m -139.72 168.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -133.58 146.79 51.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.684 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.06 138.72 44.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.504 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.1 mp -105.09 120.55 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.623 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.5 p -80.43 129.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.895 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.46 152.35 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.19 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.874 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -89.67 155.1 19.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 111.946 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 117.11 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.054 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.98 -1.97 30.09 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 39.7 t -70.11 -172.54 0.56 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.313 . . . . 0.0 110.738 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -88.87 104.82 17.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 100.95 6.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.459 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -58.68 147.55 32.45 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.875 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -80.43 -26.42 38.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.25 161.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.7 t80 -103.81 137.32 41.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -152.49 112.85 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.559 ' O ' HG12 ' A' ' 68' ' ' ILE . 50.3 m -58.45 -37.84 76.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 21.7 p-10 -79.36 -2.82 43.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.48 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -120.63 111.47 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.609 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG21 HG11 ' A' ' 25' ' ' VAL . 78.9 t -113.15 117.64 55.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.895 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.9 m95 -78.71 128.79 33.91 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 7.2 t -116.52 98.93 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 ' CD1' ' A' ' 37' ' ' LEU . 9.0 mm -83.87 122.4 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.874 HG23 ' HG3' ' A' ' 38' ' ' LYS . 30.5 m -126.66 168.35 19.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.423 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.75 -170.93 2.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -18.83 61.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.77 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.56 -1.8 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.14 24.19 38.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.3 t -96.04 131.92 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.752 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.9 t -70.92 112.82 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 111.378 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -97.14 -33.07 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 6.8 t -97.86 149.94 21.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.218 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 11' ' ' PRO . 21.3 t -66.92 108.36 2.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.541 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 10' ' ' TRP . 17.2 Cg_exo -62.19 106.14 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.211 1.941 . . . . 0.0 111.594 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.13 146.68 51.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.418 0.628 . . . . 0.0 111.768 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.571 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -47.51 109.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.668 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.453 ' OXT' HG22 ' A' ' 69' ' ' THR . 11.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.52 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.321 0 N-CA-C 112.662 -0.175 . . . . 0.0 112.662 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 9' ' ' ALA . 3.6 ttmt -69.67 148.7 48.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.592 0.234 . . . . 0.0 110.546 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -110.34 -0.16 17.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.469 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -160.48 125.55 3.83 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.896 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -113.39 67.46 1.23 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.767 0.317 . . . . 0.0 111.151 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.888 ' HA ' HG13 ' A' ' 65' ' ' VAL . 9.6 Cg_endo -52.62 -33.67 59.84 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.386 2.058 . . . . 0.0 111.907 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -64.68 -9.2 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.696 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.845 HD13 ' HB1' ' A' ' 21' ' ' ALA . 18.6 mt -84.18 -18.87 35.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.844 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' PRO . 48.6 t -56.84 113.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.746 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 -12.89 43.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.175 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -89.07 162.31 16.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 110.646 179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 p -63.97 137.53 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.497 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -52.58 -29.74 32.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.364 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -70.1 -54.24 13.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.85 95.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.06 -51.42 69.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.495 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.2 75.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.373 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.65 88.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.498 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -59.64 -45.73 91.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.531 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.896 HG13 ' CH2' ' A' ' 10' ' ' TRP . 40.3 t -64.7 -50.92 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -31.95 73.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 111.419 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -79.4 -56.51 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.181 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.17 -29.31 70.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.708 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.7 t-20 -126.7 79.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -65.14 -2.88 3.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -92.9 -9.78 38.92 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.603 0.24 . . . . 0.0 111.287 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 29' ' ' ASN . 3.0 m -140.3 169.55 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.932 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.598 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -133.88 151.06 51.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.162 0.506 . . . . 0.0 111.129 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.82 137.91 51.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.551 HD11 ' HG3' ' A' ' 51' ' ' ARG . 3.9 mp -104.86 129.07 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.514 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 65.5 t -80.16 128.39 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.04 0.447 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.727 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -150.67 143.36 24.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.518 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 157.2 17.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.95 120.46 2.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.96 55.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.738 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 14.8 t -70.49 -179.7 2.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 110.857 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.64 101.54 14.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.29 104.85 8.16 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.014 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.35 151.44 9.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -27.59 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -46.58 134.99 9.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 68' ' ' ILE . 56.0 t80 -80.44 132.16 35.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.555 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.0 mtm180 -146.9 111.82 5.38 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.602 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.471 ' O ' HG11 ' A' ' 32' ' ' VAL . 97.3 m -60.63 -34.11 73.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 19.8 p-10 -79.54 -0.32 32.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.66 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.551 ' HG3' HD11 ' A' ' 35' ' ' ILE . 47.9 ttp180 -126.43 129.49 48.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.433 . . . . 0.0 111.471 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 68' ' ' ILE . 52.7 t -128.32 116.26 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.15 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.727 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.9 m95 -78.76 133.89 37.08 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 29.3 t -115.25 96.38 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 55' ' ' ILE . 4.0 mp -84.47 121.28 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.172 0.51 . . . . 0.0 111.57 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 27.0 m -125.87 162.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.013 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -85.84 -179.7 6.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.92 -20.98 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.53 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.21 -24.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.295 . . . . 0.0 111.227 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.33 21.14 7.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.18 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.6 t -98.28 139.49 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 16' ' ' LYS . 42.9 t -72.6 111.78 7.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.816 0.341 . . . . 0.0 110.756 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -91.19 -31.3 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 48.3 t -107.59 150.13 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.888 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.4 t -64.82 102.14 0.31 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.38 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.9 Cg_endo -58.86 97.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.114 1.876 . . . . 0.0 111.596 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -123.68 157.47 33.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.551 . . . . 0.0 111.347 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -51.09 114.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.535 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.435 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.813 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . . . . . . 0 N--CA 1.45 -0.368 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.47 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 26.4 ttmt -33.23 143.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.634 0.254 . . . . 0.0 111.49 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.916 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.0 p30 -112.23 -0.54 15.47 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -157.12 121.46 4.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.86 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.2 m-90 -108.79 74.81 0.59 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.94 0.4 . . . . 0.0 111.453 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.821 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.8 Cg_endo -60.59 -33.25 93.79 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.208 1.939 . . . . 0.0 111.401 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pm0 -63.7 -14.13 49.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 21' ' ' ALA . 22.2 mt -81.07 -20.63 41.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.645 0.259 . . . . 0.0 110.565 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.41 117.34 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.614 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.76 -14.6 53.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.14 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.17 174.78 8.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.622 0.248 . . . . 0.0 110.516 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 p -75.99 144.01 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.98 -31.62 40.22 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.084 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.4 -52.87 22.77 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.708 0.289 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -29.97 70.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 109.999 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.73 -60.55 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.449 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.1 68.67 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.01 -44.58 84.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.421 ' CB ' HD21 ' A' ' 13' ' ' LEU . 91.6 m -58.85 -43.12 90.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.86 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -65.61 -51.41 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.37 -28.51 69.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.57 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 8.0 mtp180 -81.86 -54.75 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.71 -34.95 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.281 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.415 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.9 t-20 -124.63 80.0 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.656 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -5.46 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -93.53 2.52 56.39 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -137.06 170.61 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 0.0 111.663 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -137.23 126.65 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.321 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.74 135.98 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.686 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.589 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 34.8 mt -107.38 120.73 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.738 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.631 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.6 p -79.79 128.74 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 111.438 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -157.9 144.72 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.534 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.24 159.31 16.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.584 . . . . 0.0 111.915 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.67 122.05 3.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.46 29.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.594 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 15.4 t -68.09 -178.09 0.96 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 110.71 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.9 102.7 15.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.564 ' HE1' HD12 ' A' ' 55' ' ' ILE . 2.7 ptp -124.51 100.15 6.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -60.09 148.92 34.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.053 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -82.31 -24.56 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.023 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -45.95 159.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -100.82 131.98 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.064 0.459 . . . . 0.0 111.422 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.04 108.17 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 48.8 t -60.56 -36.75 79.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.576 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.64 3.46 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -129.19 128.06 42.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.025 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.0 t -127.64 119.09 50.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.017 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.807 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.4 m95 -78.7 130.52 35.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.182 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 31.1 t -113.83 95.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.934 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.564 HD12 ' HE1' ' A' ' 43' ' ' MET . 5.6 mm -79.99 119.9 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.675 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.6 m -124.94 164.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.254 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -89.72 -171.76 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -18.18 62.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.496 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -96.21 -1.57 47.97 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.502 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.9 t -99.49 137.33 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 21' ' ' ALA . 60.4 t -72.33 109.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.937 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -93.76 -28.04 16.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 t -106.57 157.7 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 111.141 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.821 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.0 t -72.19 111.02 9.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 7.8 Cg_exo -67.57 103.55 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.664 1.576 . . . . 0.0 110.517 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.622 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.9 p-80 -131.7 145.2 51.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -40.82 111.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.28 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.655 ' OXT' HG22 ' A' ' 69' ' ' THR . 16.3 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.051 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.223 0 CA-C-O 121.062 0.257 . . . . 0.0 113.154 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.6 tttt -68.24 149.86 48.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.303 . . . . 0.0 110.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -110.98 -8.33 14.48 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.58 123.81 3.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.865 0.364 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 21.7 m-90 -109.52 74.36 0.68 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.833 ' HA ' HG13 ' A' ' 65' ' ' VAL . 13.2 Cg_endo -56.11 -37.53 96.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.495 2.13 . . . . 0.0 112.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.54 -6.88 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.166 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 21' ' ' ALA . 15.8 mt -85.37 -21.2 28.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.744 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.48 HG21 HG22 ' A' ' 65' ' ' VAL . 43.9 t -56.72 113.05 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-O 120.777 0.322 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.17 -10.53 26.82 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.133 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.674 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.08 157.89 15.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.933 0.396 . . . . 0.0 110.928 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 p -56.66 141.66 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.41 -29.38 38.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -72.46 -45.19 60.68 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.514 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.448 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -65.37 -39.07 91.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.75 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -61.56 -58.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.027 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.494 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.71 -38.81 61.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -63.26 -46.21 87.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.244 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.412 ' HB ' HD11 ' A' ' 13' ' ' LEU . 13.1 m -59.97 -42.31 93.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.762 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.63 HG13 ' CH2' ' A' ' 10' ' ' TRP . 60.4 t -65.57 -51.59 61.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.6 -28.5 68.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.749 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 6.0 mpp_? -82.77 -52.32 6.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -67.32 -31.58 71.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 0.0 110.371 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.567 ' CG ' HG22 ' A' ' 32' ' ' VAL . 52.0 t-20 -126.07 76.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.601 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 1.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.196 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -95.45 -13.99 24.12 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.348 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 29' ' ' ASN . 5.1 m -134.05 168.37 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.463 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.39 140.36 51.37 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.159 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -105.01 134.77 47.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.373 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.528 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 31.5 mt -102.15 116.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.926 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 41.8 t -83.73 118.95 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.998 0.428 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.845 HD13 ' HB3' ' A' ' 41' ' ' SER . 2.2 pp -143.66 156.67 44.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.118 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.76 160.49 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.222 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 115.7 1.73 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.844 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.76 -6.53 20.2 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.361 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.845 ' HB3' HD13 ' A' ' 37' ' ' LEU . 44.8 t -64.93 178.95 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 88.06 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.445 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.5 ptm -111.42 104.88 13.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 110.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.9 p -67.47 153.72 43.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.069 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -24.94 40.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.508 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.29 139.88 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.467 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 68' ' ' ILE . 48.2 t80 -85.76 128.34 34.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HD3' ' NH1' ' A' ' 51' ' ' ARG . 69.3 mtp180 -145.73 112.68 6.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.511 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.448 ' O ' HG12 ' A' ' 68' ' ' ILE . 33.0 m -59.11 -38.71 80.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 19.3 p-10 -78.36 -0.17 27.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NH1' ' HD3' ' A' ' 48' ' ' ARG . 39.3 ttp180 -128.62 106.37 8.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.17 0.509 . . . . 0.0 111.826 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.549 HG13 ' C ' ' A' ' 67' ' ' HIS . 43.2 t -105.92 120.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.618 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.0 m95 -78.39 132.68 37.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.672 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 66' ' ' PRO . 54.6 t -123.4 87.73 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.955 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -79.95 124.1 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.71 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.844 HG23 ' HG3' ' A' ' 38' ' ' LYS . 15.9 m -121.36 162.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -91.97 -170.61 2.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.622 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 15.4 t70 -54.76 -22.7 14.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 22.41 12.18 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.0 56.34 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.626 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.9 t -93.81 138.31 20.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 16' ' ' LYS . 43.7 t -76.31 112.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.143 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -93.34 -33.81 13.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.133 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.52 151.56 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.687 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.833 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.0 t -67.06 104.53 0.64 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HB3' HG22 ' A' ' 54' ' ' VAL . 20.5 Cg_endo -60.32 99.84 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.744 1.629 . . . . 0.0 111.309 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.549 ' C ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -130.09 150.21 51.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.487 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -46.33 112.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.734 -179.458 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.202 0 CA-C-O 120.843 0.135 . . . . 0.0 113.026 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.3 ttmm -65.64 151.04 47.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -110.8 -14.92 13.92 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -148.99 130.9 15.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.3 m-90 -116.71 67.35 3.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.457 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.884 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.81 -34.41 91.19 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.211 1.941 . . . . 0.0 111.84 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.85 -10.44 20.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.636 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 20.1 mt -81.76 -23.2 36.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 65' ' ' VAL . 43.6 t -55.32 118.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.09 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.86 44.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.608 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.67 -175.4 3.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.514 0.197 . . . . 0.0 110.558 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 p -83.68 142.51 30.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.723 0.297 . . . . 0.0 110.834 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.65 -32.15 38.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.866 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -47.8 67.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.256 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 tpt -64.11 -34.35 77.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.42 -61.0 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.372 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -53.94 -40.14 66.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.02 -44.61 96.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -61.39 -42.35 98.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.798 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.8 t -63.18 -49.04 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.92 -31.42 70.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.489 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 7.4 mtp85 -77.48 -50.74 12.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.17 -37.54 72.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.671 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.6 t-20 -119.44 78.18 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -0.07 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.834 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -94.86 -9.8 33.24 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.637 0.256 . . . . 0.0 111.328 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.671 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.0 m -138.97 168.0 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.176 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 1.5 p80 -128.23 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.351 0.596 . . . . 0.0 111.942 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.83 131.17 55.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.0 mt -103.16 127.16 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 44.8 t -83.85 121.18 36.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 111.323 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.913 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -146.69 155.71 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.737 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.09 162.22 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.256 0.551 . . . . 0.0 112.061 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 55' ' ' ILE . 1.4 mm-40 -52.73 125.24 16.12 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.206 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.83 -2.91 62.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.867 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.418 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 2.9 t -57.44 134.64 56.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.54 81.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.601 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 28.6 mmt -124.73 130.2 51.95 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.845 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -56.68 152.94 11.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -23.38 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.74 152.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.466 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE2' HG22 ' A' ' 68' ' ' ILE . 51.1 t80 -93.36 133.07 36.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.116 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -149.35 110.67 4.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -59.67 -35.86 75.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -78.6 0.85 24.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 44.8 ttp180 -129.63 129.92 44.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.391 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 67' ' ' HIS . 41.1 t -126.79 118.04 49.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.973 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.913 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.7 m95 -78.7 132.88 37.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 110.229 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.2 t -114.86 83.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.6 mt -79.85 121.99 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.538 0.685 . . . . 0.0 111.466 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.5 m -125.95 165.34 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.291 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -84.19 -175.55 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 38' ' ' LYS . 2.9 t70 -59.58 -18.87 44.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.436 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -89.54 -19.9 24.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.86 20.24 13.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.958 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.5 t -95.68 132.93 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.631 HG21 ' HB2' ' A' ' 21' ' ' ALA . 40.3 t -69.29 111.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.937 0.399 . . . . 0.0 110.38 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 p -90.91 -29.55 17.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.136 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 12.9 m -104.89 148.4 26.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.884 HG13 ' HA ' ' A' ' 11' ' ' PRO . 44.9 t -63.72 106.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.615 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.62 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 35.8 Cg_exo -56.92 98.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.748 1.632 . . . . 0.0 111.538 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.641 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -125.24 166.45 16.46 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.342 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -64.39 107.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.135 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.511 -178.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.328 0 N-CA-C 112.513 -0.235 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.5 ttmt -59.59 145.36 44.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.697 0.284 . . . . 0.0 110.566 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.24 -15.32 16.67 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.72 132.36 11.36 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.139 -0.35 . . . . 0.0 110.52 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.809 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.0 m-90 -113.52 74.88 2.33 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.264 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.5 Cg_endo -56.06 -40.98 81.52 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.209 1.939 . . . . 0.0 112.417 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -62.82 -6.8 4.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.455 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 ' HG2' ' A' ' 66' ' ' PRO . 14.3 mt -83.36 -20.88 33.45 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.12 116.0 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.701 0.286 . . . . 0.0 110.791 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.41 38.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.407 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.9 tppm? -93.56 161.26 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.507 0.194 . . . . 0.0 110.705 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -62.7 141.84 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.34 -29.35 46.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.427 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.87 -49.74 35.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.371 . . . . 0.0 110.69 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.432 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 10.8 tpt -63.7 -40.97 98.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.02 -54.58 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.991 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -52.18 -44.6 64.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.573 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.66 95.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -59.8 -43.08 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.809 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.3 t -66.72 -52.31 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 8.0 mt-10 -67.11 -24.02 65.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.319 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -84.98 -56.14 3.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.683 0.278 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.49 -31.9 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.143 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 32' ' ' VAL . 53.2 t-20 -125.05 80.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.713 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -4.79 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -98.72 6.14 47.15 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.629 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 29' ' ' ASN . 5.8 m -138.4 165.95 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.32 . . . . 0.0 111.358 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -128.63 132.84 48.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.346 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.09 127.44 44.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 35' ' ' ILE . 2.5 mp -104.53 108.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.581 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 11.2 p -78.86 121.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.592 0.71 . . . . 0.0 110.874 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -146.72 155.34 42.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.296 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.672 ' HG3' HG23 ' A' ' 56' ' ' VAL . 9.2 mtmt -89.55 165.76 14.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.305 0.574 . . . . 0.0 112.264 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 122.17 6.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.518 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.97 4.89 62.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.88 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.598 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.7 t -65.73 -173.93 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.89 87.06 6.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.2 ptm -121.13 105.87 11.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.059 0.457 . . . . 0.0 110.481 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -63.52 150.9 42.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.009 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -79.65 -23.5 42.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -45.52 155.0 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.847 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 37.5 t80 -99.41 136.18 39.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.005 0.431 . . . . 0.0 111.385 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -153.0 110.11 3.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.386 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.526 ' O ' HG12 ' A' ' 68' ' ' ILE . 23.5 m -58.37 -38.82 78.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.892 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 18.6 p-10 -79.25 5.55 12.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.33 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -127.25 131.48 50.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.982 0.42 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 68' ' ' ILE . 59.8 t -134.23 117.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.582 ' CE3' HD21 ' A' ' 37' ' ' LEU . 5.0 m95 -78.77 140.34 38.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 110.614 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 64.5 t -128.05 87.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mt -79.62 128.92 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.152 0.501 . . . . 0.0 111.645 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.672 HG23 ' HG3' ' A' ' 38' ' ' LYS . 31.2 m -126.92 164.21 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -84.72 -171.49 3.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.029 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 -9.2 12.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.941 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -5.67 20.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.63 20.17 38.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.365 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.5 t -97.35 132.36 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 56' ' ' VAL . 60.0 t -66.43 110.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.781 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -87.87 -35.73 17.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.1 m -105.65 156.56 18.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 111.377 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.8 t -66.82 128.18 93.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.437 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 13' ' ' LEU . 15.6 Cg_endo -86.34 96.34 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.431 2.087 . . . . 0.0 110.766 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -128.54 153.15 47.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.19 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -44.11 103.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.159 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.504 -179.328 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.369 0 N-CA-C 112.59 -0.204 . . . . 0.0 112.59 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.633 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 1.7 ttmp? -88.42 154.9 20.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.284 . . . . 0.0 110.763 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -114.57 -2.05 13.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -157.61 130.51 7.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.633 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.2 m-90 -119.49 74.16 16.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.55 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.81 ' HA ' HG13 ' A' ' 65' ' ' VAL . 40.6 Cg_exo -55.7 -39.3 91.93 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.219 1.946 . . . . 0.0 111.986 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -62.01 -9.68 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.193 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 21' ' ' ALA . 42.4 mt -83.97 -23.67 30.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.797 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.513 HG21 HG22 ' A' ' 65' ' ' VAL . 41.0 t -58.26 111.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -7.63 29.44 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.177 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.95 166.01 11.48 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.532 0.206 . . . . 0.0 110.621 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -63.62 142.7 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.31 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.12 42.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.844 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -68.97 -42.18 76.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -65.68 -35.22 80.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.906 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -64.46 -60.1 3.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 36' ' ' VAL . . . -49.33 -50.17 40.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.11 86.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.426 ' CB ' HD21 ' A' ' 13' ' ' LEU . 94.6 m -60.11 -43.4 95.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.767 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.615 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.6 t -67.86 -51.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.23 -29.07 69.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -81.5 -57.19 3.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.53 -30.83 71.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.775 ' CG ' HG22 ' A' ' 32' ' ' VAL . 46.7 t-20 -127.11 78.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.276 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -64.62 1.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.965 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -98.36 -5.35 32.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.573 0.225 . . . . 0.0 111.482 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.775 HG22 ' CG ' ' A' ' 29' ' ' ASN . 17.9 m -148.69 166.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.422 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -129.47 152.91 48.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 111.361 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -112.3 147.93 35.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.34 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' A' ' 51' ' ' ARG . 2.5 mp -112.6 114.35 46.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.791 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 54' ' ' VAL . 57.5 t -83.25 111.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 111.345 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.669 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -135.27 154.72 51.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.535 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -85.54 157.2 20.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 0.0 111.527 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 113.61 1.18 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.718 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.79 -9.4 11.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.162 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.5 t -66.01 -174.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 97.67 11.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.119 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.635 ' CE ' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -124.83 103.69 8.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.56 160.09 23.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.27 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -87.84 -23.36 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.51 140.39 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.059 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.6 t80 -84.06 131.03 34.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.181 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -146.48 110.92 5.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.49 ' O ' HG12 ' A' ' 68' ' ' ILE . 98.3 m -59.05 -38.22 78.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.287 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 11.6 p-10 -78.8 -6.14 55.22 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.395 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HG3' HD11 ' A' ' 35' ' ' ILE . 41.3 ttp180 -119.21 105.96 11.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.989 0.424 . . . . 0.0 111.694 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 62.0 t -106.65 119.26 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.669 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.37 136.8 37.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 -178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 36' ' ' VAL . 49.0 t -127.64 84.0 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.051 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 43' ' ' MET . 4.2 mt -79.67 121.52 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.071 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.0 m -119.91 161.3 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.999 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -80.0 -171.48 2.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.272 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -20.47 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.612 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.73 -7.36 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.43 23.86 27.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.936 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.7 t -96.57 134.21 35.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.852 HG21 ' HB2' ' A' ' 21' ' ' ALA . 42.8 t -67.77 104.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.017 0.437 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -88.04 -34.74 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.17 157.27 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.922 0.392 . . . . 0.0 111.502 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.3 t -71.84 106.24 1.88 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.639 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 64' ' ' SER . 36.2 Cg_exo -58.06 103.39 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.688 1.592 . . . . 0.0 110.84 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.78 143.63 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.332 0.587 . . . . 0.0 111.474 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -41.81 107.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.685 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.083 -179.119 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.451 -0.304 0 N-CA-C 112.721 -0.152 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.1 ttmm -49.54 146.04 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 111.205 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -103.46 -16.72 15.49 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 7' ' ' LYS . . . -146.96 149.99 34.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.833 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.8 m-90 -134.56 67.64 71.71 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.229 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.853 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.7 Cg_endo -55.91 -33.08 87.77 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.101 1.867 . . . . 0.0 111.439 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.24 -12.48 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.666 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.4 mt -82.21 -20.3 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.883 HG21 HG22 ' A' ' 65' ' ' VAL . 38.2 t -61.91 111.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.15 -2.99 29.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.64 177.09 4.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -72.29 135.58 46.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.563 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.23 -30.51 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.038 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -70.94 -47.25 60.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.876 0.37 . . . . 0.0 110.399 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.4 tpt -63.18 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.783 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.54 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.577 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.01 -39.59 59.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.36 90.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.7 m -60.0 -42.54 94.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.833 HG13 ' CH2' ' A' ' 10' ' ' TRP . 19.0 t -64.41 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.01 -29.68 70.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.334 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -76.44 -54.35 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.37 -40.71 85.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.776 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.641 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.8 t-20 -115.44 80.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -64.96 -5.52 6.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.796 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 -0.66 56.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.548 0.213 . . . . 0.0 111.262 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.641 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.3 m -139.09 171.78 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -136.46 137.81 40.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.83 133.2 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.761 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 33' ' ' HIS . 45.1 mt -102.14 119.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.439 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.542 HG22 HG11 ' A' ' 54' ' ' VAL . 63.1 t -87.12 115.83 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.286 0.565 . . . . 0.0 111.275 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.873 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -138.82 156.14 47.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.899 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 151.64 21.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.278 0.561 . . . . 0.0 111.781 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.37 113.93 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.183 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.1 23.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -72.76 -164.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.98 99.1 12.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.91 96.9 5.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 111.422 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.48 155.96 39.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.428 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -87.15 -24.97 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.274 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.84 141.06 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -88.53 125.67 34.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.29 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.5 mtm180 -145.33 111.03 5.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.236 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.504 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 73.9 m -60.49 -32.78 71.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.637 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -78.94 -4.56 50.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.408 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 54.9 ttp180 -120.73 124.26 44.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.435 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 25' ' ' VAL . 69.8 t -123.54 119.39 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.398 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.873 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.1 m95 -78.71 131.35 36.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.841 0.353 . . . . 0.0 111.177 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 54' ' ' VAL . 5.5 t -122.88 91.95 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -85.72 125.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.685 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.8 m -125.16 164.79 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.492 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -89.94 -177.17 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.91 -20.76 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.316 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -88.49 -22.2 23.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.162 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.1 22.26 9.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.206 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 36.8 t -98.19 144.67 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 21' ' ' ALA . 47.6 t -75.28 110.85 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -91.53 -33.68 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.569 ' CB ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -101.96 148.46 25.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.883 HG22 HG21 ' A' ' 14' ' ' VAL . 47.8 t -67.64 108.47 2.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.214 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.3 Cg_exo -62.73 117.55 4.44 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.138 1.892 . . . . 0.0 111.471 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -151.8 143.89 23.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.98 0.419 . . . . 0.0 110.792 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.442 ' CG2' ' HA ' ' A' ' 49' ' ' CYS . 1.6 mt -40.3 122.69 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.048 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.577 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.189 0 N-CA-C 112.531 -0.227 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 32.2 ttmt -59.0 154.12 16.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.727 0.299 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.585 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -108.1 -20.4 13.17 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -147.71 127.04 13.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.693 ' CH2' HG13 ' A' ' 25' ' ' VAL . 22.7 m-90 -108.65 74.14 0.53 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.851 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.35 -37.06 92.68 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.047 1.831 . . . . 0.0 111.819 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -63.34 -9.59 12.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.865 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 21' ' ' ALA . 13.4 mt -80.88 -24.38 38.34 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.515 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 40.3 t -55.68 112.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.955 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -6.99 24.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.407 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.734 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 mmtp -102.69 160.38 14.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.287 . . . . 0.0 110.497 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.0 p -56.81 135.81 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.923 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -46.45 -30.61 4.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.171 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -44.77 64.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.827 0.346 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -32.46 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.032 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.762 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -68.04 -60.09 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.28 -39.73 67.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.755 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -64.12 -44.92 90.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.637 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.1 m -59.27 -41.0 87.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 52' ' ' VAL . 60.2 t -65.11 -57.58 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.107 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.17 -24.17 67.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 19.8 ttm-85 -80.77 -58.18 3.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.351 . . . . 0.0 110.819 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.05 -37.17 86.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.105 0.479 . . . . 0.0 110.377 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.464 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -121.16 78.22 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -0.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.22 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.29 -11.64 32.01 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.349 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' CG ' ' A' ' 29' ' ' ASN . 14.0 m -122.67 171.0 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -130.85 133.38 45.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.016 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 135.11 47.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.574 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 33' ' ' HIS . 28.7 mt -104.03 122.81 57.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.567 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 22' ' ' ALA . 60.0 t -91.3 123.02 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.722 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -150.6 158.6 44.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.478 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -89.0 159.76 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.098 0.475 . . . . 0.0 111.499 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.77 122.31 5.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.323 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.78 -8.82 43.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.933 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 32.8 t -68.69 -166.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.354 . . . . 0.0 111.123 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' CH2' ' A' ' 53' ' ' TRP . . . -71.14 93.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.543 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 1.5 ttp -121.18 99.12 6.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.48 151.52 20.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.356 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -79.82 -26.72 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.05 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.99 142.38 2.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -88.05 129.5 35.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.716 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.3 mtp180 -144.72 108.6 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.236 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -56.12 -43.21 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.282 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -79.48 3.57 18.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 40.4 ttp180 -126.65 115.71 19.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 25' ' ' VAL . 57.3 t -116.42 122.47 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.249 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.722 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.2 m95 -78.69 125.54 29.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.212 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.32 85.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mp -83.27 127.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.154 0.502 . . . . 0.0 111.73 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.8 m -124.9 163.72 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.242 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -83.55 -178.75 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.54 -22.0 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.855 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -24.43 21.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.335 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.78 22.23 7.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.318 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.0 t -99.02 140.47 18.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.4 t -70.71 112.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.098 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.9 p -94.66 -32.8 13.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.176 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 39.5 t -103.79 151.74 22.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.499 . . . . 0.0 111.543 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.5 t -64.47 114.85 15.83 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.142 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.554 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 5.3 Cg_exo -75.41 88.18 1.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.904 1.736 . . . . 0.0 111.451 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 18.0 p-80 -121.8 144.04 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.118 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -38.28 116.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.069 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.768 -179.068 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 0.122 0 CA-C-O 120.956 0.198 . . . . 0.0 113.391 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.64 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 2.8 ttmp? -55.64 149.78 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -103.73 -16.67 15.38 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -154.39 138.15 16.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.719 ' CH2' HG13 ' A' ' 25' ' ' VAL . 19.9 m-90 -120.49 71.06 17.8 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.84 0.352 . . . . 0.0 111.276 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -54.78 -37.81 92.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.328 2.019 . . . . 0.0 112.003 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -62.19 -9.15 6.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.156 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.1 mt -81.13 -24.21 37.8 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.769 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 65' ' ' VAL . 48.3 t -57.93 110.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.25 15.76 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.404 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -103.91 179.39 4.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.632 0.253 . . . . 0.0 110.625 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -76.04 143.23 41.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.664 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.71 -33.57 12.91 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.009 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.08 -36.92 66.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.987 0.422 . . . . 0.0 110.161 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -39.65 84.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.791 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.66 -58.85 4.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.504 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.66 -41.97 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.08 -45.45 94.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.95 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.444 ' CB ' HD21 ' A' ' 13' ' ' LEU . 39.9 m -61.3 -41.09 96.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' CH2' ' A' ' 10' ' ' TRP . 46.9 t -66.64 -54.96 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 33' ' ' HIS . 9.0 mt-10 -65.6 -23.88 66.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 10.0 ttm-85 -83.61 -53.01 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.824 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.67 -36.95 81.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.661 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.747 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -118.73 79.48 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.702 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -2.65 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.093 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.03 -13.9 28.05 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.695 0.283 . . . . 0.0 111.47 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.747 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.8 m -140.67 164.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.986 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.555 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -132.79 163.51 28.89 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.911 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB1' HG23 ' A' ' 54' ' ' VAL . . . -117.11 140.94 48.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.063 0.459 . . . . 0.0 111.935 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 28.6 mt -99.58 111.59 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.39 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.3 p -81.33 125.68 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 0.0 111.819 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 41' ' ' SER . 0.5 OUTLIER -155.88 160.1 39.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.195 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -89.69 155.04 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 111.627 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -47.91 115.95 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.396 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.78 -7.5 21.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.621 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.658 ' HB3' HD13 ' A' ' 37' ' ' LEU . 32.4 t -70.46 -162.38 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.91 96.88 5.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.0 110.743 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.593 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 10.1 tmm? -119.42 96.14 5.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.91 154.76 24.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.251 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -84.53 -27.93 27.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.67 130.78 5.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 68' ' ' ILE . 88.9 t80 -80.71 134.56 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.072 0.463 . . . . 0.0 111.8 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 10.4 mtp180 -152.61 109.83 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.534 ' O ' HG11 ' A' ' 32' ' ' VAL . 6.7 m -61.33 -30.36 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.09 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.555 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 17.7 p-10 -79.06 -8.25 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.637 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 39.6 ttp180 -122.26 119.2 30.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.042 0.449 . . . . 0.0 111.699 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 66.4 t -114.93 122.2 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.613 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -78.58 129.46 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.5 t -120.56 92.79 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 37' ' ' LEU . 7.3 mm -85.15 129.67 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.257 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 62' ' ' VAL . 26.4 m -129.09 164.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -86.0 -168.95 2.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.78 -18.7 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.64 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.02 4.69 51.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.31 24.76 65.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.222 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 23.3 t -97.54 131.47 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 21' ' ' ALA . 49.0 t -66.37 106.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.788 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.7 p -93.52 -29.46 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.03 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -103.94 151.14 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 11' ' ' PRO . 8.0 t -66.27 118.91 57.76 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.341 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 13' ' ' LEU . 89.7 Cg_endo -81.73 99.57 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.171 1.914 . . . . 0.0 111.351 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 7.8 p-80 -133.21 147.23 52.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.499 ' HA ' HG22 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -36.63 116.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.678 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.571 -179.872 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.285 0 N-CA-C 112.075 -0.41 . . . . 0.0 112.075 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 tttp -59.99 156.08 15.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.921 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.906 ' HA ' HD12 ' A' ' 68' ' ' ILE . 14.9 m-80 -113.77 -16.36 12.29 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.34 12.15 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.1 m-90 -108.0 73.95 0.46 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.881 0.372 . . . . 0.0 111.553 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.824 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -59.9 -35.11 94.71 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.281 1.987 . . . . 0.0 111.528 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -64.34 -12.52 43.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.47 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' HA ' ' A' ' 21' ' ' ALA . 23.4 mt -82.01 -22.41 36.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.421 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.539 HG21 HG22 ' A' ' 65' ' ' VAL . 40.5 t -55.23 114.99 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 110.619 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.52 -13.11 33.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.245 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -92.72 160.08 15.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.708 0.29 . . . . 0.0 110.59 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -60.73 140.79 57.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.77 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.87 -32.08 8.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.153 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -71.37 -45.26 63.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -38.83 92.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.881 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.26 -58.95 5.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.465 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -52.19 -39.22 59.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.66 -45.46 90.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.713 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.554 ' CB ' HD21 ' A' ' 13' ' ' LEU . 10.9 m -60.29 -41.21 92.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 26.4 t -67.32 -51.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.03 -26.99 67.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.678 0.275 . . . . 0.0 111.155 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -81.02 -56.33 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.39 -36.46 84.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.58 79.59 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -61.17 -5.62 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.231 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -88.69 -1.59 58.15 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.242 -0.286 . . . . 0.0 111.734 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -140.71 170.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.469 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.459 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -135.89 140.89 44.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -104.83 141.07 37.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.634 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.459 HG13 ' CE1' ' A' ' 33' ' ' HIS . 3.9 mt -114.83 123.09 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.639 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.7 t -79.82 123.49 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.689 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -141.49 149.6 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.789 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 155.5 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 0.0 111.55 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 55' ' ' ILE . 15.3 mt-10 -48.83 115.87 1.42 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.153 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 1.57 37.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.526 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 t -65.77 178.93 0.94 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.993 0.425 . . . . 0.0 110.599 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.07 92.73 9.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.893 ' HE1' HG12 ' A' ' 55' ' ' ILE . 2.0 ptp -112.82 105.08 13.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.979 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.66 152.07 9.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.749 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.63 -27.04 27.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.089 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.2 142.42 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.99 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.527 ' CE1' HG22 ' A' ' 68' ' ' ILE . 77.3 t80 -86.9 134.21 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 78.3 mtp180 -148.46 113.88 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.487 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -58.87 -41.07 86.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -79.43 2.73 20.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.0 ttp180 -125.56 113.49 17.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.976 0.417 . . . . 0.0 111.45 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.3 t -117.15 119.34 61.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.933 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.689 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 37.8 t -120.42 87.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.032 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.893 HG12 ' HE1' ' A' ' 43' ' ' MET . 4.3 mt -79.92 122.63 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.335 0.588 . . . . 0.0 111.836 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.0 m -122.44 163.77 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.254 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -88.99 -168.27 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.21 -17.63 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -97.8 9.85 41.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.29 22.54 77.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.311 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 44.5 t -97.98 137.61 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 66' ' ' PRO . 58.2 t -75.58 116.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . 0.579 HG21 ' OE2' ' A' ' 39' ' ' GLU . 63.2 p -95.37 -28.57 14.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.48 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 17.7 m -102.72 148.83 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.304 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 11' ' ' PRO . 23.3 t -64.18 106.84 1.05 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.37 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.584 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 24.0 Cg_exo -59.42 99.04 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 121.952 1.768 . . . . 0.0 111.744 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.19 156.74 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.293 0.568 . . . . 0.0 111.025 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.2 114.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.634 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.895 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.166 0 N-CA-C 112.584 -0.207 . . . . 0.0 112.584 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 7.1 ttmt -57.26 143.27 40.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -99.22 -26.36 14.21 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -142.38 130.64 22.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.843 0.354 . . . . 0.0 110.082 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.684 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 30.1 m-90 -110.86 73.11 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.255 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.855 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -59.89 -35.57 93.3 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.363 2.042 . . . . 0.0 111.676 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -63.01 -11.84 21.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.519 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' A' ' 21' ' ' ALA . 35.9 mt -83.69 -22.69 31.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.761 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG21 HG22 ' A' ' 65' ' ' VAL . 43.4 t -56.72 114.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.82 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.98 -11.16 29.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.373 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -97.39 161.05 13.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.288 . . . . 0.0 110.71 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -58.72 142.24 50.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -50.87 -31.89 25.22 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.187 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -47.13 63.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -34.49 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.118 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.27 -60.27 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.768 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -51.55 -42.23 61.68 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.156 0.503 . . . . 0.0 110.095 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -58.59 -48.11 82.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.288 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.615 ' CB ' HD21 ' A' ' 13' ' ' LEU . 13.4 m -59.84 -41.56 91.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.643 HG13 ' CH2' ' A' ' 10' ' ' TRP . 59.7 t -65.72 -57.09 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.78 0.324 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.47 -22.58 67.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.721 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.71 -55.5 3.95 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.116 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.44 -33.14 75.26 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.443 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.41 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.8 t-20 -127.41 76.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.309 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -2.64 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.096 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.64 -1.45 57.87 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' CG ' ' A' ' 29' ' ' ASN . 13.3 m -141.39 169.38 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.79 142.6 49.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.385 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -107.4 136.91 46.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 111.966 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 51' ' ' ARG . 19.3 mt -101.93 108.99 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.647 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.5 t -79.85 120.95 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.185 0.517 . . . . 0.0 110.659 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.601 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -148.76 159.29 44.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -89.96 161.93 15.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.262 0.553 . . . . 0.0 111.815 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.19 123.49 6.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.527 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.8 -7.35 55.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.985 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 47.9 t -66.44 -167.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.419 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -71.9 94.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.096 0.474 . . . . 0.0 110.236 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.526 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -123.04 91.98 3.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.385 0.612 . . . . 0.0 111.533 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -81.5 151.98 27.54 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -79.81 -25.0 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.48 159.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.9 t80 -104.54 132.97 50.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.0 111.596 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 28.0 mtp85 -147.28 110.9 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.838 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.1 t -56.35 -47.5 78.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.198 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -79.22 3.53 17.57 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.818 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.1 ttp180 -122.22 110.29 15.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 68' ' ' ILE . 86.9 t -111.91 121.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.21 128.9 34.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.31 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.3 t -121.88 80.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.838 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.1 mt -80.08 127.63 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.237 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.9 m -124.09 159.96 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -84.82 -171.39 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.54 -20.63 48.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -95.98 12.76 29.26 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.58 23.9 72.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.967 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.6 t -96.89 137.58 24.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 66' ' ' PRO . 44.3 t -75.84 114.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.089 0.471 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -94.55 -34.6 12.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.981 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -94.42 142.26 27.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -61.87 103.59 0.4 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 31.6 Cg_exo -54.47 95.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.603 1.535 . . . . 0.0 111.385 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -128.13 143.25 51.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.119 0.485 . . . . 0.0 110.934 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.612 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -44.23 109.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.663 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.703 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.327 0 N-CA-C 112.36 -0.296 . . . . 0.0 112.36 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.638 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.9 ttmt -77.93 151.11 33.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.614 0.245 . . . . 0.0 110.598 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -109.88 -13.07 14.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.9 128.89 11.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.891 0.376 . . . . 0.0 110.056 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.843 ' CH2' HG13 ' A' ' 25' ' ' VAL . 31.0 m-90 -114.82 70.06 2.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.4 Cg_endo -58.7 -34.11 98.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.164 1.91 . . . . 0.0 111.617 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.48 -12.93 35.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.414 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.7 mt -81.67 -22.64 37.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.708 0.289 . . . . 0.0 110.506 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 65' ' ' VAL . 46.9 t -56.95 113.46 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -10.99 29.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.321 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 171.74 8.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.643 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 p -68.4 142.53 55.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.912 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.28 -31.67 35.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.035 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -71.08 -46.22 62.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.309 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.14 -35.46 78.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.812 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.28 -63.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.219 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -50.57 -35.9 32.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.694 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.11 -46.28 78.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.271 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 13' ' ' LEU . 35.0 m -59.88 -41.37 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 10' ' ' TRP . 17.2 t -66.44 -50.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.73 0.3 . . . . 0.0 111.329 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.44 -31.7 72.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.506 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.25 -51.04 10.0 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.813 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.19 -37.81 81.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.582 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.1 t-20 -119.55 80.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.121 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -5.86 2.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -96.45 6.53 48.55 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.582 HG22 ' CG ' ' A' ' 29' ' ' ASN . 10.8 m -144.71 169.21 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.338 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.736 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -131.78 138.14 48.45 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.096 0.474 . . . . 0.0 110.852 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.16 131.98 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.736 HD11 ' NE2' ' A' ' 33' ' ' HIS . 3.6 mp -107.04 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.991 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 47.8 t -80.37 119.59 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 111.257 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.765 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -147.79 153.21 38.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.254 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 157.12 19.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 111.786 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 55' ' ' ILE . 4.0 pt-20 -50.86 118.1 2.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -7.11 31.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -61.43 -178.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.82 92.79 9.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.126 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.23 121.04 31.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.241 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.01 156.56 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -24.79 24.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -48.41 141.51 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 68' ' ' ILE . 28.9 t80 -83.26 133.77 34.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 11.2 mtm180 -146.12 114.32 6.63 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.794 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.483 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -60.07 -37.83 81.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.533 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -79.79 1.51 26.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.468 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 41.4 ttp180 -126.77 129.63 48.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.966 0.412 . . . . 0.0 111.429 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 25' ' ' VAL . 44.8 t -128.7 112.77 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.765 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.43 133.73 37.45 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 109.995 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.4 t -119.11 90.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.799 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 64' ' ' SER . 1.8 mp -79.68 119.57 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.4 m -116.51 161.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.4 -174.09 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.41 -22.07 52.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.593 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -17.14 29.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.23 22.42 13.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.928 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.3 t -99.6 143.97 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' A' ' 21' ' ' ALA . 33.5 t -73.75 115.84 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 0.0 111.023 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 p -95.7 -31.99 12.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 p -105.56 159.03 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -68.07 104.56 0.71 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.825 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.58 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 32.3 Cg_exo -59.05 100.3 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.867 1.711 . . . . 0.0 111.233 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.03 152.56 49.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.262 0.553 . . . . 0.0 111.099 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -47.71 109.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.644 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.656 -179.114 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 120.925 0.181 . . . . 0.0 112.762 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.6 ttmm -50.85 147.46 4.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.658 0.266 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -111.19 -1.53 16.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.02 132.37 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.877 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.9 m-90 -119.45 72.13 13.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.885 0.374 . . . . 0.0 111.534 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.915 ' HA ' HG13 ' A' ' 65' ' ' VAL . 15.2 Cg_endo -57.34 -35.71 98.88 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.166 1.91 . . . . 0.0 111.694 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.93 -10.42 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 16.7 mt -80.35 -22.85 40.98 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.338 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 65' ' ' VAL . 38.8 t -58.67 112.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.23 22.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -102.88 -174.64 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.623 0.249 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 p -83.03 140.32 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -49.63 -29.88 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.14 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.66 -47.9 51.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.427 ' HE2' ' HA ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -64.81 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.57 -62.2 1.53 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.29 -35.93 63.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.037 0.446 . . . . 0.0 110.452 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.5 -45.35 79.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.403 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.3 m -59.41 -40.61 87.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.877 HG13 ' CH2' ' A' ' 10' ' ' TRP . 13.7 t -66.39 -56.2 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.73 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.608 0.242 . . . . 0.0 111.331 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 30.2 ttp180 -80.75 -57.39 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.775 0.321 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.14 -33.13 75.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.444 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.549 ' OD1' HG13 ' A' ' 32' ' ' VAL . 44.7 t-20 -125.62 79.71 1.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -0.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.309 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.5 t-20 -100.37 0.18 39.45 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.607 -179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 68' ' ' ILE . 10.1 m -129.27 167.98 23.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.47 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.464 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -131.59 124.63 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.41 137.91 38.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 33' ' ' HIS . 27.7 mt -110.12 119.25 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 68.1 t -83.29 116.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.566 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.78 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -135.31 154.21 51.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.374 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.53 19.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.231 0.539 . . . . 0.0 111.779 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -45.76 117.89 1.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.476 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 1.09 41.34 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.863 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 34.4 t -67.61 -167.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 101.08 13.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.94 99.8 6.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 111.638 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -74.47 155.7 37.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.071 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.045 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.18 141.52 1.76 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.5 t80 -90.02 133.97 34.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 111.813 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -152.64 111.98 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.273 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.499 ' O ' HG12 ' A' ' 68' ' ' ILE . 73.8 m -58.86 -37.11 75.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.582 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -79.77 -1.42 38.62 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -122.99 108.67 13.19 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.984 0.421 . . . . 0.0 111.57 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 68' ' ' ILE . 94.4 t -111.88 120.04 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.828 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.78 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.5 m95 -78.63 125.24 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.429 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.2 88.13 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 23.0 mt -80.1 125.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.267 0.556 . . . . 0.0 111.827 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.4 m -124.56 164.6 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.461 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -84.57 -177.11 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -54.6 -25.44 26.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.787 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -88.38 -22.66 23.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.618 0.246 . . . . 0.0 111.358 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.08 22.67 7.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.232 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 58.3 t -96.14 135.41 30.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' A' ' 21' ' ' ALA . 61.5 t -70.18 112.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.911 0.386 . . . . 0.0 110.811 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.5 p -97.1 -30.33 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.547 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -100.85 147.64 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.136 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.9 t -64.7 103.46 0.43 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 64' ' ' SER . 39.8 Cg_endo -64.76 108.54 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.116 1.877 . . . . 0.0 111.543 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -137.95 148.7 45.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.173 0.511 . . . . 0.0 111.346 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.752 HD11 HG11 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.28 113.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.61 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.808 -179.224 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.45 -0.378 0 CA-C-O 121.066 0.259 . . . . 0.0 112.92 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.2 ttmm -67.52 157.47 34.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.674 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -115.37 -9.92 12.09 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -152.69 129.13 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.621 0.248 . . . . 0.0 110.607 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.831 ' CH2' HG13 ' A' ' 25' ' ' VAL . 26.7 m-90 -115.48 72.85 3.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.767 0.318 . . . . 0.0 111.479 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.892 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.15 -34.53 94.21 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.166 1.91 . . . . 0.0 111.506 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -64.5 -12.05 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.684 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.6 mt -81.94 -20.36 38.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 11' ' ' PRO . 47.2 t -55.44 114.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.43 -9.92 33.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.286 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -95.6 157.1 16.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.751 0.31 . . . . 0.0 110.502 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 p -59.37 141.28 54.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.51 -30.27 19.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.32 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.02 -53.15 15.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -37.11 82.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.359 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.14 -56.68 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.414 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.31 -36.64 63.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.336 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.19 88.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.316 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.0 m -59.72 -44.11 93.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.644 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.831 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.5 t -65.09 -51.99 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 33' ' ' HIS . 2.5 mt-10 -64.53 -30.06 71.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.668 0.27 . . . . 0.0 111.449 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -79.5 -55.2 5.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -64.54 -34.59 78.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.554 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.4 t-20 -124.77 80.02 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.744 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -65.16 -5.71 7.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.559 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -89.85 -2.05 58.12 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 68' ' ' ILE . 4.5 m -137.52 171.23 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.506 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -134.2 136.03 43.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.352 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.65 125.45 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.611 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.889 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 3.1 mp -94.22 143.12 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.782 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 72.6 t -99.63 114.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.646 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -142.19 144.91 33.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.986 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 153.31 24.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.337 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 107.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 -10.19 6.05 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -67.58 160.21 28.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.362 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.72 7.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.468 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.513 ' HG2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -120.55 139.45 52.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.83 0.347 . . . . 0.0 111.008 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.26 161.07 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -96.78 -24.15 16.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -41.88 163.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.333 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -102.23 130.59 48.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 20.9 mtp180 -145.96 113.22 6.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.56 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 68' ' ' ILE . 43.0 m -58.45 -39.83 80.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.618 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 23.7 p-10 -79.52 2.68 21.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD11 ' A' ' 35' ' ' ILE . 43.1 ttp180 -124.92 119.14 27.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.954 0.407 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 25' ' ' VAL . 48.6 t -122.02 116.39 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -78.82 124.29 28.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 110.73 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 42.2 t -106.07 87.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 55' ' ' ILE . 4.1 mp -80.15 114.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.8 m -119.26 165.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.507 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -85.34 -173.48 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.71 -21.69 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -89.63 -13.0 38.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.535 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.83 24.91 16.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.083 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 22.0 t -101.16 134.9 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 66' ' ' PRO . 91.1 t -68.27 107.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 110.539 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.7 p -90.05 -32.85 16.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.863 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -104.01 152.99 21.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 11' ' ' PRO . 25.6 t -64.89 106.47 1.01 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.441 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HG3' HG11 ' A' ' 62' ' ' VAL . 17.3 Cg_exo -60.81 90.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.825 1.683 . . . . 0.0 111.394 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -121.0 146.82 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 111.468 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -45.77 117.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.673 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.281 0 N-CA-C 112.666 -0.174 . . . . 0.0 112.666 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.1 ttmt -67.85 145.59 54.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.705 0.288 . . . . 0.0 110.521 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' HD12 ' A' ' 68' ' ' ILE . 15.4 m-20 -105.5 -5.81 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.81 128.31 4.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.689 0.281 . . . . 0.0 110.367 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.776 ' CH2' HG13 ' A' ' 25' ' ' VAL . 25.3 m-90 -112.62 69.89 1.09 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.44 -37.33 94.93 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.011 1.807 . . . . 0.0 111.938 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -65.05 -5.99 7.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 28.4 mt -84.44 -18.95 34.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.661 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.64 113.56 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.571 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.16 19.86 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.386 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.49 156.36 17.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.583 0.23 . . . . 0.0 110.661 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 7.6 p -56.8 145.73 28.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 111.43 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -53.76 -32.35 47.45 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.204 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.82 -47.14 66.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -44.13 97.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.271 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.25 -52.64 64.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.19 65.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.39 93.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.32 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.416 HG21 HD21 ' A' ' 13' ' ' LEU . 39.7 m -61.77 -43.46 98.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.596 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.776 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.5 t -66.9 -48.45 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.192 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.21 -31.05 71.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.395 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -81.62 -53.39 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.022 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -65.17 -33.22 75.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.66 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.422 ' CG ' ' HA3' ' A' ' 6' ' ' GLY . 55.6 t-20 -127.99 81.28 2.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 30' ' ' ARG . 1.1 ptm180 -63.3 -8.39 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.432 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -87.16 -1.32 57.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.605 0.241 . . . . 0.0 111.587 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 3.9 m -140.07 173.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.519 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -134.06 136.5 44.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.5 125.76 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.116 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.63 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 15.4 mt -98.28 111.29 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.571 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.662 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.7 p -79.67 125.29 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.565 0.698 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.679 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.96 148.86 22.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.023 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.75 158.14 17.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 111.807 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.17 123.69 4.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.201 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.41 -11.98 33.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 42.4 t -68.27 -166.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.881 0.372 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 100.0 12.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.191 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.21 96.58 4.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.265 0.555 . . . . 0.0 111.328 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.49 150.17 48.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.227 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.31 -25.06 31.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.31 141.13 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -84.78 132.25 34.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.266 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.05 109.38 4.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 55.5 m -59.61 -34.15 72.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.712 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 9.9 p-10 -79.12 -3.31 44.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.785 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -123.66 135.13 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.13 117.25 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.585 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.679 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.67 131.37 36.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.094 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.662 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 33.8 t -116.0 89.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.014 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 10.4 mm -79.72 121.33 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.358 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 18' ' ' GLY . 28.6 m -122.31 163.8 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.206 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -84.09 -177.33 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.347 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.8 -22.1 22.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.602 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -90.73 -21.88 21.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.552 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 22.04 7.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.266 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.1 t -101.27 134.23 42.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 66' ' ' PRO . 61.3 t -65.33 114.85 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.419 . . . . 0.0 111.081 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -96.9 -33.11 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 68.1 m -105.03 158.57 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 111.36 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.7 t -65.88 117.01 37.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.394 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 62' ' ' VAL . 2.4 Cg_endo -79.28 93.53 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.552 2.168 . . . . 0.0 110.673 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 12.6 p-80 -125.8 151.41 46.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.088 0.47 . . . . 0.0 111.218 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -40.75 110.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.897 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.655 -179.014 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.28 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 31.4 ttmt -66.42 150.5 48.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.594 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.35 -19.03 13.71 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -149.66 127.5 11.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 0.0 110.081 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.714 ' CH2' HG13 ' A' ' 25' ' ' VAL . 27.5 m-90 -110.34 68.93 0.54 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.388 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.878 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.5 Cg_endo -58.63 -36.56 97.1 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.999 1.799 . . . . 0.0 111.513 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -64.51 -9.36 18.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.922 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.2 mt -79.95 -21.2 44.07 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.442 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 60.7 t -55.25 117.85 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.48 -14.21 27.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.4 mmtt -95.8 158.72 15.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.666 0.27 . . . . 0.0 110.679 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.6 p -57.98 143.59 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.116 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.29 -31.48 20.11 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.255 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -45.92 60.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.712 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -39.01 92.47 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -62.97 -60.76 3.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.384 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.503 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -51.25 -44.09 61.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.431 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.97 -45.79 93.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.299 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.44 HG21 HD21 ' A' ' 13' ' ' LEU . 91.6 m -56.86 -43.18 80.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.714 HG13 ' CH2' ' A' ' 10' ' ' TRP . 57.2 t -65.91 -54.08 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.332 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt-10 -63.61 -27.08 68.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.421 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.64 -56.48 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.695 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -61.72 -35.74 78.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 110.025 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -126.02 75.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.64 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -62.58 0.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.464 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -93.56 -5.0 49.93 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.252 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 49' ' ' CYS . 4.2 m -140.51 166.45 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -126.94 145.48 50.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.415 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.26 137.38 46.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.489 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 18.1 mt -106.29 113.7 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.616 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -78.88 120.26 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.389 0.614 . . . . 0.0 111.072 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.648 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.9 OUTLIER -145.12 154.91 42.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.99 -179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 156.75 17.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.315 0.579 . . . . 0.0 112.014 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.61 110.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.06 -3.79 12.81 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.362 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 30.9 t -67.62 -176.01 0.58 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 110.585 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -90.52 101.36 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ptp -127.83 103.77 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 p -63.66 152.54 38.72 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -24.32 36.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.293 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -44.5 147.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 68' ' ' ILE . 72.2 t80 -93.46 135.16 34.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.435 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.4 mtm180 -147.97 112.02 5.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.559 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.503 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.5 OUTLIER -59.42 -36.59 76.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 20.8 p-10 -79.75 0.2 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 44.8 ttp180 -127.91 124.88 38.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 111.444 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 68' ' ' ILE . 48.6 t -122.84 118.32 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.108 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.648 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.5 m95 -78.47 133.31 37.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 25.5 t -120.43 90.63 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -81.25 123.78 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.474 0.654 . . . . 0.0 112.184 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.6 m -124.92 165.95 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.01 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -86.73 -172.68 4.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.681 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -21.28 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.501 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.67 -8.68 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.89 25.08 23.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 24.1 t -100.51 135.11 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 16' ' ' LYS . 41.2 t -72.14 114.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 111.434 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -98.74 -31.01 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.507 ' CB ' HD13 ' A' ' 55' ' ' ILE . 1.2 t -99.73 154.05 18.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.878 HG13 ' HA ' ' A' ' 11' ' ' PRO . 34.0 t -68.52 106.89 1.55 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.748 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.673 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 12.8 Cg_exo -65.69 89.29 0.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.868 1.712 . . . . 0.0 111.012 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -123.76 145.67 48.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.839 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -41.17 114.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.074 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.803 -179.435 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.252 0 N-CA-C 112.485 -0.246 . . . . 0.0 112.485 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 ttmm -69.65 154.36 42.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.584 0.23 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' A' ' 68' ' ' ILE . 1.8 t-20 -111.46 -6.41 14.45 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.92 126.7 4.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.315 -0.241 . . . . 0.0 110.362 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.798 ' CH2' HG13 ' A' ' 25' ' ' VAL . 20.0 m-90 -112.52 73.48 1.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.922 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -57.66 -33.47 96.73 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.441 2.094 . . . . 0.0 111.854 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.5 -13.08 37.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.1 mt -81.33 -22.99 38.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 65' ' ' VAL . 24.6 t -60.6 113.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -9.48 20.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -105.95 177.26 4.91 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -66.47 144.75 56.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 0.0 111.338 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -60.32 -28.22 66.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.423 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -72.7 -53.48 11.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 110.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.428 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.5 -30.92 70.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.704 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.85 -61.72 1.9 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.283 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.13 -38.17 50.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 110.129 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.91 -45.2 94.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.412 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.439 ' CB ' HD21 ' A' ' 13' ' ' LEU . 11.4 m -58.49 -43.88 89.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.798 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.2 t -64.28 -60.66 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -59.01 -23.56 62.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 0.0 111.321 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 5.4 tpp180 -81.39 -61.04 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.32 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.11 -31.79 73.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.558 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -127.41 80.86 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.726 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.64 -8.08 5.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.02 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -89.32 -2.68 58.54 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.503 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 49' ' ' CYS . 11.6 m -129.45 168.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 0.0 111.552 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.831 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -133.65 135.14 43.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.328 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . . . -108.1 123.42 48.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.424 . . . . 0.0 111.741 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.831 HD11 ' NE2' ' A' ' 33' ' ' HIS . 3.8 mp -97.87 115.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.468 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 53.4 t -79.72 113.05 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.324 0.583 . . . . 0.0 110.989 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.904 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -134.55 150.16 50.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.962 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -90.02 156.77 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.081 0.467 . . . . 0.0 111.766 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.73 123.88 3.98 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.458 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.1 -3.7 55.39 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.913 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 12.0 t -67.62 -179.32 1.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.955 0.407 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -86.02 101.68 13.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -129.73 100.05 5.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.098 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 p -59.37 147.31 36.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.099 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.91 -25.06 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.159 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.81 160.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.405 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.1 t80 -104.0 131.11 51.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.423 . . . . 0.0 111.61 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 48' ' ' ARG . 5.2 mtm180 -145.22 109.36 4.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.308 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -60.01 -33.32 71.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.536 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -79.51 -2.97 44.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.626 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -121.11 142.76 49.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 111.478 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.511 HG21 HG11 ' A' ' 25' ' ' VAL . 94.2 t -138.68 114.28 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.819 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.904 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.69 131.55 36.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.706 0.288 . . . . 0.0 110.484 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 66' ' ' PRO . 11.3 t -119.21 88.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.101 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mt -79.84 122.15 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.8 m -121.26 164.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.433 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -87.91 -174.64 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -58.11 -23.48 55.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.55 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -86.04 -20.44 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 111.162 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.67 22.66 10.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.165 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 19.2 t -98.78 144.7 11.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.55 HG11 ' HD3' ' A' ' 66' ' ' PRO . 48.0 t -75.58 112.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.993 0.425 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 p -94.04 -31.45 14.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.558 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -103.48 154.01 19.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.922 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.7 t -66.12 101.36 0.28 Allowed Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.736 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 54' ' ' VAL . 19.1 Cg_endo -57.75 92.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.618 1.545 . . . . 0.0 110.827 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 16.1 p-80 -122.67 153.76 38.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.53 115.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.792 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.941 -179.422 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . . . . . . 0 N--CA 1.452 -0.249 0 CA-C-O 121.042 0.245 . . . . 0.0 113.061 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 33.3 ttmt -66.73 146.83 54.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.795 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.728 ' HA ' HD12 ' A' ' 68' ' ' ILE . 10.1 m-20 -107.03 -4.2 19.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.32 134.51 7.31 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.808 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -119.73 68.15 11.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.852 ' HA ' HG13 ' A' ' 65' ' ' VAL . 54.5 Cg_exo -50.29 -37.35 49.7 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.283 1.989 . . . . 0.0 112.348 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.92 -13.48 25.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.968 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.695 HD22 ' HA ' ' A' ' 21' ' ' ALA . 24.8 mt -80.51 -23.42 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.67 0.272 . . . . 0.0 110.663 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.612 HG21 HG22 ' A' ' 65' ' ' VAL . 59.4 t -53.71 112.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.798 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -12.01 29.96 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.231 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -94.23 157.11 16.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.786 0.327 . . . . 0.0 110.875 179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -56.82 141.33 44.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.38 -31.59 20.98 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.319 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.35 -45.54 59.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.14 -42.08 99.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.043 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -62.56 -56.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.711 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.51 64.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.65 -45.23 93.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.5 m -58.27 -42.1 85.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.883 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' VAL . . . . . 0.808 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -67.35 -58.05 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.337 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.15 -24.89 66.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.46 0.171 . . . . 0.0 111.446 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 17.8 ttp180 -83.9 -58.72 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.833 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.98 -29.55 70.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.999 0.428 . . . . 0.0 110.269 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 32' ' ' VAL . 50.0 t-20 -131.0 85.07 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -8.57 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.25 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.76 -10.03 52.21 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 49' ' ' CYS . 13.7 m -115.06 175.5 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 112.062 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CE1' ' CG1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -143.48 125.36 15.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.549 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 129.63 44.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.12 0.485 . . . . 0.0 112.007 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.624 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 27.0 mt -106.82 119.64 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -79.45 132.45 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.369 0.604 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.826 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -157.03 150.94 24.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.17 153.87 20.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.165 0.507 . . . . 0.0 111.585 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 55' ' ' ILE . 10.9 pt-20 -49.06 115.48 1.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.31 -1.85 25.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -69.71 -177.22 1.2 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.839 0.352 . . . . 0.0 110.655 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.52 104.86 17.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -124.14 106.52 10.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.305 -178.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -56.47 147.76 21.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.079 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 mmpp? -84.54 -26.13 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.954 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.93 138.24 5.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -84.81 130.34 34.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 3.9 mtp85 -144.71 112.25 6.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' CYS . . . . . 0.957 ' O ' HG12 ' A' ' 32' ' ' VAL . 90.9 m -63.95 -13.67 47.79 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.752 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 48' ' ' ARG . 18.8 p-10 -97.88 -4.7 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.646 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -122.35 143.31 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 111.35 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 25' ' ' VAL . 59.6 t -139.36 118.47 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.645 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TRP . . . . . 0.826 ' CE3' HD21 ' A' ' 37' ' ' LEU . 4.9 m95 -78.42 135.2 37.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.253 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 43.1 t -120.13 89.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.053 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 43' ' ' MET . 6.0 mt -81.98 126.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.016 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.8 m -123.47 165.27 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.798 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -88.13 -172.72 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.964 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.62 -21.98 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -95.48 -8.85 34.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.78 21.97 24.72 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.537 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 t -96.38 140.66 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 16' ' ' LYS . 40.4 t -72.65 112.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.804 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.1 p -94.45 -32.41 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.567 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.563 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 9.0 t -100.82 146.41 27.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.7 t -62.73 101.44 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.1 Cg_endo -57.91 99.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.034 1.823 . . . . 0.0 111.647 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -127.98 152.83 47.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.115 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -49.72 116.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.453 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' THR . . . . . 0.402 ' OXT' HG22 ' A' ' 69' ' ' THR . 5.7 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.979 -179.353 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.051 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 18.7 t -75.65 94.88 3.28 Favored 'General case' 0 CA--C 1.569 1.693 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 7.9 mtp-105 -152.67 70.91 0.91 Allowed 'General case' 0 C--N 1.345 0.395 0 C-N-CA 124.748 1.219 . . . . 0.0 110.953 178.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.6 mmm180 -151.12 88.91 1.48 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.699 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 11.3 m -88.37 148.28 42.02 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.802 179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -68.72 160.84 47.88 Favored 'Trans proline' 0 N--CA 1.457 -0.676 0 C-N-CA 122.133 1.889 . . . . 0.0 112.162 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.493 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . 74.43 158.46 6.01 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.296 -0.954 . . . . 0.0 112.443 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 25.5 ttmt -56.11 142.81 35.26 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.705 0.288 . . . . 0.0 110.68 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -100.77 -11.34 19.97 Favored 'General case' 0 N--CA 1.465 0.319 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -178.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.449 ' CB ' ' HB3' ' A' ' 67' ' ' HIS . . . -155.47 140.2 17.08 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.239 -0.282 . . . . 0.0 110.239 -179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.699 ' CH2' HG13 ' A' ' 25' ' ' VAL . 17.1 m-90 -121.2 68.58 18.75 Favored Pre-proline 0 C--N 1.325 -0.483 0 C-N-CA 120.869 -0.332 . . . . 0.0 111.374 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.775 ' HA ' HG13 ' A' ' 65' ' ' VAL . 67.3 Cg_exo -49.74 -36.18 41.07 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.183 1.922 . . . . 0.0 112.177 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.0 pm0 -64.12 -8.33 11.79 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.276 -179.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.611 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.9 mt -83.71 -20.1 34.07 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.686 0.279 . . . . 0.0 110.695 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 11' ' ' PRO . 44.1 t -56.57 114.01 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.823 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.92 -8.1 31.5 Favored Glycine 0 N--CA 1.449 -0.457 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.35 -179.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.723 ' O ' HG23 ' A' ' 62' ' ' VAL . 3.2 mmtt -99.25 157.9 16.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.754 0.312 . . . . 0.0 110.716 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.7 p -56.99 139.43 52.17 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.496 -0.32 . . . . 0.0 110.951 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.401 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -51.58 -29.16 23.96 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.512 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -74.22 -46.69 40.13 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.784 0.326 . . . . 0.0 110.666 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.401 ' HG2' ' HD2' ' A' ' 16' ' ' LYS . 7.0 tpt -65.25 -33.87 77.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.032 0.444 . . . . 0.0 109.829 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.611 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -66.4 -60.88 2.35 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.367 179.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -50.71 -42.72 57.4 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 179.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.15 -46.13 91.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.429 179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.8 m -57.03 -40.47 76.77 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.84 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.699 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -66.0 -54.98 21.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.315 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -64.76 -26.05 68.19 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.609 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.571 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -83.46 -56.22 3.87 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.683 0.277 . . . . 0.0 111.186 179.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 16.5 mt-10 -63.05 -30.52 71.67 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.073 0.463 . . . . 0.0 110.322 179.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.493 ' ND2' ' HA3' ' A' ' 6' ' ' GLY . 50.2 t-20 -127.84 85.04 2.3 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.783 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -8.17 3.65 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.621 -0.718 . . . . 0.0 112.233 -179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -95.04 2.42 55.25 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.742 HG12 ' O ' ' A' ' 49' ' ' CYS . 30.6 m -129.09 167.67 23.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.209 0 C-N-CA 120.683 -0.407 . . . . 0.0 111.778 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -133.1 128.44 36.14 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.673 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.73 144.07 31.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.233 0.54 . . . . 0.0 112.139 -178.38 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.573 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.3 mt -120.19 143.46 31.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.265 -0.879 . . . . 0.0 110.159 179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.494 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 58.3 t -97.49 130.67 45.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.092 0.473 . . . . 0.0 111.765 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -157.72 151.88 24.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.97 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.415 ' HG3' HG23 ' A' ' 56' ' ' VAL . 1.3 mtpt -87.31 161.06 18.16 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.249 0.547 . . . . 0.0 112.405 -178.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.535 ' HA ' ' CG2' ' A' ' 55' ' ' ILE . 5.8 tt0 -54.12 119.29 4.89 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.228 179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.71 3.02 56.28 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.685 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.412 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 3.1 t -64.24 131.9 48.73 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 121.06 0.457 . . . . 0.0 110.908 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -66.86 81.85 0.11 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.656 179.435 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.775 ' HG3' HD13 ' A' ' 37' ' ' LEU . 13.5 mmt -113.94 164.24 14.05 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 120.886 0.374 . . . . 0.0 111.453 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -62.2 164.02 7.49 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.338 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -117.23 -25.73 7.0 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.323 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.1 p30 -52.04 171.95 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.131 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.446 ' CE1' ' CG2' ' A' ' 68' ' ' ILE . 33.4 t80 -97.96 128.4 44.5 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.962 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 51.9 mtp85 -143.87 111.2 5.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.501 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.742 ' O ' HG12 ' A' ' 32' ' ' VAL . 18.4 m -60.25 -35.96 76.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.203 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.457 ' HA ' ' HA ' ' A' ' 32' ' ' VAL . 16.2 p-10 -78.81 -3.48 44.71 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 121.024 -0.27 . . . . 0.0 111.442 -179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 40.8 ttp180 -123.04 129.99 52.21 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.194 0.521 . . . . 0.0 111.784 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 68' ' ' ILE . 84.6 t -133.16 119.79 37.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.358 178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.86 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.7 m95 -78.9 130.93 36.16 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.242 0.544 . . . . 0.0 111.384 -178.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 55.1 t -113.16 84.38 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.522 0 CA-C-N 115.356 -0.838 . . . . 0.0 109.01 178.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.65 HD13 ' HB3' ' A' ' 64' ' ' SER . 2.5 mp -79.87 118.4 27.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.62 -178.656 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.571 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 29.8 m -122.93 165.72 18.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 115.201 -0.909 . . . . 0.0 111.236 -179.492 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.17 -172.62 3.72 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.701 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -58.92 -23.36 61.24 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.379 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 13.3 t-80 -90.65 2.93 55.45 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.903 0.334 . . . . 0.0 111.903 -179.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.13 25.09 64.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.394 -0.907 . . . . 0.0 112.166 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.571 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.0 t -100.22 132.88 44.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 110.223 -0.288 . . . . 0.0 110.223 179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.723 HG23 ' O ' ' A' ' 16' ' ' LYS . 46.2 t -68.1 108.99 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.952 0.406 . . . . 0.0 110.528 -179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.6 p -93.06 -33.8 13.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.155 -179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.65 ' HB3' HD13 ' A' ' 55' ' ' ILE . 22.9 t -102.2 157.15 17.1 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 110.848 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.775 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.1 t -69.58 123.39 88.4 Favored Pre-proline 0 C--N 1.326 -0.443 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.393 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.562 ' HG2' HD12 ' A' ' 13' ' ' LEU . 91.5 Cg_endo -81.99 101.77 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.808 0 C-N-CA 122.313 2.009 . . . . 0.0 110.576 178.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.542 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.7 p-80 -132.26 145.98 51.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-O 120.931 0.396 . . . . 0.0 111.08 -179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.668 HD11 HG11 ' A' ' 32' ' ' VAL . 1.1 mt -39.34 106.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.674 179.081 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 23.7 m . . . . . 0 C--O 1.246 0.916 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.78 -179.077 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.073 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 83.3 p -74.11 82.37 1.78 Allowed 'General case' 0 CA--C 1.571 1.779 0 N-CA-C 114.749 1.388 . . . . 0.0 114.749 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.53 60.01 1.21 Allowed 'General case' 0 C--N 1.344 0.338 0 C-N-CA 124.303 1.041 . . . . 0.0 110.927 -172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 24.8 mmt180 -151.35 89.23 1.49 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.335 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.5 m -71.69 136.77 83.03 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.809 -179.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -70.61 164.69 34.47 Favored 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.06 1.84 . . . . 0.0 112.541 -179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 74.34 163.89 10.36 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.735 179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.466 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 26.2 ttmt -59.62 154.11 18.45 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.816 0.341 . . . . 0.0 111.31 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -115.92 -5.55 12.02 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.439 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -155.32 124.61 6.3 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.903 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.0 m-90 -111.4 74.93 1.2 Allowed Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.869 -178.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.861 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.6 Cg_endo -59.49 -35.67 95.34 Favored 'Trans proline' 0 N--CA 1.463 -0.288 0 C-N-CA 121.986 1.791 . . . . 0.0 111.604 179.162 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -65.0 -9.89 25.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.861 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 26.8 mt -82.81 -19.8 36.97 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.719 0.295 . . . . 0.0 110.552 179.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.549 HG23 ' O ' ' A' ' 11' ' ' PRO . 45.2 t -55.47 111.03 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-O 120.91 0.386 . . . . 0.0 110.915 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.6 -9.76 23.86 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.118 -179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.732 ' O ' HG23 ' A' ' 62' ' ' VAL . 6.0 mmtt -95.43 157.84 15.72 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.725 0.297 . . . . 0.0 110.733 179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 10.5 p -59.51 138.5 57.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.521 -0.308 . . . . 0.0 110.763 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.25 -31.63 8.92 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.084 179.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.73 -47.38 63.31 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.985 0.421 . . . . 0.0 110.268 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.2 -33.1 75.2 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.871 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.752 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.67 -59.5 4.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.507 179.261 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.674 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -55.49 -41.73 73.45 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.559 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.22 -46.63 89.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.498 179.44 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.435 HG21 HD21 ' A' ' 13' ' ' LEU . 88.0 m -57.83 -43.75 85.99 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.583 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.903 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -63.68 -52.05 62.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.854 179.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 10.1 mt-10 -63.82 -29.14 70.37 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.519 -179.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.45 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -78.66 -57.11 3.93 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.741 0.305 . . . . 0.0 110.836 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -64.4 -35.22 80.21 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.019 0.438 . . . . 0.0 110.454 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.513 ' CG ' HG22 ' A' ' 32' ' ' VAL . 49.3 t-20 -123.16 78.86 1.61 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.587 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.24 -3.15 0.8 Allowed 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.609 -179.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -93.64 -5.05 49.55 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 111.997 0.369 . . . . 0.0 111.997 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.513 HG22 ' CG ' ' A' ' 29' ' ' ASN . 12.8 m -139.72 168.52 17.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.59 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -133.58 146.79 51.31 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.684 179.067 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.06 138.72 44.96 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.504 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.657 ' N ' HD12 ' A' ' 35' ' ' ILE . 3.1 mp -105.09 120.55 55.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.623 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.5 p -80.43 129.76 37.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 121.133 0.492 . . . . 0.0 111.579 -179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.895 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.46 152.35 27.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.19 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.874 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.1 OUTLIER -89.67 155.1 19.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.238 0.542 . . . . 0.0 111.946 -179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -48.2 117.11 1.79 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.054 179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.98 -1.97 30.09 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.765 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.414 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 39.7 t -70.11 -172.54 0.56 Allowed 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.756 0.313 . . . . 0.0 110.738 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.414 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -88.87 104.82 17.29 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -127.65 100.95 6.18 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.459 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 7.0 p -58.68 147.55 32.45 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.875 179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 41.3 mttt -80.43 -26.42 38.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.984 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.25 161.12 0.08 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.736 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.485 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.7 t80 -103.81 137.32 41.99 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.612 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 18.4 mtp180 -152.49 112.85 4.06 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.419 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.559 ' O ' HG12 ' A' ' 68' ' ' ILE . 50.3 m -58.45 -37.84 76.28 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.463 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.59 ' O ' ' CD2' ' A' ' 33' ' ' HIS . 21.7 p-10 -79.36 -2.82 43.36 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.48 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 39.7 ttp180 -120.63 111.47 17.68 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.963 0.411 . . . . 0.0 111.609 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG21 HG11 ' A' ' 25' ' ' VAL . 78.9 t -113.15 117.64 55.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.821 178.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.895 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.9 m95 -78.71 128.79 33.91 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.481 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 7.2 t -116.52 98.93 7.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.767 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.694 HD13 ' CD1' ' A' ' 37' ' ' LEU . 9.0 mm -83.87 122.4 37.7 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.289 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.124 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.874 HG23 ' HG3' ' A' ' 38' ' ' LYS . 30.5 m -126.66 168.35 19.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.423 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.0 p30 -89.75 -170.93 2.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.87 -18.83 61.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.77 -179.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 -98.56 -1.8 40.19 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 111.863 0.319 . . . . 0.0 111.863 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 87.14 24.19 38.22 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.346 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.624 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.3 t -96.04 131.92 41.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 179.568 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.752 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.9 t -70.92 112.82 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.94 0.4 . . . . 0.0 111.378 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.1 p -97.14 -33.07 11.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.934 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.427 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 6.8 t -97.86 149.94 21.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.01 0.433 . . . . 0.0 111.218 -179.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 11' ' ' PRO . 21.3 t -66.92 108.36 2.37 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.541 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.441 ' HD2' ' O ' ' A' ' 10' ' ' TRP . 17.2 Cg_exo -62.19 106.14 0.45 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.211 1.941 . . . . 0.0 111.594 179.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -133.13 146.68 51.81 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.418 0.628 . . . . 0.0 111.768 -179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.571 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -47.51 109.34 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.321 -0.854 . . . . 0.0 110.668 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.453 ' OXT' HG22 ' A' ' 69' ' ' THR . 11.4 m . . . . . 0 C--O 1.246 0.891 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.52 -179.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.043 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.345 69.7 p 64.62 -93.37 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 115.577 1.695 . . . . 0.0 115.577 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 13.0 mtp180 58.87 80.11 0.2 Allowed 'General case' 0 C--N 1.355 0.818 0 C-N-CA 127.928 2.491 . . . . 0.0 111.233 172.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.42 98.13 0.09 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.603 179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 61.2 m -106.76 151.53 40.55 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 120.99 0.424 . . . . 0.0 111.203 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -55.49 153.0 30.56 Favored 'Trans proline' 0 N--CA 1.461 -0.424 0 C-N-CA 122.313 2.008 . . . . 0.0 112.542 -179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 70.04 172.12 10.01 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.662 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.469 ' HG2' ' H ' ' A' ' 9' ' ' ALA . 3.6 ttmt -69.67 148.7 48.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.592 0.234 . . . . 0.0 110.546 179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 21.8 m-20 -110.34 -0.16 17.75 Favored 'General case' 0 N--CA 1.467 0.398 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -177.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.469 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -160.48 125.55 3.83 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 110.16 -0.311 . . . . 0.0 110.16 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.896 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -113.39 67.46 1.23 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.767 0.317 . . . . 0.0 111.151 -179.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.888 ' HA ' HG13 ' A' ' 65' ' ' VAL . 9.6 Cg_endo -52.62 -33.67 59.84 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 122.386 2.058 . . . . 0.0 111.907 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.3 pm0 -64.68 -9.2 18.15 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.696 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.845 HD13 ' HB1' ' A' ' 21' ' ' ALA . 18.6 mt -84.18 -18.87 35.24 Favored 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.75 0.309 . . . . 0.0 110.844 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 11' ' ' PRO . 48.6 t -56.84 113.19 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.146 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.746 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 106.5 -12.89 43.25 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.175 -179.468 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.538 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -89.07 162.31 16.07 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.632 0.253 . . . . 0.0 110.646 179.58 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 4.2 p -63.97 137.53 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.765 0.317 . . . . 0.0 110.497 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.41 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -52.58 -29.74 32.9 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.364 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 35.5 t30 -70.1 -54.24 13.89 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-O 121.011 0.434 . . . . 0.0 110.792 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.4 -40.85 95.89 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.303 179.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.845 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.06 -51.42 69.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.495 179.438 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.04 -46.2 75.29 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.373 179.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -61.75 -38.65 88.77 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.498 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 33.2 m -59.64 -45.73 91.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.531 179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.896 HG13 ' CH2' ' A' ' 10' ' ' TRP . 40.3 t -64.7 -50.92 73.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.355 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -63.22 -31.95 73.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.686 0.279 . . . . 0.0 111.419 -179.509 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 3.1 mmm180 -79.4 -56.51 4.28 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.557 -0.292 . . . . 0.0 111.181 -179.615 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 89.5 mt-10 -63.17 -29.31 70.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.822 0.344 . . . . 0.0 110.656 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.708 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.7 t-20 -126.7 79.1 1.84 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.896 179.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 5.8 mtt180 -65.14 -2.88 3.17 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.674 179.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 14.7 t30 -92.9 -9.78 38.92 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-O 120.603 0.24 . . . . 0.0 111.287 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.708 HG22 ' CG ' ' A' ' 29' ' ' ASN . 3.0 m -140.3 169.55 15.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 116.543 -0.299 . . . . 0.0 110.932 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.598 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.3 OUTLIER -133.88 151.06 51.4 Favored 'General case' 0 C--O 1.235 0.342 0 CA-C-O 121.162 0.506 . . . . 0.0 111.129 179.413 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -114.82 137.91 51.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.595 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.551 HD11 ' HG3' ' A' ' 51' ' ' ARG . 3.9 mp -104.86 129.07 58.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.514 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 65.5 t -80.16 128.39 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.04 0.447 . . . . 0.0 110.939 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.727 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -150.67 143.36 24.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.518 -179.222 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.23 157.2 17.81 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.146 0.498 . . . . 0.0 111.468 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -45.95 120.46 2.71 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.251 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.75 3.96 55.92 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.595 -0.812 . . . . 0.0 112.738 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.43 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 14.8 t -70.49 -179.7 2.19 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.911 0.386 . . . . 0.0 110.857 -179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.43 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.64 101.54 14.23 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -127.29 104.85 8.16 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.014 -177.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -55.35 151.44 9.94 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.999 179.768 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.77 -27.59 25.1 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.915 -179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -46.58 134.99 9.0 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.894 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.419 ' CE1' HG22 ' A' ' 68' ' ' ILE . 56.0 t80 -80.44 132.16 35.69 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.555 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.0 mtm180 -146.9 111.82 5.38 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.602 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.471 ' O ' HG11 ' A' ' 32' ' ' VAL . 97.3 m -60.63 -34.11 73.78 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.541 -179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.598 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 19.8 p-10 -79.54 -0.32 32.94 Favored 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.66 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.551 ' HG3' HD11 ' A' ' 35' ' ' ILE . 47.9 ttp180 -126.43 129.49 48.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.008 0.433 . . . . 0.0 111.471 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.511 HG22 ' HA ' ' A' ' 68' ' ' ILE . 52.7 t -128.32 116.26 41.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.15 179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.727 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.9 m95 -78.76 133.89 37.08 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.519 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 29.3 t -115.25 96.38 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.596 HD12 ' H ' ' A' ' 55' ' ' ILE . 4.0 mp -84.47 121.28 36.51 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.172 0.51 . . . . 0.0 111.57 -179.046 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.625 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 27.0 m -125.87 162.61 28.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.551 -0.749 . . . . 0.0 111.013 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -85.84 -179.7 6.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.898 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -55.92 -20.98 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.53 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -88.21 -24.75 23.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.721 0.295 . . . . 0.0 111.227 -179.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.33 21.14 7.81 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.672 -0.775 . . . . 0.0 112.18 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.625 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.6 t -98.28 139.49 20.24 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 16' ' ' LYS . 42.9 t -72.6 111.78 7.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.816 0.341 . . . . 0.0 110.756 -179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 82.3 p -91.19 -31.3 16.24 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.591 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.577 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 48.3 t -107.59 150.13 27.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.869 0.366 . . . . 0.0 111.163 -179.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.888 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.4 t -64.82 102.14 0.31 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.38 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.577 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.9 Cg_endo -58.86 97.49 0.09 OUTLIER 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.114 1.876 . . . . 0.0 111.596 179.163 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.7 OUTLIER -123.68 157.47 33.79 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.256 0.551 . . . . 0.0 111.347 -179.605 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.511 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -51.09 114.06 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.535 179.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.435 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.9 m . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.181 -0.914 . . . . 0.0 110.813 -179.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.121 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 39.4 m -60.03 145.45 46.34 Favored 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 115.528 1.677 . . . . 0.0 115.528 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -156.96 72.62 0.72 Allowed 'General case' 0 C--N 1.349 0.581 0 O-C-N 120.918 -1.114 . . . . 0.0 110.747 -160.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.52 74.36 1.52 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.11 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.494 ' SG ' HD13 ' A' ' 68' ' ' ILE . 2.5 m -111.12 128.22 25.68 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.519 -179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.47 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 12.6 Cg_exo -69.56 63.46 1.68 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 121.981 1.788 . . . . 0.0 111.595 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.423 ' O ' ' C ' ' A' ' 7' ' ' LYS . . . 142.26 148.5 5.0 Favored Glycine 0 N--CA 1.45 -0.368 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.298 -179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.47 ' O ' ' CH2' ' A' ' 10' ' ' TRP . 26.4 ttmt -33.23 143.52 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 CA-C-O 120.634 0.254 . . . . 0.0 111.49 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.916 ' HA ' HD12 ' A' ' 68' ' ' ILE . 5.0 p30 -112.23 -0.54 15.47 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -178.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -157.12 121.46 4.35 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.86 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.2 m-90 -108.79 74.81 0.59 Allowed Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.94 0.4 . . . . 0.0 111.453 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.821 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.8 Cg_endo -60.59 -33.25 93.79 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 122.208 1.939 . . . . 0.0 111.401 179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.9 pm0 -63.7 -14.13 49.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.83 -0.623 . . . . 0.0 111.437 179.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.641 HD22 ' HA ' ' A' ' 21' ' ' ALA . 22.2 mt -81.07 -20.63 41.15 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 120.645 0.259 . . . . 0.0 110.565 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.0 t -57.41 117.34 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.109 0 CA-C-N 116.584 -0.28 . . . . 0.0 110.614 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 103.76 -14.6 53.12 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.565 -0.826 . . . . 0.0 112.14 -179.25 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.17 174.78 8.9 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.622 0.248 . . . . 0.0 110.516 179.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 33.9 p -75.99 144.01 41.18 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.396 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.98 -31.62 40.22 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.522 -0.847 . . . . 0.0 112.084 179.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -69.4 -52.87 22.77 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-O 120.708 0.289 . . . . 0.0 110.894 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.54 -29.97 70.96 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.894 0.378 . . . . 0.0 109.999 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.641 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.73 -60.55 2.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.449 179.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -55.48 -38.1 68.67 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.843 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.425 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.01 -44.58 84.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.632 179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.421 ' CB ' HD21 ' A' ' 13' ' ' LEU . 91.6 m -58.85 -43.12 90.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.72 179.681 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.86 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.3 t -65.61 -51.41 63.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.489 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -65.37 -28.51 69.33 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.57 -179.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 8.0 mtp180 -81.86 -54.75 5.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.699 0.285 . . . . 0.0 110.899 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -63.71 -34.95 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 110.281 179.649 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.415 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.9 t-20 -124.63 80.0 1.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.656 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.31 -5.46 2.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.944 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 20.1 t-20 -93.53 2.52 56.39 Favored 'General case' 0 CA--C 1.528 0.117 0 N-CA-C 111.617 0.229 . . . . 0.0 111.617 -179.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -137.06 170.61 17.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.051 0.453 . . . . 0.0 111.663 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.452 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -137.23 126.65 24.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.321 179.796 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.74 135.98 39.45 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.686 -179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.589 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 34.8 mt -107.38 120.73 59.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.551 -0.749 . . . . 0.0 110.738 179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.631 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.6 p -79.79 128.74 38.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.142 0.496 . . . . 0.0 111.438 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.807 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -157.9 144.72 17.9 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.534 -179.786 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.24 159.31 16.77 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.325 0.584 . . . . 0.0 111.915 -179.166 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -46.67 122.05 3.95 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.061 179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.78 -9.46 29.92 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.616 -0.802 . . . . 0.0 112.594 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.433 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 15.4 t -68.09 -178.09 0.96 Allowed 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.805 0.336 . . . . 0.0 110.71 179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.433 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -89.9 102.7 15.4 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 109.314 -0.624 . . . . 0.0 109.314 179.254 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.564 ' HE1' HD12 ' A' ' 55' ' ' ILE . 2.7 ptp -124.51 100.15 6.52 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.998 -0.547 . . . . 0.0 111.215 -178.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 p -60.09 148.92 34.11 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.601 -0.727 . . . . 0.0 110.053 179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -82.31 -24.56 34.58 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.023 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -45.95 159.36 0.08 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.822 179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -100.82 131.98 46.44 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.064 0.459 . . . . 0.0 111.422 -179.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 38.9 mtp180 -147.04 108.17 4.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.179 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.466 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 48.8 t -60.56 -36.75 79.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.576 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.9 p-10 -79.64 3.46 19.04 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 121.045 -0.262 . . . . 0.0 111.302 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 51.0 ttp180 -129.19 128.06 42.6 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-O 120.985 0.421 . . . . 0.0 111.025 -179.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.609 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.0 t -127.64 119.09 50.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.017 179.266 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.807 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.4 m95 -78.7 130.52 35.91 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.835 0.35 . . . . 0.0 110.182 -179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.631 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 31.1 t -113.83 95.35 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.934 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.564 HD12 ' HE1' ' A' ' 43' ' ' MET . 5.6 mm -79.99 119.9 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.237 0.541 . . . . 0.0 111.675 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.623 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.6 m -124.94 164.89 22.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.254 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -89.72 -171.76 3.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.651 179.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -62.93 -18.18 62.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.496 -179.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 6.1 m80 -96.21 -1.57 47.97 Favored 'General case' 0 C--N 1.332 -0.182 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 84.73 23.85 48.31 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.478 -0.867 . . . . 0.0 112.502 179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.623 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 21.9 t -99.49 137.33 27.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.625 HG21 ' HB2' ' A' ' 21' ' ' ALA . 60.4 t -72.33 109.74 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.923 0.392 . . . . 0.0 110.937 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 73.1 p -93.76 -28.04 16.14 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.996 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.406 ' CB ' ' HB ' ' A' ' 55' ' ' ILE . 4.2 t -106.57 157.7 17.48 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.075 0.464 . . . . 0.0 111.141 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.821 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.0 t -72.19 111.02 9.23 Favored Pre-proline 0 C--N 1.327 -0.394 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.205 179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 7.8 Cg_exo -67.57 103.55 0.83 Allowed 'Trans proline' 0 N--CA 1.458 -0.578 0 C-N-CA 121.664 1.576 . . . . 0.0 110.517 178.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.622 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 6.9 p-80 -131.7 145.2 51.51 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-O 121.013 0.435 . . . . 0.0 111.148 -178.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.916 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -40.82 111.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 115.577 -0.738 . . . . 0.0 111.28 179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.655 ' OXT' HG22 ' A' ' 69' ' ' THR . 16.3 m . . . . . 0 C--O 1.248 0.99 0 CA-C-O 117.854 -1.07 . . . . 0.0 110.051 -179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.143 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.356 82.8 p 71.66 -88.33 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 C-N-CA 124.898 1.279 . . . . 0.0 114.024 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.8 ptt180 -103.22 52.5 0.78 Allowed 'General case' 0 C--N 1.344 0.341 0 C-N-CA 125.07 1.348 . . . . 0.0 110.416 169.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 51.6 mtt-85 -153.68 84.24 1.17 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.263 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 9.4 m -129.76 144.12 51.74 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.27 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -74.94 -178.31 4.06 Favored 'Trans proline' 0 N--CA 1.457 -0.648 0 C-N-CA 122.137 1.891 . . . . 0.0 112.439 -179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.62 169.82 7.2 Favored Glycine 0 N--CA 1.453 -0.223 0 C-N-CA 120.428 -0.892 . . . . 0.0 113.154 179.205 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.641 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.6 tttt -68.24 149.86 48.98 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.593 -0.303 . . . . 0.0 110.484 179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -110.98 -8.33 14.48 Favored 'General case' 0 N--CA 1.464 0.264 0 N-CA-C 113.453 0.908 . . . . 0.0 113.453 -177.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.428 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.58 123.81 3.86 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.865 0.364 . . . . 0.0 110.504 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.641 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 21.7 m-90 -109.52 74.36 0.68 Allowed Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.132 -179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.833 ' HA ' HG13 ' A' ' 65' ' ' VAL . 13.2 Cg_endo -56.11 -37.53 96.26 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.495 2.13 . . . . 0.0 112.174 179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.54 -6.88 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.166 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.534 HD13 ' HB1' ' A' ' 21' ' ' ALA . 15.8 mt -85.37 -21.2 28.96 Favored 'General case' 0 C--N 1.332 -0.164 0 C-N-CA 120.959 -0.296 . . . . 0.0 110.744 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.48 HG21 HG22 ' A' ' 65' ' ' VAL . 43.9 t -56.72 113.05 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.085 0 CA-C-O 120.777 0.322 . . . . 0.0 110.775 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 112.17 -10.53 26.82 Favored Glycine 0 N--CA 1.448 -0.508 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.133 -179.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.674 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.08 157.89 15.87 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.933 0.396 . . . . 0.0 110.928 179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.9 p -56.66 141.66 42.79 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.297 -179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.41 -29.38 38.45 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.462 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -72.46 -45.19 60.68 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.852 0.358 . . . . 0.0 110.514 179.84 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.448 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -65.37 -39.07 91.84 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.141 -0.481 . . . . 0.0 109.75 179.479 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.534 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -61.56 -58.53 7.74 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.027 179.023 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.494 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.71 -38.81 61.3 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.212 178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.518 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -63.26 -46.21 87.89 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-N 115.868 -0.606 . . . . 0.0 110.244 179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.412 ' HB ' HD11 ' A' ' 13' ' ' LEU . 13.1 m -59.97 -42.31 93.87 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.762 179.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.63 HG13 ' CH2' ' A' ' 10' ' ' TRP . 60.4 t -65.57 -51.59 61.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.155 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -66.6 -28.5 68.55 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.749 -179.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.518 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 6.0 mpp_? -82.77 -52.32 6.86 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.704 0.288 . . . . 0.0 111.245 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 73.1 mt-10 -67.32 -31.58 71.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.003 0.43 . . . . 0.0 110.371 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.567 ' CG ' HG22 ' A' ' 32' ' ' VAL . 52.0 t-20 -126.07 76.99 1.64 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.601 179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.7 1.88 0.54 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.196 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 32.5 t30 -95.45 -13.99 24.12 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 121.175 -0.21 . . . . 0.0 111.348 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.567 HG22 ' CG ' ' A' ' 29' ' ' ASN . 5.1 m -134.05 168.37 24.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.173 0 N-CA-C 111.83 0.307 . . . . 0.0 111.83 -178.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.463 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -129.39 140.36 51.37 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 120.988 0.423 . . . . 0.0 111.159 -179.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.467 ' HB2' HG11 ' A' ' 25' ' ' VAL . . . -105.01 134.77 47.56 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.373 -179.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.528 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 31.5 mt -102.15 116.7 46.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.926 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.553 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 41.8 t -83.73 118.95 32.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.516 0 CA-C-O 120.998 0.428 . . . . 0.0 111.103 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.845 HD13 ' HB3' ' A' ' 41' ' ' SER . 2.2 pp -143.66 156.67 44.62 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.118 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.844 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.76 160.49 15.77 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.308 0.575 . . . . 0.0 112.222 -179.177 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -51.51 115.7 1.73 Allowed 'General case' 0 C--O 1.232 0.145 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.844 179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 115.76 -6.53 20.2 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.361 -179.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.845 ' HB3' HD13 ' A' ' 37' ' ' LEU . 44.8 t -64.93 178.95 0.73 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.006 0.431 . . . . 0.0 110.615 179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 88.06 7.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.445 179.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.5 ptm -111.42 104.88 13.35 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 120.926 0.393 . . . . 0.0 110.642 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 19.9 p -67.47 153.72 43.03 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.069 179.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.9 -24.94 40.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.508 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -44.29 139.88 2.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.467 -179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.433 ' CE1' HG22 ' A' ' 68' ' ' ILE . 48.2 t80 -85.76 128.34 34.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.11 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.459 ' HD3' ' NH1' ' A' ' 51' ' ' ARG . 69.3 mtp180 -145.73 112.68 6.05 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.511 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.448 ' O ' HG12 ' A' ' 68' ' ' ILE . 33.0 m -59.11 -38.71 80.23 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.282 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 19.3 p-10 -78.36 -0.17 27.98 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 111.774 0.287 . . . . 0.0 111.774 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.459 ' NH1' ' HD3' ' A' ' 48' ' ' ARG . 39.3 ttp180 -128.62 106.37 8.91 Favored 'General case' 0 CA--C 1.52 -0.21 0 CA-C-O 121.17 0.509 . . . . 0.0 111.826 179.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.549 HG13 ' C ' ' A' ' 67' ' ' HIS . 43.2 t -105.92 120.74 57.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 N-CA-C 109.013 -0.736 . . . . 0.0 109.013 178.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.618 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.0 m95 -78.39 132.68 37.46 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.872 0.368 . . . . 0.0 110.672 -178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.613 HG22 ' HB3' ' A' ' 66' ' ' PRO . 54.6 t -123.4 87.73 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.407 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.955 179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mp -79.95 124.1 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 115.801 -0.636 . . . . 0.0 111.71 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.844 HG23 ' HG3' ' A' ' 38' ' ' LYS . 15.9 m -121.36 162.32 20.53 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 CA-C-N 115.228 -0.896 . . . . 0.0 111.127 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.1 p30 -91.97 -170.61 2.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.109 -179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.622 ' HA ' ' HE3' ' A' ' 38' ' ' LYS . 15.4 t70 -54.76 -22.7 14.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.527 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 22.41 12.18 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.0 0.371 . . . . 0.0 112.0 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 58.69 24.0 56.34 Favored Glycine 0 CA--C 1.517 0.215 0 C-N-CA 120.359 -0.924 . . . . 0.0 112.626 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.7 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.9 t -93.81 138.31 20.74 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.267 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.674 HG23 ' O ' ' A' ' 16' ' ' LYS . 43.7 t -76.31 112.26 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.099 0.476 . . . . 0.0 111.143 -179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.1 p -93.34 -33.81 13.75 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.133 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.47 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.52 151.56 21.0 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.051 0.453 . . . . 0.0 111.687 -179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.833 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.0 t -67.06 104.53 0.64 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.502 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HB3' HG22 ' A' ' 54' ' ' VAL . 20.5 Cg_endo -60.32 99.84 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 121.744 1.629 . . . . 0.0 111.309 178.734 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.549 ' C ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -130.09 150.21 51.46 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.876 -0.602 . . . . 0.0 111.0 -179.369 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.487 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.7 OUTLIER -46.33 112.79 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.3 m . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.192 -0.909 . . . . 0.0 110.734 -179.458 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.058 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.4 49.2 m 87.08 -73.78 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 116.588 2.07 . . . . 0.0 116.588 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.0 mtt180 -154.94 73.77 0.89 Allowed 'General case' 0 C--N 1.357 0.919 0 CA-C-N 121.637 2.017 . . . . 0.0 111.042 -161.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.92 82.38 1.91 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.682 179.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 18.1 p -85.79 143.68 38.38 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.96 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 23.1 Cg_exo -63.23 -176.83 0.32 Allowed 'Trans proline' 0 N--CA 1.461 -0.436 0 C-N-CA 122.35 2.033 . . . . 0.0 112.703 -179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 58.85 168.81 0.21 Allowed Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.839 -0.696 . . . . 0.0 113.026 179.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.559 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.3 ttmm -65.64 151.04 47.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.213 -0.291 . . . . 0.0 110.213 179.581 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -110.8 -14.92 13.92 Favored 'General case' 0 C--O 1.221 -0.445 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -178.213 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -148.99 130.9 15.2 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.3 m-90 -116.71 67.35 3.87 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.457 -179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.884 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.81 -34.41 91.19 Favored 'Trans proline' 0 C--N 1.343 0.288 0 C-N-CA 122.211 1.941 . . . . 0.0 111.84 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -63.85 -10.44 20.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.636 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.545 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 20.1 mt -81.76 -23.2 36.78 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 120.775 0.322 . . . . 0.0 110.561 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.489 HG21 HG22 ' A' ' 65' ' ' VAL . 43.6 t -55.32 118.55 1.47 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.141 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.09 -179.812 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 105.61 -8.86 44.09 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.608 -179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -96.67 -175.4 3.29 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.514 0.197 . . . . 0.0 110.558 179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.1 p -83.68 142.51 30.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.723 0.297 . . . . 0.0 110.834 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.65 -32.15 38.96 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.588 -0.815 . . . . 0.0 111.866 179.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -67.85 -47.8 67.91 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.905 0.383 . . . . 0.0 110.256 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.0 tpt -64.11 -34.35 77.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.636 179.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.631 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -63.42 -61.0 2.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.616 -0.72 . . . . 0.0 110.372 179.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.528 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -53.94 -40.14 66.51 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.759 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.02 -44.61 96.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.524 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 86.4 m -61.39 -42.35 98.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.798 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 45.8 t -63.18 -49.04 84.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.1 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -68.92 -31.42 70.31 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.489 -179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 7.4 mtp85 -77.48 -50.74 12.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.688 0.28 . . . . 0.0 111.339 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -71.17 -37.54 72.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.891 0.377 . . . . 0.0 110.423 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.671 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.6 t-20 -119.44 78.18 1.28 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.974 179.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.12 -0.07 1.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.834 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 47.4 t30 -94.86 -9.8 33.24 Favored 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 120.637 0.256 . . . . 0.0 111.328 -179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.671 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.0 m -138.97 168.0 19.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.176 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 1.5 p80 -128.23 144.15 51.1 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.351 0.596 . . . . 0.0 111.942 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.528 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -109.83 131.17 55.31 Favored 'General case' 0 N--CA 1.454 -0.244 0 CA-C-N 115.441 -0.799 . . . . 0.0 110.884 -179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.646 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 20.0 mt -103.16 127.16 57.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.854 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 44.8 t -83.85 121.18 36.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 121.073 0.463 . . . . 0.0 111.323 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.913 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -146.69 155.71 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.737 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.581 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -90.09 162.22 15.42 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.256 0.551 . . . . 0.0 112.061 -179.26 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.494 ' HG2' HG22 ' A' ' 55' ' ' ILE . 1.4 mm-40 -52.73 125.24 16.12 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.206 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 96.83 -2.91 62.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.867 179.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.418 ' OG ' ' HG2' ' A' ' 43' ' ' MET . 2.9 t -57.44 134.64 56.23 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 121.042 0.449 . . . . 0.0 110.984 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.54 81.14 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.766 -0.652 . . . . 0.0 110.994 179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.601 ' HB3' ' CE2' ' A' ' 53' ' ' TRP . 28.6 mmt -124.73 130.2 51.95 Favored 'General case' 0 N--CA 1.443 -0.787 0 CA-C-N 116.498 -0.319 . . . . 0.0 110.845 -179.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 27.8 p -56.68 152.94 11.3 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.979 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.68 -23.38 24.21 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.817 179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -37.74 152.65 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.771 -0.65 . . . . 0.0 111.466 -179.857 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' CE2' HG22 ' A' ' 68' ' ' ILE . 51.1 t80 -93.36 133.07 36.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.116 -179.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -149.35 110.67 4.43 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.556 ' SG ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -59.67 -35.86 75.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.531 -179.422 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -78.6 0.85 24.71 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 121.046 -0.262 . . . . 0.0 111.706 -179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HD2' ' CH2' ' A' ' 53' ' ' TRP . 44.8 ttp180 -129.63 129.92 44.96 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-O 121.097 0.475 . . . . 0.0 111.391 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.641 HG13 ' O ' ' A' ' 67' ' ' HIS . 41.1 t -126.79 118.04 49.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.727 -0.669 . . . . 0.0 109.973 179.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.913 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.7 m95 -78.7 132.88 37.17 Favored 'General case' 0 CA--C 1.519 -0.223 0 CA-C-O 121.001 0.429 . . . . 0.0 110.229 -179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.71 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.2 t -114.86 83.11 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.56 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 6.6 mt -79.85 121.99 34.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.538 0.685 . . . . 0.0 111.466 -178.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.584 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.5 m -125.95 165.34 23.96 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.98 -1.009 . . . . 0.0 111.291 -179.293 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 45.2 p30 -84.19 -175.55 5.85 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.656 179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.483 ' HA ' ' CE ' ' A' ' 38' ' ' LYS . 2.9 t70 -59.58 -18.87 44.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.436 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -89.54 -19.9 24.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.335 -179.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.86 20.24 13.34 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.602 -0.809 . . . . 0.0 111.958 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.584 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 25.5 t -95.68 132.93 38.52 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.231 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.631 HG21 ' HB2' ' A' ' 21' ' ' ALA . 40.3 t -69.29 111.06 3.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.937 0.399 . . . . 0.0 110.38 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 54.1 p -90.91 -29.55 17.41 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.136 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.477 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 12.9 m -104.89 148.4 26.72 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.842 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.884 HG13 ' HA ' ' A' ' 11' ' ' PRO . 44.9 t -63.72 106.46 0.93 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.615 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.62 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 35.8 Cg_exo -56.92 98.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.489 0 C-N-CA 121.748 1.632 . . . . 0.0 111.538 179.014 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.641 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -125.24 166.45 16.46 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.342 179.859 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.57 HG22 ' CE2' ' A' ' 47' ' ' PHE . 0.2 OUTLIER -64.39 107.28 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.83 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.135 179.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 44.8 m . . . . . 0 C--O 1.247 0.93 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.511 -178.959 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 53.8 m -66.99 125.38 25.79 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 4.8 mtp180 -147.9 66.19 1.1 Allowed 'General case' 0 C--N 1.346 0.439 0 O-C-N 121.341 -0.849 . . . . 0.0 110.753 -160.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.48 88.78 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.498 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 89.0 m -69.3 149.49 97.38 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.765 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.414 ' HG2' ' ND2' ' A' ' 31' ' ' ASN . 32.1 Cg_endo -64.28 128.51 21.7 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.854 1.703 . . . . 0.0 111.589 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 99.66 161.28 28.92 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.513 -179.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.503 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.5 ttmt -59.59 145.36 44.76 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.697 0.284 . . . . 0.0 110.566 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -102.24 -15.32 16.67 Favored 'General case' 0 N--CA 1.464 0.272 0 N-CA-C 112.951 0.723 . . . . 0.0 112.951 -177.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -154.72 132.36 11.36 Favored 'General case' 0 C--N 1.324 -0.534 0 O-C-N 122.139 -0.35 . . . . 0.0 110.52 -179.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.809 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.0 m-90 -113.52 74.88 2.33 Favored Pre-proline 0 C--N 1.326 -0.415 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.264 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.5 Cg_endo -56.06 -40.98 81.52 Favored 'Trans proline' 0 C--O 1.233 0.275 0 C-N-CA 122.209 1.939 . . . . 0.0 112.417 -179.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 14.8 pm0 -62.82 -6.8 4.05 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.838 -0.619 . . . . 0.0 112.455 -179.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.761 HD12 ' HG2' ' A' ' 66' ' ' PRO . 14.3 mt -83.36 -20.88 33.45 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.73 -0.388 . . . . 0.0 110.971 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.9 t -58.12 116.0 1.12 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.155 0 CA-C-O 120.701 0.286 . . . . 0.0 110.791 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 107.86 -12.41 38.23 Favored Glycine 0 N--CA 1.448 -0.528 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.407 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.441 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.9 tppm? -93.56 161.26 14.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.507 0.194 . . . . 0.0 110.705 179.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 p -62.7 141.84 58.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.821 0.343 . . . . 0.0 111.039 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -54.34 -29.35 46.03 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.427 179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.87 -49.74 35.51 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 120.88 0.371 . . . . 0.0 110.69 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.432 ' HB3' ' HG3' ' A' ' 16' ' ' LYS . 10.8 tpt -63.7 -40.97 98.11 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.117 -0.492 . . . . 0.0 109.924 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.709 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.02 -54.58 44.33 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.991 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.461 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -52.18 -44.6 64.74 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.031 -0.532 . . . . 0.0 110.573 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -60.34 -44.66 95.33 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.549 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 2.0 m -59.8 -43.08 94.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.895 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.809 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.3 t -66.72 -52.31 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.654 -179.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 8.0 mt-10 -67.11 -24.02 65.88 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.319 -179.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.2 mtm-85 -84.98 -56.14 3.71 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.683 0.278 . . . . 0.0 110.919 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -63.49 -31.9 73.19 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.996 0.427 . . . . 0.0 110.143 179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.467 ' OD1' HG13 ' A' ' 32' ' ' VAL . 53.2 t-20 -125.05 80.18 1.85 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.713 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.95 -4.79 1.74 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.699 -0.682 . . . . 0.0 112.233 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.414 ' ND2' ' HG2' ' A' ' 5' ' ' PRO . 13.3 t30 -98.72 6.14 47.15 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 120.907 -0.317 . . . . 0.0 111.629 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.467 HG13 ' OD1' ' A' ' 29' ' ' ASN . 5.8 m -138.4 165.95 24.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.773 0.32 . . . . 0.0 111.358 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.557 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -128.63 132.84 48.15 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.346 179.578 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -98.09 127.44 44.04 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.173 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.681 ' N ' HD12 ' A' ' 35' ' ' ILE . 2.5 mp -104.53 108.32 24.51 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.408 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.581 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 11.2 p -78.86 121.43 31.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 CA-C-O 121.592 0.71 . . . . 0.0 110.874 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.609 ' O ' ' HA ' ' A' ' 55' ' ' ILE . 0.5 OUTLIER -146.72 155.34 42.33 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.031 -0.986 . . . . 0.0 110.296 -178.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.672 ' HG3' HG23 ' A' ' 56' ' ' VAL . 9.2 mtmt -89.55 165.76 14.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.305 0.574 . . . . 0.0 112.264 -178.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -50.4 122.17 6.65 Favored 'General case' 0 C--O 1.232 0.144 0 CA-C-N 115.231 -0.895 . . . . 0.0 111.518 179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 93.97 4.89 62.95 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.88 179.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.598 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.7 t -65.73 -173.93 0.19 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.903 0.383 . . . . 0.0 110.929 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -89.89 87.06 6.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.597 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 5.2 ptm -121.13 105.87 11.01 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-O 121.059 0.457 . . . . 0.0 110.481 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -63.52 150.9 42.8 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.009 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mtmp? -79.65 -23.5 42.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.856 -179.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -45.52 155.0 0.17 Allowed 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.892 -0.594 . . . . 0.0 110.847 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.504 ' CZ ' ' CG2' ' A' ' 68' ' ' ILE . 37.5 t80 -99.41 136.18 39.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.005 0.431 . . . . 0.0 111.385 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.9 mtp180 -153.0 110.11 3.49 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.386 -179.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.526 ' O ' HG12 ' A' ' 68' ' ' ILE . 23.5 m -58.37 -38.82 78.03 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.892 -179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 18.6 p-10 -79.25 5.55 12.01 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.33 -179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 42.0 ttp180 -127.25 131.48 50.55 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.982 0.42 . . . . 0.0 111.206 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.438 HG22 ' HA ' ' A' ' 68' ' ' ILE . 59.8 t -134.23 117.26 24.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.846 179.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.582 ' CE3' HD21 ' A' ' 37' ' ' LEU . 5.0 m95 -78.77 140.34 38.27 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.88 0.372 . . . . 0.0 110.614 -179.454 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 64.5 t -128.05 87.34 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.605 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.167 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.609 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 3.0 mt -79.62 128.92 38.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.271 0 CA-C-O 121.152 0.501 . . . . 0.0 111.645 -179.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.672 HG23 ' HG3' ' A' ' 38' ' ' LYS . 31.2 m -126.92 164.21 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.138 179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.6 p30 -84.72 -171.49 3.66 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.029 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -63.62 -9.2 12.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.941 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.28 -5.67 20.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.696 0.258 . . . . 0.0 111.696 -179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.63 20.17 38.38 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.277 -0.963 . . . . 0.0 112.365 -179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.609 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.5 t -97.35 132.36 42.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 N-CA-C 110.075 -0.343 . . . . 0.0 110.075 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.505 ' HA ' HG12 ' A' ' 56' ' ' VAL . 60.0 t -66.43 110.3 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.045 0.45 . . . . 0.0 110.781 -179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 32.6 p -87.87 -35.73 17.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.093 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.483 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 2.1 m -105.65 156.56 18.15 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.093 0.473 . . . . 0.0 111.377 -179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.495 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.8 t -66.82 128.18 93.76 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.437 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.761 ' HG2' HD12 ' A' ' 13' ' ' LEU . 15.6 Cg_endo -86.34 96.34 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.275 0 C-N-CA 122.431 2.087 . . . . 0.0 110.766 178.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -128.54 153.15 47.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.19 -179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.582 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.7 OUTLIER -44.11 103.54 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.159 179.398 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 24.4 m . . . . . 0 C--O 1.245 0.854 0 CA-C-O 118.236 -0.887 . . . . 0.0 110.504 -179.328 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.166 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 17.3 t -64.85 121.8 15.44 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 114.255 1.206 . . . . 0.0 114.255 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.7 ttm105 -158.38 75.3 0.73 Allowed 'General case' 0 C--N 1.347 0.459 0 O-C-N 121.162 -0.961 . . . . 0.0 110.728 -163.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -174.4 94.83 0.09 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.954 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 96.4 m -138.43 146.44 51.15 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -53.22 155.82 11.46 Favored 'Trans proline' 0 N--CA 1.457 -0.671 0 C-N-CA 122.172 1.915 . . . . 0.0 112.092 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.27 -168.82 44.67 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.438 -0.886 . . . . 0.0 112.59 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.633 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 1.7 ttmp? -88.42 154.9 20.0 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.631 -0.284 . . . . 0.0 110.763 -179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 8.1 p30 -114.57 -2.05 13.23 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 112.833 0.679 . . . . 0.0 112.833 -178.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.443 ' H ' ' HG2' ' A' ' 7' ' ' LYS . . . -157.61 130.51 7.53 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.844 0.354 . . . . 0.0 110.118 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.633 ' CZ2' ' HB3' ' A' ' 7' ' ' LYS . 29.2 m-90 -119.49 74.16 16.36 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.55 -179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.81 ' HA ' HG13 ' A' ' 65' ' ' VAL . 40.6 Cg_exo -55.7 -39.3 91.93 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.219 1.946 . . . . 0.0 111.986 179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -62.01 -9.68 7.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.886 -0.597 . . . . 0.0 112.193 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.636 HD22 ' HA ' ' A' ' 21' ' ' ALA . 42.4 mt -83.97 -23.67 30.95 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.797 179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.513 HG21 HG22 ' A' ' 65' ' ' VAL . 41.0 t -58.26 111.75 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-O 120.784 0.326 . . . . 0.0 110.61 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.91 -7.63 29.44 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.177 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.405 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -98.95 166.01 11.48 Favored 'General case' 0 C--O 1.226 -0.147 0 CA-C-O 120.532 0.206 . . . . 0.0 110.621 179.638 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.7 p -63.62 142.7 58.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.75 0.31 . . . . 0.0 111.069 -179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -53.14 -32.12 42.47 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.683 -0.77 . . . . 0.0 111.844 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.2 t-20 -68.97 -42.18 76.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.03 0.443 . . . . 0.0 110.03 179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -65.68 -35.22 80.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.906 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.852 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -64.46 -60.1 3.56 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.043 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.46 ' HB2' HG23 ' A' ' 36' ' ' VAL . . . -49.33 -50.17 40.85 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.738 179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -57.82 -44.11 86.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.748 179.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.426 ' CB ' HD21 ' A' ' 13' ' ' LEU . 94.6 m -60.11 -43.4 95.63 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.767 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.615 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.6 t -67.86 -51.66 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.487 -179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -65.23 -29.07 69.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.507 -0.315 . . . . 0.0 111.136 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.2 ttp180 -81.5 -57.19 3.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.096 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 6.1 mt-10 -62.53 -30.83 71.58 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.842 0.353 . . . . 0.0 110.429 179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.775 ' CG ' HG22 ' A' ' 32' ' ' VAL . 46.7 t-20 -127.11 78.98 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.276 -179.651 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.6 ptt180 -64.62 1.88 0.76 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.965 179.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -98.36 -5.35 32.95 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-O 120.573 0.225 . . . . 0.0 111.482 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.775 HG22 ' CG ' ' A' ' 29' ' ' ASN . 17.9 m -148.69 166.33 4.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.831 -0.168 . . . . 0.0 111.422 -179.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.528 ' CD2' ' O ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -129.47 152.91 48.5 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.076 0.465 . . . . 0.0 111.361 179.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.518 ' HB2' ' HB ' ' A' ' 52' ' ' VAL . . . -112.3 147.93 35.28 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.34 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.545 HD11 ' HG3' ' A' ' 51' ' ' ARG . 2.5 mp -112.6 114.35 46.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.791 179.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.758 HG22 HG11 ' A' ' 54' ' ' VAL . 57.5 t -83.25 111.91 20.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.405 0.621 . . . . 0.0 111.345 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.669 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -135.27 154.72 51.46 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.535 179.756 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.597 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -85.54 157.2 20.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 121.098 0.475 . . . . 0.0 111.527 -179.33 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -53.15 113.61 1.18 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.718 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.79 -9.4 11.5 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.162 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.413 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 46.5 t -66.01 -174.24 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.822 0.344 . . . . 0.0 110.742 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 97.67 11.32 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.119 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.635 ' CE ' HD11 ' A' ' 55' ' ' ILE . 0.0 OUTLIER -124.83 103.69 8.21 Favored 'General case' 0 CA--C 1.512 -0.507 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.8 -179.433 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.56 160.09 23.19 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.27 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -87.84 -23.36 24.03 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.027 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -45.51 140.39 3.25 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.059 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.532 ' CE2' HG22 ' A' ' 68' ' ' ILE . 42.6 t80 -84.06 131.03 34.84 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.181 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 15.5 mtp180 -146.48 110.92 5.14 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.632 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.49 ' O ' HG12 ' A' ' 68' ' ' ILE . 98.3 m -59.05 -38.22 78.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.287 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 32' ' ' VAL . 11.6 p-10 -78.8 -6.14 55.22 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.833 -0.347 . . . . 0.0 111.395 -179.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.545 ' HG3' HD11 ' A' ' 35' ' ' ILE . 41.3 ttp180 -119.21 105.96 11.87 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-O 120.989 0.424 . . . . 0.0 111.694 -179.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.518 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 62.0 t -106.65 119.26 55.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.669 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.37 136.8 37.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.011 0.434 . . . . 0.0 110.839 -178.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.758 HG11 HG22 ' A' ' 36' ' ' VAL . 49.0 t -127.64 84.0 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.051 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.635 HD11 ' CE ' ' A' ' 43' ' ' MET . 4.2 mt -79.67 121.52 33.12 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.317 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.071 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.627 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.0 m -119.91 161.3 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.611 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.999 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.5 p30 -80.0 -171.48 2.94 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.272 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.71 -20.47 61.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.612 -179.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -94.73 -7.36 40.81 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.43 23.86 27.84 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.416 -0.897 . . . . 0.0 111.936 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 41.7 t -96.57 134.21 35.08 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.255 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.852 HG21 ' HB2' ' A' ' 21' ' ' ALA . 42.8 t -67.77 104.72 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.017 0.437 . . . . 0.0 110.888 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 33.2 p -88.04 -34.74 17.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.118 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.523 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -99.17 157.27 16.48 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.922 0.392 . . . . 0.0 111.502 -179.442 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.81 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.3 t -71.84 106.24 1.88 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.639 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.523 ' HD3' ' O ' ' A' ' 64' ' ' SER . 36.2 Cg_exo -58.06 103.39 0.15 Allowed 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 121.688 1.592 . . . . 0.0 110.84 178.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -136.78 143.63 43.31 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 121.332 0.587 . . . . 0.0 111.474 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.573 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.6 OUTLIER -41.81 107.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.685 178.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 33.0 m . . . . . 0 C--O 1.246 0.901 0 CA-C-O 118.197 -0.906 . . . . 0.0 111.083 -179.119 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.128 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.326 60.5 p 71.09 -61.49 0.48 Allowed 'General case' 0 N--CA 1.502 2.156 0 N-CA-C 117.208 2.299 . . . . 0.0 117.208 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -154.69 61.84 0.67 Allowed 'General case' 0 C--N 1.341 0.221 0 C-N-CA 125.243 1.417 . . . . 0.0 110.822 -179.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -155.64 95.14 1.64 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.565 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.411 ' HB3' ' HD2' ' A' ' 5' ' ' PRO . 56.1 m -97.78 158.37 33.06 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.958 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 4' ' ' CYS . 93.9 Cg_exo -43.61 133.05 7.5 Favored 'Trans proline' 0 N--CA 1.458 -0.576 0 C-N-CA 122.548 2.166 . . . . 0.0 112.848 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.4 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 88.38 154.76 28.52 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.721 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.587 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.1 ttmm -49.54 146.04 4.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.695 0.283 . . . . 0.0 111.205 179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -103.46 -16.72 15.49 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.526 ' O ' ' HD3' ' A' ' 7' ' ' LYS . . . -146.96 149.99 34.29 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.833 ' CH2' HG13 ' A' ' 25' ' ' VAL . 29.8 m-90 -134.56 67.64 71.71 Favored Pre-proline 0 C--N 1.321 -0.653 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.229 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.853 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.7 Cg_endo -55.91 -33.08 87.77 Favored 'Trans proline' 0 C--O 1.233 0.258 0 C-N-CA 122.101 1.867 . . . . 0.0 111.439 179.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -64.24 -12.48 41.42 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.666 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.623 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.4 mt -82.21 -20.3 38.02 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 0.0 110.496 179.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.883 HG21 HG22 ' A' ' 65' ' ' VAL . 38.2 t -61.91 111.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.688 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.15 -2.99 29.86 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.429 -179.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mttm -102.64 177.09 4.95 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.709 0.29 . . . . 0.0 110.498 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.6 p -72.29 135.58 46.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.525 -0.307 . . . . 0.0 110.563 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -49.23 -30.51 11.07 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.038 179.672 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -70.94 -47.25 60.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.876 0.37 . . . . 0.0 110.399 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 3.4 tpt -63.18 -31.3 72.42 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.033 -0.53 . . . . 0.0 109.783 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.689 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.54 -62.88 1.21 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.577 179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.534 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -52.01 -39.59 59.69 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.038 0.447 . . . . 0.0 110.714 179.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.65 -44.36 90.7 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.712 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 91.7 m -60.0 -42.54 94.5 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.718 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.833 HG13 ' CH2' ' A' ' 10' ' ' TRP . 19.0 t -64.41 -53.04 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.361 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -66.01 -29.68 70.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.626 -0.261 . . . . 0.0 111.334 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 2.2 ttp85 -76.44 -54.35 6.85 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.772 0.32 . . . . 0.0 110.929 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.37 -40.71 85.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.776 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.641 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.8 t-20 -115.44 80.68 1.47 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.057 -179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 14.9 ttt85 -64.96 -5.52 6.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.796 179.572 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -93.48 -0.66 56.3 Favored 'General case' 0 C--O 1.232 0.133 0 CA-C-O 120.548 0.213 . . . . 0.0 111.262 179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.641 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.3 m -139.09 171.78 14.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.958 0.409 . . . . 0.0 111.544 -179.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.484 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -136.46 137.81 40.79 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.669 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -103.83 133.2 49.21 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.761 -179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.484 HG12 ' CE1' ' A' ' 33' ' ' HIS . 45.1 mt -102.14 119.64 50.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.439 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.542 HG22 HG11 ' A' ' 54' ' ' VAL . 63.1 t -87.12 115.83 28.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.286 0.565 . . . . 0.0 111.275 -179.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.873 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -138.82 156.14 47.57 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.899 179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.12 151.64 21.5 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.278 0.561 . . . . 0.0 111.781 -179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.37 113.93 0.72 Allowed 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.183 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.21 -2.1 23.91 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.555 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 34.3 t -72.76 -164.23 0.15 Allowed 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.805 0.336 . . . . 0.0 110.814 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -88.98 99.1 12.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.024 0.44 . . . . 0.0 110.131 179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.91 96.9 5.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.253 0.549 . . . . 0.0 111.422 -179.108 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -69.48 155.96 39.63 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.428 179.649 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 16.0 mttm -87.15 -24.97 24.31 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.274 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -44.84 141.06 2.28 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.181 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.9 t80 -88.53 125.67 34.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.29 -179.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.439 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 12.5 mtm180 -145.33 111.03 5.42 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.236 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.504 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 73.9 m -60.49 -32.78 71.76 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.637 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -78.94 -4.56 50.48 Favored 'General case' 0 C--N 1.325 -0.487 0 C-N-CA 121.051 -0.26 . . . . 0.0 111.408 -179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.439 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 54.9 ttp180 -120.73 124.26 44.71 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.013 0.435 . . . . 0.0 111.435 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.458 HG21 HG11 ' A' ' 25' ' ' VAL . 69.8 t -123.54 119.39 57.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.858 -0.61 . . . . 0.0 109.398 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.873 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.1 m95 -78.71 131.35 36.57 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.841 0.353 . . . . 0.0 111.177 -178.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.545 ' O ' HG12 ' A' ' 54' ' ' VAL . 5.5 t -122.88 91.95 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.09 179.272 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.569 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -85.72 125.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.158 0.504 . . . . 0.0 111.685 -179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 30.8 m -125.16 164.79 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.351 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.492 -179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 41.5 p30 -89.94 -177.17 5.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.913 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.91 -20.76 39.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.316 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 79.5 m80 -88.49 -22.2 23.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.723 0.297 . . . . 0.0 111.162 -179.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 103.1 22.26 9.41 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.646 -0.788 . . . . 0.0 112.206 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 36.8 t -98.19 144.67 10.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 N-CA-C 110.275 -0.269 . . . . 0.0 110.275 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.689 HG21 ' HB2' ' A' ' 21' ' ' ALA . 47.6 t -75.28 110.85 10.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.835 0.35 . . . . 0.0 110.648 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -91.53 -33.68 15.07 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.964 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.569 ' CB ' HD13 ' A' ' 55' ' ' ILE . 0.2 OUTLIER -101.96 148.46 25.33 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.066 -179.812 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.883 HG22 HG21 ' A' ' 14' ' ' VAL . 47.8 t -67.64 108.47 2.65 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.214 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.3 Cg_exo -62.73 117.55 4.44 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.138 1.892 . . . . 0.0 111.471 179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 67' ' ' HIS . 0.6 OUTLIER -151.8 143.89 23.9 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.98 0.419 . . . . 0.0 110.792 -179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.442 ' CG2' ' HA ' ' A' ' 49' ' ' CYS . 1.6 mt -40.3 122.69 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.048 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.577 ' OXT' HG22 ' A' ' 69' ' ' THR . 2.0 m . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.254 -0.879 . . . . 0.0 110.739 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.226 -0.134 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 8.6 t 68.53 110.0 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 114.895 1.443 . . . . 0.0 114.895 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 3.9 tpt180 -159.47 77.87 0.71 Allowed 'General case' 0 C--N 1.348 0.543 0 O-C-N 119.793 -1.817 . . . . 0.0 110.721 -178.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.7 mtp180 46.82 83.28 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.373 -0.376 . . . . 0.0 110.724 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 3.9 t -112.86 128.44 25.59 Favored Pre-proline 0 CA--C 1.516 -0.345 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.524 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 22.1 Cg_exo -64.24 160.83 36.74 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.858 1.705 . . . . 0.0 111.76 179.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 54.98 174.5 0.1 OUTLIER Glycine 0 C--N 1.33 0.203 0 C-N-CA 120.516 -0.85 . . . . 0.0 112.531 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 32.2 ttmt -59.0 154.12 16.17 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.727 0.299 . . . . 0.0 110.818 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.585 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -108.1 -20.4 13.17 Favored 'General case' 0 N--CA 1.465 0.295 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -178.112 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -147.71 127.04 13.06 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.289 -0.263 . . . . 0.0 110.289 -179.618 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.693 ' CH2' HG13 ' A' ' 25' ' ' VAL . 22.7 m-90 -108.65 74.14 0.53 Allowed Pre-proline 0 C--N 1.327 -0.381 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.851 -179.35 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.874 ' HA ' HG13 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.35 -37.06 92.68 Favored 'Trans proline' 0 C--O 1.233 0.26 0 C-N-CA 122.047 1.831 . . . . 0.0 111.819 179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.2 pm0 -63.34 -9.59 12.68 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.865 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.588 HD22 ' HA ' ' A' ' 21' ' ' ALA . 13.4 mt -80.88 -24.38 38.34 Favored 'General case' 0 C--N 1.332 -0.166 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.515 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 40.3 t -55.68 112.32 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.955 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -6.99 24.29 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.407 -179.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.734 ' O ' HG23 ' A' ' 62' ' ' VAL . 7.8 mmtp -102.69 160.38 14.63 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.704 0.287 . . . . 0.0 110.497 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 11.0 p -56.81 135.81 55.55 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.923 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.458 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -46.45 -30.61 4.49 Favored Glycine 0 C--N 1.331 0.262 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.171 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -71.32 -44.77 64.5 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.827 0.346 . . . . 0.0 110.336 179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.25 -32.46 74.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.032 179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.762 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -68.04 -60.09 2.75 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.545 179.336 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.554 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.28 -39.73 67.19 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.755 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -64.12 -44.92 90.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.637 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 89.1 m -59.27 -41.0 87.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.506 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 52' ' ' VAL . 60.2 t -65.11 -57.58 10.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.107 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -63.17 -24.17 67.76 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.527 0.203 . . . . 0.0 111.442 -179.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.455 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 19.8 ttm-85 -80.77 -58.18 3.21 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.836 0.351 . . . . 0.0 110.819 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -64.05 -37.17 86.46 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.105 0.479 . . . . 0.0 110.377 179.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.464 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -121.16 78.22 1.39 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.659 -0.701 . . . . 0.0 110.356 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -63.91 -0.85 1.2 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.764 -0.653 . . . . 0.0 112.22 -179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -93.29 -11.64 32.01 Favored 'General case' 0 C--N 1.333 -0.143 0 C-N-CA 121.063 -0.255 . . . . 0.0 111.349 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG22 ' CG ' ' A' ' 29' ' ' ASN . 14.0 m -122.67 171.0 12.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.951 0.405 . . . . 0.0 111.584 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.448 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -130.85 133.38 45.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.016 179.638 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.55 135.11 47.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.93 0.395 . . . . 0.0 111.574 -179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.448 HG12 ' CE1' ' A' ' 33' ' ' HIS . 28.7 mt -104.03 122.81 57.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.567 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.554 ' CG2' ' HB2' ' A' ' 22' ' ' ALA . 60.0 t -91.3 123.02 43.28 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.083 0.468 . . . . 0.0 111.014 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.722 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -150.6 158.6 44.34 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.478 -179.724 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 33.4 mttm -89.0 159.76 17.45 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.098 0.475 . . . . 0.0 111.499 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -48.77 122.31 5.53 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.323 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.78 -8.82 43.44 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.933 179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.499 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 32.8 t -68.69 -166.09 0.07 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.842 0.354 . . . . 0.0 111.123 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' O ' ' CH2' ' A' ' 53' ' ' TRP . . . -71.14 93.58 1.07 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.776 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.543 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 1.5 ttp -121.18 99.12 6.31 Favored 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.302 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.48 151.52 20.75 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.226 -0.897 . . . . 0.0 110.356 179.705 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.3 mptt -79.82 -26.72 40.41 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.05 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.9 t70 -45.99 142.38 2.71 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.129 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -88.05 129.5 35.26 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.716 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.475 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.3 mtp180 -144.72 108.6 4.72 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.236 179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.407 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 1.1 m -56.12 -43.21 77.96 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.282 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.9 p-10 -79.48 3.57 18.23 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.976 0.361 . . . . 0.0 111.976 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.475 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 40.4 ttp180 -126.65 115.71 19.87 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-O 121.076 0.465 . . . . 0.0 111.295 -179.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.706 HG21 HG11 ' A' ' 25' ' ' VAL . 57.3 t -116.42 122.47 69.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.249 178.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.722 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.2 m95 -78.69 125.54 29.5 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.991 0.424 . . . . 0.0 111.212 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.32 85.24 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.881 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.581 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mp -83.27 127.99 39.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 121.154 0.502 . . . . 0.0 111.73 -179.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.621 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 31.8 m -124.9 163.72 24.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.448 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.242 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -83.55 -178.75 7.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.231 -179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.54 -22.0 11.83 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.855 -179.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -89.56 -24.43 21.74 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.673 0.273 . . . . 0.0 111.335 -179.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.78 22.23 7.09 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.318 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.621 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.0 t -99.02 140.47 18.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.213 0 N-CA-C 109.943 -0.391 . . . . 0.0 109.943 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 21' ' ' ALA . 43.4 t -70.71 112.47 5.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-O 120.915 0.388 . . . . 0.0 111.098 -179.499 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 48.9 p -94.66 -32.8 13.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.176 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.417 ' HB3' ' HB ' ' A' ' 55' ' ' ILE . 39.5 t -103.79 151.74 22.7 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.149 0.499 . . . . 0.0 111.543 -179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.874 HG13 ' HA ' ' A' ' 11' ' ' PRO . 4.5 t -64.47 114.85 15.83 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.608 -0.723 . . . . 0.0 111.142 179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.554 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 5.3 Cg_exo -75.41 88.18 1.3 Allowed 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 121.904 1.736 . . . . 0.0 111.451 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 18.0 p-80 -121.8 144.04 49.04 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.118 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.585 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -38.28 116.43 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.069 179.729 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 16.0 m . . . . . 0 C--O 1.248 0.993 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.768 -179.068 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.227 -0.107 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . 0.291 50.9 m 76.1 120.05 0.05 Allowed 'General case' 0 N--CA 1.497 1.914 0 N-CA-C 115.2 1.556 . . . . 0.0 115.2 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.0 mtp180 -113.85 59.28 0.67 Allowed 'General case' 0 C--N 1.353 0.76 0 O-C-N 120.896 -1.128 . . . . 0.0 110.653 162.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.73 81.31 0.1 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.174 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.0 OUTLIER -102.44 137.92 19.53 Favored Pre-proline 0 CA--C 1.517 -0.316 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.549 179.732 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 30.6 Cg_exo -61.11 157.99 36.79 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 122.055 1.837 . . . . 0.0 112.57 -179.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 67.05 168.96 3.62 Favored Glycine 0 C--N 1.331 0.298 0 C-N-CA 121.086 -0.578 . . . . 0.0 113.391 179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.64 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 2.8 ttmp? -55.64 149.78 13.5 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.656 0.265 . . . . 0.0 110.901 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.5 t-20 -103.73 -16.67 15.38 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -177.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.47 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -154.39 138.15 16.16 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 110.327 -0.249 . . . . 0.0 110.327 -179.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.719 ' CH2' HG13 ' A' ' 25' ' ' VAL . 19.9 m-90 -120.49 71.06 17.8 Favored Pre-proline 0 C--N 1.325 -0.473 0 CA-C-O 120.84 0.352 . . . . 0.0 111.276 -179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.812 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.0 Cg_endo -54.78 -37.81 92.02 Favored 'Trans proline' 0 N--CA 1.464 -0.249 0 C-N-CA 122.328 2.019 . . . . 0.0 112.003 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -62.19 -9.15 6.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.156 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.647 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.1 mt -81.13 -24.21 37.8 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.769 179.617 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.549 HG21 HG22 ' A' ' 65' ' ' VAL . 48.3 t -57.93 110.3 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.174 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.845 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 118.29 -4.25 15.76 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.404 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 mmtt -103.91 179.39 4.29 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.632 0.253 . . . . 0.0 110.625 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.1 p -76.04 143.23 41.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.732 0.301 . . . . 0.0 110.664 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -48.71 -33.57 12.91 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.009 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -73.08 -36.92 66.92 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.987 0.422 . . . . 0.0 110.161 179.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -67.79 -39.65 84.04 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.791 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.827 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.66 -58.85 4.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.751 -0.659 . . . . 0.0 110.504 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -53.66 -41.97 67.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.08 -45.45 94.67 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.95 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.444 ' CB ' HD21 ' A' ' 13' ' ' LEU . 39.9 m -61.3 -41.09 96.4 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.835 -179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.719 HG13 ' CH2' ' A' ' 10' ' ' TRP . 46.9 t -66.64 -54.96 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.121 179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.488 ' HG3' ' HA ' ' A' ' 33' ' ' HIS . 9.0 mt-10 -65.6 -23.88 66.93 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 111.785 0.291 . . . . 0.0 111.785 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.416 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 10.0 ttm-85 -83.61 -53.01 5.98 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.74 0.305 . . . . 0.0 110.824 179.65 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -67.67 -36.95 81.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.661 179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.747 ' CG ' HG22 ' A' ' 32' ' ' VAL . 45.9 t-20 -118.73 79.48 1.4 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.702 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.45 -2.65 1.64 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.093 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.03 -13.9 28.05 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-O 120.695 0.283 . . . . 0.0 111.47 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.747 HG22 ' CG ' ' A' ' 29' ' ' ASN . 4.8 m -140.67 164.89 20.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.986 -179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.555 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -132.79 163.51 28.89 Favored 'General case' 0 C--O 1.232 0.182 0 C-N-CA 120.802 -0.359 . . . . 0.0 110.911 179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.551 ' HB1' HG23 ' A' ' 54' ' ' VAL . . . -117.11 140.94 48.9 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.063 0.459 . . . . 0.0 111.935 -178.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.401 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 28.6 mt -99.58 111.59 29.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.39 179.234 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 6.3 p -81.33 125.68 39.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.185 0.517 . . . . 0.0 111.819 -179.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.658 HD13 ' HB3' ' A' ' 41' ' ' SER . 0.5 OUTLIER -155.88 160.1 39.88 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.195 179.637 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.618 ' HG3' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -89.69 155.04 19.48 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.212 0.53 . . . . 0.0 111.627 -179.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -47.91 115.95 1.34 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.396 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.78 -7.5 21.99 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.621 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.658 ' HB3' HD13 ' A' ' 37' ' ' LEU . 32.4 t -70.46 -162.38 0.06 Allowed 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.804 0.335 . . . . 0.0 110.971 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -78.91 96.88 5.81 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.037 0.446 . . . . 0.0 110.743 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.593 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 10.1 tmm? -119.42 96.14 5.09 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.227 -179.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.91 154.76 24.42 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.251 179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 10.8 mtpt -84.53 -27.93 27.02 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.827 179.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.67 130.78 5.4 Favored 'General case' 0 CA--C 1.529 0.156 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.014 179.848 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.423 ' CE1' HG22 ' A' ' 68' ' ' ILE . 88.9 t80 -80.71 134.56 35.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.072 0.463 . . . . 0.0 111.8 -179.262 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 10.4 mtp180 -152.61 109.83 3.53 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.904 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.534 ' O ' HG11 ' A' ' 32' ' ' VAL . 6.7 m -61.33 -30.36 70.46 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.09 -179.694 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.555 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 17.7 p-10 -79.06 -8.25 58.8 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.651 -0.25 . . . . 0.0 111.637 -179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 39.6 ttp180 -122.26 119.2 30.47 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-O 121.042 0.449 . . . . 0.0 111.699 -179.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.513 ' HB ' ' HB2' ' A' ' 34' ' ' ALA . 66.4 t -114.93 122.2 68.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.206 178.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.613 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.0 OUTLIER -78.58 129.46 34.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.854 0.359 . . . . 0.0 111.036 -178.521 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.594 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.5 t -120.56 92.79 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.323 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.597 HD13 ' CD1' ' A' ' 37' ' ' LEU . 7.3 mm -85.15 129.67 37.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.267 0 CA-C-O 121.247 0.546 . . . . 0.0 111.257 -179.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.627 HG12 ' HA ' ' A' ' 62' ' ' VAL . 26.4 m -129.09 164.62 31.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.885 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -86.0 -168.95 2.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.857 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -62.78 -18.7 63.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.64 -179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -97.02 4.69 51.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 111.728 0.27 . . . . 0.0 111.728 -179.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 77.31 24.76 65.1 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.369 -0.92 . . . . 0.0 112.222 -179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 23.3 t -97.54 131.47 44.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 110.336 -0.246 . . . . 0.0 110.336 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.827 HG21 ' HB2' ' A' ' 21' ' ' ALA . 49.0 t -66.37 106.27 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 121.052 0.453 . . . . 0.0 110.788 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 45.7 p -93.52 -29.46 15.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.03 -179.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.1 m -103.94 151.14 23.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.964 0.412 . . . . 0.0 111.203 -179.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.812 HG13 ' HA ' ' A' ' 11' ' ' PRO . 8.0 t -66.27 118.91 57.76 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.341 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.595 ' HG2' HD12 ' A' ' 13' ' ' LEU . 89.7 Cg_endo -81.73 99.57 1.04 Allowed 'Trans proline' 0 N--CA 1.456 -0.684 0 C-N-CA 122.171 1.914 . . . . 0.0 111.351 178.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.511 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 7.8 p-80 -133.21 147.23 52.0 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.721 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.499 ' HA ' HG22 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -36.63 116.52 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 115.621 -0.718 . . . . 0.0 111.678 179.374 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.9 m . . . . . 0 C--O 1.249 1.045 0 CA-C-O 118.356 -0.831 . . . . 0.0 110.571 -179.872 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.5 p -86.44 87.17 7.38 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -155.58 64.14 0.6 Allowed 'General case' 0 C--N 1.356 0.848 0 O-C-N 120.342 -1.473 . . . . 0.0 110.836 -176.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.5 ptp85 -140.34 92.3 2.52 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.217 179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.467 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.1 OUTLIER -117.12 131.3 24.06 Favored Pre-proline 0 C--N 1.325 -0.48 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.525 -179.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 15.8 Cg_exo -66.81 62.57 0.58 Allowed 'Trans proline' 0 N--CA 1.456 -0.692 0 C-N-CA 122.118 1.879 . . . . 0.0 112.014 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.418 ' N ' ' O ' ' A' ' 4' ' ' CYS . . . 155.07 176.85 27.74 Favored Glycine 0 N--CA 1.452 -0.285 0 CA-C-N 115.802 -0.635 . . . . 0.0 112.075 -179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.453 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 tttp -59.99 156.08 15.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.701 0.286 . . . . 0.0 110.921 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.906 ' HA ' HD12 ' A' ' 68' ' ' ILE . 14.9 m-80 -113.77 -16.36 12.29 Favored 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 112.308 0.485 . . . . 0.0 112.308 -178.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -145.2 123.34 12.15 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CH2' HG13 ' A' ' 25' ' ' VAL . 28.1 m-90 -108.0 73.95 0.46 Allowed Pre-proline 0 C--N 1.321 -0.643 0 CA-C-O 120.881 0.372 . . . . 0.0 111.553 -178.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.824 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -59.9 -35.11 94.71 Favored 'Trans proline' 0 N--CA 1.464 -0.255 0 C-N-CA 122.281 1.987 . . . . 0.0 111.528 179.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.7 pm0 -64.34 -12.52 43.01 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.47 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.725 HD22 ' HA ' ' A' ' 21' ' ' ALA . 23.4 mt -82.01 -22.41 36.53 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.824 0.345 . . . . 0.0 110.421 179.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.539 HG21 HG22 ' A' ' 65' ' ' VAL . 40.5 t -55.23 114.99 0.63 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.905 0.383 . . . . 0.0 110.619 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.52 -13.11 33.03 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.245 -179.298 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -92.72 160.08 15.14 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.708 0.29 . . . . 0.0 110.59 179.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.6 p -60.73 140.79 57.41 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.77 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -47.87 -32.08 8.35 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.153 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 12.3 m-80 -71.37 -45.26 63.3 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.049 0.452 . . . . 0.0 110.282 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -63.11 -38.83 92.73 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.881 179.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.725 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.26 -58.95 5.46 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.465 179.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.562 ' HA ' ' HB3' ' A' ' 34' ' ' ALA . . . -52.19 -39.22 59.81 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.915 179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -63.66 -45.46 90.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.713 179.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.554 ' CB ' HD21 ' A' ' 13' ' ' LEU . 10.9 m -60.29 -41.21 92.91 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.147 179.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.726 HG13 ' CH2' ' A' ' 10' ' ' TRP . 26.4 t -67.32 -51.16 55.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.432 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -67.03 -26.99 67.04 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.678 0.275 . . . . 0.0 111.155 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 11.0 mtm180 -81.02 -56.33 4.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.839 0.352 . . . . 0.0 110.757 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -64.39 -36.46 84.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.522 179.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -125.58 79.59 1.83 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.95 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 10.1 mtp85 -61.17 -5.62 1.62 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.817 -0.628 . . . . 0.0 112.231 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -88.69 -1.59 58.15 Favored 'General case' 0 C--N 1.334 -0.109 0 O-C-N 122.242 -0.286 . . . . 0.0 111.734 -179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 9.7 m -140.71 170.29 14.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.75 0.31 . . . . 0.0 111.469 -179.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.459 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -135.89 140.89 44.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 179.778 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.562 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -104.83 141.07 37.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.914 -0.584 . . . . 0.0 111.634 -179.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.459 HG13 ' CE1' ' A' ' 33' ' ' HIS . 3.9 mt -114.83 123.09 70.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.639 179.662 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.528 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 60.7 t -79.82 123.49 36.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 121.4 0.619 . . . . 0.0 111.261 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.689 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.5 OUTLIER -141.49 149.6 41.13 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.056 -0.975 . . . . 0.0 109.789 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.22 155.5 18.96 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.972 0.415 . . . . 0.0 111.55 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.625 ' HG3' HG22 ' A' ' 55' ' ' ILE . 15.3 mt-10 -48.83 115.87 1.42 Allowed 'General case' 0 C--O 1.231 0.127 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.153 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.48 1.57 37.68 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.526 179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.6 t -65.77 178.93 0.94 Allowed 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.993 0.425 . . . . 0.0 110.599 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.07 92.73 9.09 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.893 ' HE1' HG12 ' A' ' 55' ' ' ILE . 2.0 ptp -112.82 105.08 13.12 Favored 'General case' 0 CA--C 1.509 -0.605 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.979 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.66 152.07 9.92 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.749 179.473 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -84.63 -27.04 27.44 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.089 -179.495 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.2 142.42 2.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.99 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.527 ' CE1' HG22 ' A' ' 68' ' ' ILE . 77.3 t80 -86.9 134.21 33.54 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.246 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.446 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 78.3 mtp180 -148.46 113.88 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.67 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.487 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 0.1 OUTLIER -58.87 -41.07 86.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.385 -179.888 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -79.43 2.73 20.74 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 111.957 0.355 . . . . 0.0 111.957 -179.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.446 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.0 ttp180 -125.56 113.49 17.49 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-O 120.976 0.417 . . . . 0.0 111.45 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' HA ' ' A' ' 68' ' ' ILE . 60.3 t -117.15 119.34 61.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.733 -0.667 . . . . 0.0 109.933 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.689 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.56 133.62 37.32 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 -179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.528 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 37.8 t -120.42 87.59 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.032 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.893 HG12 ' HE1' ' A' ' 43' ' ' MET . 4.3 mt -79.92 122.63 35.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.335 0.588 . . . . 0.0 111.836 -178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.65 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.0 m -122.44 163.77 20.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.254 -179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -88.99 -168.27 2.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.705 179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -62.21 -17.63 58.76 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.363 -179.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -97.8 9.85 41.61 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 111.821 0.304 . . . . 0.0 111.821 -179.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.29 22.54 77.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.371 -0.919 . . . . 0.0 112.311 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.65 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 44.5 t -97.98 137.61 25.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 179.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.578 HG11 ' HG3' ' A' ' 66' ' ' PRO . 58.2 t -75.58 116.89 19.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.848 0.356 . . . . 0.0 110.95 -179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . 0.579 HG21 ' OE2' ' A' ' 39' ' ' GLU . 63.2 p -95.37 -28.57 14.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.351 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.48 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 17.7 m -102.72 148.83 25.11 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.98 0.419 . . . . 0.0 111.304 -179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.824 HG13 ' HA ' ' A' ' 11' ' ' PRO . 23.3 t -64.18 106.84 1.05 Allowed Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.37 179.565 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.584 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 24.0 Cg_exo -59.42 99.04 0.11 Allowed 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 121.952 1.768 . . . . 0.0 111.744 179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.447 ' O ' HG13 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -124.19 156.74 36.23 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.293 0.568 . . . . 0.0 111.025 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.906 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -55.2 114.57 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.634 179.485 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 18.7 m . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.244 -0.884 . . . . 0.0 110.895 -179.49 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.023 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 29.0 t 53.6 58.5 5.1 Favored 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 117.392 2.367 . . . . 0.0 117.392 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.21 78.5 0.11 Allowed 'General case' 0 C--N 1.36 1.041 0 C-N-CA 127.233 2.213 . . . . 0.0 110.579 -173.471 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.79 105.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.143 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.476 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 0.8 OUTLIER -120.92 119.17 30.05 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.836 -179.168 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 8.1 Cg_exo -70.35 163.24 39.47 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 C-N-CA 121.978 1.785 . . . . 0.0 111.732 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 60.24 173.07 0.79 Allowed Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.389 -0.91 . . . . 0.0 112.584 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.53 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 7.1 ttmt -57.26 143.27 40.07 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -99.22 -26.36 14.21 Favored 'General case' 0 N--CA 1.465 0.306 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -177.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -142.38 130.64 22.18 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.843 0.354 . . . . 0.0 110.082 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.684 ' HE3' ' O ' ' A' ' 66' ' ' PRO . 30.1 m-90 -110.86 73.11 0.83 Allowed Pre-proline 0 C--N 1.323 -0.584 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.255 -179.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.855 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -59.89 -35.57 93.3 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.363 2.042 . . . . 0.0 111.676 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.1 pm0 -63.01 -11.84 21.83 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.89 -0.595 . . . . 0.0 111.519 179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.652 HD22 ' HA ' ' A' ' 21' ' ' ALA . 35.9 mt -83.69 -22.69 31.98 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-O 120.73 0.3 . . . . 0.0 110.761 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG21 HG22 ' A' ' 65' ' ' VAL . 43.4 t -56.72 114.32 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.82 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.98 -11.16 29.46 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.373 -179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.468 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -97.39 161.05 13.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.706 0.288 . . . . 0.0 110.71 179.615 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 15.0 p -58.72 142.24 50.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.837 0.351 . . . . 0.0 110.835 -179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.43 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -50.87 -31.89 25.22 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.187 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.99 -47.13 63.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.822 0.344 . . . . 0.0 110.574 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -63.3 -34.49 77.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.118 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.652 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.27 -60.27 3.17 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.768 179.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -51.55 -42.23 61.68 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-O 121.156 0.503 . . . . 0.0 110.095 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -58.59 -48.11 82.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.288 179.001 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.615 ' CB ' HD21 ' A' ' 13' ' ' LEU . 13.4 m -59.84 -41.56 91.63 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.816 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.643 HG13 ' CH2' ' A' ' 10' ' ' TRP . 59.7 t -65.72 -57.09 12.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 120.78 0.324 . . . . 0.0 111.111 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mt-10 -64.47 -22.58 67.01 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.721 -179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.606 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -85.71 -55.5 3.95 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 121.116 -0.233 . . . . 0.0 111.116 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -65.44 -33.14 75.26 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 120.907 0.384 . . . . 0.0 110.443 179.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.41 ' CG ' HG22 ' A' ' 32' ' ' VAL . 44.8 t-20 -127.41 76.61 1.68 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.309 179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -61.15 -2.64 0.67 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.096 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -90.64 -1.45 57.87 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.4 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.41 HG22 ' CG ' ' A' ' 29' ' ' ASN . 13.3 m -141.39 169.38 14.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-O 120.739 0.304 . . . . 0.0 111.317 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -132.79 142.6 49.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.385 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.401 ' HB3' ' HA ' ' A' ' 22' ' ' ALA . . . -107.4 136.91 46.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.188 0.518 . . . . 0.0 111.966 -178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.463 HD11 ' HG3' ' A' ' 51' ' ' ARG . 19.3 mt -101.93 108.99 24.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.647 179.443 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.615 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 45.5 t -79.85 120.95 32.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 CA-C-O 121.185 0.517 . . . . 0.0 110.659 179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.601 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -148.76 159.29 44.28 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.324 -0.853 . . . . 0.0 110.324 -179.264 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 1.4 ptpp? -89.96 161.93 15.65 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.262 0.553 . . . . 0.0 111.815 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -48.19 123.49 6.45 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.527 179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.8 -7.35 55.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.985 179.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.558 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 47.9 t -66.44 -167.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.831 0.348 . . . . 0.0 110.906 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.419 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -71.9 94.78 1.47 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.096 0.474 . . . . 0.0 110.236 179.585 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.526 ' HG2' ' CD1' ' A' ' 53' ' ' TRP . 0.0 OUTLIER -123.04 91.98 3.6 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.385 0.612 . . . . 0.0 111.533 -179.237 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.7 p -81.5 151.98 27.54 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.058 -0.974 . . . . 0.0 110.134 179.587 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 8.2 mtmt -79.81 -25.0 40.99 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.746 179.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -46.48 159.56 0.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.902 179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.478 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.9 t80 -104.54 132.97 50.18 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.053 0.454 . . . . 0.0 111.596 -179.549 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.474 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 28.0 mtp85 -147.28 110.9 4.95 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.838 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.467 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.1 t -56.35 -47.5 78.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.99 -0.55 . . . . 0.0 112.198 -179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.2 p-10 -79.22 3.53 17.57 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.818 -179.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.474 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 30.1 ttp180 -122.22 110.29 15.54 Favored 'General case' 0 N--CA 1.453 -0.307 0 CA-C-O 121.055 0.455 . . . . 0.0 111.223 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.612 HG22 ' HA ' ' A' ' 68' ' ' ILE . 86.9 t -111.91 121.02 63.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.601 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.3 m95 -78.21 128.9 34.43 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.753 0.311 . . . . 0.0 110.31 -179.036 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.615 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 46.3 t -121.88 80.97 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.838 179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.576 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 14.1 mt -80.08 127.63 39.17 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.237 -179.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.638 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 26.9 m -124.09 159.96 28.84 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 CA-C-N 115.287 -0.87 . . . . 0.0 111.364 -179.74 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.6 p30 -84.82 -171.39 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.708 179.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.54 -20.63 48.06 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.49 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 60.0 m80 -95.98 12.76 29.26 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 66.58 23.9 72.3 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.126 -1.035 . . . . 0.0 111.967 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.638 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 32.6 t -96.89 137.58 24.23 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.254 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 179.612 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.535 HG11 ' HG3' ' A' ' 66' ' ' PRO . 44.3 t -75.84 114.63 16.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.089 0.471 . . . . 0.0 111.214 -179.5 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 30.9 p -94.55 -34.6 12.6 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.981 -179.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.5 OUTLIER -94.42 142.26 27.63 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 -179.57 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.855 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -61.87 103.59 0.4 Allowed Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.321 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.684 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 31.6 Cg_exo -54.47 95.46 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 121.603 1.535 . . . . 0.0 111.385 179.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -128.13 143.25 51.04 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.119 0.485 . . . . 0.0 110.934 -179.76 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.612 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -44.23 109.39 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 115.436 -0.802 . . . . 0.0 110.663 179.343 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 21.3 m . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.24 -0.886 . . . . 0.0 110.703 -179.101 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.144 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 94.6 p -56.72 109.51 0.64 Allowed 'General case' 0 N--CA 1.494 1.757 0 N-CA-C 115.343 1.609 . . . . 0.0 115.343 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -168.2 68.16 0.08 Allowed 'General case' 0 C--N 1.349 0.547 0 O-C-N 121.331 -0.856 . . . . 0.0 110.842 -167.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 14.6 mmt-85 -143.52 78.2 1.59 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.268 179.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 12.9 p -84.94 151.78 58.09 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.533 -179.541 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.7 -174.85 2.02 Favored 'Trans proline' 0 N--CA 1.457 -0.67 0 C-N-CA 122.309 2.006 . . . . 0.0 112.231 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 64.15 -179.24 7.2 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.391 -0.909 . . . . 0.0 112.36 179.703 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.638 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 3.9 ttmt -77.93 151.11 33.88 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.614 0.245 . . . . 0.0 110.598 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.0 m-20 -109.88 -13.07 14.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 -178.079 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -151.9 128.89 11.03 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.891 0.376 . . . . 0.0 110.056 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.843 ' CH2' HG13 ' A' ' 25' ' ' VAL . 31.0 m-90 -114.82 70.06 2.31 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.355 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.947 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.4 Cg_endo -58.7 -34.11 98.73 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.164 1.91 . . . . 0.0 111.617 179.457 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.2 pm0 -63.48 -12.93 35.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.414 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.575 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 18.7 mt -81.67 -22.64 37.37 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.708 0.289 . . . . 0.0 110.506 179.397 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.537 HG21 HG22 ' A' ' 65' ' ' VAL . 46.9 t -56.95 113.46 0.57 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.788 179.785 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.86 -10.99 29.77 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.321 -179.524 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.85 171.74 8.45 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 120.592 0.234 . . . . 0.0 110.643 179.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 17.0 p -68.4 142.53 55.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.884 0.373 . . . . 0.0 110.912 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -52.28 -31.67 35.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.035 179.609 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 39.2 m-80 -71.08 -46.22 62.28 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.846 0.355 . . . . 0.0 110.309 179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -62.14 -35.46 78.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.812 179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.714 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -65.28 -63.19 1.16 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.219 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.582 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -50.57 -35.9 32.11 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.694 179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.542 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.11 -46.28 78.13 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.271 179.368 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.455 ' HB ' HD11 ' A' ' 13' ' ' LEU . 35.0 m -59.88 -41.37 91.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.007 -179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.843 HG13 ' CH2' ' A' ' 10' ' ' TRP . 17.2 t -66.44 -50.53 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.73 0.3 . . . . 0.0 111.329 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -67.44 -31.7 72.07 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.506 -179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.25 -51.04 10.0 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-O 120.814 0.34 . . . . 0.0 110.813 -179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -68.19 -37.81 81.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.823 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.582 ' CG ' HG22 ' A' ' 32' ' ' VAL . 50.1 t-20 -119.55 80.66 1.6 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.074 0.464 . . . . 0.0 111.121 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.25 -5.86 2.69 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.803 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -96.45 6.53 48.55 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 111.549 0.203 . . . . 0.0 111.549 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.582 HG22 ' CG ' ' A' ' 29' ' ' ASN . 10.8 m -144.71 169.21 8.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.338 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.736 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -131.78 138.14 48.45 Favored 'General case' 0 C--O 1.236 0.368 0 CA-C-O 121.096 0.474 . . . . 0.0 110.852 179.822 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -107.16 131.98 53.55 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.289 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.736 HD11 ' NE2' ' A' ' 33' ' ' HIS . 3.6 mp -107.04 114.19 45.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.991 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.636 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 47.8 t -80.37 119.59 30.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.078 0.466 . . . . 0.0 111.257 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.765 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.2 OUTLIER -147.79 153.21 38.91 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.254 179.828 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.44 157.12 19.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.038 0.447 . . . . 0.0 111.786 -179.192 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' HG23 ' A' ' 55' ' ' ILE . 4.0 pt-20 -50.86 118.1 2.93 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.408 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.52 -7.11 31.94 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.621 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 41.1 t -61.43 -178.0 0.11 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.881 0.372 . . . . 0.0 110.641 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -87.82 92.79 9.25 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.126 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -126.23 121.04 31.58 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.241 -179.278 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -70.01 156.56 38.96 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 178.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -87.46 -24.79 24.03 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.057 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -48.41 141.51 6.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.17 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.511 ' CE2' HG22 ' A' ' 68' ' ' ILE . 28.9 t80 -83.26 133.77 34.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.061 -179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 11.2 mtm180 -146.12 114.32 6.63 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.794 179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.483 ' O ' HG12 ' A' ' 68' ' ' ILE . 1.3 m -60.07 -37.83 81.06 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.528 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.533 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 12.2 p-10 -79.79 1.51 26.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.468 -179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.532 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 41.4 ttp180 -126.77 129.63 48.73 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 120.966 0.412 . . . . 0.0 111.429 -179.517 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.558 HG21 HG11 ' A' ' 25' ' ' VAL . 44.8 t -128.7 112.77 27.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.825 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.765 ' CE3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.43 133.73 37.45 Favored 'General case' 0 CA--C 1.518 -0.254 0 CA-C-O 120.89 0.376 . . . . 0.0 109.995 -179.59 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.636 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 48.4 t -119.11 90.4 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.519 0 CA-C-N 115.965 -0.561 . . . . 0.0 109.799 179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.582 ' HB ' ' OG ' ' A' ' 64' ' ' SER . 1.8 mp -79.68 119.57 29.32 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.24 0 CA-C-O 121.393 0.616 . . . . 0.0 111.402 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.626 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 34.4 m -116.51 161.96 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.378 -179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -82.4 -174.09 4.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.93 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -58.41 -22.07 52.85 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.593 -179.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.48 -17.14 29.25 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 111.74 0.274 . . . . 0.0 111.74 -179.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.23 22.42 13.04 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.485 -0.864 . . . . 0.0 111.928 -179.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.626 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 40.3 t -99.6 143.97 12.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 179.584 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.714 HG21 ' HB2' ' A' ' 21' ' ' ALA . 33.5 t -73.75 115.84 15.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-O 120.914 0.388 . . . . 0.0 111.023 -179.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 43.8 p -95.7 -31.99 12.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.435 -179.68 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.582 ' OG ' ' HB ' ' A' ' 55' ' ' ILE . 1.8 p -105.56 159.03 16.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.002 0.429 . . . . 0.0 111.521 -179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.947 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.3 t -68.07 104.56 0.71 Allowed Pre-proline 0 C--N 1.33 -0.276 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.825 -179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.58 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 32.3 Cg_exo -59.05 100.3 0.12 Allowed 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 121.867 1.711 . . . . 0.0 111.233 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.03 152.56 49.36 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.262 0.553 . . . . 0.0 111.099 -179.503 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.545 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -47.71 109.92 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.644 179.299 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 7.6 m . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.219 -0.896 . . . . 0.0 110.656 -179.114 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.229 0.016 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 24.8 p 70.01 166.51 0.28 Allowed 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 116.646 2.091 . . . . 0.0 116.646 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 15.9 mtt180 -106.69 60.86 0.63 Allowed 'General case' 0 C--N 1.347 0.496 0 O-C-N 120.29 -1.506 . . . . 0.0 110.733 155.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.28 97.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.02 -0.537 . . . . 0.0 110.943 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 94.4 m -115.22 137.87 23.25 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.017 0.437 . . . . 0.0 110.952 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.41 ' HG2' ' CB ' ' A' ' 31' ' ' ASN . 97.2 Cg_endo -80.06 168.34 18.96 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.121 1.881 . . . . 0.0 112.658 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 69.2 157.75 1.47 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.762 179.549 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.6 ttmm -50.85 147.46 4.91 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.658 0.266 . . . . 0.0 111.135 179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.6 m120 -111.19 -1.53 16.11 Favored 'General case' 0 N--CA 1.466 0.356 0 N-CA-C 112.43 0.53 . . . . 0.0 112.43 -178.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.484 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.02 132.37 6.4 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.877 ' CH2' HG13 ' A' ' 25' ' ' VAL . 24.9 m-90 -119.45 72.13 13.98 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.885 0.374 . . . . 0.0 111.534 -179.26 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.915 ' HA ' HG13 ' A' ' 65' ' ' VAL . 15.2 Cg_endo -57.34 -35.71 98.88 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.166 1.91 . . . . 0.0 111.694 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.6 pm0 -63.93 -10.42 20.98 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.896 179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.562 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 16.7 mt -80.35 -22.85 40.98 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.812 0.339 . . . . 0.0 110.338 179.359 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.562 HG21 HG22 ' A' ' 65' ' ' VAL . 38.8 t -58.67 112.16 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.93 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 114.87 -5.23 22.44 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.449 -179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.7 mmtt -102.88 -174.64 2.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.623 0.249 . . . . 0.0 110.734 179.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.0 p -83.03 140.32 32.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.789 0.328 . . . . 0.0 110.765 -179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.405 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -49.63 -29.88 12.82 Favored Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.14 179.783 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -71.66 -47.9 51.22 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.734 0.302 . . . . 0.0 110.741 179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.427 ' HE2' ' HA ' ' A' ' 20' ' ' MET . 0.0 OUTLIER -64.81 -30.43 71.43 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 179.425 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.648 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -67.57 -62.2 1.53 Allowed 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.482 179.119 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.484 ' HB2' ' CG2' ' A' ' 36' ' ' VAL . . . -54.29 -35.93 63.13 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-O 121.037 0.446 . . . . 0.0 110.452 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -66.5 -45.35 79.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.403 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 85.3 m -59.41 -40.61 87.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.621 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.877 HG13 ' CH2' ' A' ' 10' ' ' TRP . 13.7 t -66.39 -56.2 15.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.458 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -62.73 -27.27 69.16 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.608 0.242 . . . . 0.0 111.331 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 30.2 ttp180 -80.75 -57.39 3.58 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.775 0.321 . . . . 0.0 110.997 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -64.14 -33.13 75.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.444 179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.549 ' OD1' HG13 ' A' ' 32' ' ' VAL . 44.7 t-20 -125.62 79.71 1.84 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.684 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.46 -0.85 0.98 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.916 -0.584 . . . . 0.0 112.309 -179.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.41 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . 27.5 t-20 -100.37 0.18 39.45 Favored 'General case' 0 C--N 1.333 -0.128 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.607 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.752 HG11 HD11 ' A' ' 68' ' ' ILE . 10.1 m -129.27 167.98 23.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 120.894 0.378 . . . . 0.0 111.47 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.464 ' CE1' HG12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -131.59 124.63 30.38 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.26 179.907 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.41 137.91 38.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.553 -179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.464 HG12 ' CE1' ' A' ' 33' ' ' HIS . 27.7 mt -110.12 119.25 58.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.941 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.569 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 68.1 t -83.29 116.14 26.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.153 0.501 . . . . 0.0 110.566 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.78 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.7 OUTLIER -135.31 154.21 51.61 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.66 -0.7 . . . . 0.0 110.374 -179.361 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.26 154.53 19.66 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.231 0.539 . . . . 0.0 111.779 -179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -45.76 117.89 1.63 Allowed 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.476 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 105.21 1.09 41.34 Favored Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.863 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.479 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 34.4 t -67.61 -167.68 0.07 Allowed 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 120.934 0.397 . . . . 0.0 110.945 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.26 101.08 13.81 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.865 179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -124.94 99.8 6.3 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.271 0.558 . . . . 0.0 111.638 -179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 25.1 p -74.47 155.7 37.72 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.071 179.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 -25.13 37.69 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.045 -179.914 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -44.18 141.52 1.76 Allowed 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.939 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.429 ' CE1' HG22 ' A' ' 68' ' ' ILE . 86.5 t80 -90.02 133.97 34.51 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.056 0.455 . . . . 0.0 111.813 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 8.6 mtp180 -152.64 111.98 3.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.273 179.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.499 ' O ' HG12 ' A' ' 68' ' ' ILE . 73.8 m -58.86 -37.11 75.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.582 -179.534 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.8 p-10 -79.77 -1.42 38.62 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 37.6 ttp180 -122.99 108.67 13.19 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-O 120.984 0.421 . . . . 0.0 111.57 -179.568 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG22 ' HA ' ' A' ' 68' ' ' ILE . 94.4 t -111.88 120.04 61.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.828 179.02 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.78 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.5 m95 -78.63 125.24 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.823 0.344 . . . . 0.0 110.429 -179.19 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.569 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 24.4 t -118.2 88.13 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.375 -179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.557 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 23.0 mt -80.1 125.95 39.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.267 0.556 . . . . 0.0 111.827 -179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.4 m -124.56 164.6 22.82 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.461 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 p30 -84.57 -177.11 6.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.441 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 20.4 p30 -54.6 -25.44 26.46 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.868 -0.606 . . . . 0.0 111.787 -179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 37.7 t-80 -88.38 -22.66 23.67 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.618 0.246 . . . . 0.0 111.358 -179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 108.08 22.67 7.09 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.478 -0.868 . . . . 0.0 112.232 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.611 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 58.3 t -96.14 135.41 30.31 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.184 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.648 HG21 ' HB2' ' A' ' 21' ' ' ALA . 61.5 t -70.18 112.67 5.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.911 0.386 . . . . 0.0 110.811 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 65.5 p -97.1 -30.33 13.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.02 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.547 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -100.85 147.64 25.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.136 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.915 HG13 ' HA ' ' A' ' 11' ' ' PRO . 19.9 t -64.7 103.46 0.43 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.578 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 64' ' ' SER . 39.8 Cg_endo -64.76 108.54 1.09 Allowed 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.116 1.877 . . . . 0.0 111.543 178.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.484 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -137.95 148.7 45.5 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.173 0.511 . . . . 0.0 111.346 -179.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.752 HD11 HG11 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -44.28 113.38 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.61 179.07 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 5.6 m . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.808 -179.224 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.063 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 16.9 t -77.22 155.78 31.94 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.8 mtp85 52.86 60.08 4.03 Favored 'General case' 0 C--N 1.36 1.043 0 C-N-CA 127.1 2.16 . . . . 0.0 111.221 -175.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 6.0 tmm_? -161.54 98.99 1.14 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.815 -0.63 . . . . 0.0 110.295 179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . 0.419 ' HA ' ' HD3' ' A' ' 5' ' ' PRO . 13.8 m -112.67 148.26 38.88 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.065 0.46 . . . . 0.0 111.403 -179.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 4' ' ' CYS . 31.9 Cg_exo -57.45 153.66 39.98 Favored 'Trans proline' 0 N--CA 1.461 -0.421 0 C-N-CA 122.588 2.192 . . . . 0.0 113.161 -179.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.407 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 80.42 170.07 41.28 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.92 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 16.2 ttmm -67.52 157.47 34.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.607 -0.296 . . . . 0.0 110.674 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -115.37 -9.92 12.09 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 112.97 0.73 . . . . 0.0 112.97 -178.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.451 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -152.69 129.13 10.64 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.621 0.248 . . . . 0.0 110.607 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.831 ' CH2' HG13 ' A' ' 25' ' ' VAL . 26.7 m-90 -115.48 72.85 3.8 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 120.767 0.318 . . . . 0.0 111.479 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.892 ' HA ' HG13 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.15 -34.53 94.21 Favored 'Trans proline' 0 C--O 1.232 0.222 0 C-N-CA 122.166 1.91 . . . . 0.0 111.506 179.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -64.5 -12.05 40.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.684 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.619 HD22 ' HA ' ' A' ' 21' ' ' ALA . 17.6 mt -81.94 -20.36 38.82 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 120.772 0.32 . . . . 0.0 110.565 179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 11' ' ' PRO . 47.2 t -55.44 114.52 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.431 -0.35 . . . . 0.0 110.702 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 109.43 -9.92 33.05 Favored Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.574 -0.822 . . . . 0.0 112.286 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.419 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.2 OUTLIER -95.6 157.1 16.05 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.751 0.31 . . . . 0.0 110.502 179.727 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.8 p -59.37 141.28 54.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.778 0.323 . . . . 0.0 110.518 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.51 -30.27 19.27 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.32 179.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 -71.02 -53.15 15.78 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.74 0.305 . . . . 0.0 111.175 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.65 -37.11 82.84 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.853 0.359 . . . . 0.0 110.182 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.619 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -63.14 -56.68 14.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.414 179.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -54.31 -36.64 63.95 Favored 'General case' 0 C--O 1.232 0.155 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.336 179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -66.24 -42.19 88.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.316 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 25.0 m -59.72 -44.11 93.88 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.644 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.831 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.5 t -65.09 -51.99 59.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.481 -179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' OE2' ' HA ' ' A' ' 33' ' ' HIS . 2.5 mt-10 -64.53 -30.06 71.09 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.668 0.27 . . . . 0.0 111.449 -179.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 1.8 tmm_? -79.5 -55.2 5.22 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.835 0.35 . . . . 0.0 110.84 -179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -64.54 -34.59 78.59 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.965 0.412 . . . . 0.0 110.537 179.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.554 ' CG ' HG22 ' A' ' 32' ' ' VAL . 48.4 t-20 -124.77 80.02 1.82 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.744 179.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 4.4 tpt180 -65.16 -5.71 7.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.559 179.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -89.85 -2.05 58.12 Favored 'General case' 0 N--CA 1.456 -0.159 0 CA-C-O 120.6 0.238 . . . . 0.0 111.159 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.725 HG11 HD11 ' A' ' 68' ' ' ILE . 4.5 m -137.52 171.23 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 CA-C-O 120.967 0.413 . . . . 0.0 111.363 -179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.506 ' CE1' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -134.2 136.03 43.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.352 179.544 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.65 125.45 51.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.611 -179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.889 HD13 ' CZ3' ' A' ' 53' ' ' TRP . 3.1 mp -94.22 143.12 12.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 115.835 -0.62 . . . . 0.0 109.782 179.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.471 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 72.6 t -99.63 114.57 38.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.257 0.551 . . . . 0.0 111.646 -179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.767 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.1 OUTLIER -142.19 144.91 33.62 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.986 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.76 153.31 24.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.337 -179.312 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -56.64 107.92 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.588 179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 129.75 -10.19 6.05 Favored Glycine 0 N--CA 1.447 -0.617 0 CA-C-N 115.63 -0.714 . . . . 0.0 112.093 -179.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 19.4 t -67.58 160.21 28.26 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-O 120.805 0.336 . . . . 0.0 110.362 179.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.68 88.72 7.73 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.468 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.513 ' HG2' HD13 ' A' ' 37' ' ' LEU . 0.0 OUTLIER -120.55 139.45 52.92 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 120.83 0.347 . . . . 0.0 111.008 -179.559 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.26 161.07 11.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.138 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -96.78 -24.15 16.06 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.932 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -41.88 163.34 0.01 OUTLIER 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.333 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 58.8 t80 -102.23 130.59 48.95 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.537 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.447 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 20.9 mtp180 -145.96 113.22 6.21 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.56 179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.475 ' O ' HG12 ' A' ' 68' ' ' ILE . 43.0 m -58.45 -39.83 80.94 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.618 -179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.464 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 23.7 p-10 -79.52 2.68 21.23 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 111.85 0.315 . . . . 0.0 111.85 -179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.615 ' HG3' HD11 ' A' ' 35' ' ' ILE . 43.1 ttp180 -124.92 119.14 27.94 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 120.954 0.407 . . . . 0.0 110.983 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.553 HG21 HG11 ' A' ' 25' ' ' VAL . 48.6 t -122.02 116.39 49.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.93 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.889 ' CZ3' HD13 ' A' ' 35' ' ' ILE . 1.0 OUTLIER -78.82 124.29 28.07 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.102 0.477 . . . . 0.0 110.73 -179.236 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 42.2 t -106.07 87.35 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 178.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.65 HD12 ' H ' ' A' ' 55' ' ' ILE . 4.1 mp -80.15 114.22 20.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.589 -178.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.555 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 24.8 m -119.26 165.81 14.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 115.52 -0.764 . . . . 0.0 111.507 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.7 p30 -85.34 -173.48 4.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.918 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -60.71 -21.69 63.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.411 -179.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -89.63 -13.0 38.03 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.535 -179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.83 24.91 16.15 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.508 -0.853 . . . . 0.0 112.083 -179.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.555 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 22.0 t -101.16 134.9 39.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.62 HG11 ' HG3' ' A' ' 66' ' ' PRO . 91.1 t -68.27 107.63 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.449 . . . . 0.0 110.539 -179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 51.7 p -90.05 -32.85 16.55 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.863 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.497 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.3 OUTLIER -104.01 152.99 21.37 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.772 -179.88 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.892 HG13 ' HA ' ' A' ' 11' ' ' PRO . 25.6 t -64.89 106.47 1.01 Allowed Pre-proline 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.441 -179.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.62 ' HG3' HG11 ' A' ' 62' ' ' VAL . 17.3 Cg_exo -60.81 90.82 0.09 OUTLIER 'Trans proline' 0 N--CA 1.461 -0.439 0 C-N-CA 121.825 1.683 . . . . 0.0 111.394 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -121.0 146.82 46.29 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.446 0.641 . . . . 0.0 111.468 -179.754 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.725 HD11 HG11 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -45.77 117.73 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.673 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 3.3 m . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.127 -0.94 . . . . 0.0 110.713 -179.428 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.228 -0.04 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 60.4 m 44.28 55.65 5.42 Favored 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 118.327 2.714 . . . . 0.0 118.327 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 51.64 81.9 0.07 Allowed 'General case' 0 C--N 1.36 1.024 0 C-N-CA 127.15 2.18 . . . . 0.0 111.381 -174.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.19 94.17 0.45 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.342 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 8.3 m -115.12 153.19 47.25 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.36 -179.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.18 160.02 14.07 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.685 2.257 . . . . 0.0 112.928 -179.058 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.422 ' HA3' ' CG ' ' A' ' 29' ' ' ASN . . . 66.67 172.71 5.14 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.666 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.518 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 10.1 ttmt -67.85 145.59 54.48 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.705 0.288 . . . . 0.0 110.521 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.4 ' HA ' HD12 ' A' ' 68' ' ' ILE . 15.4 m-20 -105.5 -5.81 19.93 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.824 0.675 . . . . 0.0 112.824 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.81 128.31 4.97 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.689 0.281 . . . . 0.0 110.367 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.776 ' CH2' HG13 ' A' ' 25' ' ' VAL . 25.3 m-90 -112.62 69.89 1.09 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 120.902 0.382 . . . . 0.0 111.075 -179.81 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.838 ' HA ' HG13 ' A' ' 65' ' ' VAL . 11.8 Cg_endo -55.44 -37.33 94.93 Favored 'Trans proline' 0 N--CA 1.463 -0.319 0 C-N-CA 122.011 1.807 . . . . 0.0 111.938 179.674 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -65.05 -5.99 7.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.033 -0.53 . . . . 0.0 112.318 -179.8 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.587 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 28.4 mt -84.44 -18.95 34.31 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.938 -0.305 . . . . 0.0 110.661 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.4 t -58.64 113.56 0.7 Allowed 'Isoleucine or valine' 0 C--O 1.231 0.122 0 CA-C-O 120.801 0.334 . . . . 0.0 110.571 179.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.1 -12.16 19.86 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.386 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.49 156.36 17.32 Favored 'General case' 0 N--CA 1.462 0.163 0 CA-C-O 120.583 0.23 . . . . 0.0 110.661 179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . 0.433 ' HA ' ' HA ' ' A' ' 61' ' ' VAL . 7.6 p -56.8 145.73 28.43 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-O 120.994 0.426 . . . . 0.0 111.43 -179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.594 ' HA3' HG11 ' A' ' 56' ' ' VAL . . . -53.76 -32.35 47.45 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 120.924 -0.655 . . . . 0.0 112.204 179.147 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -68.82 -47.14 66.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.738 0.304 . . . . 0.0 110.866 179.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.52 -44.13 97.11 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.271 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.587 ' HB1' HD13 ' A' ' 13' ' ' LEU . . . -60.25 -52.64 64.41 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.327 179.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.43 -45.19 65.85 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.623 179.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -64.53 -39.39 93.69 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.32 179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.416 HG21 HD21 ' A' ' 13' ' ' LEU . 39.7 m -61.77 -43.46 98.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.596 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.776 HG13 ' CH2' ' A' ' 10' ' ' TRP . 44.5 t -66.9 -48.45 79.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.192 179.962 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mm-40 -67.21 -31.05 71.16 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.395 -179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttp180 -81.62 -53.39 6.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.022 -179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.0 mt-10 -65.17 -33.22 75.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.66 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.422 ' CG ' ' HA3' ' A' ' 6' ' ' GLY . 55.6 t-20 -127.99 81.28 2.01 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.353 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 30' ' ' ARG . 1.1 ptm180 -63.3 -8.39 8.47 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.432 179.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -87.16 -1.32 57.81 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.605 0.241 . . . . 0.0 111.587 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.423 ' CG1' ' O ' ' A' ' 49' ' ' CYS . 3.9 m -140.07 173.04 11.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.891 0.377 . . . . 0.0 111.441 -179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.519 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.1 OUTLIER -134.06 136.5 44.03 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.346 179.075 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -102.5 125.76 49.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.116 -179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.63 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 15.4 mt -98.28 111.29 27.63 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.571 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.662 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 7.7 p -79.67 125.29 38.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-O 121.565 0.698 . . . . 0.0 111.489 -179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.679 HD21 ' CZ3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -156.96 148.86 22.7 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.181 -0.918 . . . . 0.0 110.023 -179.478 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.75 158.14 17.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.225 0.536 . . . . 0.0 111.807 -179.086 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -45.17 123.69 4.14 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.201 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 109.41 -11.98 33.37 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.547 -0.835 . . . . 0.0 112.789 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.437 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 42.4 t -68.27 -166.58 0.07 Allowed 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.881 0.372 . . . . 0.0 110.775 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.33 100.0 12.91 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.191 179.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 2.1 ptm -125.21 96.58 4.89 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.265 0.555 . . . . 0.0 111.328 -179.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.49 150.17 48.81 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.227 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 12.1 mtpt -83.31 -25.06 31.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.895 -179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -48.31 141.13 6.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.828 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -84.78 132.25 34.45 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.885 -0.598 . . . . 0.0 111.266 -179.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -148.05 109.38 4.34 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.63 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.423 ' O ' ' CG1' ' A' ' 32' ' ' VAL . 55.5 m -59.61 -34.15 72.4 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.712 -179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 9.9 p-10 -79.12 -3.31 44.84 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.94 -0.304 . . . . 0.0 111.785 -179.014 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 50.3 ttp180 -123.66 135.13 53.73 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.986 0.422 . . . . 0.0 111.23 -179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 42.9 t -131.13 117.25 36.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.857 -0.61 . . . . 0.0 109.585 178.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.679 ' CZ3' HD21 ' A' ' 37' ' ' LEU . 1.8 m95 -78.67 131.37 36.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.981 0.42 . . . . 0.0 111.094 -178.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.662 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 33.8 t -116.0 89.48 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.014 179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.4 ' HB ' ' HB2' ' A' ' 64' ' ' SER . 10.4 mm -79.72 121.33 32.79 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.23 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.358 -179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.594 HG11 ' HA3' ' A' ' 18' ' ' GLY . 28.6 m -122.31 163.8 20.26 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.206 179.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 55.8 p30 -84.09 -177.33 6.63 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.347 -179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -55.8 -22.1 22.84 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.602 -179.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 88.5 m-70 -90.73 -21.88 21.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.58 -0.282 . . . . 0.0 111.552 -179.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 106.57 22.04 7.96 Favored Glycine 0 CA--C 1.519 0.283 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.266 -179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 39.1 t -101.27 134.23 42.15 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.299 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 179.4 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.575 HG11 ' HG3' ' A' ' 66' ' ' PRO . 61.3 t -65.33 114.85 2.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.981 0.419 . . . . 0.0 111.081 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 41.3 p -96.9 -33.11 11.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.489 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.4 ' HB2' ' HB ' ' A' ' 55' ' ' ILE . 68.1 m -105.03 158.57 16.47 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.0 0.429 . . . . 0.0 111.36 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.838 HG13 ' HA ' ' A' ' 11' ' ' PRO . 3.7 t -65.88 117.01 37.89 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.394 179.785 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HG3' HG11 ' A' ' 62' ' ' VAL . 2.4 Cg_endo -79.28 93.53 1.09 Allowed 'Trans proline' 0 N--CA 1.456 -0.719 0 C-N-CA 122.552 2.168 . . . . 0.0 110.673 178.575 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.514 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 12.6 p-80 -125.8 151.41 46.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 121.088 0.47 . . . . 0.0 111.218 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.546 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.3 OUTLIER -40.75 110.23 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.897 179.48 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 15.7 m . . . . . 0 C--O 1.247 0.961 0 CA-C-O 118.099 -0.953 . . . . 0.0 110.655 -179.014 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.032 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 15.3 t -76.89 78.95 3.47 Favored 'General case' 0 CA--C 1.573 1.838 0 CA-C-O 122.727 1.251 . . . . 0.0 114.313 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 57.97 78.16 0.25 Allowed 'General case' 0 C--N 1.352 0.68 0 C-N-CA 127.953 2.501 . . . . 0.0 111.055 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.99 67.63 0.31 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.154 0.502 . . . . 0.0 110.817 179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 6.0 p -133.87 147.08 62.79 Favored Pre-proline 0 C--N 1.325 -0.468 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.986 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -63.03 150.59 88.2 Favored 'Trans proline' 0 N--CA 1.454 -0.833 0 C-N-CA 121.795 1.663 . . . . 0.0 111.387 179.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 90.87 173.98 44.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.454 -0.879 . . . . 0.0 112.257 -179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.59 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 31.4 ttmt -66.42 150.5 48.83 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.745 0.307 . . . . 0.0 110.708 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.594 ' HA ' HD12 ' A' ' 68' ' ' ILE . 0.7 OUTLIER -107.35 -19.03 13.71 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.512 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.454 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -149.66 127.5 11.79 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 120.853 0.359 . . . . 0.0 110.081 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.714 ' CH2' HG13 ' A' ' 25' ' ' VAL . 27.5 m-90 -110.34 68.93 0.54 Allowed Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.388 -179.293 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.878 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.5 Cg_endo -58.63 -36.56 97.1 Favored 'Trans proline' 0 C--N 1.343 0.259 0 C-N-CA 121.999 1.799 . . . . 0.0 111.513 179.386 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.8 pm0 -64.51 -9.36 18.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.922 179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.578 ' HG ' ' HB3' ' A' ' 10' ' ' TRP . 15.2 mt -79.95 -21.2 44.07 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 120.806 -0.357 . . . . 0.0 110.442 179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 11' ' ' PRO . 60.7 t -55.25 117.85 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 CA-C-O 120.825 0.345 . . . . 0.0 110.91 179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 111.48 -14.21 27.67 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.454 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 62' ' ' VAL . 1.4 mmtt -95.8 158.72 15.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.666 0.27 . . . . 0.0 110.679 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 24.6 p -57.98 143.59 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.116 -179.74 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.29 -31.48 20.11 Favored Glycine 0 C--N 1.329 0.163 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.255 179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -71.55 -45.92 60.94 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.718 0.294 . . . . 0.0 110.712 179.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.62 -39.01 92.47 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.701 ' HB2' HG21 ' A' ' 62' ' ' VAL . . . -62.97 -60.76 3.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.384 179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.503 ' O ' ' HG3' ' A' ' 26' ' ' GLU . . . -51.25 -44.09 61.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.431 179.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -60.97 -45.79 93.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.299 179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.44 HG21 HD21 ' A' ' 13' ' ' LEU . 91.6 m -56.86 -43.18 80.91 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.932 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.714 HG13 ' CH2' ' A' ' 10' ' ' TRP . 57.2 t -65.91 -54.08 31.12 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.332 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.503 ' HG3' ' O ' ' A' ' 22' ' ' ALA . 6.3 mt-10 -63.61 -27.08 68.99 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.696 -0.229 . . . . 0.0 111.421 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.64 -56.48 3.83 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 121.053 -0.259 . . . . 0.0 110.695 179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -61.72 -35.74 78.92 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.065 0.459 . . . . 0.0 110.025 179.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 47.4 t-20 -126.02 75.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.64 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 12.8 ptt-85 -62.58 0.97 0.41 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.643 -0.708 . . . . 0.0 112.464 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 28.0 t-20 -93.56 -5.0 49.93 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 120.935 -0.306 . . . . 0.0 111.252 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' O ' ' A' ' 49' ' ' CYS . 4.2 m -140.51 166.45 19.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.964 -179.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.431 ' HD2' ' O ' ' A' ' 50' ' ' ASP . 0.6 OUTLIER -126.94 145.48 50.67 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-O 121.269 0.557 . . . . 0.0 111.415 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -108.26 137.38 46.34 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.126 -179.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.489 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 18.1 mt -106.29 113.7 43.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.616 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.559 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -78.88 120.26 29.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 CA-C-O 121.389 0.614 . . . . 0.0 111.072 -179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.648 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.9 OUTLIER -145.12 154.91 42.96 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.006 -0.997 . . . . 0.0 109.99 -179.129 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.69 156.75 17.86 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.315 0.579 . . . . 0.0 112.014 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -51.61 110.87 0.5 Allowed 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.165 179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.06 -3.79 12.81 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.362 -179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.4 ' OG ' ' N ' ' A' ' 42' ' ' ALA . 30.9 t -67.62 -176.01 0.58 Allowed 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 120.86 0.362 . . . . 0.0 110.585 179.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.4 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -90.52 101.36 14.1 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 179.349 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 1.9 ptp -127.83 103.77 7.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.144 -178.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.5 p -63.66 152.54 38.72 Favored 'General case' 0 N--CA 1.442 -0.844 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -81.51 -24.32 36.75 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.985 -0.552 . . . . 0.0 111.293 -179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 41.4 m-20 -44.5 147.4 0.59 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.722 179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.514 ' CE1' HG22 ' A' ' 68' ' ' ILE . 72.2 t80 -93.46 135.16 34.98 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.89 0.376 . . . . 0.0 111.435 -179.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.507 ' HB2' ' HB3' ' A' ' 51' ' ' ARG . 15.4 mtm180 -147.97 112.02 5.16 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.559 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.503 ' O ' HG12 ' A' ' 68' ' ' ILE . 0.5 OUTLIER -59.42 -36.59 76.17 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.535 -179.906 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.431 ' O ' ' HD2' ' A' ' 33' ' ' HIS . 20.8 p-10 -79.75 0.2 31.63 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 48' ' ' ARG . 44.8 ttp180 -127.91 124.88 38.49 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.053 0.454 . . . . 0.0 111.444 -179.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.676 HG22 ' HA ' ' A' ' 68' ' ' ILE . 48.6 t -122.84 118.32 54.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.108 179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.648 ' CE3' HD21 ' A' ' 37' ' ' LEU . 3.5 m95 -78.47 133.31 37.45 Favored 'General case' 0 N--CA 1.465 0.292 0 N-CA-C 109.544 -0.539 . . . . 0.0 109.544 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.559 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 25.5 t -120.43 90.63 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.383 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.507 HD13 ' CB ' ' A' ' 64' ' ' SER . 3.0 mp -81.25 123.78 38.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.474 0.654 . . . . 0.0 112.184 -178.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.6 m -124.92 165.95 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.01 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 54.8 p30 -86.73 -172.68 4.12 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.681 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -61.47 -21.28 64.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.501 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.6 t-80 -91.67 -8.68 46.41 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 111.917 0.34 . . . . 0.0 111.917 -179.219 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 91.89 25.08 23.52 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.408 -0.901 . . . . 0.0 112.264 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.588 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 24.1 t -100.51 135.11 37.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 16' ' ' LYS . 41.2 t -72.14 114.09 10.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.895 0.379 . . . . 0.0 111.434 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 44.2 p -98.74 -31.01 12.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.956 179.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.507 ' CB ' HD13 ' A' ' 55' ' ' ILE . 1.2 t -99.73 154.05 18.62 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.266 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.878 HG13 ' HA ' ' A' ' 11' ' ' PRO . 34.0 t -68.52 106.89 1.55 Allowed Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 115.631 -0.713 . . . . 0.0 111.748 179.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.673 ' O ' ' HE3' ' A' ' 10' ' ' TRP . 12.8 Cg_exo -65.69 89.29 0.23 Allowed 'Trans proline' 0 N--CA 1.459 -0.545 0 C-N-CA 121.868 1.712 . . . . 0.0 111.012 178.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.3 OUTLIER -123.76 145.67 48.86 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.839 -179.653 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.676 ' HA ' HG22 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -41.17 114.22 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.074 179.507 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 C--O 1.247 0.935 0 CA-C-O 118.298 -0.858 . . . . 0.0 110.803 -179.435 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.104 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 89.5 p -75.86 69.64 2.53 Favored 'General case' 0 CA--C 1.574 1.867 0 N-CA-C 115.9 1.815 . . . . 0.0 115.9 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 1.4 ptm180 -160.46 84.66 0.71 Allowed 'General case' 0 C--N 1.346 0.445 0 O-C-N 120.319 -1.488 . . . . 0.0 111.117 168.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -154.01 77.34 1.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.632 179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 4.4 p -138.38 143.31 38.18 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.393 -179.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . 0.405 ' HG2' ' CB ' ' A' ' 31' ' ' ASN . 43.8 Cg_endo -69.49 158.42 57.35 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.935 1.757 . . . . 0.0 111.975 179.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 80.74 173.93 47.7 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.485 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.536 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 5.9 ttmm -69.65 154.36 42.1 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.584 0.23 . . . . 0.0 111.124 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.458 ' ND2' HD12 ' A' ' 68' ' ' ILE . 1.8 t-20 -111.46 -6.41 14.45 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.083 0.772 . . . . 0.0 113.083 -177.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.505 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -159.92 126.7 4.43 Favored 'General case' 0 C--N 1.326 -0.445 0 O-C-N 122.315 -0.241 . . . . 0.0 110.362 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.798 ' CH2' HG13 ' A' ' 25' ' ' VAL . 20.0 m-90 -112.52 73.48 1.44 Allowed Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 120.884 0.373 . . . . 0.0 111.726 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.922 ' HA ' HG13 ' A' ' 65' ' ' VAL . 19.6 Cg_endo -57.66 -33.47 96.73 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.441 2.094 . . . . 0.0 111.854 179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.8 pm0 -63.5 -13.08 37.33 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.383 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.704 HD22 ' HA ' ' A' ' 21' ' ' ALA . 21.1 mt -81.33 -22.99 38.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.957 0.408 . . . . 0.0 110.392 179.521 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.473 HG21 HG22 ' A' ' 65' ' ' VAL . 24.6 t -60.6 113.15 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.695 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.2 -9.48 20.51 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.64 -0.791 . . . . 0.0 112.481 -179.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HD2' HD22 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -105.95 177.26 4.91 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.755 0.312 . . . . 0.0 110.943 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 6.7 p -66.47 144.75 56.3 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.892 0.377 . . . . 0.0 111.338 -179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.42 ' HA2' ' CG2' ' A' ' 62' ' ' VAL . . . -60.32 -28.22 66.72 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.423 179.501 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 -72.7 -53.48 11.59 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.849 0.357 . . . . 0.0 110.736 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.428 ' HB3' ' HD3' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -61.5 -30.92 70.92 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.704 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -65.85 -61.72 1.9 Allowed 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.283 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -51.13 -38.17 50.35 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.066 0.46 . . . . 0.0 110.129 178.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.402 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -61.91 -45.2 94.76 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.412 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.439 ' CB ' HD21 ' A' ' 13' ' ' LEU . 11.4 m -58.49 -43.88 89.2 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.279 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.798 HG13 ' CH2' ' A' ' 10' ' ' TRP . 39.2 t -64.28 -60.66 2.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.074 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -59.01 -23.56 62.05 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.621 0.248 . . . . 0.0 111.321 -179.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.402 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 5.4 tpp180 -81.39 -61.04 2.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.771 0.32 . . . . 0.0 111.023 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -63.11 -31.79 73.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.558 179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -127.41 80.86 1.98 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.726 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.64 -8.08 5.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.02 179.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . 0.405 ' CB ' ' HG2' ' A' ' 5' ' ' PRO . 27.9 t-20 -89.32 -2.68 58.54 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 111.749 0.278 . . . . 0.0 111.749 -179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.464 HG12 ' O ' ' A' ' 49' ' ' CYS . 11.6 m -129.45 168.88 21.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.89 0.376 . . . . 0.0 111.552 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.831 ' NE2' HD11 ' A' ' 35' ' ' ILE . 0.2 OUTLIER -133.65 135.14 43.95 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.328 179.638 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' A' ' 52' ' ' VAL . . . -108.1 123.42 48.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.989 0.424 . . . . 0.0 111.741 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.831 HD11 ' NE2' ' A' ' 33' ' ' HIS . 3.8 mp -97.87 115.75 38.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.468 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.524 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 53.4 t -79.72 113.05 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 CA-C-O 121.324 0.583 . . . . 0.0 110.989 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.904 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.3 OUTLIER -134.55 150.16 50.71 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.249 -0.887 . . . . 0.0 109.962 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 12.8 pttm -90.02 156.77 18.17 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.081 0.467 . . . . 0.0 111.766 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 21.5 tt0 -44.73 123.88 3.98 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.458 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.1 -3.7 55.39 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.913 179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.465 ' CB ' ' HB2' ' A' ' 37' ' ' LEU . 12.0 t -67.62 -179.32 1.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.955 0.407 . . . . 0.0 110.702 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' N ' ' OG ' ' A' ' 41' ' ' SER . . . -86.02 101.68 13.14 Favored 'General case' 0 N--CA 1.452 -0.333 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.165 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -129.73 100.05 5.36 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.098 -178.605 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.7 p -59.37 147.31 36.64 Favored 'General case' 0 N--CA 1.447 -0.61 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.099 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 39.3 mmtt -79.91 -25.06 40.68 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.159 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -44.81 160.84 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.853 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.405 ' O ' ' HG2' ' A' ' 48' ' ' ARG . 68.1 t80 -104.0 131.11 51.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.987 0.423 . . . . 0.0 111.61 -179.252 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.429 HH11 ' HD3' ' A' ' 48' ' ' ARG . 5.2 mtm180 -145.22 109.36 4.84 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.308 179.474 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.474 ' HA ' HD13 ' A' ' 68' ' ' ILE . 1.3 m -60.01 -33.32 71.84 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.536 -179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 20.3 p-10 -79.51 -2.97 44.64 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 121.06 -0.256 . . . . 0.0 111.626 -179.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 47.5 ttp180 -121.11 142.76 49.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.051 0.453 . . . . 0.0 111.478 -179.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.511 HG21 HG11 ' A' ' 25' ' ' VAL . 94.2 t -138.68 114.28 9.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.819 179.196 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.904 ' CE3' HD21 ' A' ' 37' ' ' LEU . 2.3 m95 -78.69 131.55 36.67 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.706 0.288 . . . . 0.0 110.484 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.575 HG22 ' HB3' ' A' ' 66' ' ' PRO . 11.3 t -119.21 88.88 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 CA-C-O 120.834 0.35 . . . . 0.0 110.101 179.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.596 ' HA ' ' O ' ' A' ' 37' ' ' LEU . 2.8 mt -79.84 122.15 34.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.651 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 21.8 m -121.26 164.46 17.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.433 179.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.5 p30 -87.91 -174.64 4.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.843 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -58.11 -23.48 55.05 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.55 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 66.9 m170 -86.04 -20.44 28.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.697 0.284 . . . . 0.0 111.162 -179.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 100.67 22.66 10.89 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.165 -179.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.651 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 19.2 t -98.78 144.7 11.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.55 HG11 ' HD3' ' A' ' 66' ' ' PRO . 48.0 t -75.58 112.86 13.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.993 0.425 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 52.7 p -94.04 -31.45 14.22 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.978 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.558 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -103.48 154.01 19.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.208 -179.926 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.922 HG13 ' HA ' ' A' ' 11' ' ' PRO . 5.7 t -66.12 101.36 0.28 Allowed Pre-proline 0 C--O 1.222 -0.386 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.736 179.824 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.575 ' HB3' HG22 ' A' ' 54' ' ' VAL . 19.1 Cg_endo -57.75 92.17 0.06 OUTLIER 'Trans proline' 0 N--CA 1.463 -0.311 0 C-N-CA 121.618 1.545 . . . . 0.0 110.827 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.564 ' ND1' ' O ' ' A' ' 65' ' ' VAL . 16.1 p-80 -122.67 153.76 38.95 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.229 -178.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.492 HG22 ' O ' ' A' ' 68' ' ' ILE . 0.2 OUTLIER -48.53 115.03 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.792 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . . . . . . . . . 22.5 m . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.941 -179.422 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' ACE . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.106 . . . . . . . . 0.0 . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 22.6 t -63.99 124.04 20.55 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 118.9 -0.572 . . . . 0.0 112.24 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -149.19 62.82 1.04 Allowed 'General case' 0 C--N 1.357 0.926 0 CA-C-N 120.171 1.35 . . . . 0.0 110.734 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.77 90.65 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.986 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' CYS . . . . . . . . . . . . . 57.7 m -113.41 142.17 27.1 Favored Pre-proline 0 CA--C 1.518 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.961 179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -74.61 168.28 25.17 Favored 'Trans proline' 0 N--CA 1.454 -0.825 0 C-N-CA 122.141 1.894 . . . . 0.0 112.316 -179.434 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.424 ' HA3' ' ND2' ' A' ' 29' ' ' ASN . . . 63.45 170.46 1.56 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.741 -0.742 . . . . 0.0 113.061 179.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 10' ' ' TRP . 33.3 ttmt -66.73 146.83 54.03 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.502 -0.349 . . . . 0.0 110.795 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.728 ' HA ' HD12 ' A' ' 68' ' ' ILE . 10.1 m-20 -107.03 -4.2 19.23 Favored 'General case' 0 N--CA 1.468 0.449 0 N-CA-C 112.968 0.729 . . . . 0.0 112.968 -178.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.503 ' HA ' ' HA ' ' A' ' 67' ' ' HIS . . . -160.32 134.51 7.31 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.808 ' CH2' HG13 ' A' ' 25' ' ' VAL . 21.6 m-90 -119.73 68.15 11.48 Favored Pre-proline 0 C--N 1.324 -0.506 0 N-CA-C 112.057 0.392 . . . . 0.0 112.057 -179.304 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.852 ' HA ' HG13 ' A' ' 65' ' ' VAL . 54.5 Cg_exo -50.29 -37.35 49.7 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 122.283 1.989 . . . . 0.0 112.348 179.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.6 pm0 -61.92 -13.48 25.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.968 -179.797 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.695 HD22 ' HA ' ' A' ' 21' ' ' ALA . 24.8 mt -80.51 -23.42 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.67 0.272 . . . . 0.0 110.663 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.612 HG21 HG22 ' A' ' 65' ' ' VAL . 59.4 t -53.71 112.78 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.798 179.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 110.74 -12.01 29.96 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.231 -179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.726 ' O ' HG23 ' A' ' 62' ' ' VAL . 0.1 OUTLIER -94.23 157.11 16.21 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.786 0.327 . . . . 0.0 110.875 179.765 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 19.2 p -56.82 141.33 44.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.361 -0.381 . . . . 0.0 111.086 -179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -50.38 -31.59 20.98 Favored Glycine 0 CA--C 1.519 0.291 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.319 179.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -72.35 -45.54 59.41 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.812 0.339 . . . . 0.0 110.788 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' MET . . . . . 0.414 ' HB3' ' CG ' ' A' ' 16' ' ' LYS . 0.0 OUTLIER -63.14 -42.08 99.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.043 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.695 ' HA ' HD22 ' A' ' 13' ' ' LEU . . . -62.56 -56.27 19.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.811 -0.632 . . . . 0.0 110.711 179.464 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.51 64.93 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.775 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' O ' ' HB2' ' A' ' 27' ' ' ARG . . . -62.65 -45.23 93.8 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.659 179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 57.5 m -58.27 -42.1 85.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.883 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' VAL . . . . . 0.808 HG13 ' CH2' ' A' ' 10' ' ' TRP . 21.8 t -67.35 -58.05 7.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.337 179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -61.15 -24.89 66.62 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.46 0.171 . . . . 0.0 111.446 -179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.526 ' HB2' ' O ' ' A' ' 23' ' ' ALA . 17.8 ttp180 -83.9 -58.72 2.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.749 0.309 . . . . 0.0 110.833 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.0 mt-10 -61.98 -29.55 70.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.999 0.428 . . . . 0.0 110.269 179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.439 ' O ' HG22 ' A' ' 32' ' ' VAL . 50.0 t-20 -131.0 85.07 2.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.794 179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.46 -8.57 6.41 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.25 -179.838 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -87.76 -10.03 52.21 Favored 'General case' 0 CA--C 1.528 0.118 0 N-CA-C 112.016 0.376 . . . . 0.0 112.016 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.957 HG12 ' O ' ' A' ' 49' ' ' CYS . 13.7 m -115.06 175.5 2.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 121.515 0.674 . . . . 0.0 112.062 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' HIS . . . . . 0.443 ' CE1' ' CG1' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -143.48 125.36 15.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.855 -1.066 . . . . 0.0 109.549 178.816 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.38 129.63 44.6 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.12 0.485 . . . . 0.0 112.007 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.624 HD12 ' CZ3' ' A' ' 53' ' ' TRP . 27.0 mt -106.82 119.64 56.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.259 179.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.493 ' HA ' ' HB ' ' A' ' 54' ' ' VAL . 8.0 p -79.45 132.45 32.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 121.369 0.604 . . . . 0.0 111.648 -179.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.826 HD21 ' CE3' ' A' ' 53' ' ' TRP . 0.4 OUTLIER -157.03 150.94 24.69 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.347 -0.842 . . . . 0.0 110.239 -179.326 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 6.4 mtmt -89.17 153.87 20.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.165 0.507 . . . . 0.0 111.585 -179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.405 ' HA ' HG23 ' A' ' 55' ' ' ILE . 10.9 pt-20 -49.06 115.48 1.31 Allowed 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.998 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 113.31 -1.85 25.21 Favored Glycine 0 N--CA 1.448 -0.522 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.491 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.2 t -69.71 -177.22 1.2 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.839 0.352 . . . . 0.0 110.655 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.52 104.86 17.39 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' MET . . . . . 0.967 ' HE1' HD11 ' A' ' 55' ' ' ILE . 0.5 OUTLIER -124.14 106.52 10.39 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.976 -0.557 . . . . 0.0 111.305 -178.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 2.9 p -56.47 147.76 21.0 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.079 179.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.4 mmpp? -84.54 -26.13 28.26 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.954 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -45.93 138.24 5.13 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.955 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -84.81 130.34 34.69 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.077 -179.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.422 ' HB3' ' OD1' ' A' ' 50' ' ' ASP . 3.9 mtp85 -144.71 112.25 6.15 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.02 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' CYS . . . . . 0.957 ' O ' HG12 ' A' ' 32' ' ' VAL . 90.9 m -63.95 -13.67 47.79 Favored 'General case' 0 C--O 1.223 -0.334 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.752 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.422 ' OD1' ' HB3' ' A' ' 48' ' ' ARG . 18.8 p-10 -97.88 -4.7 36.07 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.847 -0.341 . . . . 0.0 111.646 -179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -122.35 143.31 49.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.048 0.451 . . . . 0.0 111.35 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.51 HG21 HG11 ' A' ' 25' ' ' VAL . 59.6 t -139.36 118.47 12.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.645 178.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TRP . . . . . 0.826 ' CE3' HD21 ' A' ' 37' ' ' LEU . 4.9 m95 -78.42 135.2 37.36 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-O 120.782 0.325 . . . . 0.0 110.253 -179.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.493 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 43.1 t -120.13 89.05 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.053 -179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.967 HD11 ' HE1' ' A' ' 43' ' ' MET . 6.0 mt -81.98 126.93 39.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.016 -179.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.643 ' HA ' ' O ' ' A' ' 61' ' ' VAL . 33.8 m -123.47 165.27 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.798 -179.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 56.8 p30 -88.13 -172.72 3.93 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.964 179.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -58.62 -21.98 55.14 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.922 -179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' HIS . . . . . . . . . . . . . 1.9 m170 -95.48 -8.85 34.14 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 94.78 21.97 24.72 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.537 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.643 ' O ' ' HA ' ' A' ' 56' ' ' VAL . 26.7 t -96.38 140.66 16.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 179.533 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.726 HG23 ' O ' ' A' ' 16' ' ' LYS . 40.4 t -72.65 112.23 8.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.926 0.393 . . . . 0.0 110.804 -179.693 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' THR . . . . . . . . . . . . . 35.1 p -94.45 -32.41 13.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.567 -179.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.563 ' O ' ' HD3' ' A' ' 66' ' ' PRO . 9.0 t -100.82 146.41 27.33 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.93 0.395 . . . . 0.0 111.35 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.852 HG13 ' HA ' ' A' ' 11' ' ' PRO . 18.7 t -62.73 101.44 0.26 Allowed Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.63 . . . . 0.0 111.509 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.563 ' HD3' ' O ' ' A' ' 64' ' ' SER . 18.1 Cg_endo -57.91 99.86 0.1 OUTLIER 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.034 1.823 . . . . 0.0 111.647 179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' HIS . . . . . 0.503 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 0.6 OUTLIER -127.98 152.83 47.43 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.115 -179.55 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' A' ' 8' ' ' ASN . 0.3 OUTLIER -49.72 116.96 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.672 -0.694 . . . . 0.0 110.453 179.177 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' THR . . . . . 0.402 ' OXT' HG22 ' A' ' 69' ' ' THR . 5.7 m . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.193 -0.908 . . . . 0.0 110.979 -179.353 . . . . . . . . 1 1 . 1 stop_ save_